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Abstract 
Aims: Coronary Revascularization (CR) has increased patients’ survival rate globally. However, 
the lack of a consensus definition of Health Related Quality of Life (HRQoL) and the different 
methodological and conceptual approaches adopted by researchers in the cardio-revascularization 
field create an incomplete picture of the influence of CR on individuals’ HRQoL. By using mixed 
methodology, the current research aimed to explore Greek CHD patients’ perspectives of their 
HRQoL after CR (Coronary Artery Bypass Grafting (CABG) or Percutaneous Coronary 
Interventions (PCI)), as well as detect and explain individual disparities.  
 
Method: Two studies were conducted with a total sample of 487 individuals: (1) The translation 
and validation of the Coronary Revascularization Outcome Questionnaire (CROQ) into Greek and 
(2) The longitudinal mixed methods study, the main study of the thesis, following a sequential 
explanatory design with two research components: a) the longitudinal quantitative component 
aimed to detect changes in patients’ HRQoL (both overall and its subdomains) following CR over 
a 12-month period based on individuals’ subjective evaluation as captured by the CROQ, detect 
the influence of CR type on the outcome and to explore potential predictors (individuals’ 
demographic, clinical and behavioural features). Data were analysed using multilevel modelling; 
b) the qualitative component aimed to capture individuals’ lived experience, their view and 
understanding of themselves and their life approximately 12 months after treatment using 
Interpretive Phenomenological Analysis (IPA). 
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Results/findings: Based on participants’ subjective evaluations as captured by the validated 
Greek version of the CROQ, one year after CR Greek Coronary Heart Disease (CHD) patients 
experience an increase in their HRQoL level compared to prior to CR. The pattern of change though 
is not constant; initially HRQoL increases with time, and then decreases again, however, remaining 
much greater compared to prior to CR one year after CR. Regarding the influence of the CR type of 
treatment on patients’ HRQoL level, a year after CR mixed findings are revealed. In the symptoms 
and physical functioning subdomain, patients treated with CABG demonstrate a greater increase 
compared to patients treated with PCI. In the psychosocial functioning subdomain no difference is 
found. In the cognitive functioning subdomain, patients treated with CABG demonstrate a decline 
compared to their cognitive functioning prior to the CR. Various demographic, clinical and 
behavioural features are demonstrated to be predictors of the outcome though not consistent for all 
subdomains. The main predictors associated with larger positive changes following CR seem to be 
sex, BMI and smoking; females with low BMI that do not smoke tend to demonstrate a greater 
increase in HRQoL after CR.   
According to individuals’ lived experience, participants,  reflecting on their experience one year 
after treatment, perceive CR as a simple process and their negative experience is mostly related to 
medical care. Many participants with no symptoms or adverse effects tend to misperceive CHD, 
viewing their health condition as an acute disease treated with CR. Trying to understand disease 
causality they tend to adopt medical discourse especially in relation to stress as a factor that can be 
controlled by themselves and reflect on their own responsibility as a causal factor. Feeling grateful 
for being alive, sensing a different body, a “revitalized body” as many participants suggest, as well 
as a fear of re-occurrence or disease progression motivate individuals to work on aspects of the self 
related to the CHD development in an effort to regain control over their life which has been reduced 
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after the CHD diagnosis. In effect a dramatic change in how the self and life are viewed is reported, 
highlighting a positive growth; a greater appreciation of life, a personal growth and effort to build 
more meaningful relationships. Challenges that participants face in modification of their lifestyle 
are attributed to both external and internal factors. Concerning smoking participants’ accounts point 
to a lack of knowledge regarding the relationship between smoking and CHD, a lack of support (by 
experts or family members) and conscious denial as a way to cope with every day anxiety and 
stress, but also a pleasure in everyday life.  
The findings provide a complementary insight into perceptions of individuals with CHD about 
their quality of life one year after CR, suggesting that other factors beyond CR may influence their 
perspectives.   
 
Conclusions/implications: This study highlights the benefits of using a mixed methods 
longitudinal design in exploring HRQoL. Both the quantitative and qualitative findings support the 
notion that HRQoL is a multidimensional, continuously changing concept, providing support for 
the Wold Health Organization’s definition. Also, the findings suggest that CR has a positive 
influence on individuals’ HRQoL. The effect of the CR type needs further investigation as mixed 
findings are observed in the present thesis. Moreover, it seems difficult to investigate the pure 
effect of CR on individuals’ HRQoL without taking into consideration individuals’ adjustment 
processes and positive growth triggered by the CR.  
The self regulation model (SRM) might be considered a useful theoretical framework for 
developing theory-based interventions aiming to alter patients’ false beliefs since individuals’ 
making-meaning process seems to be aligned with it. Finally, the complementary insights 
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concerning smoking may help health care providers to develop smoking cessation interventions 
tailored to cardiac patients.   
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Chapter One 
1. Introduction to Coronary Heart Disease and its clinical treatment 
1.1. Introduction  
This thesis focuses on patients with coronary heart disease (CHD) and the impact of 
Coronary Revascularization (CR) on their Health Related Quality of Life (HRQoL) over a one-
year period, by using a mixed methods approach. The scope of this chapter is to introduce 
essential concepts related to CHD as well as to present a rationale for conducting this study in 
Greece. Issues presented address the following questions: 1) What is the nature and the burden 
of CHD? 2) What are the symptoms and how can a diagnosis be made? 3) Which are the risk 
factors for CHD development? 4) What are the most common ways of treatment as well as what 
may be the pros and cons of each type of treatment regarding clinical outcomes? 5) What does 
research evidence indicate about the incidence of CHD and its treatment in Greece and why is it 
important to investigate the HRQoL of individuals who have undergone CR in the Greek 
context?  
 
 
1.2. Coronary Heart Disease  
Coronary heart disease or coronary artery disease is a non-communicable chronic disease 
caused by the atherosclerosis of the coronary arteries. Atherosclerosis refers to the hardening 
and narrowing of the blood vessels (coronary arteries) due to fat deposits known as plaques in 
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the walls of the arteries. Atherosclerosis reduces the normal flow of blood towards the heart 
and, as a result, the oxygen and energy supply reaching the heart muscle are insufficient for its 
normal functioning (Fuster, Moreno, Fayad, Corti, & Badimon, 2005). The common medical 
term for a condition where the heart does not get enough oxygen is ischemia.  
Long lasting ischemia due to atherosclerosis may result in a myocardial infarction (MI– that 
is, heart attack) and sudden cardiac death. A heart attack causes damage to the heart muscle 
from the blood supply being completely cut off due to a spasm or blood clot in the coronary 
arteries. Heart attacks and angina can cause electrical disturbances in the heart which can result 
in abnormal heart rhythms (arrhythmias) such as ventricular fibrillation, which is a fatal 
condition. Repeated heart attacks where substantial parts of the heart muscle have died can lead 
to heart failure (HF). In turn, heart failure may provoke various conditions such as paroxysmal 
nocturnal dyspnea (PND), that is shortness of breath during sleep at night (Ju Young, Martin, & 
Bryant Howren, 2009). CHD cannot be cured, but the appropriate treatment can improve the 
functioning of the heart muscle providing a relief of symptoms (these will be discussed in the 
next section) and diminish the risk of further problems, such as MI or HF (Fuster et al., 2005).  
According to reports by the World Health Organization (The Whoqol Group, 2011a, 2011b, 
2011c) in 2008 17.3 million individuals died from cardiovascular disease representing 30% of 
total deaths in the world. Of these deaths, approximately 7.3 million were due to coronary heart 
disease, making this disease one of the leading causes of global deaths. Moreover, based on a 
recent report (Nichols, Townsend, Scarborough, & Rayner, 2013), CHD is the most common 
cause of death in Europe, representing 1.8 million deaths in the most recent year for which the 
data were available; approximately 22% of females and 20% of males. Furthermore, in 2009 the 
total health care costs for CHD in European countries was approximately 19.9 million EUROS 
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(2% of the total health care expenditure) while the non-healthcare cost of CHD was 40.3 million 
EUROS (informal care, productivity losses due to morbidity and mortality).  
Moreover, the life of people with CHD may be dramatically affected. CHD symptoms can 
cause great discomfort and/or pain resulting in a reduction of performance of daily activities and 
even absence from work. These can lead to a loss of income, which may affect health care 
(inability to buy medicines, undergo mandatory re-examination and support a healthy diet) and 
may negatively influence individuals’ lives.  
 
1.3. Symptoms and diagnosis 
1.3.1. Symptoms  
The common symptoms of CHD are angina pectoris (chest pain) and shortness of breath 
during various daily activities or low/moderate exercise (Mittal, 2005). However, the 
manifestations of CHD may be experienced differently by different individuals. For instance, 
research evidence demonstrates that females may have different or additional CHD 
manifestations compared to males. They may experience fuzzy symptoms, such as extreme 
fatigue, discomfort in the shoulder blades, shortness of breath, nausea, and a burning sensation 
in the chest or upper abdomen (Young et al., 2009; Kumar, Kaur, & Devi, 2011; O'Keefe-
McCarthy, 2008). Additionally, some studies maintain that females experience greater levels of 
chest pain resulting from angina compared to males (Ghezeljeh et al., 2010). At this point it is 
important to mention that there are cases, less common but still existing, where individuals do 
not experience any symptoms (Lindsay & Gaw, 2004).  
Angina pectoris is the medical term for chest pain, which can appear at exertion or at rest. It 
is usually described as pain in the chest or as a radiating pain in arms, shoulders, neck, back, 
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epigastrium (upper central part of the abdomen) and jaw (Lindsay & Gaw, 2004). In some cases, 
the angina is not perceived as pain, but as a sensation of discomfort, squeezing, pressure, 
strangling, bursting in the chest (Lindsay & Gaw, 2004; Sangareddi et al., 2004). The experience 
of angina pectoris is the condition that typically leads individuals to seek medical help. There are 
three main types of angina pectoris caused by coronary heart disease: a) stable angina, which is 
experienced during a state of physical exertion or emotional or mental stress, b) unstable angina, 
which is experienced at rest when chest pain is unexpected and c) variant angina pectoris which 
is more rare and mostly experienced at rest (during sleep) due to a coronary artery spasm.   
Researchers point out that the levels of angina may be influenced by the weather and food 
consumption. In fact, there are a number of studies supporting that angina is worse when there is 
cold (Ezekowitz et al., 2013) or windy weather and after heavy meals (Bhowmik, Das, & Dutta, 
2011).  
1.3.2. Diagnosis  
The diagnosis of CHD and angina is made partly on the basis of the medical history and 
assessment of risk factors for artherosclerosis and partly on the basis of a clinical test. Three 
different types of clinical assessment usually take place: an initial assessment consisting of blood 
tests and measurement of blood pressure, a functional and an anatomic assessment (Kantor, 
Nagel, Schoenhagen, Barkhausen, & Gerber, 2009). 
An initial assessment is made in order to detect the level of certain fats, cholesterol, glucose 
and low levels of proteins (e.g. C-reactive protein (CRP) and Hemoglobin, an iron-rich protein) 
in the blood. Additionally, blood pressure is measured. Abnormal levels may suggest existing 
risk factors for CHD. 
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A functional assessment is made in order to find support for the diagnosis of CHD by 
recording heart rhythm and electrical function. The most common functional assessment is an 
electrocardiogram (ECG). However, an ECG is usually obtained not at rest, but during exercise 
on a treadmill or on an exercise bicycle in order to identify an irregular heart rhythm; this 
procedure is known as stress ECG or stress test or exercise tolerance test (ETT (Aaronson & 
Ward, 2007). 
An anatomic assessment is made in order to detect narrowing in the arteries. Cardiac 
catheterization is the most accurate test, however, it is mostly employed in cases where there are  
severe CHD symptoms or where intervention treatment is being considered, because there is a 
small possibility of creating arrhythmia or a myocardial infarction (Aaronson, & Ward, 2007). 
The cardiac catheterization procedure involves a catheter being inserted into an arm or leg 
artery, which is then threaded through to the coronary arteries affected. Then an X-ray liquid is 
injected to show the blood supplies from the arteries to the heart while X-ray filming (a 
coronary angiogram) takes place in order to identify any blockages of the coronary arteries. In 
the last decade more noninvasive tests have been used for anatomic and functional imaging of 
CHD: cardiac computed tomography (CCT) and cardiac magnetic resonance (CMR). According 
to researchers (Kantor et al., 2009), these tests can demonstrate the degree of coronary artery 
blockage and the presence of ischemia while avoiding the risk of plaque rupture during the test 
which may lead to MI.  
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1.4. Risk factors 
Since both prevention and treatment of CHD involve consideration of risk factors, it is 
essential to present these briefly. Risk factors may broadly be separated into two categories: the 
conventional (behavioural and medical) and the non-conventional (psychosocial) risk factors 
related to CHD.  
1.4.1. Conventional risk factors 
Researchers have identified several environmental and biochemical factors that can account 
for pathogenesis and progression of coronary heart disease. A family history of premature 
coronary artery disease (Lloyd-Jones et al., 2004), especially if it is associated with coronary 
artery calcification (Nasir et al., 2007), smoking (Al-Nozha et al., 2009; Khot et al., 2003), high 
blood pressure (Khot et al., 2003), diabetes (Khot et al., 2003), high cholesterol levels (Khot, et 
al., 2003; Roeters van Lennep, Westerveld, Erkelens, & van der Wall, 2002), obesity (Roeters 
van Lennep, et al., 2002), physical inactivity, diet and stress are the most common factors that 
can increase the risk of CHD (Mittal, 2005; Schenck-Gustafsson, 2009). A large cross-national 
study demonstrated that eating fruit and vegetables, moderate exercising, and avoiding smoking 
could lead to an about 80% lower relative risk for a heart attack (Yusuf, et al., 2004). These 
findings are supported by the WHO (2011) report on noncommunicable diseases indicating that 
80% of coronary heart disease deaths are related to behavioural risk factors such as an unhealthy 
diet, physical inactivity and tobacco use.  
Additionally, recent research findings point out some additional risk factors as being 
associated with CHD, such as periodontal infections (Bahekar, Singh, Saha, Molnar, & Arora, 
2007; Berent et al., 2011; Spahr et al., 2006) and polycystic ovary syndrome in females 
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(Alexander, Tangchitnob, & Lepor, 2009; Christian et al., 2003). Furthermore, age is also a risk 
factor for developing CHD. Researchers maintain that atherosclerosis begins in childhood and 
develops over adolescence and adulthood and, if left untreated, can lead to CHD in middle or 
older age (McGill & McMahan, 2003; McMahan et al., 2006) Finally, there are contradictory 
findings regarding sex as a risk factor, a recent review points out that sex could be considered a 
risk factor but only in interaction with age. Based on Tan, Gast and van der Schouw (2010), 
young and early middle-aged males are at greater risk compared to females. However, the risk 
of CHD in females increases dramatically after menopause. In fact, the earlier menopause 
occurs, the greater the risk becomes (Tan et al., 2010). 
1.4.2. Non-conventional risk factors 
According to literature, traditional or conventional risk factors (e.g. smoking, hypertension, 
hypercholesterolemia, diabetes) do not completely explain the presence of CHD. A plethora of 
studies have investigated the role of psychological factors such as personality type (please see 
appendix 1.1), negative affect (hostility and anger, depression, anxiety) and social factors such 
as social support, social isolation not only as possible risk factors for the development and 
progression of CHD, but also as predictors for treatment outcome. 
Regarding the influence of anger and hostility in the development and progress of CHD, the 
literature demonstrates contradictory findings (Siegman & Smith, 2013). Based on a recent 
systematic review, the harmful effects of anger and hostility on CHD are not significant after 
fully controlling for conventional risk factors such as smoking, physical activity and obesity 
(Chida & Steptoe, 2009). This could be explained by the fact that these two traits could lead to 
the development of biochemical disturbances. For instance, hostility level has been associated 
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with the level of hypertension (Yan et al., 2003) while anger has been associated with high 
blood pressure (Steffen, McNeilly, Anderson, & Sherwood, 2003), and especially diastolic 
blood pressure (Schum, Jorgensen, Verhaeghen, Sauro, & Thibodeau, 2003), which is 
significantly associated with coronary heart disease (D'Agostino, Belanger, Kannel, & 
Cruickshank, 1991). In fact, inhibition of anger expression is strongly associated with increased 
risk of CHD, especially in males (Davidson & Mostofsky, 2010), major cardiac events 
(Denollet, Gidron, Vrints, & Conraads, 2009) and adverse effects after coronary 
revascularization (Denollet, Gidron, Vrints, & Conraads, 2010). Furthermore, the conflicting 
finding may be explained by the fact that specific types of anger expression (constructive anger, 
destructive anger justification and destructive anger rumination) may account for different 
levels of risk and many researchers do not differentiate between these (Siegman & Smith, 
2013). Constructive anger refers to anger expression motivated by constructive reasons (e.g. to 
solve a problem). This type of anger expression is considered to make individuals more 
creative. An example of constructive anger expression might be a director who is angry due to 
rumors suggesting that s/he is not a good team leader and as a result s/he is motivated to take 
actions to increase team bonding and interaction. Destructive anger justification refers to anger 
expression to justify one’s current feelings by blaming others. For instance, using the same 
example, the director expressing this type of anger will defend her/himself by minimizing own 
fault and by blaming the staff. Destructive anger rumination refers to the tendency to 
repetitively think about the situation that provoked anger. During angry rumination, anger is re-
provoked by the repeated focus on the cause and consequences of the anger trigger. Angry 
rumination results in increasing and maintaining anger levels and aggressive response (Siegman 
& Smith, 2013). Following on with the same example, the director will repetitively think about 
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the event that elicited her/his anger, developing increased levels of anger. Based on research 
findings, reduced constructive anger in males and increased destructive anger justification in 
both sexes are associated with increased risk of CHD (Davidson & Mostofsky, 2010), while 
destructive anger rumination is related to increased acute coronary events (Fernandez, et al., 
2010).  
Concerning depression, there is established research evidence that it is a compelling risk 
factor for CHD incidence (Bunker et al., 2003; Ferketich, Schwartzbaum, Frid, & Moeschberger, 
2000; Wulsin & Singal, 2003), progression (Lett et al., 2004) and treatment (Parissis et al., 
2007). While a number of reviewers maintain that studies vary in the assessment methodology, 
leading to an inability to conclude on the exact degree to which depression accounts for CHD 
development and progression (Goldston, & Baillie, 2008; Van der Kooy et al., 2007; Wulsin & 
Singal, 2003), more recently reviewers have demonstrated that the prevalence of depression in 
the cardiac population is high (Celano & Huffman, 2011). In fact, 31-41% of patients with 
coronary artery disease (CAD; including those with stable CAD, unstable angina, or myocardial 
infarction) show depressive symptoms (Celano & Huffman, 2011). Moreover, the findings of a 
recent study conducted by Mcguire, Eastwood, Hays, Macabasco-O’Connell & Doering (2014) 
who aimed to assess depression in a sample of 323 patients hospitalized with coronary heart 
disease revealed that approximately 31% experienced depressive symptoms. Compared with 
patients who were not depressed, patients who were depressed had higher scores for dysphoria, 
loss of appetite, sleep disturbance, fatigue, loss of libido, and irritability (p < .001). Interestingly 
patients with acute coronary syndrome were less likely to have depressive symptoms than those 
who had not experienced ACS (p = .02). The incidence of depression among Greek patients with 
CHD seems to be high as well. The findings of a recent Greek study with a sample of 702 heart 
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patients suggest that approximately 40% of patients experience depression (19.1% moderate and 
20% high levels of depression; Polikandrioti et al, 2012 ). Furthermore, a number of behavioural 
factors may affect the relationship between depression and heart disease. Patients with 
depressive symptoms are less likely to be engaged in health-promoting behaviours (e.g. 
following a healthy diet, regular physical activity (Whooley et al., 2008), adherence to prescribed 
medicines (Gehi et al., 2007) and completion of cardiac rehabilitation programs (Casey et al., 
2008; Gehi et al., 2007). CHD patients with depressive symptoms tend to have greater difficulty 
with lowering other conventional risk factors (e.g. cholesterol level) related to the development, 
progression and recurrence of cardiac events (Gehi et al., 2007).  
A plethora of research findings has demonstrated that anxiety is significantly associated 
with the development and progression of CHD (Sirois & Burg, 2003). Anxious individuals are at 
higher risk of experiencing cardiac episodes independently of demographic variables, biological 
risk factors and health behaviours (Olafiranye, Jean-Louis, Zizi, Nunes &  Vincent, 2011; Roest, 
Martens, De Jonge &  Denollet, 2011). Prevalence of anxiety in patients with stable CHD seems 
to range from 16% to 42% (Polykandrioti & Olympios, 2014). However, there are a number of 
researchers maintaining that anxiety is not a significant predictor of the development of CHD for 
both males and females. For example, Nabi, and his colleagues (Nabi et al., 2010) found that 
none of the measured components of anxiety (psychological and physiological symptoms) were 
associated with an increased risk of CHD in males after adjusting for socio-demographic 
characteristics, behavioral risk factors, and clinically significant symptoms of depression. On the 
other hand, in females, only somatic symptoms of anxiety were associated with an increased risk 
of CHD after adjustments (Nabi et al., 2010). The prevalence of anxiety in Greek patients with 
CHD in Polikandrioti et al.’s (2012) study seems to be quite high. In a sample of 702 cardiac 
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patients (from four public hospitals in Attica and two provincial hospitals), almost half 
experienced moderate or high levels of anxiety (26% and 32.7% respectively; Polikandrioti et al., 
2012).  
Research evidence demonstrates that anxiety is associated not only with the onset and 
progression of CHD but also with the treatment outcome both directly and indirectly. Anxiety 
directly influences physiological functioning  (e.g. activation of the sympathetic nervous system 
results in increased heart rate, elevated levels of hypercortisolemia and recurrent ischemia, which 
impede recovery; Moser, 2007; Olafiranye et al., 2011). Anxiety also indirectly affects treatment 
outcome by impairing levels of energy and cognition; CHD patients tend to demonstrate poor 
psychological functioning (e.g. intense worry about future cardiac events or disease progression, 
restriction of pleasure activities (Karimi-Moonaghi, Mojalli, & Khosravan, 2014)), self-care 
behaviour (e.g. low adherence to lifestyle change recommendations and medicines (Olafiranye et 
al., 2011)) and psychosocial functioning (e.g. low sense of emotional control (Lionis et al., 
2010), low levels of positive adjustment and interpersonal conflicts (Moser, 2007; Olafiranye et 
al., 2011), and early retirement (Glozier et al., 2013)) .  
Regarding psychosocial issues, the literature (e.g. Bunker et al., 2003; Karimi-Moonaghi et 
al., 2014). Rosengren et al., 2004; Lett et al., 2005) reveals that the experience of major life 
events and lack of social support are strongly related to the development and progression of 
CHD and recurrent adverse cardiac events. A number of studies suggest that major life events 
during the last year (e.g. death within family, divorce, unemployment; Lett et al., 2005) as well 
as financial problems, job satisfaction (Glozier et al., 2013; Panagiotakos et al., 2007), severe 
intra-family conflicts (Karimi-Moonaghi et al., 2014) increase the risk and progression of CHD 
(Colquhoun et al., 2013) in both sexes (Rosengren et al., 2004). For females only another 
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psychosocial aspect associated with the development and progress of CHD is responsibilities at 
home (Low, Thurston & Matthews, 2010). Another psychosocial factor that is associated with 
CHD is social support. A literature review conducted by different independent investigators on 
57 prospective studies (Bunker et al., 2003) proposes that there is a strong association between 
social isolation or lack of social support and CHD. Based on Heaney and Israel (2008) social 
supports refers to having a social network, i.e. individuals have people around them that 
understand their needs and are willing to help them by providing either emotional (e.g. by 
listening and empathic understanding) or instrumental support (e.g. by offering physical or 
financial assistance). Social isolation refers to a lack of social network (e.g. living alone with no 
friends or no participation in group activities). This “lack” of social interaction could lead to 
reduced access to information that can influence one’s lifestyle and health related behaviours on 
the one hand, and absence of emotional support in stressful situations, on the other (Lett et al., 
2005). At this point it is essential to mention that both lack of social support or exaggerated 
support may lead to social isolation as the individuals may either lose their trust in others or 
confidence in themselves (Karimi-Moonaghi et al., 2014).   
1.5. Treatment  
CHD prevention is a challenging issue. However, this thesis focuses only on QoL following 
treatments for established CHD. Therefore, only treatment will be discussed. Treatment for CHD 
involves attention to biopsychosocial risk factors, medicine therapy (MED) and coronary 
revascularization (CR) which includes two main types: interventional procedures (Percutaneous 
Coronary Intervention - PCI) and surgical procedures (Coronary Artery Bypass Graft Surgery- 
CABG). Both types of CR deal directly with artery blockage. Briefly, PCI, widely known as 
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balloon angioplasty or stent, is used in order to open any blocked arteries during cardiac 
catheterization; the insertion of a fine tube into a vein in the groin or sometimes in the arm, 
reaching the coronary artery and then the blocked section (Holmes & Williams, 2008). CABG, 
widely known as bypass, involves an opening in the chest bone (sternoctomy), which gives the 
cardiac surgeon adequate access to the heart in order to bypass the blockage with a new vein 
(usually from the patient’s leg or arm which is used as a graft; Peterson et al., 2002). Usually, 
CABG takes place when the coronary artery is too small, there is a complete blockage or more 
than two arteries are narrowed (NICE team guidelines, 2012). For further information about 
medical therapy and CR treatment please see Appendix 1.2 
 
1.5.1 Clinical outcomes: Comparing PCI, CABG and MED  
Regarding PCI vs CABG mortality rates, Bravata et al. (2007), based on 13 RCTs with 9,963 
patients of whom 5,019 were randomly assigned to PCI and 4,944 to CABG treatment, with a 
range of 6 months to 13 years follow-up after initial treatment, conclude that the mortality rates 
of patients treated either with PCI or CABG are less than 1%. Comparing the pros and cons of 
the two procedures is rather hard due to many changes and ongoing technical improvements.  
In general terms, the advantages of PCI over CABG are a brief hospital stay, less discomfort 
from an operation, more rapid recovery (Hong et al., 2005) and return to work (Sellier, 2007). 
The most essential long-term disadvantage of PCI (balloon or with stent) is restenosis. 
Comparing the two procedures, it is very important to consider the exact technique used (e.g. 
balloon angioplasty vs off-pump bypass or drug stenting vs MIDCAB) and the severity of 
coronary artery disease (single vs multiples vessels). There have been a number of trials 
comparing percutaneous coronary interventions vs coronary artery graft bypass surgery. 
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However, the results should be viewed with caution due to the fact that there is great 
heterogeneity of methodology among studies. Comparative meta-analyses and systematic 
reviews give various insights. For instance, some investigators suggests that the overall mortality 
and myocardial infarction rates are similar for bare metal stents and MIDCAB patients (Jaffery, 
Kowalski, Weaver, & Khanal, 2007), or PCI and CABG patients (Bravata, et al., 2007; Hlatky et 
al., 2009), but surgical approaches are associated with fewer repeated revascularizations 
(Edelman, Yan, Padang, Bannon, & Vallely, 2010). Others point out that off-pump surgery 
significantly reduces major adverse cardiac events compared to PCI and the only disadvantage is 
the longer hospital stay (Bainbridge, Cheng, Martin, & Novick, 2007). Similar findings have 
been demonstrated by Serruys and his colleagues (2009) who have compared CABG with PCI 
(with a drug eluting stent) for severe CHD (three-vessel or left main coronary artery disease). 
Based on this meta-analysis, CABG may be a more favourable procedure for severe CHD 
because of fewer major adverse cardiac events (MACE) after one year. Other meta-analysts 
claim that there is no difference between CABG and PCI patients with unprotected left main 
coronary artery stenosis in terms of MACE (Lee, Yang, Dhoot, & Liao, 2010). Nevertheless, due 
to the great heterogeneity of trials and limitations in the methodology of each study, firm 
conclusion cannot be drawn. Moreover, many issues are left uninvestigated. For example, it is 
unknown if these findings are equally applicable to males and females or if they apply long term. 
Regarding Coronary Revascularization (CR) vs medical treatment (MED), Jeremias, et al. 
(2009) carried out a meta-analysis based on 28 RCTs with 13,121 patients of whom 6,476 were 
revascularized and 6,645 treated with medicines, with a median of 3 years after initial treatment 
follow-up. These authors conclude that these two procedures successfully reduce the mortality 
rate. Actually, patients treated with CABG and PCI have greater survival rates (OR= 0.62 (95% 
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CI, 0.50-0.77) and 0.82 (95% CI, 0.68-0.99) respectively) compared to medical treatment. A 
more recent meta–analysis (Pursnani et al., 2012), however, based on 12 RCTS with 7,182 
patients comparing PCI and medical treatment did not find evidence for the superiority of PCI. 
However, the same review highlighted that PCI is related to fewer angina symptoms compared to 
medical treatment. In another study (Hueb et al., 2010) comparing CABG, PCI and MED in 
terms of morbidity rates, 10 years after treatment, the authors concluded  that MED compared to 
CABG was related to a significantly higher incidence of subsequent myocardial infarction, and a 
higher incidence of cardiac death. 
 
1.6. Assessing the outcome of coronary revascularization 
As pointed out earlier, the majority of clinicians treat their patients with the aim of increasing 
longevity, preventing future morbidity and making them feel better (Guyatt et al., 2007), by 
reducing various symptoms such as chest pain and discomfort which affect their physical 
functioning and make them distressed. Therefore, a plethora of randomised controlled trials have 
been conducted in order to evaluate the effectiveness of treatments for CHD and many are still 
ongoing as new procedures are being developed. In the literature, various trials have been 
reported which explore the impact of intervention on the full spectrum of coronary 
revascularization outcomes. A number of them focus on mortality and morbidity rates and others 
also consider patients’ health related quality of life (HRQoL), viewing illness as having a 
pervasive effect on various aspects of life (Guyatt, Feeny, & Patrick, 1993).  
In previous decades, postoperative clinical outcomes after coronary revascularisation were 
initially measured on the basis of clinical events (e.g. mortality, myocardial infarction, stroke) 
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and complications (such as arrhythmias, atrial fibrillation, infections). Having achieved the goals 
of raising patients’ survival rate (Guru, Fremes, Austin, Blackstone, & Tu, 2006; Singh et al., 
2008), especially among male patients (Kim, Redberg, Pavlic, & Eagle, 2007; Tillmanns et al., 
2005; Vaccarino, Abramson, Veledar, & Weintraub, 2002) and reducing MACE due to the 
procedures via the advances in revascularization techniques, the focus of attention has shifted 
onto the improvement of patients’ symptomatic and functional status. 
Assessment of treatment outcomes has turned to symptom alleviation and improvement of 
physical functioning (Hlatky et al., 1989), assuming that physiological improvement is strongly 
associated with functional improvement and well-being (Guyatt, et al., 2007). Actually, research 
has shown that coronary revascularisation improves patients’ functional status and successfully 
reduces chest pain (Hlatky, 2004). However, physiological/objective measures provide essential 
information to the clinician, but they do not fully capture what is of interest to patients 
themselves (Guyatt, et al., 1993). For patients, objective measures sometimes represent just 
values that may not be comprehensible or even meaningful. For example, the treadmill exercise 
test which is an attempt to reproduce patients’ daily exercise in a controlled environment, cannot 
take into account the realities of life, and thus it cannot be an adequate measure of everyday 
activities. Hence, self-reported activity may be a better predictor than treadmill exercise where 
patients’ functional capacity is concerned (Asakuma, Ohyanagi, & Iwasaki, 2000). Investigators 
that incorporate this aspect tend to conduct more patient-oriented trials. In other words, a 
growing number of trials assess subjective measures focusing on patients’ point of view 
alongside with objective measures in order to address the basic question of how patients may 
experience treatment and how they perceive treatment to influence their HRQoL. Such 
information, along with patient characteristics (e.g. demographics and existing comorbidities), 
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may help doctors to gain a deeper understanding, to draw conclusions about the benefits of 
treatment and help them in deciding what is the most appropriate treatment (Jokinen, 
Hippelainen, Turpeinen, Pitkanen, & Hartikainen, 2010). In fact, HRQoL data from CABG and 
PCI research could play a key role in identifying which patient groups (concerning e.g. age) 
benefit mostly from each revascularization procedure. This will be discussed over the next two 
chapters. 
 
1.7. CHD in Greece 
Until the late 1970s, coronary heart disease (CHD) was of low prevalence in Greece 
compared to other European countries (WHO, 1983 in Kalandidi et al., 1992; Gigkas, 
Soriropoulos, Panagiotakos & Papas, 2004). Forty years later, Greece has turned into a country 
with a high prevalence of CHD among European nations (Mennotti & Puddu, 2013). The results 
of a recent epidemiological study (ATTICA; Panagiotakos et al., 2015) demonstrated that the 
incidence of CHD has increased 9% between 2001 and 2006 (Panagiotakos, Pitsavos, 
Chrisohoou, Skoumas, & Stefanadis, 2008) and approximately another 7% between 2006 and 
2012 (Panagiotakos et al., 2015). Consequently, this increase raised the risk of mortality from 
CHD.  Based on Nichols et al.’s (2013) report, in 2009 CHD was the third most likely cause of 
mortality in Greece. Recent reports suggest that there is a decline in CHD mortality, especially 
among urban citizens, due to developments in CHD treatment, but there is still an ongoing 
increase in non-fatal CHD incidence, in both sexes (Panagiotakos et al., 2009). 
Some researchers suggest that the increased incidence of CHD in the Greek population 
reflects the lack of adherence to a Mediterranean diet (which used to be followed in the past; 
Trichopoulou, Lagiou, & Trichopoulos, 1994; Vlismas et al., 2011) as well as an aging 
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population (Panagiotakos et al., 2008). Also, researchers maintain that beyond these factors, the 
continuing increased rates of CHD may be explained by the altered modern life style which has 
increased the prevalence of various risk factors in the Greek population, both biological (e.g. 
hypertension, diabetes mellitus, hypercholesterolemia; Karalis et al., 2007; Kiritsi, Tsiou, 
Gouvelou-Deligianni & Stamou, 2008) and behavioural (e.g. physical inactivity, smoking, 
unhealthy diet; Gigkas et al., 2004; Panagiotakos et al., 2008; Sbarouni et al., 2014). Other 
researchers refer to additional psychological factors such depression (Athanasiadou, Tzotzi, 
Eumorfia, Alevizopoulos, & Kallergis, 2015) and anxiety (Polikandrioti et al., 2012). 
Another factor related to the increased incidence of CHD in the Greek population seems to 
be the financial crisis experienced since 2009 (Simou & Koutsogeorgou, 2014). A number of 
studies demonstrated that during these years the prevalence of various biopsychosocial risk 
factors increased (e.g. diabetes mellitus (Panagiotakos et al., 2013a), depression (Efthimiou, 
Argalia, Kaskaba & Makri, 2013), unemployment and work loss anxiety (Drydakis, 2015)). 
Moreover, a recent study reports that adherence to medication is lessening due to financial 
constraints which in turn increase the risk of acute coronary syndromes (Notara et al., 2015). 
All these issues might explain the worse profile of Greeks with CHD compared to their 
counterparts in Western Europe. A study by Sbarouni et al. (2014) revealed that Greek patients 
with CHD tend to be younger, have a higher body mass index (BMI) and higher prevalence of 
hyperlipidemia and smoking.   
Regarding treatment, although no national statistics are available at the current moment, the 
findings of Sbarouni and colleagues (2014) suggest that Greek CHD patients are treated with 
coronary revascularization (CR) more often compared to their counterparts in other Western 
European countries, while medication is used to an equal degree.  
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Taking into consideration: a) differences in the CHD profile and CR rates between Greeks 
and Western Europeans, b) the increasing survival rates in the Greek population (which can be 
viewed as an additional economical burden not only for Greece and its inhabitants but for all 
Europeans and c) the limited research on CR treatment in Greece regarding individuals’ 
evaluation and lived experience (issues that will be discussed at the following chapter) compared 
to other Western European countries and the US, a Greek study could be very useful. A 
longitudinal study in Greece in this area may provide further information about the profile of 
individuals who undergo CR, throw light on essential factors that influence individuals’ 
perceptions of the impact of CR on their life and help the development of tailored cost-effective 
policies and practice guidelines.  
 
1.8. Conclusion  
Coronary heart disease (CHD) is a leading cause of mortality. The most common way to treat 
coronary heart disease is through coronary revascularization (PCI or CABG). Those types of CR 
have prolonged the life expectancy of people with CHD. However, a lot of questions still remain 
to be addressed, such as why CHD is still a leading cause of mortality and how good survivors’ 
quality of life is after CR. Regarding the first question, a possible answer could be that 
revascularization may save someone’s life temporarily, but if biological factors such as diabetes 
mellitus remain unregulated, behavioural (e.g. smoking) and psychological (e.g. overwhelming 
anxiety) risk factors remain unchanged, then the problem is ongoing. The factors that led to the 
development of CHD in the first place may lead to a recurrence. So it is important to investigate 
if survivors make appropriate changes in their everyday life and, if not, explore the reasons why.   
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Concerning the question about patients’ well-being and quality of life, a systematic literature 
review (Chapter 3) has been conducted to address this, focusing on global literature since very 
few studies have been published in this area with Greek patients. However, before presenting this 
review, it is essential to comprehend the notions of QoL, HRQoL as well as to highlight related 
issues such as major factors that influence HRQoL and concerns when measuring HRQoL, as 
will be discussed in the following chapter (Chapter 2).    
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Chapter two 
2. Introduction to HRQoL and its measurement 
2.1. Introduction  
The previous chapter introduced essential concepts related to coronary heart disease (CHD) 
and its treatment as well as presented reasons for conducting such a study in Greece. As 
discussed, the main evaluation of treatment outcomes is based on biomedical aspects. However 
there is a growing body of researchers who espouse the notion that health is not solely a 
biomedical issue but rather a biopsychosocial one which is linked with the concept of the health 
related quality of life (HRQoL) as defined by the World Health Organization (WHO, 1948). 
Therefore, the scope of this chapter is to introduce the biopsychosocial model of health and 
disease, the conceptual framework of HRQoL and to discuss the importance of its adequate 
evaluation in health care. Various theoretical issues and methodological approaches that should 
be taken into consideration when aiming to investigate patients’ subjective perspectives will be 
discussed. The challenge of selecting the most appropriate instrument for measuring HRQoL 
after coronary revascularization (CR) and the main instruments used in this research arena will 
be presented. Finally, the approach to HRQoL adopted in this thesis as well as the thesis 
rationale will be outlined in the final section of the chapter.  
 
 
22 
 
2.2. Defining the Biopsychosocial (BPS) model of health and disease  
For many decades the biomedical model guided the notions of health and disease and clinical 
practice (Engel, 1980). However, this approach was challenged by many established 
professionals such as Lazare (1973), suggesting that the biomedical model focused on: 
“…etiology, pathogenesis, signs and symptoms, differential diagnosis, treatment and prognosis. 
Knowing the syndrome or disease determines the treatment”(p. 346) leaving aside many other 
influential aspects such as psychological and social issues that influence physical state and 
functioning.   
Engel (1977), in response to the shortcomings of the biomedical model, acknowledging both 
the huge advantages of the biomedical approach but also the necessity of an extensive model, 
developed the well-known Biopsychosocial (BPS) model (Engel, 1980). Based on this model the 
patient should be viewed as a person with an individual lifestyle and not simply as a patient with 
a disease who has deviated from “normal” physical functioning. As Engel (1980) argued, 
ignoring other important and interconnected aspects of a disease such as psychological, social 
and cultural aspects and disregarding the individual’s experience and focusing solely on 
biological factors provides a poor understanding of disease and clinical practice; a holistic 
conceptualization of disease should take into account the individual and the environment too 
(Butler, Evans, Greaves, & Simpson, 2004; Engel, 1980). 
In short, the BPS model examines three aspects of a disease; the “bio”, the “psycho” and the 
“social”. The “bio” component refers to aspects of biology that influence health such as genetics, 
functioning of body organs (e.g. heart, liver, the kidneys), and body biochemistry. The “psycho” 
component refers to psychological components such as thoughts, emotions, or behaviours. The 
“social” component refers to social factors such as interactions with others, culture and economic 
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status. At this point it is essential to highlight that these components are interconnected. Biology 
can affect psychology, which can affect social well-being, which can further affect biology, and 
so on. For example, a heavy smoker after prolonged work stress may experience angina which 
may raise feelings of fears of sudden death which may produce overwhelming anxiety and 
depression which may prevent the person from making life style changes, e.g. to quit smoking or 
go out (leaving the safety of the house) making him/her unable to fulfill his/her social role which 
might trigger problems with existing friends which, in turn, may influence the progression of 
his/her disease. The power of the BPS model is its holistic view, examining a symptom or 
disease from different perspectives and trying to find out how the interaction of different factors 
leads to specific issues for an individual. 
Thus, the utilization of the model in healthcare settings allows clinicians to explore various 
aspects of a disease before making a diagnosis and being able to make tailored recommendations 
about how an individual may adjust his/her lifestyle in order to have a better quality of life 
(Havelka, Despot, & Lučanin, 2009). For instance, in relation to the previous example, the 
individual’s doctors may incorporate medical therapy to deal with the angina, psychological 
therapy (e.g. cognitive behavioural therapy (CBT; Lichtman et al., 2008) to help individuals to 
cope with anxiety and depression and may suggest smoking cessation group therapy in order to 
both quit smoking and increase their social network. 
There is a growing body of evidence demonstrating that the use of model has helped in the 
art of good communication and understanding of an individual’s disease (Frankel & McDaniel, 
2003; Weiner, 2008) which in turn has led to advances in the treatment of disease. As has been 
demonstrated in the previous chapter, research in coronary heart disease (CHD) has found not 
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only biomedical but also psychological and social components to its development and 
progression.   
The World Health Organization (WHOQOL group, 1993) seems to agree with Engel's 
perspective in that it defines an individual’s well-being as an overall state of health and well-
being in biological, psychological and social aspects. 
 
2.3. Defining QoL and HRQoL 
The term Quality of Life (QoL) can be perceived as a multi-dimensional though elusive 
concept. Many different definitions can be found in the published literature (Barcaccia et al., 
2013; Moons, Budts, & De Geest, 2006), so that, as Gasper (2010) suggests, QoL can be 
understood as an “umbrella term” covering various definitions. QoL may portray the notion of a 
“good life”, but its “ingredients” vary dramatically among scholars (Moons, Budts, & De Geest, 
2006). Overall, Feinstein (1987) states that QoL is a multidimensional concept, which involves 
functioning, health status, perceptions, life conditions, behaviour, happiness, lifestyle, and 
symptoms.   
Over the last decades, it was believed that the QoL definition was related to both objective 
and subjective aspects. For instance, Felce and Perry (1995) suggested that QoL should be 
defined as the overall well-being that encompasses objective descriptors as well as subjective 
evaluations of physical, material, social, and emotional well-being along with the extent of 
individual development and purposeful activity, assessed by a personal set of values. Similarly, 
Haas (1999) concurs that the definition of QoL should include both objective indicators as well 
as a subjective evaluation, arguing that if only the subjective point of view is assessed then well-
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being rather than QoL is captured. Gradually, the objective aspect tended to be left aside, leading 
to a more concrete view that QoL refers to subjective perceptions of well-being although the 
factors that are assumed to influence subjective perceptions may vary. The World Health 
Organisation (Kuyken & Orley, 1995; WHOQOL Group, 1993) proposes a broad definition 
according to which QoL refers to: 
“individuals’ perception of their position in life in the context of the 
culture and value system in which they live and in relation to their goals, 
expectations and standards and concerns. It is a broad ranging concept 
affected in a complex way by the person’s physical health, psychological 
state, level of independence, social relationships, and their relationship 
to salient features of their environment” (p. 1403). 
 
Similarly, Costanza et al. (2007) claim that QoL should be defined with reference to the 
extent that individual needs (e.g. security, affection, understanding, participation, spirituality, 
identity, freedom) are fulfilled in relation to perceived subjective well-being, which in turn is 
evaluated based on one’s sense of happiness, life satisfaction, utility, or welfare. The relation 
between specific individual needs and perceived satisfaction is affected partially by elements like 
mental capacity, cultural context, information, educational level and temperament and partially 
by the weights that individuals or cultures may give to reaching each of the individual’s needs 
compared to the others. Malkina-Pykh and Pykh (2008) suggest that QoL should be perceived as 
individual appraisal of well-being, that is the positive or negative subjective perception of one’s 
life consisting of three basic aspects: the built environment (e.g. house, facilities), the social 
environment (e.g. friends, family, entertainment, health and education) and the economic 
environment (employment, money). They place particular emphasis on the notion that QoL is a 
subjective concept strongly dependent on cultural perspectives and values.  
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Since there is no consensus definition of QoL, factors that may influence it vary in 
accordance to the model adopted. According to the WHOQOL Group (1996) factors that 
influence QoL can be clustered under four pillars: physical health (e.g. activities of daily living, 
dependence on medicinal substances and medical aids, energy and fatigue, mobility, pain and 
discomfort, sleep, work capacity), psychological state (e.g. body image and appearance, negative 
feelings (such as anxiety, depression, anger, self-esteem, spirituality, thinking, learning, memory 
and concentration) social relationships (e.g. personal relationships, social support, social 
isolation, sexual activity), and environment (e.g. financial resources, freedom/independence, 
physical safety and security, health and social care including both accessibility and quality, home 
environment, opportunities for acquiring new information and skills, participation in leisure 
activities, physical environment such as pollution noise, traffic, climate), transport. Individual 
indicators (e.g. age; Hansen, Slagsvold, & Moum, 2008), however, can also influence perception 
of QoL as the four pillars are strongly influenced by an individual’ value system which varies 
across cultures, context and stage of life. For example, various studies have revealed that old 
people are more satisfied with their finances than young people with similar income levels 
(George, 1992; Hansen et al., 2008).   
The terms Quality of Life (QoL) and Health Related Quality of Life (HRQoL) are often used 
interchangeably in the literature. However, there is a major difference between these two 
concepts (Crosby, Kolotkin, & Williams, 2003; Revicki et al., 2000). HRQoL refers to the effect 
of a medical condition and/or its treatment on patients’ subjective perspective of QoL (Schipper, 
Clinch, & Olweny, 1990). In other words, HRQoL is a narrowed concept of QoL. Consequently, 
there is no consensus about the definition of HRQoL too. The most widely accepted definition of 
HRQoL is based on the World Health Organization’s (WHO, 1948) definition of health 
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suggesting that health is not only a biomedical issue, but rather as “a state of complete physical, 
mental and social well-being” (WHOQOL group, 1993). Moreover, many scholars agree upon 
the subjective nature of HRQoL maintaining that its evaluation should be based on patients’ 
reflection on the impact of disease and treatment across the physical (e.g. daily activities 
[ranging from activities of daily living (ADL) such as bathing and grooming to more demanding 
instrumental activities of daily living (IADL) such as cleaning, laundry], exercise [physical 
activity], energy and fatigue, mobility), psychological (e.g. anxiety, depression, frustration) and 
social aspects (e.g. support of family and friends, social isolation, employment, sexual activity) 
of their life, as well as their overall well-being (Bowling, 2001; Duits, Boeke, Taams, Passchier, 
& Erdman, 1997; Hawthorne, Richardson, & Osborne, 1999; Szygula-Jurkiewicz, Zembala, 
Wilczek, Wojnicz, & Polonski, 2005). Furthermore, many researchers in the field aiming to 
evaluate people’s HRQoL include additional components such as disease-related somatic 
domains (Revicki et al., 2000), cognitive functioning (Ford et al., 2008), and sexual satisfaction 
(Lukkarinen & Lukkarinen, 2007; Przewlocki et al., 2000).  
In the field of coronary heart disease, research evidence demonstrates various factors that 
influence patients HRQoL. A critical review (Pragodpol, & Ryan, 2013) on factors that can 
predict HRQoL in newly diagnosed individuals with CHD carried out on studies published 
between 1997 and 2009 suggested that these factors can be divided into three main categories; 
sociodemographic (education level, marital status and sex), clinical (angina and physical 
functioning) and psychological (anxiety, depression, social support). More recent research 
evidence provides further support for the factors associated with poor HRQoL indicating factors 
such as depression (Hsu, Tsao, Chen, & Chou, 2014; León-Pérez, Wallston, Goggins, 
Poppendeck, & Kripalani, 2015; Middel et al., 2014), anxiety (Hsu, Tsao, Chen, & Chou, 2014; 
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Middel et al., 2014), lack of social support (León-Pérez, Wallston, Goggins, Poppendeck, & 
Kripalani, 2015), low income (Wang et al., 2015) restriction of daily activities (Sin, Yaffe, & 
Whooley, 2015) including sexual activity (Steinke, 2015), fatigue (Eckhardt, DeVon, Piano, 
Ryan, & Zerwic, 2014) chest or bodily pain (Chiou, Hsu, & Hung, 2016), and diabetes 
(Uchmanowicz, Loboz-Grudzien, Jankowska-Polanska, & Sokalski, 2013; Wang et al., 2015) 
that interfere with physical, psychological and social aspects of HRQoL (Sin, Yaffe, & Whooley, 
2015; Uchmanowicz, Loboz-Grudzien, Jankowska-Polanska, & Sokalski, 2013).  
2.4. Benefits of evaluating HRQoL 
HRQoL evaluation can have several benefits for patients, physicians and associated health 
professionals both in routine practice and clinical trials. 
For patients, assessing HRQoL can be beneficial because they have the opportunity to 
express themselves and identify those aspects of their health condition that are critical for them. 
At the same time, HRQoL assessment may facilitate doctor-patient communication, allowing 
doctors to become aware of the problems that affect their patients (Varni, Burwinkle, & Lane, 
2005; Walters, 2009). Moreover, for medical doctors, the evaluation of patients HRQoL can 
provide additional input to clinical information. As they focus not only on prolonging patient life 
and reducing morbidity, but also on improving their patients’ well-being (Guyatt et al., 2007), 
information about patients’ HRQoL at each crucial time point (e.g. prior to intervention and after 
intervention) can help them form a complete picture of patients’ subjective experience and 
therefore apply the best therapeutic regimen in daily practice (Walters, 2009). The assessment of 
patients’ HRQoL on average as provided by clinical trials can also facilitate clinicians in many 
ways: drawing conclusions about the pros and cons of a specific treatment; being aware about 
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the efficiency of different aspects of therapeutic management; recognizing any negative effects 
of treatment; and, thus, being more confident in making decisions on the most appropriate 
medical treatment for their patients (Efficace et al., 2007; Parameswaran et al., 2008; Rumsfeld 
et al., 2003; Singh & Dixit, 2010). Furthermore, the assessment of HRQoL can reveal 
individuals’ level of functioning after treatment, allowing other health professionals (e.g. 
psychologists) to facilitate patients’ transition, provide additional care (if needed) and tailor 
interventions (Kugler et al., 2010; Singh & Dixit, 2010) during rehabilitation. Moreover, the 
longitudinal assessment of HRQoL can provide both clinicians and the wider scientific 
community with knowledge about the long-lasting effects of treatment or disease status and 
associated symptoms such as pain, discomfort and fatigue and capture shifts in patients’ 
subjective perceptions concerning the impact of disease on their QoL (Singh & Dixit, 2010; 
Varni, et al., 2005). However, what is essential to mention at this point is that there is no 
consensus on whether all domains incorporated in a definition should be considered when 
drawing inferences about the effect of a treatment on patients’ HRQoL. For instance, if there is 
improvement in physical functioning, can improvement in overall HRQoL be claimed? Based on 
Coons, Rao, Keininger and Hays (2000), claiming improvement in HRQoL implies that all core 
domains should be improved. Thus, the authors suggest that whatever definition is adopted, 
conclusions about the effect of the treatment on QoL should be established on the basis of an 
overall picture. 
In summary, the evaluation of HRQoL is an essential aspect of health care assessment and 
health intervention programmes. Due to the fact that it reflects patients’ subjective experiences of 
their daily functioning and well-being concerning their disease, HRQoL data enhances 
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understanding, facilitates communication, guides therapeutic management and aids transition as 
well as increases the ability to establish the effectiveness of rehabilitation. 
2.5. Considerations in exploring HRQoL 
As the concept of HRQoL lacks a consensus definition, HRQoL evaluation has been 
conducted by using various approaches. The literature indicates that the more widely used 
methods are quantitative, with an increasing advocacy for mixed methods. Still, in the field of 
HRQoL research, especially when measuring changes in HRQoL level as a result of a treatment, 
various considerations and debates exist regarding a) the influence of adjustment and post-
traumatic growth, b) the most appropriate methodological approach (qualitative vs quantitative), 
and c) type of patient-based instrument (generic vs specific) that should be used if the 
quantitative approach is selected. These issues are discussed below. 
2.5.1. Adjustment and Post-Traumatic Growth 
As HRQoL is a dynamic concept and may change over time, longitudinal assessment should 
be made. However, when the aim is to detect the influence of a treatment on changes in HRQoL 
level, the pure effect is hard to measure due to individual adjustment to the disease as well as 
potential emotional growth (Tedeschi & Calhoun, 1996). In fact, as the literature highlights, 
human beings tend to adjust to their life conditions due to changes in their internal standards, 
expectations, needs, reprioritization of values, and/or general re-conceptualizations of their 
HRQoL (Beeken, Eiser, & Dalley, 2011; Sprangers & Schwartz, 1999). Research evidence 
provides support for various adjustment theories (e.g. Response Shift (Sprangers & Schwartz, 
1999) and Cognitive Adaptation Theory (Taylor, 1983)) in people with chronic disease 
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(Pierobon, Giardini, Callegari, & Majani, 2011) such as spinal cord injuries (e.g. Dibb, Ellis-Hill, 
Donovan-Hall, Burridge, & Rushton, 2014), cancer (e.g. Christianson, Weis, & Fouad, 2013), 
arthritis (Arends, Bode, Taal, & Van de Laar, 2013), CHD (Helgeson, 2003) or other chronic 
health conditions such as HIV (Dibb & Kamalesh, 2012).  
According to the theoretical model known as Response Shift (RS) of Sprangers and Schwartz 
(1999) on QoL, the “meaning” of an individual’s self-assessment can alter with time as a result 
of three things: a) an alternation in the individual’s internal standards (known as recalibration, 
i.e. changes in how the individual evaluates what is good or bad), b) a change in the components 
that comprise QoL (known as reprioritization, i.e. changes on what the individual assesses as 
important), and c) redefinition of QoL (known as reconceptualization, i.e. changes in what the 
individual evaluates as meaningful; Schwartz et al., 2007; Sprangers & Schwartz, 1999; 
Schwartz & Sprangers, 1999; Visser et al., 2013). Ring, Höfer, Heuston, Harris and O'Boyle 
(2005) suggest that these cognitive changes, i.e., response shift, in internal standards of 
measurement, values, and definition may be due to various adopted strategies such as coping 
strategies and observations of others who are in a better and worse conditions than themselves, 
but may also be due to external factors such as a treatment effect. Thus, the response shift can be 
present in any pre-post or longitudinal study challenging the interpretation of changes in QoL 
over time (Visser et al., 2013). Therefore, a consideration of the RS would be helpful. In the 
literature, various ways for evaluating response shift have been suggested (Visser et al., 2013). 
The most widely documented technique is “The Then Test” (Visser et al., 2013). This approach 
consists of asking individuals to provide a re-evaluation on their pre-treatment level of 
functioning. As Schwartz and Sprangers (1999) note:  
32 
 
The conventional posttest and Then Test measures are presumed to be completed 
with the same internal standard of measurement since they are collected at the same 
time. Consequently, comparison of posttest and Then Test scores would eliminate 
treatment-induced response-shift effects ... The Then Test can be implemented on 
entire measures or on selected items (p. 1539). 
 
The Then Test has been used by many researchers in order to detect RS effects showing 
contradictory results; some researchers concluded that the treatment effect was underestimated, 
some others that it was overestimated while others did not detect any RS effect in level of change 
of HRQoL (Hamidou, Dabakuyo, & Bonnetain, 2011). This diversity in findings might be 
explained by the fact that this approach has been criticized for recall biases, i.e. that memory can 
affect the then-test evaluation (Ahmed, Mayo, Wood-Dauphinee, Hanley, & Cohen, 2004). In the 
field of heart disease, response shift in HRQoL assessment is very limited. Nagl, & Farin, 
(2012), using the Then Test, found a recalibration effect (changes in the individual’s internal 
standards) which may have led, they suggest, to an underestimation of the actual effects of the 
treatment on change. However, when they used structural equation modelling (SEM) to evaluate 
the RS effect on change in QoL they did not detect any essential influence. Thus, RS detection is 
an ongoing challenge. As a number of researchers suggest, the evaluation of response shift is an 
important element and has to be considered in order to identify “true” change. However, further 
research should be conducted in order to identify the most accurate way to capture RS impact 
when measuring change in QoL (Hamidou, Dabakuyo, & Bonnetain, 2011). 
According to the Cognitive Adaptation Theory (CAT; Taylor, 1983), after experiencing a 
negative event individuals experience a decline in self-esteem as well as a loss of control. 
Therefore, as this theory suggests, the adjustment process is related to three major issues: (1) 
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search for meaning in the experience, (2) effort to regain mastery (i.e. control) over the situation 
and life overall and (3) effort to restore self-esteem through self-enhancement. In other words, 
individuals develop a need to make sense of the condition (e.g. why has this happened to me?), 
make efforts to regain control (e.g. what can I do to prevent recurrence?) and enhance the self 
(i.e. compare themselves with others of the same condition) in order to restore self-esteem. The 
limited research in the field of CHD provides support for CAT (Helgeson, 2003; Helgeson, 1999, 
Helgeson, & Fritz, 1999). In fact, based on Helgeson (2003) CAT factors can predict positive 
adjustment and individuals with positive adjustment are less likely to experience recurrent 
cardiac events.    
Furthermore, the Post Traumatic Growth model (PTG; Tedeschi & Calhoun, 1996) suggests 
that individuals experience positive changes and emotional growth as a response to challenging 
traumatic events or life crises. PTG is an ongoing process influenced by life span wisdom 
(Tedeschi & Calhoun, 1996). It is not the traumatic event itself, but rather the experience that 
motivates individuals to “re-build” their lives (Tedeschi & Calhoun, 2004). PTG’s most evident 
manifestations are related to increased life appreciation, increased sense of personal strength, 
changing priorities, more meaningful interpersonal relationships, and a richer spiritual life 
(Tedeschi & Calhoun, 2004). Research evidence indicates that PTG is related to better HRQoL 
in various diseases (Kahana, Feeny, Youngstrom, & Drotar, 2006) such as cancer (Arpawong, 
Richeimer, Weinstein, Elghamrawy, & Milam, 2013; Tomich & Helgeson, 2012), HIV (Sawyer, 
Ayers, & Field, 2010) and rheumatoid arthritis (Minkin, 2014). Regarding perceived benefits and 
PTG in the heart disease field, the limited research, mostly carried out on patients after a heart 
attack (Affleck, Tennen, Croog, & Levine, 1987; Garnefski, Kraaij, Schroevers, & Somsen, 
2008; Hassani, Afrasiabifar, Khoshknab, & Yaqhmaei, 2009; Petrie, Buick, Weinman, & Booth, 
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1999; Bluvstein, Moravchick, Sheps, Schreiber, & Bloch, 2013; Leung et al., 2010; Sheikh, 
2004), reveals that individuals experience positive changes after the challenging event. However, 
findings are inconsistent regarding the relationship between PTG and HRQoL. For instance, 
Leung et al. (2010) found that predictors of PTG were younger age, non-smoking status, high 
physical dysfunction and greater psychological functioning. Ai, Hall, Pargament, and Tice’s 
(2013) findings demonstrated that CABG survivors showing an increased spirituality (one aspect 
of PTG) had better HRQoL. On the other hand, interestingly, Bluvstein and colleagues (2013) 
found that the psychological aspects of HRQoL (the mental compotent summary of the Short 
Form-12; Ware, Keller, Gandek, Brazier, & Sullivan, 1995) is negatively correlated with PTG. 
Another recent qualitative study (Waight, Strodl, Sheridan, & Tesar, 2015) exploring 
posttraumatic growth in post-surgical coronary artery bypass graft patients (CABG) revealed that 
patients experienced two types of cognitive growth following CABG; ‘greater appreciation of 
life’ (living in the moment instead of focusing on what the future may bring) and ‘new 
possibilities’ as they view surgery as the event that helped them to improve their physical 
functioning as well as provided the motivation to adopt healthy behaviours to control the risk of 
recurrence.  
Moreover, the Self-Regulation Model of illness (SRM; Leventhal, 1992) provides a 
framework for understanding how individual symptoms and emotions experienced during a 
health threat or diagnosis can influence illness perception (illness beliefs) and guide subsequent 
coping behaviour. This model suggests that individuals go through three major stages: 1) 
Interpretation (i.e. identify illness (diagnosis), causality, consequences, time line, cure /control), 
2) Coping (i.e. dealing with the problem in order to regain a state of equilibrium either by 
approaching, e.g. taking pills, or by avoiding e.g. not taking the pill, minimize the severity of the 
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disease and so on) and 3) Evaluation of coping (i.e. self evaluation regarding the effectiveness of 
coping adopted). Specifically, the model suggests that when a threatening event is present 
individuals’ “status quo” becomes unbalanced and, therefore, they are internally motivated to 
undergo a problem-focused process in order to regain a sense of balance. Interpretation is very 
important because, based on this, individuals develop approach or avoidance coping strategies 
aiming to regain control over their lives and a sense of equilibrium. Individuals are involved with 
a continuous evaluation of their coping strategies in order to maintain it or adopt a different 
strategy (Cameron, & Leventhal, 2003; Leventhal, Leventhal, & Contrada, 1998). The literature 
in the field of CR and HRQoL demonstrates that patients’ illness perceptions are significantly 
correlated with the level of HRQoL experienced; negative illness beliefs predict a decline in 
HRQoL (Foxwell, Morley, & Frizelle, 2013). Moreover, research evidence (Lin, Wang, Tung, & 
Furze, 2012) shows that there are many cardiac patients who hold misconceptions (inaccurate 
beliefs) while others may hold accurate illness beliefs but intentionally minimize the problem in 
order to reduce distress level. In any case, they adopt maladaptive coping strategies (e.g. low 
adherence to medication and doctors’ recommendations for a healthy lifestyle; Platt, Green, 
Jayasinghe, & Morrissey, 2014). As a result, their health condition and overall well-being may 
be affected by recurrent events for instance. Such elements may influence the assessment of the 
true impact of a treatment in HRQoL level over time.  
Thus, when researchers focus on detecting the influence of a treatment on individuals’ 
HRQoL over time, adjustment and emotional growth should be considered. Efforts to detect 
positive adjustment, post-traumatic growth but also illness self-management pattern (including 
illness beliefs) may allow the researcher to draw more plausible conclusions about the true 
impact of the treatment.  
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2.5.2. The methodological approach: Quantitative vs qualitative methodology 
First of all, there is a plethora of research that has assessed subjective HRQoL with the use of 
valid and reliable patient-based or patient-reported outcome (PRO) instruments, aiming to elicit 
patients’ subjective perceptions regarding the impact of treatment on QoL. However, the 
majority of instruments used have been developed on the basis of researchers’ definitions of QoL 
or HRQoL and associated theoretical frameworks (Taillefer, Dupuis, Roberge, & LeMay, 2003) 
rather than on the basis of points of view about QoL of the individuals concerned. Also, many 
instruments used have been based on rigorous statistical analysis (e.g. factor analysis); yet, this 
procedure may reduce content validity as those items that are less often reported are eventually 
excluded (Carr & Higginson, 2001; Lasch et al., 2010; Patrick et al., 2011). Thus, it could be 
claimed that those instruments may have limited validity in terms of content. There are some 
instruments though (e.g. the CROQ, discussed below) that deal with such issues by adding an 
open-ended question in order to capture other issues experienced by respondents as relevant or 
significant. 
Moreover, through the use of structured quantitative instruments confounding variables such 
as major life events (death of a close relative, job loss, divorce) that can influence someone’s 
perception and experience remain undetected. Pre-existing or different confounding variables at 
different points in time of testing may produce false negative levels of HRQoL. Research 
evidence shows that stressful negative events may affect dramatically psychological functioning 
(Pagano et al., 2004) and overall HRQoL level (Eastwood, Doering, Roper, & Hays, 2008; Le 
Grande et al., 2006). Thus, the results of quantitative research, when such confounders cannot be 
detected, might be doubtful.  
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Furthermore, a number of researchers suggest that, in some cases, the effect size of a 
treatment on HRQoL levels might be underestimated when solely conventional psychometric 
testing is used (Ring, Hofer, Heuston, Harris, & O'Boyle, 2005). Some others argue that it is an 
oxymoron to try to quantify quality (Hammell, 2004; Murray & Chamberlain, 1999) without a 
deeper understanding.  
Many of these points concerning under-represented or undetected aspects related to QoL may 
be addressed by qualitative approaches. On the other hand, limitations of qualitative 
methodology (QUAL) may be addressed by the strengths of quantitative (QUAN) methodology 
(Yilmaz, 2013). Specifically, the major pros of QUAN research are in relation to its contribution 
to the body of knowledge. It addresses questions through valid and reliable instruments and is 
theoretically driven. Valid conclusions can be drawn about the causation or predictability of the 
phenomenon under investigation with a potential for generalizability. These conclusions are 
viewed as valid due to robust methods employed (e.g. rigorous sampling, large sample size, valid 
and reliable measurements, sophisticated statistical analysis). On the other hand, QUAN research 
has been severely criticized for not recognizing the individuality of human beings and grouping 
individuals into set of categories that can be “easily” analyzed resulting in an oversimplification 
of both human nature and experience. A reduction of data to numbers may result in lost 
information. Many types of information are difficult to be obtained through structured data 
collection instruments, particularly on sensitive topics (e.g. domestic violence). Also, a large 
sample size might not be possible for certain conditions (e.g. drug users, patients with rare health 
conditions). Self-reported information obtained from questionnaires may be inaccurate (e.g. due 
to social desirability biases) or incomplete (i.e. missing data; Streiner and Norman, 2008; Ogden, 
2007). Moreover, due to the complexity of human experience, controlling for all related variables 
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is not feasible, meaning that other uncontrolled variables can influence the outcome (Creswell, 
2014; Gelo, Braakmann, & Benetka, 2008; Yilmaz, 2013).  
The major pros of QUAL research are that it provides a in-depth understanding of subjective 
experience as data collection is less structured as well as an opportunity to explore sensitive 
topics and rare conditions. QUAL research, however, has been severely criticized for its lack of 
“validity” and “reliability” as conventional standards cannot be employed. Data collection and 
analysis is rather demanding and requires researchers with specialist skills. Furthermore, its 
findings are subject to researchers’ interpretations, which can be influenced by their personal 
biases and idiosyncrasies. It is almost impossible to identify predictors and findings cannot be 
generalized to the wider population or other settings (Creswell, 2014; Gelo, Braakmann, & 
Benetka, 2008; Yilmaz, 2013).  
Therefore, many researchers in HRQoL research endorse mixed methods to address their 
research question(s) (Creswell & Clark, 2007). The mixed methods approach, acknowledging 
both the advantages and the disadvantages of each methodology, suggests a combination of 
qualitative and quantitative methods; a “triangulation of method” in order to gain a better 
understanding and draw insightful conclusions on the topic under investigation with fewer 
possible biases and confounding (Bentahar, & Cameron, 2015; Dunning, Williams, Abonyi, & 
Crooks, 2008). In fact, an ongoing body of researchers suggest that the present dualism between 
qualitative and quantitative research approaches should be abandoned and an emphasis should be 
placed on mixed methods  (Tashakkori & Teddlie, 2003).  
According to Johnson, Onwuegbuzie, and Turner (2007), based on a synthesis of 19 
definitions, mixed methods research is: 
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… the type of research in which a researcher or team of researchers combines 
elements of qualitative and quantitative research approaches (e.g., use of 
qualitative and quantitative viewpoints, data collection, analysis, inference 
techniques) for the broad purposes of breadth and depth of understanding and 
corroboration. (p. 123) 
 
However, a number of researchers, especially those espousing the philosophical dualism in 
research (e.g. in social and behavioural sciences post-positivism vs constructivism or 
interpretivism; Guba & Lincoln, 2005) have challenged whether it is possible to reconcile the 
two methodological approaches as they differ fundamentally in their epistemological and 
ontological assumptions (Hathcoat, & Meixner, 2015; Howe, 1988). Some others have argued 
that the reconciliation of the two worldviews in a mixed methods approach is nothing more than 
a “bastardization of positivism” (Giddings & Grant, 2007 in De Lisle, 2011, p.90). As Giddings 
(2006) stated:  
... mixed methods could serve as a cover for the continuing hegemony of 
positivism, and maintain the marginalisation of non-positivist research 
methodologies. I argue here that mixed methods as it is currently promoted 
is not a methodological movement, but a pragmatic research approach that 
fits most comfortably within a post-positivist epistemology (p. 195) 
 
 
Even researchers espousing the mixed methods approach (e.g. Yardley, 2001) have 
developed doubts about this reconciliation of quantitative and qualitative approaches. As various 
scholars have highlighted, the design and evaluation of research is influenced by its 
philosophical stance; a simple integration of techniques without maintaining the integrity of each 
one (i.e. underpinning epistemological assumptions about knowledge and its legitimate sources) 
cannot optimize contribution to knowledge (e.g. Bishop, 2016). Furthermore, many scholars (e.g. 
Giddings, & Grant, 2007; Greene, Caracelli, & Graham, 1989, in Bryman, 2007) have raised 
concerns about mixed methods approach employed in many studies. Some have observed many 
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instances where the term mixed methods is misused as what was actually mixed were methods 
(often only a part of them) rather than methodologies, and often the role of the qualitative part 
was inferior (Tashakkori & Creswell, 2007). Greene and colleagues (1989, in Bryman, 2007) in 
their review paper highlighted that only five articles among a sample of 57 claiming that their 
study followed a mixed methods approach, carried out  the final step of interpretation to integrate 
the quantitative and qualitative findings. Tashakkori and Creswell (2007) through a search in 
academic databases identified several studies where their authors considered their research as 
‘‘mixed’’ because they had utilized qualitative or quantitative approaches in only some aspect(s) 
of their research. For instance, they may have used both approaches e.g. on developing different 
kind of research questions (qualitative and quantitative); and/or two types of sampling 
procedures (e.g. probability and purposive), and/or two types of data collection procedures (e.g. 
surveys and focus groups), and/or two types of data (e.g. numerical and textual), and/or two 
types of data analysis (statistical and thematic), and two types of conclusions (arising from the 
results of the quantitative study and from the findings of the qualitative study). However, those 
claims somewhat violate a major tenet of the mixed methods approach, that of the integration of 
results/findings in interpretation (Tashakkori and Creswell, 2007). Similarly many researchers 
(e.g. Bryman, 2007; De Lisle, 2011) raise concerns about the “genuine” integration of findings in 
mixed methods studies. As Bryman (2007) states, the main aim for conducting a mixed method 
study is to maximize knowledge and understanding of the research problem and complex 
phenomena at hand and thus “the end product” should not simply be a summary of findings of 
the individual quantitative and qualitative studies within a research project, but rather integrate 
quantitative and qualitative findings in order to offer insights that could not otherwise be gained . 
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In response to all these concerns, various paradigms have been proposed and adopted by 
mixed methods researchers (Teddlie & Tashakkori, 2003). The three most frequently discussed 
paradigms in the mixed methods literature are: a) the a‐paradigmatic stance (which bypass the 
paradigm issue claiming that methodology is independent of epistemology; Patton, 1990 in Hall, 
2012), b) the dialectic stance (which suggests multiple paradigms in a single study as they can 
contribute to a better understanding; Greene, 2007) and c) the single paradigm stance (which 
proposes that the two research approaches, quantitative and qualitative, can be combined into 
one paradigm; Johnson & Onwuegbuzie, 2004).  
Regarding the latter case, three diverse positions have been developed and espoused: the 
pragmatism, the critical realism and the transformative paradigm (Creswell, 2014; Greene, 2007; 
Teddlie & Tashakkori, 2003. Among them, the most recognized and adopted paradigm in mixed 
methods research is that of pragmatism (Teddlie & Tashakkori, 2003; Creswell, 2014). 
Pragmatism refers to a paradigm that focuses on the use of mixed methods in research, putting 
aside the debatable issues of truth and reality (Feilzer, 2010), focusing on ‘what works’ for 
addressing the research questions (Tashakkori & Teddlie, 2003). Pragmatism “accepts, 
philosophically that there are singular and multiple realities that are open to empirical inquiry 
and orients itself toward solving practical problems in the ‘real world’ ” (p. 8, Feilzer, 2010). In 
other words, pragmatist approaches acknowledge the epistemological differences between 
qualitative and quantitative approaches but perceive the different forms of inquiry as 
commensurable and sharing a common goal, namely that of producing positive change in the 
world (Bishop, 2015).  
According to Owuegbuzie and Leech (2005), pragmatism, as a paradigm, is driven by 
“consequences”. For instance, for a health psychologist such consequences could be related to 
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increased levels of HRQoL of individuals with a health problem (e.g. heart disease) or more 
effective health care services targeting specific behaviours (e.g. smoking cessation).    
For pragmatism it is essential that the “right questions” are asked by the research. For 
instance, with a research question such as “Does treatment x result in changes in depression 
levels and how does individual experience influence these” the quantitative component 
(quantitative study) will address the descriptive and/or comparative part (e.g. the influence of the 
treatment on depression level) while the qualitative component (qualitative study) will address 
“what” might be those experiences and “how” may they interfere with the phenomenon under 
investigation.  These questions will guide researchers to choose the most appropriate design (e.g. 
explanatory), sampling type (e.g. sub-group sampling), sample size, material of data collection 
(e.g. the most appropriate questionnaire), data analysis techniques per sub-study as well as the 
way that the interpretation of results and findings could be integrated in the discussion 
(Owuegbuzie & Leech, 2006). 
The particular mixed methods design adopted plays a crucial role for the pragmatic 
epistemological stance; a good and suitable design will allow researchers to achieve their desired 
external consequences (Bishop, 2015). Creswell and Plato-Clark (2011) proposed two mixed 
methods design typologies; concurrent (when both quantitative and qualitative studies are carried 
out simultaneously) and sequential (when either the quantitative or qualitative study is carried 
out first and after completion the second begins). These two typologies based on timing and 
emphasis are clustered into six types (Figure 2.1); Sequential: explanatory (QUAN-QUAL-
interpretation) and exploratory (QUAL-QUAN-interpretation). Concurrent: convergent parallel 
(QUAN and QUAL-compare-interpretation). Concurrent or sequential: transformative (many 
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combinations of methods), multiphase (QUAL-QUAN-Mixed methods) and embedded (multiple 
combinations).  
 
1. Concurrent design (convergent pararell) 
 
 
 
 
 
2. Exploratory Sequential design  
   
 
 
3. Explanatory Sequential design  
 
 
 
4. Embedded design (concurrent or sequential) 
 
 
 or 
 
 
5. Transformative design  
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6. Multiphase design (concurrent or sequential) 
 
 
 
Figure 2.1 Mixed methods research designs. Adapted from Creswell and Plato Clark (2011). 
 
 
At this point, it should be mentioned that many other scholars have proposed other typologies 
(e.g. Morgan, 1998; Jonson & Onwuegbuzie, 2004; Van Ness, Fried, & Gill, 2011) especially in 
relation to timing. For example, Van Ness, Fried, and Gill (2011) have proposed another 
classification based on “priority” and “sequence” of data collection: prospective (qualitative data 
collection once at the beginning of the study prior to repeated quantitative data collection), 
retrospective (qualitative data collection once at the end of the study after repeated quantitative 
data collection) and fully longitudinal (qualitative and quantitative data collection at all time 
points).  
Another fundamental issue is related to the way in which interpretation of results and 
findings is integrated in order to enlighten the phenomenon of interest.  Based on Creswell and 
Plato-Clark (2011) with the pragmatic stance this usually takes place in the discussion where the 
results of the quantitative components are integrated with the findings of any qualitative 
components. The limited literature in this area (e.g. O’Cathain, Murphy, & Nicholl, 2010) 
suggests three main types: triangulation (in particular following a triangulation protocol), 
following a thread and theoretical explanatory integration.  
The triangulation protocol suggests triangulating findings after both data sets have been 
analyzed separately. Researchers (e.g. Farmer, Robinson, Elliott, & Eyles, 2006; Sampson, 
O’Cathain, & Goodacre, 2010) typically list the findings from each componenton the same page 
Overall Programme Objective  
QUAL 
data collection & 
analysis 
QUAN 
data collection & 
analysis 
Mixed methods 
data collection & 
analysis 
45 
 
and consider where findings from each study agree (convergence), offer complementary 
information on the same issue (complementarity), or appear to contradict each other (discrepancy 
or dissonance), producing a “convergence coding matrix”. This allows them to develop meta-
themes that contribute to shedding light on the phenomenon of interest (O’Cathain, Murphy, & 
Nicholl, 2010). The ‘following a thread’ approach (Moran-Ellis et al., 2006) for integrating the 
findings suggests that integration takes place at the analysis stage. It starts with an initial analysis 
of each component to identify key themes and questions needing further exploration. Then the 
researchers choose a question or theme from one component and follow it across the other 
component(s). Finally, theoretical explanatory interpretation refers to the fact that data generated 
by different components may be integrated by bringing them together into one explanatory 
framework. This means that contradictions, divergences and convergences in the findings 
produced by each analysis are reconciled at the point of interpretation and explanation (Green, 
2003). 
The contribution of mixed methods is widely recognized in various fields, particularly in 
health care research (Curry, 2010). Researchers and clinicians interested in the study of QoL find 
mixed methods useful (either in cross-sectional or longitudinal studies depending on the aim of 
the study), as they are helping them to gain a greater understanding not only of what and how 
often, but also of why, and thus to be able to draw more confident conclusions based on “total 
evidence” (Dunning, Williams, Abonyi, & Crooks, 2008; Ring, Gross, & McColl, 2010). 
However, as mentioned earlier, researchers often do not directly refer to the paradigm adopted or 
to the particular design employed to address their research questions (Bishop, 2015; Bryman, 
2007; Klassen, Creswell, Plano Clark, Smith, & Meissner, 2012) which in turn, challenges the 
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quality of their research (Bryam, 2006; De Lisle, 2011; Heyvaert, Hannes, Maes, & Onghena, 
2013).  
For example, in a recent cross-sectional mixed methods study (Chan & Wang, 2013) 
exploring the impact of obesity on children’s QoL, the quantitative results demonstrated that 
children with normal weight and increased weight did not significantly differ in physical 
functioning. However, the qualitative findings based on some children’s accounts revealed that 
overweight children experienced difficulties with playing activities. Furthermore, in the same 
research study, quantitative analysis indicated that overweight children experienced lower social 
functioning but not emotional functioning compared to normal weight children. The qualitative 
findings, on the other hand, showed that obese children were severely unhappy and experienced 
various worries. However, neither the philosophical stance nor particular mixed methods design 
adopted was mentioned. Also, no clarification of how the final interpretation based on 
integration of the findings was arrived at was presented. Thus, the validity of the conclusions 
might be challenged.   
Another study focusing on exploring individuals’ QoL after allogeneic haematopoietic stem 
cell transplantation (HSCT; Niederbacher, Them, Pinna, Vittadello, & Mantovan, 2012) supports 
the complementarity of insights gained through a sequential mixed methods research design. The 
study involved 44 patients and applied a disease-specific instrument for measuring QoL over a 3-
month period after treatment. The quantitative results demonstrated that individuals perceived 
their QoL as quite good. On the other hand, the qualitative findings revealed that although those 
individuals had experienced many changes in their life (e.g. loss of independence), their medical 
experience led them to a re-prioritization and for many of them “a new world has opened up”. 
The researchers concluded that individuals’ physical functioning might have been dramatically 
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affected, but they started to appreciate life, focus on and appreciate the things that they could do 
instead of things that they could not do anymore. Thus, they experienced a sense of 
psychological and interpersonal growth which affected their perception of well-being positively. 
This kind of insight is very helpful for medical doctors who tend to overestimate the influence of 
the treatment on their patients’ QoL (Pidala, Anasetti, & Jim, 2009).   
Moreover, many researchers aiming to detect the influence of a factor (e.g. treatment or 
activity) on QoL or HRQoL change over time conduct longitudinal mixed methods studies. A 
recent longitudinal mixed methods study (Bath-Hextall et al., 2013) on 77 patients with non-
melanoma skin cancer explored patients’ needs, knowledge and experiences over one year by 
employing a fully longitudinal design at four time points. The researchers used a disease-specific 
instrument for measuring QoL as well as other questionnaires for measuring anxiety, depression 
and emotions regarding appearance, and interviewed a sub-sample of participants. The 
quantitative results demonstrated that individuals’ QoL increased at 8 weeks and 12 months post 
treatment while the qualitative findings showed that people experienced relief from the fact that 
the lesion(s) had been removed, but many of them still worried about new lesions resulting in 
constant skin checking. Another essential issue revealed was the lack of information on skin 
checking even one year after treatment, especially among older individuals who might delay 
treatment due to the misconception that the spot was a mark due to old age. This understanding 
offered important insights for promoting best practice and designing tailored interventions for 
both primary and secondary prevention. However, again the researchers did not discuss clearly 
either their philosophical stance or how final interpretation was guided.  
Another mixed methods study (with a pre-post quantitative component; Ray, & Verhoef, 
2013) on 100 female breast cancer survivors examined the influence of a team-based activity 
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(dragon boat racing) on survivors’ HRQOL. Researchers employed a sequential explanatory 
design (first the quantitative part was conducted and data were analyzed, then the qualitative part 
took place and data were analyzed). The quantitative and qualitative findings were combined 
afterwards during the interpretation of the data, where qualitative themes were used to better 
explain and elaborate on the quantitative results. The researchers used a disease-specific 
instrument for measuring HRQoL and other instruments for measuring spiritual well-being and 
fatigue. The quantitative results demonstrated that a positive significant change was experienced 
by participants in most areas examined in relation to HRQoL; social /family well-being was 
almost significant (p=0.059). The findings of the qualitative part supported the quantitative 
results by highlighting and explaining why this positive chance may have occurred. For instance, 
the positive evaluation of emotional well-being was explained by individuals’ experiences with 
regard to emotional strength and reduced anxiety, while the non-significant change on social 
well-being was explained by the fact that positive aspects of the dragon boat experiences were 
reduced through differences in competitive drive, commitment level as well as personality 
conflicts. In this case, researchers provided their readers with many details about the methods 
employed including the “genuine” interpretation (Bryman, 2006), increasing the quality of the 
mixed methods study (Heyvaert, Hannes, Maes, & Onghena, 2013).  
In the field of coronary heart disease (CHD) or coronary revascularization (CR) in relation to 
individuals’ HRQoL only limited mixed methods research has been carried out; either cross-
sectional (e.g. Dantas, Rossi, Costa, & Vila, 2010) or longitudinal (e.g. Lukkarinen, 2005).  
Lukkarinen (2005) conducted a longitudinal mixed methods study on 280 patients with CHD 
aiming to explore individuals’ perceptions of their HRQoL employing methodological 
triangulation. She followed the patients from the onset of treatment (medication, percutaneous 
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coronary interventions (PCI) or coronary artery bypass grafting (CABG)) throughout 12 months 
initially through the quantitative and then the qualitative part of the study. The quantitative 
analysis (based on data collected through a HRQoL generic instrument) revealed that one year 
after bypass surgery or angioplasty, individuals’ HRQoL was significantly better on the 
dimensions of energy, pain and mobility, but poorer, especially in the younger age group (34-55 
years), on the dimensions of social isolation and emotional reactions. Moreover, divorced and 
widowed individuals, individuals with poor financial status, smokers, and those with a history of 
traumatic life experiences had more psychosocial problems. The qualitative analysis (based on 
phenomenology) revealed that individuals with a passive attitude towards treatment tended to 
maintain their lifestyle previous to the CHD diagnosis, typically developed CHD in early 
adulthood and tended to have a pessimistic view of the future, while females suffered from a lack 
of emotional support more often than male participants. On the other hand, individuals with an 
active attitude towards treatment and re-orientation of their life course typically developed CHD 
in middle adulthood. Individuals with an active approach felt their surviving a serious disease to 
be a new opportunity in life, and tried to build stronger bonds with family members. Lukkarinen, 
in her interpretation integrating the findings of both components according to the triangulation 
protocol, concluded that both the quantitative and the qualitative findings revealed that the 
psychosocial component of HRQoL of the youngest CHD patients was poorest (confirmative 
triangulation). Moreover, she concluded that a poor psychosocial state is related to acute onset of 
illness at a young age, financial problems, concern for one’s family and a lack of emotional 
support, which was a specific challenge for females with CHD (complementary triangulation). 
Still, although the author of the present thesis acknowledges Lukkarinen’s major contribution in 
the field, it should be noted that she made used of a generic disease instrument to capture 
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individuals’ perceptions and her type of qualitative data collection and analysis neither permitted 
her to capture CR patients’ specific concerns nor individuals’ in-depth experience. 
All the above examples highlight the beneficial impact of mixed-methods research on 
knowledge in the HRQoL field. Longitudinal mixed methods studies in addition to cross-
sectional studies can capture individuals’ perspectives of their HRQoL over various time points 
allowing researchers both to detect changes on HRQoL level related to a factor of interest (e.g. 
treatment) through the quantitative component of their study as well as to explore individuals’ 
experience through the qualitative component. At the final interpretation stage where findings of 
both components are integrated, depending on the type of the integration espoused, convergent, 
complementary and/or contradictory meta-themes and/or exploratory or explanatory models can 
be revealed and presented. However, in order to draw upon the advantages of a mixed-methods 
approach, researchers should be cautious with regard to design selection and final interpretation 
(integration of findings from each sub-study) which should be based on their research questions 
and intended “consequences” (e.g. how individuals’ HRQoL level can be increased).    
2.5.3. Patient-based instruments for measuring HRQoL: Generic vs specific measurement 
Hundreds of patient-based measures aiming to detect patients’ HRQoL have been established 
over recent decades (Coons et al., 2000). The vast majority are aligned with the perspective that 
HRQoL should capture patients’ points of view about the effects of disease on their physical, 
psychological (including emotional and cognitive), and social functioning (Patrick et al., 2007). 
Most of them are established in line with rigid criteria and scientific standards (Schroter & 
Lamping, 2004) in order to be able to provide accurate and meaningful results (Streiner & 
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Norman, 2008), while also acknowledging that measures with poor psychometric properties may 
produce misleading results.  
These instruments are divided into two main categories: generic and specific. Generic 
instruments, such as the Medical Outcomes Study 36-Item Short Form (SF-36 (Ware, 2008; 
Ware & Gandek, 1998)), and the Nottingham Health Profile (NHP (Hunt, McKenna, McEwen, 
Williams, & Papp, 1981)), are designed to capture subjective perceptions of a wide range of 
populations regarding a wide range of interventions. Specific instruments, such as the Coronary 
Revascularization Outcome Questionnaire (CROQ (Schroter & Lamping, 2004)) and the 
MacNew (Hofer, Lim, Guyatt, & Oldridge, 2004), are designed to measure the individual 
perceptions of a specific subgroup of the population (e.g. cancer patients, heart disease patients) 
and/or with regard to specific interventions (Coons et al., 2000). A large library of generic and 
specific HRQoL instruments can be found on the Mapi Research Trust -PROQOLID website. 
The essential difference between these two categories is that a generic tool may be less 
sensitive to particular domains in relation to a disease than a specific one (Chen, Li, & Kochen, 
2005). The generic instrument may only superficially cover each HRQoL domain and it may fail 
to detect the impact of adverse effects. Specific pains (e.g. pain in a groin wound), for example, 
that are common and influence HRQoL in CR patients (Schroter & Lamping, 2006) cannot be 
investigated by those instruments. On the other hand, generic measures are very helpful to build 
a clearer picture about patients’ QoL, especially in the long-term when individuals have adjusted 
to a new way of life and have temporally moved from the experience of a certain treatment or 
condition. For instance, severe anxiety due to coronary revascularization (identified by a specific 
measure) might not be present, but anxiety due to work problems might be detected. This aspect 
of QoL can be identified only through generic measures (Chen, Li, & Kochen, 2005).  
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In short, patient-based instruments are widely used in order to capture patients’ subjective 
perspectives about their HRQoL. A great number of instruments focus on capturing the general 
perception of HRQoL whereas others focus on the perception of HRQoL in relation to a 
particular disease. However, due to the fact that there is no single established and accepted 
definition, researchers investigating HRQoL include various dimensions perceived as being 
strongly connected with the concept under investigation. For a presentation and brief discussion 
of HRQoL instruments more commonly used in the CR field please see appendix 2.1.  
 
2.6. Approach to HRQoL in this thesis  
In this thesis, HRQoL is defined drawing on the WHO definition (1948;1996) linked to the 
Biopsychosocial model of health and disease (Engel, 1980) which states that HRQoL refers to 
the individuals’ perception of health status (related to disease symptoms and/or treatment side 
effects), physical, psychosocial and mental functioning. Furthermore, based on the general 
agreement in the literature that HRQoL is not static but rather a dynamic concept which can 
change over time a longitudinal design has been employed to capture changes over a one year 
period. As this thesis focuses on the influence of coronary revascularization (CR) on patients’ 
HRQoL, a disease-specific self-rated measure has been chosen to capture individuals’ subjective 
evaluations, the Coronary Revascularization Outcome Questionnaire (CROQ) as it measures 
dimensions consistent with the adopted definition. Also, as the author endorses the pragmatic 
stance in research, it was assumed that HRQoL could be better explored by employing a mixed  
methods study. Thus, in order to explore individuals’ perceptions of their HRQoL after CR and 
to measure changes over a 12-month period, a longitudinal mixed methods study with two 
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components, a quantitative and a qualitative, was carried out. This allowed the author to capture 
individuals’ perspectives based on both CR specific items related to HRQoL and additional 
issues via the open- ended question (e.g. financial issues) not investigated through the structured 
questionnaires (quantitative component) as well as individuals’ lived experience (qualitative 
component). The integration of the findings of each component at the end, at the interpretation 
stage, employing a narrative explanatory synthesis, allowed to present support, convergence and 
complementary insights (both in terms of new issues and explanation of other findings). This in 
turn allowed to identify individuals’ conceptualization of HRQOL as well as understand their 
individual perspectives.  
2.7. Rationale of the present thesis 
Based on World Health Organization reports Coronary Heart Disease (CHD) can be viewed 
as a leading cause of morbidity and mortality globally (WHO, 2014). Coronary revascularization 
(CR), consisting of two types, percutaneous coronary intervention (PCI) and coronary bypass 
graft surgery (CABG), is one of the main treatment of CHD. Research evidence indicates that 
CR results in prolonged life expectancy (Bravata et al., 2007; Jeremias et al., 2009) and has 
reduced morbidity rates through increasing the physical functioning of patients with coronary 
diseases (Jeremias et al., 2009). While physical functioning is an important factor in the 
treatment of CHD, there is growing evidence that non-clinical variables such as psychological 
and social factors have great influence on the life of CHD patients (Funder, Steinmetz & 
Rasmussen, 2009; Herlizt et al., 2005; Hofer, Doering, Rumpold, Oldridge & Benzer, 2006; Lett 
et al., 2004, 2005; Mallik et al., 2005), which have received less attention compared to 
biomedical ones (Lett et al., 2004; 2005).  
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Therefore, over the last decades, due to the general acceptance that a health issue like CHD 
can be more efficiently understood if viewed in a holistic, biopsychosocial manner, an ongoing 
body of research has been devoted to investigating the impact of CHD and its treatment on 
patients’ HRQoL. However, the lack of a consensus definition of HRQoL and the different 
methodological and conceptual approaches adopted by researchers in the cardio-
revascularization field, create an incomplete picture about the influence of CR on patients’ 
HRQoL. The few recent reviews in the field are aligned with this claim (Abah et al., 2015; 
Blankenship et al., 2013; Jokinen et al., 2010; Noyez, de Jager, & Markou, 2011).  
Undoubtedly, the insight provided by the few reviews in this area is essential. Still a number 
of issues remain to be explored; for instance, the extent of the effect size (ES) of CR on CHD 
patients’ HRQoL as measured by self-rating instruments or related influential factors (issues that 
will be discussed in chapter 3).   
Against this background, the present thesis aims to develop a more holistic and deep insight 
into the influence of CR on CHD patients’ HRQoL. Initially, a systematic review employing 
meta-analytic techniques (Chapter 3) has been conducted aiming primarily to summarize 
research evidence and evaluate the impact of coronary revascularization (CR; including CR types 
(CABG and PCI)), on patients’ HRQoL. The findings helped in establishing conclusions about 
the influence on CR on patients’ HRQoL, detecting possible factors that may be related to the 
outcome, as well as revealing possible methodological problems in quantitative research that 
should be addressed. The main research questions addressed were: 
1. What does the research evidence suggest concerning the effect of type of 
treatment for CHD on patients’ HRQoL?  
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2. What does the research evidence indicate concerning factors that influence the 
effect size (ES) of CR on patients’ HRQoL?  
3. What does the research evidence demonstrate regarding the influence of CR or its 
types (PCI and CABG) on the main subdomains of patients’ HRQoL (i.e. physical 
and psychosocial aspects)? 
 
Taking into consideration: a) the findings of the systematic review (part of it already in press; 
Takousi et al., 2016); b) the author’s adopted definition of the HRQoL concept (i.e. the WHO’s 
definition (WHOQoL, 1993) linked to the Biopsychosocial model (BPS; Engel, 1980)); c) the 
author’s endorsed mixed methods pragmatic stance (where quantitative and qualitative research 
methods are combined to generate a clearer picture; Creswell, 2014); d) the extremely limited 
research in this field in Greece (where the incidence of CHD has been constantly increasing over 
the last decades, and where CR treatment is mostly applied, as discussed in section 1.7), two 
studies have been carried out:  
(1) The translation, adaptation and validation of the Coronary Revascularization Outcome 
Questionnaire (CROQ) into Greek (presented in Chapter 5; part of it has been already published; 
Takousi et al., 2015) since the study would be conducted with Greek patients. The selection of 
the particular instrument was made based on the fact that it is currently the only 
disease/treatment specific instrument which captures individuals’ subjective evaluation  of their 
HRQoL and health outcomes following CR and it is developed based on the WHO’s definition 
(Schroter, 2001).  
(2) The longitudinal mixed methods study, the main study of the thesis, following a 
sequential explanatory design, refers to a 3-part study consisting of two research components:  
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a) Part 1 (presented in Chapter 6), the longitudinal quantitative component, aimed to detect 
changes in patients’ HRQoL (both overall and in its subdomains) following CR over a 12-month 
period based on individuals’ subjective evaluation as captured by the CROQ, exploring various 
clinical, behavioural and demographic predictors as well.  
b) Part 2 (presented in Chapter 7), the qualitative component aimed to capture individuals’ 
lived experience, their view and understanding of themselves and their life approximately 12 
months after treatment as well as explore in depth and explain aspects of the quantitative 
findings (e.g. individual differences related to the type of CR treatment, smoking).  
c) Part 3 (presented within Chapter 8), the integration of the findings of both components 
(interpretation and explanation) aimed to address the following questions: 
1) How do Greek individuals with CHD conceptualize HRQoL?  
2) How do aspects of the disease experience after CR and meaning-making processes 
inform individuals’ perspectives on their HRQoL? 
 
Thus, it is expected that this thesis will contribute to the field in various ways: 
• The systematic review will be the first to include literature on both CR types (PCI and 
CABG) in relation to HRQoL. 
• The Greek version of the CROQ will fill a gap in the Greek literature, since there is no 
scientifically valid and reliable instrument detecting HRQoL and health outcomes after 
coronary revascularization.  
• The longitudinal quantitative study will reveal changes in HRQoL over time and its 
predictors more accurately than previous studies since it makes use of a disease-specific 
instrument with a 12-month follow-up.  
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• The qualitative study will be the first to explore lived experience and subjective meanings 
of quality of life and lifestyle modifications after intervention/surgery in CHD patients 
employing Interpretive Phenomenological Analysis.  
• The mixed methods approach employed in the main study will facilitate the development 
of research-based theoretical considerations of the concept of HRQoL, with specific 
emphasis on aspects related to coronary revascularization. 
• The final discussion based on the integration of findings will build the overall picture of 
CHD patients’ subjective perspectives on their life following CR and identifying needs 
that should be addressed by tailored interventions. 
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Chapter three 
3. Health Related Quality of Life after Coronary Revascularization: A 
systematic review with a meta-analysis 
3.1. Introduction  
The two previous chapters introduced essential concepts related to coronary heart disease 
(CHD), its treatment focusing mainly on coronary revascularization (CR) and its two types, 
percutaneous coronary intervention (PCI) and coronary artery bypass graft surgery (CABG), 
including a rationale for conducting this study in Greece. In addition, the concept of health 
related quality of life (HRQoL) was introduced as well as the benefit of exploring it and ways to 
do so. Since there is a general acceptance that a health issue like CHD can be more efficiently 
understood using a holistic, biopsychosocial approach, an ongoing body of research has been 
devoted to investigating the impact of CHD and its treatment on patients’ HRQoL. This chapter 
aims primarily to: a) explore research evidence approximately over the last two decades (1996-
2012, where great advances in CR treatment have been made) in order to establish the effect size 
(ES) of CR on patients’ HRQoL as well as examining the influence of the different CR types on 
the extent of the ES, and b) explore whether various individual characteristics (e.g. age), and 
various methodological issues (e.g. quality of the study) are associated with the ES. The 
secondary aim is to develop recommendations, especially for future research that in turn will 
guide the quantitative part of the mixed methods study. In order to fulfill these aims, the use of 
rigorous search, screening and meta-analytic techniques are employed in order to address the 
following research questions:   
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1 What does the research evidence suggest concerning the effect of type of 
treatment for CHD on patients’ HRQoL? 
2 What does the research evidence indicate concerning factors that influence the 
effect size (ES) of CR on patients’ HRQoL?  
3 What does the research evidence demonstrate regarding the influence of CR or its 
types (PCI and CABG) on the main subdomains of patients’ HRQoL (i.e. physical 
and psychosocial aspects)? 
 
3.1.1. Overview of systematic reviews and meta-analyses 
The field of coronary heart disease has advanced considerably in the last decade. Coronary 
procedures, either interventional (percutaneous coronary interventions; PCI) or surgical 
(coronary artery bypass graft surgery; CABG), have been used in treating coronary heart disease 
and have increased the survival rate globally (Jeremias et al., 2009). However, it is important to 
mention that the comparative effectiveness of CABG and PCI remains poorly understood for 
patients that are eligible for either procedure (Bravata et al., 2007). A recent review, conducted 
by Hlatky and colleagues (2009) suggests that only diabetes and age may be related to the effect 
of type of CR on the survival rate of patients with multi-vessel coronary disease. Specifically, 
older patients and those with diabetes have lower mortality rates when treated with CABG than 
with PCI, but younger and non-diabetic patients demonstrate similar rates.  
Apart from the survival benefit and relief of symptoms, patients’ health-related quality of life 
(HRQoL) is a critical issue (Sawatzky & Naimark, 2009). As discussed in chapter 2, although no 
consensus definition exists, HRQoL includes aspects of physical, psychological and social well-
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being (Bowling, 2001; Patrick et al., 2007). Enhancing coronary patients’ HRQoL should be 
among the priorities of the medical team. 
A search of the literature shows that few systematic reviews have been carried out over the 
past ten years on the effect of coronary interventions on HRQoL. In fact, in relation to HRQoL, 
only one review of randomized controlled trials focusing on CABG (Jokinen et al., 2010), one 
review focusing on cardiac surgery (Noyez, de Jager, & Markou, 2011), two meta-analyses on 
cognitive functioning (one aspect of HRQoL) following coronary heart surgery (Cormack et al., 
2012; Sun, Wu, Wang, & Jin, 2012) and one review centered on coronary interventions (PCI; 
(Blankenship et al., 2013)) have been reported. More specifically, Jokinen and colleagues (2010) 
reviewed 21 randomized controlled trials using CABG. They concluded that post-surgically 
patients experience improved HRQoL regardless of the procedure followed (on- vs off-pump 
CABG), especially when performed by experienced surgeons. Furthermore, Jokinen and 
colleagues (2010) suggest that pre-operative HRQoL predicted post-treatment HRQoL in an 
RCT and the beneficial effect is long lasting and comparable to that of the general population. 
Noyez et al. (2011) reviewed 29 articles on the effect of cardiac surgery. They concluded that 
many studies do not present preoperative QoL data, only postoperative QoL data, which limits 
conclusions concerning the beneficial effect of heart surgery on QoL. Furthermore, they 
highlighted the need for good clinical trials with a longer follow up (greater than one year). Sun 
et al. (2012) and Cormack et al. (2012) reviewed 13 RCTs and 28 longitudinal studies 
respectively using CABG. Both reviews concluded that CABG patients may experience a decline 
in cognitive functioning during the first weeks after treatment but that this reverses at twelve 
months post surgery. Finally, Blankenship et al. (2013) reviewed 25 studies and concluded that 
the effect of PCI on QoL is greater than medical treatment (drug treatment), however this benefit 
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decreased over time. Moreover, the findings of the same review highlight that PCI’s effect on 
QoL in the first months post treatment is greater than that of CABG but, in the longer term, the 
effect of both procedures leads to similar improvements. Also, Blankenship et al.’s (2013) 
findings suggest that all ages benefit equally regardless of which revascularization procedure is 
performed although females report lower HRQoL than males following PCI. Unemployment 
status, smoking and medical co-morbidities after PCI are related to lower QoL experience 
(Blankenship et al., 2013). Soo Hoo, Gallagher, and Elliott (2014) reviewed 18 studies using PCI 
and supported Blankenship et al.’s (2013) suggestion that all individuals, regardless of their age, 
report improvements in their HRQoL and that age, therefore, cannot be considered a moderator, 
especially when other co-morbidities are taken into consideration. Abah and colleagues (2015) 
reviewed 44 studies (mostly retrospective) on the influence of heart surgery (CABG, PCI, Valve) 
on older patients’ HRQoL. Results show that the majority of patients demonstrated improvement 
following heart surgery while 8-19% demonstrated a decline.   
Although these reviews provide insight regarding the effect of CR on cardiac patients’ 
HRQoL, a number of issues need to be addressed in order to draw a clear picture and be able to 
make suggestions for clinical practice. For instance, Sun et al. (2012) and Cormack et al. (2012) 
focus only on one aspect of HRQoL, cognitive functioning, thus, a clear conclusion about the 
effect of CR on HRQoL cannot be drawn. Blankenship et al.’s study (2013) while of good 
standard, is actually a literature review, implying a lack of rigorous systematic methodology (e.g. 
many studies included are of  low quality and/or provide only post treatment data for the effect 
of CR on HRQoL), thus, the results may be biased. Noyez et al.’s (2011) and Abah et al.’s 
(2015) work focuses on surgical treatment of various heart problems (e.g. aortic or mitral valve 
surgery) not only on coronary artery disease. Hence, a clear conclusion about the effect of CR 
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requires further investigation. Jokinen et al.’s (2010) review was limited to RCTs published in 
English as their main aim was to compare on- vs off-pump CABG effects on patients’ HRQoL. 
As a result, they excluded a number of studies that may influence conclusions. Finally, it should 
be mentioned that none of the above reviews provide the effect size of CR on HRQoL as they did 
not use meta-analytic techniques to calculate the effect size and identify its moderators. Thus, a 
systematic review with a meta-analysis would update the literature and at the same time, due to 
the nature of its methodology, allow for conclusions based on quantitatively integrated results 
about the impact of CR on patients’ HRQoL and its possible moderators.  
 
 
3.2. Methods 
The methodology used in the present study follows the guidelines of the Centre for Reviews 
and Dissemination (CRD (University of York, 2008) for undertaking systematic reviews, the 
Cochrane Collaboration (Higgins & Green, 2011) and Field and Gillett’s (2010) suggestions for 
systematic reviews with meta-analysis. 
 
3.2.1. Systematic literature search  
The literature search was carried out from December 2012 to January 2013 making use of 
five online databases: Medline (PubMed), EMBASE, Cochrane Library, Sciverse (Science 
Direct and Scopus) and PsycInfo. Key words used in all searches were: 
 
“Quality of life”  
“QoL”  
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“Health related quality of life”  
“HRQoL”  
“Health status”  
“Heart surgery”  
“Coronary Revascularization” 
“Coronary bypass”  
“CABG”  
“PCI”  
“PTCA”  
“Coronary angioplasty”  
“Coronary percutaneous interventions”  
 
Those terms were searched in combination (and/or (e.g. Quality of life or HRQoL and 
Coronary Revascularization)) with only one restriction “not adolescent not children”. 
Furthermore, they were searched for in the title, abstract and keywords. The search included 
studies published in the 13 years between January 2000 and December, 2012. In addition, 
“snowball” techniques (Greenhalgh & Peacock, 2005) were used in order to detect more studies. 
In line with this technique, reference lists of studies and reviews published from 2000-2012 were 
searched manually in order to detect studies that may fulfill the eligibility criteria for inclusion.  
Moreover, abstracts written in English were considered as well, even if the research paper was 
written in another language. When an abstract seemed relevant to the topic under investigation, 
and the paper was published in a language other than English, Greek, French, German, or 
Spanish the authors were contacted in order to ask whether a full English version, or results 
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section, were available. Authors were also contacted when their papers seemed eligible for 
inclusion, but not all information needed for the analysis was presented.  
Studies were included when fulfilling the follow criteria: (1) participants should be ≥ 18 
years of age, (2) HRQoL was the primary outcome (dependent) variable in order to be the 
variable of greatest importance and values were provided either for total HRQoL or all its 
subdomains per measured time-point as assessed by the instrument used, (3) the design of the 
study was randomised, non-randomised or observational, (4) reported at least two interval times, 
pre treatment (baseline) and after intervention, (5) data collection after 1996, (6) published in a 
peer reviewed journal, (7) published in various language in which the present authors were 
proficient (i.e. English, Greek, French, Spanish, German) or the author(s) of the articles 
provided/sent an English translation following a request.  
The cut-off point of 1996 was set in order to reduce heterogeneity in outcome caused by 
“old” medical procedures, that are less applied nowadays. According to the cardiology literature, 
in the last fifteen years new methods have been developed in the field of both interventional and 
surgical coronary revascularization (Holmes & Williams, 2008; Thanikachalam, Lombardi, 
Tehrani, Katariya, & Salerno, 2004).  
Studies were excluded when (1) they used a questionnaire that did not measure all 
subdomains of HRQoL (based on the WHO definition) or that had poor/unknown psychometric 
properties. As the literature suggests that meta-analysts should pay attention to the constructs 
being tested and responsiveness of instruments in order to decide on the appropriateness for 
inclusion (Puhan, Soesilo, Guyatt, & Schunemann, 2006), (2) studies were excluded if they were 
case reports, (3) the available data were not sufficient for effect size estimation (e.g. only graphs 
without SD, only post data, no scores for all subdomains) even after contacting the  
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corresponding author, (4) only norm based summary scores were presented (these two summary 
scores represent scores related to the US population (Taft, Karlsson, & Sullivan, 2001; Ware, 
2007)) and (5) they were psychometric studies testing the properties of a QoL instrument. 
 
3.2.2. Screening identified studies 
A total of 1123 citations were identified from the searches; snowball techniques did not 
reveal any additional studies based on the inclusion criteria. Details about the exclusion 
procedure are shown in the flow diagram below (Figure 3.1). After reading the title or abstract a 
vast number of studies (901) were excluded as either irrelevant or lacking emphasis on CR. Of 
the remaining 222 studies, after entering them in the Endnote® software (X3), 11 studies were 
duplications (the same article was retrieved from both of the databases). Moreover, 14 papers 
referred to the same study examining different predictors of QoL after revascularization (Gjeilo, 
Wahba, Klepstad, Lydersen, & Stenseth, 2008, 2012; Jarvinen, Julkunen, Saarinen, Laurikka, & 
Tarkka, 2005; Jarvinen, Julkunen, & Tarkka, 2007; Järvinen, Saarinen, Julkunen, Huhtala, & 
Tarkka, 2003; Jarvinen et al., 2004; Peric et al., 2010; Peric, Borzanovic, Stolic, Jovanovic, & 
Sovtic, 2006). Moreover, 126 were excluded as reporting only post-CR HRQoL (e.g. focusing on 
rehabilitation or comparison with other heart operations and/or populations, follow up design). 
From the remaining 71 papers, three studies were excluded based on the instrument used for 
measuring HRQoL. Eleven studies were excluded as providing data earlier to 1996.  
Furthermore, four papers were excluded due to the fact that they presented only norm based 
scoring and not the total raw score for each subscale. For instance, some authors presented only 
the Mental Component Summary (MCS) and Physical Component Summary (PCS) of the SF-36 
(Ware, 2008).  
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Figure 3.1 Flow diagram illustrating the study selection procedure 
 
Actually, some meta-analysts conduct a separate analysis for papers that report only those 
two scores (Trevisol, Moreira, Kerkhoff, Fuchs, & Fuchs, 2011), or transform all subdomain 
scores into such scores with the use of the SAS programme following a three step procedure 
(Kuspinar, Rodriguez, & Mayo, 2012). Finally, 19 papers were excluded as providing inadequate 
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data for effect size calculation of HRQoL after CR. In order to reduce systematic biases from the 
main reviewer, a second reviewer (Dr Manaras, the external supervisor) was involved from the 
beginning of the study, following the same steps as described above. In the final step, regarding 
inclusion of studies, there was only one disagreement (concerning Zwoliński et al.’s [2013] 
study). After discussion it was decided to exclude the study on the basis of the data being 
collected prior to 1996.  
After the overview of remaining papers, the number of eligible studies was dramatically 
reduced. Only 34 papers were identified as fulfilling the criteria for inclusion in this review. 
From these articles, five articles were written in a language other than English (2 were in 
German, 2 in Spanish, 1 in Greek). Therefore, the help of other psychologists who were 
proficient in the particular language was requested. Appendix 3.1 gives the reason for exclusion 
of each of the 34 papers excluded through the last screening.  
 
3.2.3. Data extraction 
Studies were coded for: year of publication, country, type of CR, study design, sample size at 
baseline and at the follow ups, participants’ mean age, sex distribution, percentage who smoked, 
percentage with hypertension, percentage with diabetes (I or II) as displayed at Table 3.2. 
Intervention duration, numbers of follow up assessments, HRQoL measurement tool, HRQoL 
pre- and/or post-intervention score (raw means score for total HRQoL or each subscale at 
baseline and for the last follow up and their standard deviations (or effect size if directly 
reported) and authors’ main findings. In some cases where the standard deviation (SD) was 
missing confidence intervals (CI) and/or standard error (SE), were extracted in order to calculate 
SD (as suggested by Higgins & Green, 2011). An SPSS data sheet was created for each included 
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study in order to facilitate d conversions avoiding hand calculation errors. Table 3.4 summarizes 
studies’ intervention duration, numbers of follow up assessments, effect size, and authors’ main 
findings. 
 
3.2.4. Quality assessment of the included studies 
Studies were assessed for quality using a combination of the Downs and Black (1998) 
checklist focusing on methodological quality (e.g. reporting, validity), Noyez et al.’s (2011) 
suggestions about characteristics of a good study, and the Critical Appraisal Skills Programme 
(CASP, 2013) for cohort studies, focusing on the overall quality of studies. There were 10 
criteria in total; listed in Table 3.1). Answers were scored 0 when the criterion was not met, 0.5 
when partially met and 1 when totally met.  Scores could therefore range from 0 to 10. 
 
Table 3.1 Quality criteria of the primary studies  
 Criteria Source 
1 Did the study address a clearly focused issue? CASP*, 2013&  
Downs and Black, 1998 
2 Are patient characteristics clearly described? Downs and Black, 1998 
3 Was the outcome accurately measured (valid and reliable 
instrument)? 
CASP , 2013 & 
Downs and Black, 1998 
4 Were confounding factors taken into consideration? CASP, 2013 &  
Downs and Black, 1998 
5 Have the characteristics of patients lost to follow-up been 
described? 
Downs and Black, 1998 
6 Were losses of patients to follow-up taken into account? Downs and Black, 1998 
7 Is the procedure fully described? Noyez, de Jager, and Markou, 2011 
8 Were the statistical tests used to assess the main outcomes 
appropriate? 
Downs and Black, 1998 
9 Are the main findings of the study clearly described? Downs and Black, 1998 
10 Was the follow-up of participants long enough** Noyez, de Jager, and Markou, 2011 
* CASP= Critical Appraisal Skills Programme  
**No specific guidelines are given for this thus the author set that point to 12 months (a yearly follow up)  
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3.2.5. Methodological considerations in the meta-analysis  
3.2.5.1. Effect size  
The effect size reveals the impact that an intervention may have in a quantitative way (Puhan, 
et al., 2006). There are various ways to calculate effect size.  
Among the most widely used are Person’s r and Cohen’s d. Pearson’s correlation coefficient 
r is calculated by using the following formula √t2/√(t2+df). An effect size of 0.10 is viewed as 
small, 0.30 as medium and 0.50 as large (Field, 2005). Cohen’s d is calculated by dividing the 
mean change (post treatment mean-pre treatment mean) by the standard deviation (Kinnear & 
Gray, 2008). Based on Cohen an effect size of 0.20 is defined as small, 0.50 as moderate and 
0.80 or greater as large (Cohen, 1988). For the present study, Cohen’s d was selected.   
 
3.2.5.2. Fixed vs random effects models  
For systematic reviews with meta-analysis, the effect size of each study should be established 
and these effect sizes are then combined in order to estimate overall effect size. However, due to 
the fact that not all studies are identical, a simple mean of effect sizes might be misleading. In 
order to resolve this problem, a weighted mean should be computed giving some studies more 
weight and some less weight (Borenstein, Hedges, & Rothstein, 2007).  Based on the literature, 
there are two ways to calculate the overall effect size: the fixed and the random effects models. 
These two approaches differ in their assumptions concerning the nature of each study. The fixed 
effect model (Hedges & Vevea, 1998) suggests that there is only “one true effect size” 
(Borenstein, Hedges, Higgins, & Rothstein, 2009) which is represented by the overall effect. In 
this model, it is accepted that all factors affecting the effect size are the same and that any 
70 
 
variation observed is due to random error. Therefore, the sample size of the study (regarding 
information) strongly affects its weight in the calculation of the overall effect.  
On the other hand, the random effect model (Hunter & Schmidt, 2004) suggests that the 
“true” effect could dramatically differ from study to study due to design, sample (Borenstein et 
al., 2007), cultural differences and so on. Thus, the overall effect size is assumed to be the mean 
of the distribution of true effect sizes. In this model, it is accepted that there is not only one true 
effect, not only because of random error, but also due to the variation of true effect size among 
studies as each study represents the scores of a “unique” population. Therefore, the size of the 
study should not be overemphasised because it underestimates the findings of small studies that 
may reveal important and interesting aspects of the topic under study. The aim in this model is to 
summarize the range of various effect sizes.  
In short, the fixed effect model assumes homogeneity in the studies under investigation. 
Thus, one true effect size exists and any variation in the effect sizes is due to random error. Large 
studies are weighted more heavily when calculating the average effect. Conversely, the random 
effect model assumes heterogeneity among studies, giving equal importance to all studies 
regardless of sample size. The mean effect size represents the sum of effect ranges.   
 
3.2.5.3. Quantifying heterogeneity between studies 
The heterogeneity/homogeneity notions refer to the level of consistency in results of the 
studies included in the meta-analysis. When the effect sizes of the included studies have poor 
overlap heterogeneity is present. The presence of heterogeneity provides less rigorous results and 
thus, weaker conclusions. When heterogeneity is present, an investigation of the source of this 
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phenomenon should be made, usually by employing both a moderator and subgroup analysis 
(Higgins et al., 2011).   
A conventional heterogeneity statistical test, widely used in meta-analysis, is the Q-test 
(Cochran Q statistics; Cochran (1954)). The Q index presents the summary of the squared 
deviations of each study’s effect estimate from the overall effect estimate, weighting the 
contribution of each by its inverse variance and it is influenced positively by the number of 
studies (k) included in the meta-analysis (Rucker, Schwarzer, Carpenter, & Schumacher, 2008). 
If the test reveals a non-significant result homogeneity is assumed whereas if the significance of 
Q is p<0.05, heterogeneity is assumed (Field & Gillett, 2010). However, the Q index should not 
be used in order to decide the appropriate model, random or fixed, that is employed in the meta-
analysis. This method is useful just for conceptualizing results. Based on the literature, the Q test 
has poor power to detect true heterogeneity (especially when the number of studies included is 
small) and it does not reliably demonstrate the extent to which heterogeneity is present (Huedo-
Medina, Sanchez-Meca, Marin-Martinez, & Botella, 2006). 
A more sophisticated way to detect heterogeneity in meta-analysis is the I2 index suggested 
by Higgins, Thompson, Deeks, and Altman (2002). The I2 index represents the percentage of 
total variation in study outcomes regarding effect sizes. It calculates the extent of the 
heterogeneity by dividing the difference between the result of the Q test and its degrees of 
freedom by the Q value itself, and then, multiply it by 100. Based on the Cochrane Collaboration 
guidelines, percentages of  I2 between 0 and 40% count as having non important heterogeneity, 
around 50% (I2 = 50) as having medium, and 75% (I2 = 75) as having considerable 
heterogeneity. However, the I2 index has been severely criticized for its use in interpreting 
heterogeneity and, in turn, for deciding whether to include studies or not, especially when 
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continuous data are involved (Rucker et al., 2008). Based on research findings, authors argue that 
the I2 index might be misleading, as it emphasizes precision (size of k included) and does not 
acknowledge sampling error. Researchers have suggested that as precision increases, the I2 index 
increases accordingly, becoming nearly 100%. This phenomenon was present in 157 meta-
analyses (Rucker et al., 2008). In order to resolve this problem, the τ2 index (Tau squared; 
(DerSimonian & Laird, 1986)) can be used. 
The τ2 index assesses the between-study variance without being influenced by the number of 
studies included in the meta-analysis. When τ2 > 1, then substantial heterogeneity can be 
assumed.  
 
 
 
3.2.6. Sensitivity analysis  
Based on Higgins and Green (2011), the aim of a sensitivity analysis is to detect whether the 
studies included in the meta-analysis or the method used (fixed vs random) to obtain the 
combined effect may dramatically influence the findings. The literature suggests a number of 
ways of dealing with such concerns (Bartolucci & Hillegass, 2010; Walker, Hernandez, & 
Kattan, 2008). Some of them are: a) employing both fixed and random effects models and 
compare the outcomes, b) excluding studies that seem to be outliers (their results differ from the 
other studies) and then compare the results of both methods of analysis (all vs remaining after 
exclusion of outliers) and c) examining the presence or absence of publication biases. 
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3.2.7. Publication bias  
A basic concern shared by the majority of meta-analysts refers to publication bias. This 
concern is based on the fact that many meta-analyses are based only on published papers, usually 
written in the English language. Published papers generally reveal a positive effect. Thus, papers 
with negative or inconclusive findings are unrepresented because they are less like to be found in 
journals or other published sources. Th literature (Field & Gillett, 2010; Thornton & Lee, 2000) 
suggests various ways to detect publications biases: funnel plots, Begg’s z index and Egger’s t 
index.  
The funnel plot is an easy way to determine publication bias through a graphical 
representation (Sterne & Egger, 2001). A funnel plot demonstrates effect sizes against the 
sample size or standard error. A symmetrical distribution indicates little publications bias while 
an asymmetrical distribution indicates the presence of publication bias.   
Begg’s rank correlation test demonstrates the rank correlation between the standardized mean 
differences in effect size and their variances, assuming that selective distribution will result a 
correlation between them (Begg & Mazumdar, 1994). This test should result in a significant a 
(alpha) value (p<0.05) and should include a range of effect sizes in order to allow clear 
conclusions about the absence of publication bias (Borenstein, 2005).   
Egger’s regression model, similar to Begg’s, aims at detecting publication bias, but makes 
use of the actual effect sizes and not the ranks. Again, clear conclusions can be drawn when a 
range of effect sizes is included (Sterne, Egger, & Smith, 2001).  
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3.2.8. Moderators of effects  
Reviewers highlight various factors as potential moderators of effect sizes such as study 
quality, study design, outcome measure (instrument) and length of the study (Conn, Ruppar, 
Phillips, & Chase, 2012). Furthermore, based on the CR literature a number of factors may affect 
the outcome (e.g. proportion of each sex, smokers; Soo Hoo, Gallagher, & Elliott, 2014). 
Therefore, as will be shown in the analysis section, an analysis of possible moderators will be 
carried out.   
 
3.2.9. Calculations   
For the analysis of the present study, calculations and conversion have been made. The mean 
difference was computed as the mean change before and after intervention (last follow-up). The 
effect size was computed based on Cohen’s d formula, by dividing the mean change by the pre-
intervention standard deviation, as appropriate for repeated measures design studies (Field, & 
Gillett, 2010b). Afterwards, conversion of d to Hedge’s g was employed in order to correct small 
sample size  bias. 
Where Cohen’s d was not directly provided, the appropriate formula was employed, 
revealing a d for each subscale and then, calculating the mean of ds. Where the standard 
deviation (SD) was not reported, it was calculated based on other indices provided. For instance, 
where the standard error was given the SD was computed by multiplying the standard error by 
the square root of the number of participants (SD=SE x √n ; (Higgins & Green, 2011)). Where 
confidence intervals were given, the following formula SD=√n x (upper - lower limit) / 3.92 was 
applied (Higgins, & Green, 2011). For conversion of d to Hedge’s g (for reducing sample bias) 
the following formula was employed Hedge’s g=d*(SQRT((n1+n2-2)/(n1+n2))). 
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3.3. Analysis   
Cohen’s d formula was used to compute effect size (ES) for each study in accordance with 
the guidelines of many experts (Field & Gillett, 2010; Olive & Smith, 2005).  
Forest plot diagrams were created in order to show graphically the effect size for each study 
as well as the average (combined) effect size produced by all studies. The overall effect size is 
indicated by a “diamond” while a zero effect is marked with a line for easy interpretation.  
Sensitivity analysis was conducted by excluding outliers (studies with very different results) 
and poorer quality studies (Higgins et al., 2011). 
Moderator analysis on mean difference (md; last follow up- prior to revascularization) was 
obtained by running a multiple linear regression weighted by mean difference inverse variance. 
Design and type of instrument variables, as these are categorical, were converted to dummy 
variables in order to fulfill regression assumptions regarding data type. 
Univariate Analysis of Variance was conducted to detect differences between treatment types 
and weighted multiple comparisons (using Bonferroni post hoc tests) were carried out in order to 
compare the effect of CABG vs MED, PCI vs MED and CABG vs PCI. 
Finally, a subgroup analysis was carried out for the two basic subdomains involved in 
HRQoL (physical and psychosocial) per CR type for studies using the SF-36 (Ware, 2008) as 
this instrument was most used and there were no other measures used sufficiently often to do a 
subgroup analysis. The subgroup analysis was conducted based on the average difference (md; 
last follow up- prior to revascularization) of the physical and psychosocial component summary 
respectively. Component summaries were calculated with the use of the Health Outcomes 
Scoring Software 3.0.  
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Analyses were performed using MIX 2.0 Pro (Bax, Yu, Ikeda, & Moons, 2007; Bax, Yu, 
Ikeda, Tsuruta, & Moons, 2006), Excel (MS office Excel, 2007) and SPSS 20 (IBM, 2011). 
 
3.4. Results  
A total of 34 prospective longitudinal studies published between 2000 and 2012 were 
included in the present systematic review (see flow diagram). Figure 3.2 presents the exact 
number of the studies included per procedure.   
 
 
 
Figure 3.2 Diagram for studies included in the meta-analysis 
per CR type  
 
Data for the PCI procedure were extracted partially from studies focusing mainly on PCI and 
partially from studies including both procedures (k=14), whereas data for the CABG procedure 
were extracted from studies focusing mainly on CABG and partially from studies including both 
procedures (k=26).  
 
34k 
 
6k 
Both  
CABG & PCI 
8k 
PCI 
20k 
CABG 
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In total, 15,992 patients were included in the present systematic review and meta-analysis 
(8,027 underwent PCI, 6,348 underwent CABG and 1,617 received medication treatment). 
Patients’ demographic and clinical characteristics per study are summarized in Table 3.2.  
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Table 3.2 Characteristics of participants in studies included in the systematic review and meta-analysis 
 
 
 
Study (year) 
 
Country 
sample size 
(T1)  
Instrument† 
 
Female 
% 
 
Mean age 
 
Smoking  
% 
 
Hyper-
tension 
% 
 
Diabetes 
% PCI CABG 
1 Benzer (2003)                 Austria 64 33 MAcNew 35.3 64.5 44.3 NR NR 
2 Cohen (2011)                  USA 903 897 SF-36 † 22.5 65.2 18.5/21.9 NR 38.1/28.9 
3 Hofer (2006;2005)             Austria 60 121 MAcNew† 24.1 61.8 28.3/33.9 50/69.4 15/19.8 
4 Lukkarinen (2006)             Finland  100 100 NHP 32.5 57.2/61.8 4 NR NR 
5 Škodová (2011)                Slovakia  37 41 SF-36 15.1 55.8/59.4 NR NR NR 
6 Zang(2003)                     Eur& can.  488 500 SAQ† 21 61.4 NR 45.2 14.4 
7 de Quadros (2011)             Brazil 110   SAQ 38 62.8 24 90 32 
8 Denvir (2006)                 UK 1346   EQ-5D 32.5 60.9 38.6 32.5 11.1 
9 Melberg (2010)                Norway  427   SF-36 20.3 58.4 29.9 23.9 6.1 
10 Li (2010)                      China 287   SF-36 26.2 64 31 58 30 
11 Viswanathan (2011)            UK 2935   NHP 29.3 58.1 26.7 30.7 6.4 
12 Weilu (2011)                  China 223   SF-36 14.3 60.6 51.6 52.9 13.9 
13 Weintraub (2008)              USA & Can 969   RAND-36 15 62 29 67 34 
14 Wong (2007)                   Hong Kong 78   SF-36 24.6 66 15.4 42.9 29.2 
15 Azzopardi (2009)               Australia   87 SF-36 14.6 66.6 24.2 97.9 42 
16 Barolia (2012) Pakistan  65 WHOQOL-Bref 15.3 59.7 20.0 72.0 51.0 
17 Colak (2008)                   Coatia   111 SF-36 12.6 61.1 NR 87 28.2 
18 Damgaard (2011)                Denmark    331 SF-36 11.8 59 46.5 47.6 25.3 
19 Gjeilo (2008;2012)                  Norway    534 SF-36 22.7 NR NR NR NR 
20 Houlind (2012) Denmark  900 SF-36 23.0 75 25.5 71.0 20.0 
21 Hunt (2000)                    Australia   123 SF-36 22 64 NR NR NR 
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Table 3.2 Characteristics of participants in studies included in the systematic review and meta-analysis (continued) 
 
 
 
Study (year) 
 
Country 
sample size 
(T1)  
Instrument† 
 
Female 
% 
 
Mean age 
 
Smoking  
% 
 
Hyper-
tension 
% 
 
Diabetes 
% PCI CABG 
22 Jensen (2006)                  Denmark    120 SF-36 40 76 18.3 60.8 18.3 
23 Kiebzak (2002)                 USA    85 SF-36 21.2 62 NR NR NR 
24 Krecki, (2010)                  Poland   55 SF-36 25 61.5 36 96 49 
25 Krannich (2007) Germany  142 SF-36 19.0 65.1 NR NR NR 
26 Lie (2009)                     Norway    185 SF-36 10.3 62 29 NR 16.2 
27 Martin (2012) USA  495 SF-12 17.1 63.9 44.0 78.0 32.0 
28 Mathisen (2005)                Norway    120 SF-36 21.6 64.4 NR 40 14.2 
29 Merkouris (2009)               Greece    63 MAcNew 23.8 72.9 64 62 35 
30 Peric (2010; 2006)             Serbia    243 NHP 20 58.7 43 70 19 
31 Pfaffenberger(2010)           German   55 SF-36 14.8 64.8 35.2 66.7 NR 
32 Pirraglia (2003)                USA   590 SF-36 28 65.1 68.3 52.4 25.6 
33 Puskas (2004)                  USA   200 SF-36 22.5 62.3 29.4 63.8 33 
34 Rothenhäusler(2010)           German    147 SF-36 16.5 60.8 NR NR NR 
†The instrument used for ES calculations    
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Most studies (k=15) assessed HRQoL after CR up to year (Benzer, Hofer, & Oldridge, 2003; 
Cohen et al., 2011; Colak et al., 2008; Damgaard et al., 2011; de Quadros et al., 2011; Denvir et 
al., 2006; Gjeilo, et al., 2008; Hunt, Hendrata, & Myles, 2000; Kiebzak, Pierson, Campbell, & 
Cook, 2002; Krannich, Lueger, Weyers, & Elert, 2007; Krecki et al., 2010; Mathisen et al., 2005;  
Merkouris, et al., 2009; Puskas et al., 2004; Zhang et al., 2003). Fourteen studies (k=14) had 
outcome assessment(s) less than 12 months, ranging from 1 to 6 months (Barolia, Ali, & Jaffar, 
2012; Hofer, Doering, Rumpold, Oldridge, & Benzer, 2006; Houlind et al., 2012; Jensen, 
Hughes, Rasmussen, Pedersen, & Steinbrüchel, 2006; Li, et al., 2010; Lie, Arnesen, Sandvik, 
Hamilton, & Bunch, 2009; Martin, et al., 2012; Melberg, Nordrehaug, & Nilsen, 2010; Peric, et 
al., 2010; Pfaffenberger et al., 2010; Pirraglia, Peterson, Williams-Russo, & Charlson, 2003; 
Rothenhausler, Stepan, Hetterle, & Trantina-Yates, 2010; Weilu et al., 2011; Wong & Chair, 
2007) and only five (k=5) had additional outcome assessments that were longer than 12 months, 
ranging from 24 to 96 months (Azzopardi & Lee, 2009; Lukkarinen & Hentinen, 2006; Škodová 
et al., 2011; Viswanathan, Mayurathan, Hildreth, Worthley, & Zaman, 2011; Weintraub et al., 
2008). 
The majority of studies (k=24) used the SF-36 to measure HRQoL. Other measures used 
were the SAQ (k=2), the NHP (k=3), the WHOQoL (k=1), the MacNew (k=3) and the EQ-5D 
(k=1). Table 3.3 displays additional characteristics, such as the main focus of the study and the 
main finding of each study in plain English.  
The majority of studies (k=26) had a moderate to good quality ranging from 5 to 7.5 points 
while the remaining studies (k=8) had a low quality ranging from 3.5 to 4.5. Appendix 3.2 
displays the analytical scoring per study. 
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Table 3.3. Additional characteristics and main findings of studies included in the review 
ID Author QoL Focus 
N(prior to 
treatment) N FU Main findings 
Both interventions  
1 Benzer, 2003   PCI vs 
CABG vs 
MED 
64 
33  
109 
1(12m) Greater improvement in QoL 1 year after CABG or PCI 
compared to medical therapy.  
2 Cohen, 2011 PCI vs 
CABG 
903 
897 
3(1,6,12m) PCI group score higher in physical aspects of QoL compared 
to CABG, but NS differences among treatment group at 12 
months. 
3 Hofer, 2006  PCI vs 
CABG vs 
MED 
60 
121  
  96 
2(1,3m) CR groups demonstrate greater change compared to MED 
groups. PCI group experience a significant increase 1 month 
post treatment with a little further increase at 3months.  
CABG group experience a significant increase at 3m. 
Depression & anxiety score accounted for most of the change 
in HRQoL (64-69%) whereas treatment accounted for less 
than 1% in HRQoL changes at 3m post treatment.  
4 Lukkarinen, 
2006  
PCI vs 
CABG vs 
MED 
100 
100 
  80 
2(12,96m) PCI & CABG pts have greater QoL after 12 & 96 months 
compared to MED pts.  
CABG pts score significantly better on mobility, energy & 
pain.  PCI pts had a sign. better HRQoL on emotional 
reactions, pain, mobility & energy at 96 months post.  
NFU= Number of Follow Ups, PCI=Percutaneous Coronary Intervention, CABG=Coronary Bypass Graft Surgery, 
MED=Pharmacotherapy, d=days, w=weeks, m= months, pts= patients, NS= not significant,  PTSD=post traumatic stress 
disorder 
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Table 3.3. Additional characteristics and main findings of studies included in the review 
ID Author QoL Focus 
N(prior to 
treatment) N FU Main findings 
5 Škodová, 
2011  
PCI vs  
CABG vs 
MED 
37 
41 
28 
2(12,24m) Significantly better QoL after all types of treatment. PCI and 
CABG groups demonstrate significantly greater mean change 
at physical aspects compared to MED, while CABG and 
MED groups demonstrate significantly greater mean change 
at mental aspects. 
6 Zang, 2003 
 
PCI vs 
CABG 
488 
500 
2(6,12m) Both CABG and PCI group demonstrate improvement in 
cardiac-related health status.  
7 de Quadros, 
2011   
PCI 
predictors 
110 2(6,12m) Pts demonstrate a significant improvement after treatment. 
Male gender and QoL at baseline are significant predictors of 
post QoL level. 
8 Denvir, 2006 PCI  
High vs 
low SES 
1346 1(12m) Pts demonstrate a significant improvement after treatment. Pts 
with low SES demonstrate significantly lower mean HRQoL 
score at baseline and 12 months post treatment compared to 
those with high SES.  
9 Melberg, 2010 
 
PCI  
 non surg 
vs surg 
hospital 
427 1(6m) Significant improvement of QoL after treatment. Similar 
improvement in both types of hospitals.  
NFU= Number of Follow Ups, PCI=Percutaneous Coronary Intervention, CABG=Coronary Bypass Graft Surgery, 
MED=Pharmacotherapy, d=days, w=weeks, m= months, pts= patients, NS= not significant,  PTSD=post traumatic stress 
disorder    
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Table 3.3. Additional characteristics and main findings of studies included in the review 
ID Author QoL Focus 
N(prior to 
treatment) N FU Main findings 
10 Li, 2012 PCI vs 
MED 
 
287 
298 
 
1(6m) PCI pts score higher in QOL 6 months post treatment 
compared to MED. 
PCI elderly patients, especially those ≥80 years of age, 
experienced the greatest benefit in QoL 6 months post 
treatment.        
11 Viswanathan, 
2011 
PCI  
with & 
without 
prior 
CABG 
2935 3(3,12,24,m) Patients with previous CABG had less improvement in 
HRQOL after PCI. 24 months patients with prior CABG 
demonstrate worse physical functioning than at baseline. 
12 Weilu, 2011 PCI 
stent effect 
223 1(6m) 6 months after intervention, HRQOL increased in all 8 
domains. Factors negatively related to 6 month scores seem to 
be: gender, age and activity with bodily pain; activity with 
physical functioning; age and activity with mental health, and 
general health.  
13 Weintraub, 
2008  
PCI vs 
MED 
969 
958 
7(1,3,6,12, 
24,36m) 
12 months after treatment pts underwent PCI demonstrate 
greater mean change compared to those with medication. 36 
months after treatment NS difference between groups exists. 
14 Wong, 2007 PCI  78 2(1,3m) Increased scores after treatment. NS change at physical and 
social functioning. 
NFU= Number of Follow Ups, PCI=Percutaneous Coronary Intervention, CABG=Coronary Bypass Graft Surgery, 
MED=Pharmacotherapy, d=days, w=weeks, m= months, pts= patients, NS= not significant,  PTSD=post traumatic stress 
disorder    
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Table 3.3. Additional characteristics and main findings of studies included in the review 
ID Author QoL Focus 
N(prior to 
treatment) N FU Main findings 
CABG interventions  
15 Azzopardi, 
2009    
CABG 87 3(6, 12, 24m) Increased scores at 24 months-NS difference between pts and 
normative Australian individuals.  
16 Barolia, 2011 CABG 
gender & 
age dif 
65 1(1m) Significant improvement in all domains. 1month post surgery 
females indicated significantly lower psychological health, 
while patients>60 yrs show significantly greatly social 
satisfaction.  
17 Colak, 2008  CABG & 
comparison 
with norm  
111 1(12m) 12m post treatment pts demonstrate improvement in all 6 
domains of QoL. NS mean change to all subdomains. 
18 Damgaard, 
2011  
CABQ vs 
CABG  
170 
161 
2(3,11m) Significant improvement 11months after treatment. NS 
differences between the two groups. 
19 Gjeilo, 2012   CABG 
 Gender & 
age effect 
 
413 
 
2(6,12m) Female pts score lower compared to male at all measured 
time. Pts ≥75 years demonstrate lower general health, 
physical, social functioning and role emotional compared to 
younger patients.  
12 months pts have almost equal HRQoL with non-cardiac 
population with an exemption to Role physical where ≥75 
score rather lower.   
 
NFU= Number of Follow Ups, PCI=Percutaneous Coronary Intervention, CABG=Coronary Bypass Graft Surgery, 
MED=Pharmacotherapy, d=days, w=weeks, m= months, pts= patients, NS= not significant, PTSD=post traumatic stress 
disorder    
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Table 3.3. Additional characteristics and main findings of studies included in the review 
ID Author QoL Focus 
N(prior to 
treatment) N FU Main findings 
20 Houlind, 2012 CABG     
on vs off 
900 1(6m) Pts demonstrate a significant improvement in all domains. NS 
differences between groups. 
21 Hunt, 2000  CABG 
 
123 1(12m) Pts demonstrate a significant improvement.  NS gender 
differences. 
22 Jensen, 2006  CABG     
on vs off 
120 1(3m) Pts demonstrate a significant improvement in all domains NS 
difference between groups. 
23 Kiebzak, 2002  CABG 85 1(12m) Improvement at 1yr. NS change in role emotional and general 
health subscales. 
24 Krannich, 
2007 
CABG  142 2(10d,12m) Pts demonstrate a significant improvement in all domains. At 
1yr post GABG, pts demonstrate almost equal HRQoL with 
non-cardiac population.  
25 Krecki, 2010  CABG vs 
MED 
55 
52 
1(12m) CABG pts demonstrate a significant improvement in all 
domains while MED pts demonstrate a significant 
improvement only to pain and limitation due to emotional 
problems.  
NFU= Number of Follow Ups, PCI=Percutaneous Coronary Intervention, CABG=Coronary Bypass Graft Surgery, 
MED=Pharmacotherapy, d=days, w=weeks, m= months, pts= patients, NS= not significant,  PTSD=post traumatic stress 
disorder    
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Table 3.3. Additional characteristics and main findings of studies included in the review 
ID Author QoL Focus 
N(prior to 
treatment) N FU Main findings 
26 Lie, 2009  CABG 
Rehabilitati
on effects  
185 2(6w,6m) Improvement in QoL level. NS differences between groups. 
27 Martin, 2012 CABG 
gender 
effect 
495 1(6m) Improvement in all domains. Women significantly score 
lower in baseline and 6 month post treatment compared to 
men.  
28 Mathisen, 
2005 
CABG 
on vs off 
120 3(3,6,12m) QoL improved in both groups. NS differences between 
groups.  
29 Merkouris, 
2009  
CABG 
age effect 
63 2(4,12m) Pts demonstrate a significant improvement in all domains 
except cognitive. Almost 1/3 of pts report cognitive decline.  
12 months post treatment women significantly score lower 
compared to men.   
30 Peric, 2010  CABG 
gender 
effect 
243 1(6m) Pts demonstrate improvement after treatment women score 
worse preoperative and postoperative compared to men.  
NFU= Number of Follow Ups, PCI=Percutaneous Coronary Intervention, CABG=Coronary Bypass Graft Surgery, 
MED=Pharmacotherapy, d=days, w=weeks, m= months, pts= patients, NS= not significant,  PTSD=post traumatic stress 
disorder    
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Table 3.3. Additional characteristics and main findings of studies included in the review 
ID Author QoL Focus 
N(prior to 
treatment) N FU Main findings 
31 Pfaffenberger 
2010  
CABG 
 anxiety, 
depression 
effect 
54 2(4w,3m) Pts demonstrate sig improvement after treatment Anxiety is a 
sig predictor of all QoL subdomains when MacNew is used as 
outcome measure, but only of Mental Health if SF-36 is used. 
Depression is a significant predictor of mental health only. 
32 Pirraglia, 
2003 
CABG  590 1(6m) Pts demonstrate a significant improvement after treatment. 
33 Puskas, 2004  CABG  
on vs off  
200 
 
4(4,6w,6,12m) Pts demonstrate a significant improvement after treatment. NS 
differences between groups. 
34 Rothenhäusler
2010  
CABG  
depression, 
PTSD  
147 1(6m) Pts demonstrate a significant improvement after treatment. 
Clinical depression and PTSD are related to lower 
improvement. 
NFU= Number of Follow Ups, PCI=Percutaneous Coronary Intervention, CABG=Coronary Bypass Graft Surgery, 
MED=Pharmacotherapy, d=days, w=weeks, m= months, pts= patients, NS= not significant,  PTSD=post traumatic stress 
disorder    
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3.4.1. The Overall Effect of CR on HRQoL 
The overall effect size of CR on HRQoL after treatment, both for random and fixed effects 
models, is displayed in Table 3.4. Results suggested a moderate to low improvement on HRQoL 
after all types of treatments even after controlling for the length of study.  
 
Table 3.4 Central tendency and variability in the impact of coronary treatment on Health Related 
Quality of Life 
Groups k N  (pre/last f-up) 
Hedge’s g (95% CI) Homogeneity of effect sizes 
Fixed-effects 
assumptions 
Random-effects 
assumptions I
2† τ2‡ 
Prior to sensitivity analysis  
All studies 
(CR)   34 14375/12502 0.53 (0.51, 0.56) 0.59 (0.48, 0.69) 93.02 (91.21, 94.45) 0.08 
PCI groups  14 8027/6857 0.43 (0.39, 0.46) 0.55 (0.40, 0.69) 93.01 (89.93, 95.15) 0.06 
CABG 
groups 26 6348/5645 0.67 (0.64, 0.71) 0.60 (0.48, 0.72) 89.95 (86.59, 92.47) 0.08 
MED 
groups  7 1617/1039 0.25 (0.18, 0.33) 0.25 (0.18, 0.33) 0.00 (0.00, 70.81) 0.00 
After exclusions of outliers 
All studies 
(CR)   19 5431/4656 0.54 (0.49, 0.57) 0.53 (0.47, 0.59) 29.92 (0.00, 59.85) 0.01 
PCI groups  6 1955/1742 0.50 (0.44, 0.57) 0.48 (0.38, 0.59) 52.02 (0.00, 79.58) 0.01 
CABG 
groups 15 3476/2914 0.54 (0.49, 0.59) 0.54 (0.47, 0.60) 25.42 (0.00, 0.45) 0.01 
MED 
groups 3 390/290 0.32(0.17,0.43) 0.32(0.17,0.43) 0.00 (0.00, 89.60) 0.00 
†based on precision ‡based on variance  
I2 = 25 accounts as having minor heterogeneity, I2 = 50 moderate, and I2 = 75 as having considerable heterogeneity) 
τ2 > 1, considerable heterogeneity is present  
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The exact contribution per study on the overall effect of coronary revascularization (using 
random effects assumptions) on patients’ HRQoL can been seen in Figure 3.3.  
 
 
Figure 3.3. Forest plot diagram showing the effect (hg) of CR within each study and the 
overall effect (k=34) after synthesis. CI= confidence interval.  Q=472.67, p<0.005, 
I2=93.02%  
 
 
Univariate Analysis of Variance showed a significant difference among treatment types (F(2, 
44) = 4.57, p<.05). The weighted multiple comparisons (using a Bonferroni post hoc test) 
revealed that patients who underwent CABG or PCI experienced a significantly greater 
improvement of HRQoL compared to patients treated with MED while patients treated with PCI 
and CABG did not differ significantly from each other (CABG>MED, mean difference (md)= 
0.35, p<.005; PCI>MED, md=0.32, p<.05; CABG>PCI, md=0.03, p= 0.72).  
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Furthermore, when the τ2 index is used to detect the level of heterogeneity on CR effect size, 
all studies seem to be homogeneous (τ2=0.08), while when the I2 estimate is used a high level of 
heterogeneity (I2 = 93%) is present, suggesting there are studies that should be excluded as 
outliers. 
When examining for publications biases, the trim-and fill method identified only one study as 
being necessary to be added to normalize effect size distribution. The results of a Begg’s test 
(z=0.03, p=0.98) and Egger’s test [t=4.98 (CI=0.25,0.61), p=0.19] rejected the probability of a 
significant publication bias. 
Sensitivity analysis demonstrated that 15 studies should be excluded as outliers (Table 3.4). 
Even after exclusion, the combined effect size remained moderate for both coronary 
revascularization and low for MED. Overall the mean difference became slightly lower but no 
essential changes were detected, [F(2, 32) =10.42, p<0.001, CABG>MED, md= 0.27, p<0.001; 
PCI>MED, md=0.20, p<0.001, CABG>PCI, md=0.07, p= 0.28).  
The forest plots (Figure 3.4) show a graphical representation of effects sizes and CI after 
sensitivity analysis. 
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Figure 3.4 Forest plot diagram showing the effect (hg) of CR within each study and the 
overall effect (k=19) after excluding outliers. CI= confidence interval. Q=40.35, p<0.005, 
I2=50.44%  
 
 
 
3.4.2. Moderator analysis  
Including all 34 studies, three factors were associated with the outcome: the type of 
instrument, length of the study (time) and study quality. Factors examined apart from the three 
presented were study design (single vs two or more treatments), demographic factors (mean age, 
proportion of female participants), and proportion of smokers; these factors were not associated 
with the outcome (p>0.05). The multiple linear regression of mean difference weighted by the 
inverse variance demonstrated that these moderators accounted for 93.4% of the variability in 
the outcome. In fact, 19.4% of the variance can be accounted by quality of study [F(1, 31) = 
7.43, p<0.05], 73% by type of instrument [F(7, 25) = 49.62, p<0.001], while time (study 
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duration) accounts for a tiny but significant 1% of the variance [F(1, 24) = 8.21, p<0.05]. 
Specifically, the analysis indicated that there is a larger effect for lower quality studies (b=-2.69, 
t(33) = -2.36, p=0.025) and short term follow-ups (b=-0.52, t(33) = -2.87, p=0.007) and that the 
effect size depends on the measure used; a larger effect was obtained for disease-specific 
measures (e.g. larger effect for the disease-specific measure SAQ (b=20.83, t(33)= 10.25, 
p<0.001) than for the generic SF-36 (b=11.91, t(33)= 14.66, p<0.001)).   
When the analysis was repeated with 19 studies (after excluding outliers and poorer quality 
studies), the effect of CR on HRQoL was significant. Quality of study emerged as a significant 
predictor. The effect of time could not be detected as the pooled variance was reduced 
considerably. Also, measurement type could be not analysed as the majority of remaining studies 
(89%) used the SF-36.  
 
3.4.2.1. Subgroup analysis: Psychosocial vs Physical domains 
The subgroup analysis was conducted with studies using the SF-36 as an instrument for 
capturing patients’ HRQoL after CR to detect any differences in the effect of CR on HRQoL 
between psychosocial and physical subdomains. Overall, in 21 studies (participants n=5,232) 
findings revealed that CR has a greater impact on the physical than on the psychosocial domain 
(md= 4.45, 95% CI, 3.93 to 5.20; p<0.001; τ2 =5.98).  
The mean difference between physical and psychosocial domain was significant for CABG 
(p<0.001) but not for PCI (p= 0. 173; Figure 3.5). Meta-regression analysis for possible 
moderators in this difference in CABG effect between the physical and psychosocial dimensions 
did not reveal any significant result suggesting that the effect of CABG is not moderated by any 
of the variables measured. In short, results suggest that PCI impacts on both patients’ physical 
93 
 
and psychosocial functioning equally, whereas CABG has a greater effect on the physical 
functioning compared to psychosocial functioning.   
.  
 
Figure 3.5 Forest plots for graphical representation of mean difference and CI between 
psychosocial and physical domains per CR type 
 
 
 
 
3.5. Discussion  
3.5.1. Overview of the results  
The present study reviewed 34 primary studies, identified as suitable based on the inclusion 
criteria. Strong evidence of the positive influence of the treatment on CHD patients’ HRQoL 
emerged from the meta-analysis. Results showed that there was a significant increase from pre to 
post HRQoL level; a moderate effect size was revealed for both CR types (PCI and CABG) and 
a low effect size was revealed for MED. These findings are partially in line with Blankenship, et 
al.’s (2013) conclusions who highlighted the superiority of PCI over medical treatment, and 
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partially consistent with Jokinen et al. (2010) who highlighted the  superiority of CABG over 
drug treatment. The CR procedures did not differ significantly in their effect on HRQoL which is 
consistent with Blankenship et al.’s (2013) and Jokinen et al.’s (2010) conclusions.  
Regarding the maintenance of improved HRQoL most studies suggest that the positive effect 
of CR is long lasting, but decreases a little over years. This evidence is in line with Blankenship 
et al.’s (2013) conclusions.  
Concerning moderators, from all the variables examined, for both CR procedures only type 
of instrument used and study quality were strong moderators of the outcome. A discussion can 
be found in the literature about the instruments used in HRQoL research. In the current analysis 
all studies used valid and reliable measures but the majority used generic rather than disease-
specific measures. Most studies using a disease-specific instrument reported a greater effect size 
than studies using generic measures. As there is no consensus definition of QoL, results 
produced by various measurements may vary significantly as each instrument may include 
common as well as different domains based on the authors’ theoretical concepts (Kendel, 2009). 
While generic measures like the SF-36 (Ware & Sherbourne, 1992) are valid and reliable, some 
items are likely to be less sensitive in detecting treatment effects (Guyatt et al., 2007; Wiebe, 
Guyatt, Weaver, Matijevic, & Sidwell, 2003) for specific health conditions (Jordan-Marsh, 
2002).  
Neither mean age nor the proportion of female participants was associated with the level of 
the effect size of CR on patients’ HRQoL. These findings are in line with Lansky et al.’s (2005) 
and Hartman et al.’s (2014) conclusions, namly that females’ worse outcome compared to males 
may lie in the higher risk profile of females referred to CR and that the difference in mortality or 
health outcomes that appears in some studies is related to risk factors other than sex. In short, the 
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findings of the present study imply that both age and sex might be not considered risk factors 
when treatment decisions about coronary artery disease are made, at least in relation to HRQoL.  
Subgroups analysis showed a greater effect for CABG on physical functioning compared to 
psychosocial functioning, but not for PCI. This finding implies that PCI may have a more 
“universal” effect on HRQoL than CABG. The literature supports these results (e.g. Abdallah et 
al., 2013). It should be mentioned, however, that research evidence indicates that this difference 
diminishes over time (Abdallah et al., 2013). Moreover, this result may suggest that when the 
overall effect is calculated (i.e. incorporating both physical and psychocial aspects of HRQoL) 
the PCI effect may not be influenced but the CABG effect may be dramatically reduced, 
providing potentially misleading results. Thus, one the one hand, subgroup analysis should be 
considered as an essential part of a researcher’s analysis in order to highlight differences in 
subdomains effects as well as to avoid oversimplicity. On the other hand, the presence of 
difference in the mean change between the two subdomains in CABG treatment or the absence 
in the mean change between the two subdomains in PCI treatment might be related to the 
outcome measure used. As discussed earlier, the SF-36 (Ware & Sherbourne, 1992) is a generic 
measure meaning that it may leave disease/treatment-specific factors (e.g. adverse effects) 
underestimated (Chen, Li, & Kochen, 2005). Furthermore, other influential psychosocial aspects 
may remain unexplored as they cannot be captured solely by quantitative approaches (Mitchell, 
Benito-León, González, & Rivera-Navarro, 2005).  
A large literature focuses on a debate about the appropriate index for detecting heterogeneity 
level in continuous data. Findings may change dramatically depending on the index chosen.  The 
findings in the present study highlight this difference. When the τ2 index is used, homogeneity 
among studies is suggested and type of instrument as well as female sex appear to have a 
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moderating effect on the effect of CR on improvements in HRQoL. However, when the I2 index 
is chosen, 15 studies would have to be excluded as outliers to increase homogeneity. With the 
subsequent decrease in heterogeneity, the effect of CABG and PCI on improvement in HRQoL 
was maintained but none of the variables examined had a significant moderating effect. This 
highlights two basic issues: a) that statisticians should focus on resolving this issue to allow 
researcher to detect the authentic heterogeneity level and b) that findings from heterogeneous 
studies should be considered carefully before any recommendations are made.  
 
3.5.2. Limitations and Strengths 
Several limitations are present in this study. First of all, only a few studies examined the 
severity of angina prior to treatment, or provided data on complex coronary lesions. As a result 
such important variables were not included in the analysis, raising questions about the precision 
of the estimation of the effect of CR on HRQoL. Similarly, stressful events, changes in 
lifestyle, adherence to medical advice and other potentially relevant factors are not considered 
since these were not routinely measured in the studies reviewed. Secondly, the majority of 
studies do not include control groups or alternative treatment. Only 30% of the studies reviewed 
presented comparisons between types of CR treatment, which may result in a misleading 
conclusion. According to the literature, studies using between-group designs demonstrate lower 
effect sizes in the change in HRQoL compared to single group designs due to the way effect 
size is estimated (Morris & DeShon, 2002). Thirdly, as this review focused on CR treatment of 
CHD, a comparison with medical treatment was made only via studies investigating this type of 
treatment thus conclusions might be doubtful. Furthermore, in the studies included in many 
cases the type of medication patients used was not systematically reported. Even if it was 
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described, it differed dramatically between medical treatment groups, suggesting 
methodological biases that could not be controlled.   
The strengths of this study are the efforts to adopt a rigorous methodology. Papers included 
were not limited to having been written in English or by cultural constraints. Furthermore, it 
placed emphasis on the last decade of research evidence highlighting that various factors, such 
as age, identified in the past as moderators, do not influence the beneficial effect of CR on 
patients’ HRQoL. Thus, decision making regarding treatment is enhanced. To our knowledge, 
this is the first systematic review with meta-analysis that summarizes, evaluates and synthesizes 
research-based evidence concerning coronary patients’ HRQoL following CR.  
 
3.5.3. Recommendations  
Measurement of HRQoL should be included in the routine assessment of coronary patients in 
order to have a complete picture as well as enhance conclusions about the effectiveness of 
treatment. Cardiothoracic surgeons should pay attention to their patients’ psychosocial 
functioning too and if necessary advise them to seek professional guidance and support in order 
to maximize well-being. 
Further high quality research should be developed in order to enable the scientific 
community to establish rigorous conclusions about factors that influence the effect of CR on 
patients’ HRQoL. Specifically, more RCTs and Cohort studies (including patients with different 
treatment types, i.e. MED, PCI, CABG) are needed in order to inform health care professionals 
about the beneficial aspects of each treatment. More variables should be included in each study 
examining additional issues such as medical (e.g. angina), behavioural (e.g. adherence to 
medication, diabetes management, obesity) and psychological (e.g. stressful life events, 
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emotional distress, personality) in order to identify relevant predictors. Studies should also 
include multiple time points in measuring HRQoL. More studies using disease-specific HRQoL 
instruments should also be conducted as the literature suggests disease-specific instruments 
allow clearer and more accurate conclusions than those derived from general instruments. 
Studies should also report all HRQoL subdomains, not just totals, and all relevant indices should 
be presented (e.g. including pre-post mean scores and p values) in order to avoid transformations 
and calculations by reviewers that might lead to misleading results (Higgins & Green, 2008; 
Higgins et al., 2011). 
 
 
3.6. Conclusion  
This systematic review with a meta-analysis provides evidence about the beneficial impact of 
coronary interventions and operations on patients’ HRQoL. These results may help medical 
doctors to not only to justify their decision to operate but also to be able to inform their patients 
about the pros and cons of each CR type in terms of HRQoL, a need partially highlighted by 
many researchers (Creswell & Clark, 2007; Koch, Khandwala, & Blackstone, 2008). Best 
practice in research requires careful methodological design to maximize the quality of studies to 
produce trustworthy conclusions. Researchers should carefully select the QoL instrument 
because it plays an important role in the effect estimation and in detecting moderators and it may 
affect the results and, thus, conclusions. Despite the gains that have been accomplished, 
considerable challenges and questions remain to be addressed. Further rigorous research should 
be developed to illuminate the dark spots in this area.  
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Regarding the present thesis, these findings have guided the research to identify a 
disease/treatment specific instrument for assessing CHD individuals’ subjective evaluations of 
their HRQoL following CR as well as to design and conduct a longitudinal mixed methods 
study to investigate the influence of various clinical, demographic, and behavioural features on 
the outcome in terms of statistical associations (of overall HRQoL and its subdomains) and the 
lived experience.  
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Chapter Four 
4. Method 
4.1. Introduction  
This thesis has set out to explore individuals’ perspectives on their HRQoL prior to coronary 
revascularization (CR), 3 and 12 months after (CR). Building on the knowledge acquired by a) 
the overview of the literature on coronary heart disease (CHD) and CR treatment (chapter 1), b) 
the overview of theoretical and research considerations on the concept of Health Related Quality 
of Life (HRQoL) (chapter 2) as well as c) the results of the systematic review with a meta-
analysis guided the researcher to adopt a mixed methods approach for achieving the main aim of 
the study.  
This chapter initially presents a short discussion of philosophical and methodological issues 
in research that led to the decision to use a mixed methods design (introduced in chapter 2, 
section 2.5.2). Then, it outlines the overall research design that involves two studies: a) the 
translation, adaptation and validation of the CROQ instrument into Greek, since the study was 
conducted in Greece and b) a longitudinal mixed methods study with two research components;  
the first is the quantitative component (the longitudinal, quantitative part of the study) aimed 
mainly to detect changes in CHD patients’ HRQoL over a one-year period following CR and 
potential predictors of the outcome, and the second is the qualitative component (qualitative part 
of the study) aimed at capturing the lived experience of CHD individuals one year after CR, 
placing particular emphasis on a deeper understanding of some of the quantitative results. 
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Methods of data collection and data analysis employed in each study and issues related to 
research ethics and research quality assurance will be presented in the following sections.  
 
4.1.1.The choice of a mixed methods research design 
4.1.1.1. Paradigm considerations in research 
According to the literature (e.g. Bryman, 2015; Creswell, 2014; Hussain, Elyas, & Nasseef, 
2013) research is defined as a systematic enquiry that aims to produce and expand knowledge. 
However, the way that researchers try to address their questions and contribute to the body of 
knowledge is guided by the paradigm they adopt.  Paradigm refers to a set of assumptions which 
underpins the researcher’s worldview and thus guides their work in terms of ontology, i.e., their 
position on what constitutes reality, what is the nature of reality; epistemology, their assumption 
about what constitutes valid knowledge; methodology, the theory that underpins the principles of 
the research, how can the researcher go about obtaining the desired knowledge and 
understanding; and methods, the specific techniques and procedures that are used to collect and 
analyze data (Guba & Lincoln, 2005). The literature suggests that the two traditional paradigms 
that guide researchers are positivism and interpretivism (Creswell, 2013; Mackenzie, & Knipe, 
2006). This categorization can be criticized as very simplistic (Reichardt and Rallis, 1994) as 
many more paradigms exist in the field of psychological research (e.g. critical realism, 
constructivism (which occasionally is used interchangeably with interpretivism; Creswell, 
2013)). However, the presentation of such a simplistic approach is mainly for introducing the 
main paradigms that underpin quantitative and qualitative approaches to research in the social 
and behavioural sciences.  
Briefly, the positivist ontological position is close to realism i.e. “reality is out there in the 
world and driven by permanent natural laws” (Guba & Lincoln, 2005, p. 201) while the 
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epistemology of positivism stresses the assumption that the knowledge is objective and value 
free and can be obtained solely through the application of a scientific method. In other words, the 
social world can be studied in the same way that the natural world is studied. The aims of 
positivism are description, prediction, control, and explanation while the goal of positivism is to 
discover universal laws (Mackenzie & Knipe, 2006; Hussain, Elyas, & Nasseef, 2013). The 
positivist view restrics research to what can be observed, leaving areas such as subjective 
perceptions, feelings, thinking underinvestigated. This led to the rejection of the narrow 
positivist view and to the development of postpositivism. Post-positivists maintain the 
assumption of theory verification, i.e. hold the belief that laws and theories can explain various 
realities remaining though open to the verification establishing the “truth” by talking about 
“supporting” rather than “proving” hypotheses. The role of evidence is to establish a high degree 
of probability, rather than certainty, that something is “true” (Guba & Lincoln, 2005; Polit, 2001 
in Giddings & Grant, 2007). Also, post-positivists, although maintaining  that it is important to 
establish generalizability, acknowledge that is rather hard as they accept that other factors such 
as culture may influence the phenomenon under investigation. Post-positivism is linked with 
quantitative research methods (Creswell, 2014; Howe, 1988; Scotland, 2012).  
On the other hand, ontological position of interpretivism is close to relativism, i.e. “reality is 
constructed and interpreted by individuals according to their ideological and cultural positions” 
(p.2376, Hussain, Elyas, & Nasseef, 2013), while its epistemological position is that of 
subjectivism, i.e. knowledge is personal and unique (Cohen, Manion, & Morrison, 2013). The 
role of the researcher is not limited to demonstrating how individuals or social groups interpret 
the world around them. Interpretation of an individual’s understanding in relation to existing 
theories is an essential concept (Bryman, 2015; Cohen, Manion, & Morrison, 2013). The aims of 
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interpretivism are to explore and understand not only the complexity of individual experience or 
social phenomena but also to give meaning (Hussain, Elyas, & Nasseef, 2013). Interpretivism is 
linked with qualitative research methods (Creswell, 2013; Howe, 1988; Scotland, 2012).  
These differences in researchers’ worldview have led to an ongoing debate between 
quantitative and qualitative researchers; the well-known war of paradigms. However, as has been 
discussed in section 2.5.2, both research approaches (quantitative and qualitative) have strengths 
and limitations (Yilmaz, 2013; Creswell & Plano-Clark, 2007). A growing number of researchers 
(e.g. Bryman, 2006; Hall, 2012; Teddlie and Tashakkori, 2003; Greene, 2007, Creswell & Plano-
Clark, 2007) have challenged this dichotomous view arguing that quantitative and qualitative 
research can be combined leading to the maximization of the knowledge; this stance led to the 
development of mixed methods research and various paradigms encompassing mixed methods 
(e.g. pragmatism; Teddlie & Tashakkori, 2003).  
Many researchers have challenged the mixed methods stance suggesting that these two 
dominant paradigms are incompatible as they hold different points of view and fundamentally 
differ in epistemological and ontological assumptions; the incompatibility thesis (Howe, 1988). 
As discussed earlier, Reichardt and Rallis (1994) among many others (e.g. Howe, 1988; Creswell 
& Plano-Clark, 2007) are opposed to the incompatibility thesis based on the “paradigm-method 
fit” suggesting that different philosophical paradigms and methods can be compatible and that 
paradigms and methods are not “inherently linked”.  
One of the most widely recognized and adopted paradigms in mixed methods research is that 
of pragmatism (Teddlie & Tashakkori, 2003; Creswell, 2014). Pragmatism refers to a 
“deconstructive” paradigm (Teddlie & Tashakkori, 2003) that focuses on the use of mixed 
methods in research, “sidesteps the contentious issues of truth and reality” (p. 8, Feilzer, 2010), 
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and “focuses instead on ‘what works’ as the truth regarding the research questions under 
investigation” (p. 713, Tashakkori & Teddlie 2003,). Pragmatism “accepts, philosophically that 
there are singular and multiple realities that are open to empirical inquiry and orients itself 
toward solving practical problems in the ‘real world’ ”(p. 8, Feilzer, 2010).  
4.1.1.2. Choosing a mixed methods longitudinal sequential explanatory research design 
As mentioned elsewhere, pragmatism underpins the worldview of the author of this thesis. 
She adopts the definition by Creswell and colleagues (2003) that a mixed methods study refers to 
the collection and analysis of both quantitative and qualitative data in a single study in which the 
data can be collected concurrently or sequentially (based on aims and research questions) and 
involves the integration of the data at the final stage of research. By employing a mixed methods 
approach a more comprehensive understanding of the research area can be established as level of 
change can be detected, various predictors can be explored and the richness of subjective 
experience can be captured.  
A mixed methods longitudinal sequential explanatory research design was selected for the 
main research study. This design is perceived as the most suitable design for the particular study 
for several reasons. Firstly, the longitudinal aspect was chosen based on the notion that HRQoL 
is a dynamic concept that changes over time, thus repeated measures would allow a greater 
understanding of the pattern of change. Secondly, the sequential explanatory aspects, where 
priority is given to quantitative data (the quantitative repeated data collection and analysis are 
carried out first and then qualitative data are collected and analysed) was chosen based on the 
assumption that quantitative data and their analysis would provide a general understanding of the 
research questions (e.g. trends in HRQoL change) while the qualitative data and analysis using 
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the Interpretative Phenomenological Analysis (IPA) approach could refine and provide a deeper 
understanding by exploring participants’ point of view and experience. Thirdly, the approach 
allows the integration of the findings from each part (quantitative and qualitative) at the end, at 
the interpretation stage, allowing the presentation of converging, diverging and complementary 
insights (in terms both of new, additional issues and explanation; Creswell & Plano-Clark, 2011).  
For example, the quantitative results may reveal an improvement in HRQoL post treatment 
while the qualitative analysis may suggest how individuals define HRQoL one year later and 
whether individuals actually experience the degree of improvement suggested by the quantitative 
results as well as reveal other related concepts (e.g. post traumatic growth that may influence 
evaluation of quality of life, as discussed in Chapter 2).  
At this point it is essential to explain the methodological approach chosen for the qualitative 
study; the Interpretative Phenomenological Analysis (IPA; Pietkiewicz & Smith, 2014; Smith, 
Flowers, & Larkin, 2009). IPA was chosen after considering four main issues. First of all, IPA 
best suits the research aims as it has been developed in order to explore individuals’ 
understanding and sense-making of various phenomena as experienced in participants’ own 
words. Secondly, it is interpretative with a double hermeneutic heuristic (Smith, 2004). In other 
words, the researcher makes an effort to understand and make sense of individuals’ points of 
view and experience, with an emphasis on psychological interpretation, i.e., to extract meaning 
beyond individuals’ direct claims. As Smith and colleagues (2009) argue, a good IPA should 
reveal more about the individuals than the individuals are aware of themselves. Thirdly, IPA is 
idiographic in nature. It treats each case as a case study and afterwards explores convergence and 
divergence across themes from the analysis of different interviews (Smith et al., 2009). This 
approach suggests that a phenomenon is experienced by an individual in a particular and unique 
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way and allows the researcher to detect and illustrate important theme(s) even if they are only 
produced by one participant (Smith, et al., 2009). As Smith and Osborn (2003) state “The 
resulting analysis respects both theoretical convergence but also, within that, individual 
idiosyncrasy” (p.75).  This facility for highlighting unique perspectives as well as shared 
experiences is one of the cornerstones of IPA (Smith, 2010; Smith and Osborn, 2003). The two 
latter aspects (i.e. idiography and interpretation) differentiate IPA from thematic analysis. This is 
important to be highlighted because there is a general misapprehension that IPA is a form of 
thematic analysis (Hefferon & Gil-Rodriguez, 2011). Idiography and interpretation guide 
researchers who endorse the IPA approach to recruit small purposeful samples (four to ten), have 
short interview schedules and starting with a generic question giving participants the opportunity 
to set the parameters of interest. This in turn allows researchers to explore in depth these 
parameters in addition to specified open-ended questions of the research schedule to gain a 
greater and deeper understanding (Hefferon & Gil-Rodriguez, 2011; Smith et al., 2009). 
Fourthly, findings from IPA studies can influence and contribute not only to theory but also to 
best health care services. Regarding theory, analysis can offer the development of an explanatory 
model, or elements that might be added to an existing theoretical framework. Concerning best 
health care services the better understanding of lived experiences regarding a health topic and 
health care can improve service provision as it can guide health care providers in their 
understanding of, for example, what behaviour should be targeted and how healthy lifestyles can 
be promoted (Fade, 2004; Pringle, Drummond, McLafferty, & Hendy, 2011). 
As stated earlier IPA was found more suitable compared to other qualitative approaches, e.g. 
Thematic Analysis (TA; Braun & Clark, 2006), Grounded Theory (GT; Strauss, & Corbin, 
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2015), Discourse Analysis (DA; Jorgensen, & Phillips, 2002), Ethnography (E; Atkinson, & 
Pugsley, 2005).  
ΤΑ as stated above often seems very similar to IPA, especially if it is guided by the 
phenomenological stance. It focuses on capturing commonly recurring themes (Braun & 
Wilkinson, 2003), on patterning meaning across the dataset that may answer the research 
question(s). In other words this approach places emphasis on predominant themes across 
participants’ accounts, it does not aim to capture ideographic aspects (Braun & Clark, 2006; 
2013). This makes TA and IPA differ markedly (Braun & Clark, 2006), both in sample size 
required and in the analysis steps. Briefly, the TA needs a larger sample compared to IPA (Smith 
et al., 2009), since the focus of TA is on patterning meaning, whereas IPA needs a smaller 
sample size (1-10) in order to maintain a more idiographic focus (Pietkiewicz & Smith, 2014; 
Smith et al., 2009). As Smith et al. (2009) suggest “less is more”. Furthermore, IPA focuses on 
developing each stage of the analysis for each data item (case by case), before moving to the next 
in order to capture even the less frequent themes, whereas TA involves developing each stage of 
analysis across the whole dataset (Braun & Clark, 2006; Pietkiewicz & Smith, 2014; Smith et al., 
2009).  
GT (Strauss, & Corbin, 2015) was excluded due to the fact that it aims to detect factors that 
may explain the phenomenon experienced, usually rooted sociologically, not to understand the 
essence and meaning of the experience per se. It focuses on exploring common experiences to 
inductively develop a theory based usually on a large sample (10-30) and by using triangulation 
both in data collection (more than one type, e.g. interviews and focus group) and analysis (more 
than one analyst). On the other hand, IPA is more psychologically rooted focusing on the 
personal experience of a small sample (1-10) (Smith et al., 2009). 
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DA (Jorgensen & Phillips, 2002) was excluded as it aims to explore the language that people 
use and how it relates to the dominant discourses that influence individuals’ ways of thinking, 
speaking and acting; which is far from the study’s aim. 
Finally, Ethnography (Atkinson & Pugsley, 2005; Mackenzie, 1994) was ruled out as it 
focuses on exploring the shared culture (e.g. values, beliefs, behaviours) of a group of people via 
the viewpoint of an insider; which again is rather dissimilar to the study’s aim.   
 
4.1.2.Overall research design and research questions   
As discussed in the rationale for the thesis in Chapter 2, taking into consideration the findings 
of the systematic review, the author’s endorsement of a mixed methods (pragmatic) stance and 
the extremely limited research in this field in Greece, two studies have been carried out (see 
Figure 4.1 for a graphical illustration of the studies and their procedure):  
(1) The translation, adaptation and validation of the Coronary Revascularization Outcome 
Questionnaire (CROQ) into Greek, since the study would be conducted with Greek patients. This 
study addresses the following research questions: 
1. Does the Coronary Revascularization Outcome Questionnaire Greek version (CROQ-
Gr) seem straightforward and relevant to Greek patients?  
2. Is there evidence to support the reliability of the CROQ-Gr? 
3. Is there evidence to support the validity (both internal and external) of the CROQ-Gr? 
4. Is there evidence to support that the CROQ-Gr is sensitive to change? 
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Figure 4.1 Graphical illustration of the study conducted and mixed 
methods steps and procedure.  
 
 
(2) The longitudinal mixed methods study, the main study of this thesis, which consists of 
three main parts with two research components. In particular,   
a) Part 1 (presented in Chapter 6), the longitudinal quantitative component aimed to detect 
changes in patients’ HRQoL (both overall and its subdomains) following CR over a 12-month 
period based on individuals’ subjective evaluation as captured by the CROQ-Gr, exploring as 
well as various behavioural, clinical and demographic predictors. Also this study, on the basis of 
the recommendations of the meta-analysis, incorporates a number of features in order to improve 
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issues and problems identified in the design of previous studies. This component addresses the 
following research questions: 
1) What is the trajectory of change in HRQoL over a one-year period post CR? 
2) Does the type of CR influence the level of change? 
3) What are the predictors of change in HRQoL over a one-year period?  
4) What is the trajectory of change in HRQoL specific aspects (symptoms, physical, 
psychosocial, cognitive function) and what are the predictors of change in each 
subdomain?  
 
b) Part 2 (presented in Chapter 7), the qualitative component aimed to capture individuals’ 
lived experience, their view and understanding of themselves and their life approximately 12 
months after treatment as well as to explain individual differences highlighted by the quantitative 
results. This component focused on “How do individuals make sense of HRQoL after CR?”  
Consequently, the following research questions are addressed: 
1) How does having been diagnosed with CHD and undergone CR influence CHD 
patients’ perspectives regarding QoL?  
2) How do CHD individuals experience life changes after CR and what might be the 
adjustment process that follows? 
3) What concerns do CHD individuals have about life style modifications, in particular 
smoking cessation?  
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c) Part 3 (presented within Chapter 8), the integration of the findings of both components 
(interpretation) aimed to address the following research questions:  
1) How do Greek individuals with CHD conceptualize HRQoL?  
2) How do aspects of the disease experience after CR and meaning-making processes 
inform individuals’ perspectives on their HRQoL? 
 
4.1.3. Participants and recruitment  
All participating patients were recruited at the Cardiology departments of three general 
hospitals: Metropolitan (private hospital), Attiko (public hospital), Thriasio (public hospital), in 
the prefecture of Attica, Greece. The main inclusion criteria for potential participants were five: 
a) they are scheduled to undergo coronary catheterization or CABG, b) individuals have no 
previous experience of a CR, c) are aged 18 and above, d) have an adequate knowledge and 
comprehension of the Greek language, e) do not experience another serious threatening disease 
(e.g. cancer).  
A total of 487 patients were recruited between March 2010 and September 2012. All patients 
underwent either CABG or PCI and were over 18 years old.  
Fifteen participants were recruited to assist with the translation validity (e.g. clarity of 
questions and items) of the CROQ (study 1). 405 participants were recruited prior to CR, 321 of 
whom completed the 3 month follow-up (response rate 79.26%) and 291 completed the 12 
month follow-up (response rate 71.85 %). Additionally, 67 participants were recruited who had 
had their CR 3 months prior to recruitment in order to increase the sample size for the validation 
study of the CROQ-Gr. Out of these individuals 38 completed the 12 month follow-up (response 
rate for this subsample 56.72%) . The data collected from 472 participants (i.e. 405+67 please 
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see Figure 4.2) were used both in the validation study of the CROQ-Gr as well as the quantitative 
component of the mixed methods study (Part 1). A subset of 10 participants was interviewed for 
the purposes of the qualitative component (Part 2). According to Ivankova and Creswell (2006), 
the sample for Part 2, should be purposively selected in order to explain aspects of the 
quantitative findings. Therefore, the subset of these 10 participants were five typical cases of 
each type of CR treatment who had participated at all three time points measured in the 
quantitative component (Part 1) of the mixed methods study in order to understand and explain 
differences in the HRQoL level of change.   
This information is shown graphically in Figure 4.2 which demonstrates the exact number of 
participants in each part of study.  
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Figure 4.2 Flow diagram of research participants (mth=months) 
 
  
The demographic and medical information for all participants in the sample per CR type is 
given in Table 4.1. The majority of participants were male (n=371) representing 76.1% of the 
total sample. Furthermore, the vast majority lived in Athens, were married and retired from 
work. Furthermore, half of the participants had a CHD family history and almost half of them 
were smokers. Interestingly, the vast majority were slightly overweight.  
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The clinical profile of participants followed over twelve months and those lost at some point in 
the research process (dropped out or passed away) did not significantly differ (p values range 
from 0.12 to 0.75; see Appendix 4.1). Regarding demographic characteristics, individuals 
differed only in marital and occupational status (Appendix 4.1). The majority of individuals lost 
at follow-ups lived alone (p<0.01) and were pensioners (p=0.02). Also, concerning the type of 
Table 4.1 Demographic and medical characteristics of the study participants 
per CR type (n=487) 
  N(%)/Mean(SD) 
(n=487) 
N(%)/Mean(SD) 
PCI* (n=307) 
N(%)/Mean(SD) 
CABG** (n=180)  
Age (yr) 60.59(10.9) 59.68(11.44) 62.16(9.64) 
Sex (female %) 116(23.9) 72(23.5) 44(24.4) 
Place of residence (%) 
Athens 
Other big city 
Rural areas 
 
379(77.8) 
31(6.4) 
77(15.8) 
 
261(85.0) 
12(11.1) 
34(3.9) 
 
118(65.6) 
19(10.5)  
43(23.9) 
Marital status(%) 
Unmarried/living alone 
Married  
 
399(81.9) 
88(18.1) 
 
62(20.2) 
245(79.8) 
 
26(14.4) 
154(85.6) 
Educational status(%) 
6  years or less  
7-12 years (high school   
12+ years  
 
122(25.2) 
234(48.2) 
129(26.6) 
 
82(26.7) 
150(48.9) 
74(24.1) 
 
41(22.4) 
84(46.9) 
55(30.7) 
Occupational status  
Unemployed 
Public/Private servant 
Freelance 
Pensioner  
 
71(14.6) 
127(26.1) 
102(20.9) 
187(38.4) 
 
47(15.3) 
89(29.0) 
56(18.2) 
115(37.5) 
 
24(13.3) 
38(21.1) 
46(25.6) 
72(40.0) 
Risk factors (%) 
CHD family history  
Hypertension  
Cholesterol  
Diabetes 
Smoking 
BMI***(kg/m2) 
 
243(50.0) 
187(38.8) 
162(33.7) 
143(29.7) 
234(48.3) 
28.59(4.44) 
 
154(50.3) 
114(37.6) 
92(30.4) 
76(25.1) 
161(53.0) 
28.44(4.9) 
 
89(49.4) 
73(40.5) 
70(38.8) 
67(37.2) 
73(40.5) 
28.84(4.67) 
* PCI= Percutaneous Coronary Interventions **Coronary Artery Bypass Grafting 
***BMI Categories: Underweight = <18.5, Normal weight = 18.5–24.9, Overweight = 25–29.9, 
Obesity = BMI of 30 or  greater 
115 
 
coronary revascularization, the majority of individuals lost at follow-ups had undergone PCI 
(p=0.01; Appendix 4.1).  
Furthermore, it is worth mentioning that a final call two months prior to thesis submission 
(November 2014) was made to the 128 (please see Figure 4.2) patients lost at follow-ups. The 
aim of this communication was not to ask them to complete the questionnaires but rather to find 
out about their current status. Information on 71 individuals was obtained either directly from 
them or by their relatives. Out of those contacted, 11 had passed away. Thus, from the total of 
472 individuals (excluding those 15 patients who participated only in the examination of 
translation validity for the CROQ-Gr) recruited for the main study, 26 individuals had passed 
away, nine had been treated with PCI (Mage=70.22, SD=6.44) and seventeen had been treated 
with CABG (Mage=69.94, SD= 11.39).  
 
4.1.4. Material  
4.1.4.1.Measures 
Study 1 & 2 (Part 1- quantitative component) 
Coronary Revascularization Outcome Questionnaire (CROQ; Schroter & Lamping, 2004) 
The CROQ was selected based on the fact that, at the current moment, it is the only CR-
specific measurement with satisfactory psychometric properties. All versions of the original 
English version (Appendix 4.2) have a good level of acceptability (missing data per subscale 
ranges from 1 to 5%; floor effects from 0 to 2%, ceiling effects from 7 to 62% and increased 
ceiling effects are related to absence of adverse effects), reliability (internal consistency, 
Cronbach’s α ranging from 0.81 to 0.96; interclass correlation coefficient (ICC) ranging from 
0.80 to 0.93 for all scales and subscales; Schroter, 2001) and both internal validity (principal axis 
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factoring and inter-item correlations provide evidence for the proposed structure) and external 
validity (high and positive correlations between the CROQ and other measures of HRQoL such 
as the SF-36 and SAC (Schroter & Lamping, 2004)). Moreover, the CROQ has been shown to be 
more sensitive than other generic or disease specific measures of HRQoL (Schroter, & Lamping, 
2006). Also it has been validated in other languages (e.g. Italian; Pintor et al., 2002) and 
Japanese (Seki et al., 2011) indicating that it may retain its properties in cross-cultural validation. 
Thus, it might not be severely influenced by Greek cultural discrepancies. 
The CROQ developed by Schroter and Lamping (2004) is a patient-based, self-report 
instrument, specified for measuring HRQoL and health outcomes of patients undergoing CR. 
The CROQ consists of four versions (Table 4.2); one pre-PCI, one post- PCI, one pre-CABG and 
one post-CABG. The two pre-operative versions (pre-PCI and pre-CABG) are identical for the 
two procedures and capture four domains containing 32 core evaluative items and one 
descriptive item, the latter of which is not taken into account for scoring. More specifically, the 
four domains refer to: symptoms (7 items) “During the past 4 weeks, how much were you 
bothered by each of the following problems related to your heart condition?” e.g. “pain due to 
angina”; physical functioning (8 items) “During the past 4 weeks, has your heart condition 
limited you in your usual daily activities?” e.g. “Lifting or carrying groceries”); psychosocial 
functioning (14 items:  a) social functioning (4 items) “During the past 4 weeks, how often have 
you experienced the following as a result of your heart condition” e.g. “family or friends being 
overprotective toward you?”b) psychological functioning (10 items) “During the past 4 weeks, 
how often have you felt” e.g. “Worried about your heart condition?”, and cognitive functioning 
(3 items) “During the past 4 weeks, how much of the time did you” e.g. “Forget, for example 
things that happened recently, where you put things or appointments?”  
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The two post-operative versions contain the same 33 items as the pre-PCI/CABG versions as 
well as two more domains calculated from 12 (post-PCI version) or 17 (post-CABG version) 
core evaluative items. In addition, they include two items that are not taken into account when 
calculating scale scores; for example, “Since your heart operation, have you been readmitted to 
hospital for an overnight stay for any reason to do with your heart condition or heart 
operation?”. The two additional domains are adverse effects (“During the past 4 weeks, how 
much were you bothered by the following problems?”; 6 items for the post-PTCA version e.g. 
“pain in your groin wound” and 11 for the post-CABG version e.g. “pain in your chest wound”) 
and satisfaction with outcome (6 items for both versions “How satisfied are you with the” e.g. 
“Results of your heart operation?”). The CROQ subscale items are measured on 3 to 6-point 
Likert scales and then transformed into 0-100 score. Furthermore, at the end of all versions there 
Table 4.2 CROQ- Subdomains and Number of Items per scale 
Subdomain Number of items  
Common items in  pre & post - versions  PCI† CABG‡ 
Symptoms  7 7 
Physical functioning  8 8 
Psychosocial functioning  14 14 
Cognitive functioning  3 3 
Not classified  1 1 
Additional items in post - version    
Satisfaction  6 6 
Adverse effects  6 11 
Not classified  2 2 
Total  47 52 
†PCI= percutaneous coronary interventions  
‡CABG= coronary artery bypass graft surgery 
118 
 
is an open-ended question: “Is there anything else you would like to tell us about your heart 
condition or heart operation that is not covered in this questionnaire? If so please write bellow”.  
A more detailed description of items included can be seen either in Chapter 5 where the 
translation, adaption and validation of the CROQ’s Greek version will be presented or in 
Appendix 4.2. What is important to mention, by way of avoiding confusion of terms, is that the 
non-surgical procedure originally named as PTCA was changed to PCI with the developers’ 
consent in order to be in line with the scientific term widely used for non-surgical coronary 
revascularization. 
 
Short Form 36 (SF-36v2; Ware, Keller, Gandek, Brazier, & Sullivan, 1995) 
The SF-36v2 (Appendix 4.3) consists of 36 questions that are combined in eight subscales. 
Moreover, it can be combined into two component summary scales; the physical component 
summary (PCS) and the mental component summary (MCS) (Ware, 2008). It was chosen for six 
reasons. Firstly, it is a valid and reliable generic measure of HRQoL that has already been 
translated into Greek and validated (Anagnostopoulos, et al., 2005; Pappa, Kontodimopoulos, & 
Niakas, 2006). The Greek version has a good level of acceptability (missing data per subscale 
varies from 0.1 to 1.3%; floor effects from 0.6 to 16%, ceiling effects from 3 to 77%), reliability 
(internal consistency, Cronbach’s α ranging from 0.83 to 0.93 (Pappa, Kontodimopoulos, & 
Niakas, 2005)) and validity (Anagnostopoulos, Niakas, & Pappa, 2005). Secondly, as the 
literature indicates, it can be used for examining the external validity of the CROQ for two 
reasons: a) the SF-36 is a measure that has been widely used for measuring individuals’ 
subjective evaluation of HRQoL and also, has been used in examining the external validity of 
other measures (Guermazi et al., 2012; Usta et al., 2013) and b) the SF-36 has already been used 
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for testing CROQ external validity and responsiveness (Schroter & Lamping, 2006). Thirdly, the 
CROQ’s developers borrowed items from the SF-36 (especially for the physical functioning 
subdomain) indicating some similarity between the SF-36 and CROQ. In addition the developers 
adopted the SF-36 scoring system, making these two instruments straightforward to compare. 
Forthly, the SF-36 totals and summary scores can be calculated using a computer program 
meaning that the results are more trustworthy since they are free from errors in calculation. 
Fifthly, it has been used by the majority of researchers interested in patients’ HRQoL in the field 
of CR (e.g. Damgaard et al., 2011; Houlind et al., 2012; Hunt et al., 2000; Kendel, 2009; Lie et 
al., 2009; Mallik et al., 2005; Mathisen et al., 2005; Pfaffenberger et al., 2010; Rothenhäusler, 
2010; Seto et al., 2000). This is important as it facilitates comparison of the present thesis results 
and the wider literature, leading to a clearer picture about the influence of the measure used. 
Sixthly, the SF-36 as a generic measure can highlight differences in long-term patients’ HRQoL 
after CR, in a way that complements that of a disease-specific one (e.g. due to patients’ 
adjustment).     
Both instruments (CROQ and SF-36v2) measure their subscales on 3 to 6-point Likert scales. 
The total of each subscale ranges from 0 to 100  with higher scores indicating better status. 
 
 
Demographic information 
The demographic information questionnaire consisted of 6 questions: date of birth, sex, place 
of residence, family, educational and occupational status (Appendix 4.4). The specific questions 
were incorporated based on the literature that highlights these as the typical demographic 
questions that should be included in a survey (Wentworth & Chell, 2005).   
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Clinical and behavioural information 
The self-reported clinical and behavioural record consisted of 5 dichotomous questions (yes/no) 
and 2 descriptive questions. This record was developed based on the literature review (chapters 1 
and 2) and expert suggestions about behavioural and biological conditions related to CHD. The 
questions asked patients to indicate whether they had a family history of CHD and if they were 
on medication for hypertension, cholesterol, and/or diabetes. Also, there were questions on 
smoking, participants’ weight and height (in order to calculate their BMI), and finally it 
investigated if they knew the number of arteries that would be revascularized as well as the kind 
of revascularization that they would undergo (Appendix 4.5). As a number of participants did not 
know the answers to the two last questions, such information was also retrieved and/or cross 
checked with clinical records.  At this point it is essential to mention that time since diagnosis 
was not captured, mainly for consistency reasons, meaning that it would have only been possible 
to measure this variable for patients who had undergone CABG, not for patients who underwent 
PCI, as the majority of PCI individuals firstly underwent coronary catheterization as a screening 
process for a coronary heart disease. If a problem is detected doctors decide at hoc to proceed to 
a coronary revascularization through the implantation of a stent (as mentioned in Chapter 1).  
At the post-CR measurement four questions were asked. Patients were asked to state the 
exact CR procedure that they underwent (e.g. off-pump CABG, on-pump CABG, PCI with 
Metal Stent, PCI with Drug Eluting Stent) and the number of arteries revascularized. They were 
also asked if they smoked and what their weight status was.  
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4.1.4.1.1. Semi-structured interview (Study 2, Part 2- qualitative component) 
For study 2, part 2, a semi-structured interview plan was developed following Smith et al’s 
(Smith et al., 2009; Smith & Osborn, 2003) guidelines for qualitative interview. It consisted of 
thirteen open-ended questions (Appendix 4.6), developed to explore patients’ perceptions in five 
key areas: a) HRQοL in general; b) symptoms and physical functioning; c) psychosocial 
functioning; d) changes in attitude towards self and life; and e) changes in lifestyle/behavioural 
changes and how these areas might “guide” patients in making sense of their experience. Table 
4.2 displays the main questions of the topic guide. These questions were developed based on the 
theoretical framework of the definition of HRQoL adopted in the present thesis as well as on the 
longitudinal research findings. The topics were confirmed after discussion with the supervisors. 
 
Table 4.3 Main questions of the Topic Guide  
Opening questions  How would you describe your life during the last year? 
What do you think caused coronary disease? 
How would you describe yourself now? 
HRQοL in general   What does “quality of life” mean to you? 
HRQοL, symptoms and physical 
functioning area  
How do you feel about your body after CR? 
HRQοL psychosocial 
functioning area  
How do you experience your social life after CR? 
How do you feel about your heart condition? 
Changes in attitude towards self 
and life  
 
Have you observed any changes regarding the way you perceive life 
after CR?Have there been any life events (apart from CR) that have 
affected the way you perceive yourself and your life? 
Changes in lifestyle/behavioural 
changes  
 
Can you describe any changes in aspects of your lifestyle and habits 
that you made/had to make/intended to make after CR? How did you 
feel about changing (then and now)/having to change these aspects? 
Ending  
 
What would you say to an individual who now faces CR? (e.g. about 
what to expect, what life changes they may experience, how to deal 
with these) 
Is there something else that you would like to add in relation to your 
experience of CR? 
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4.1.5. Procedure 
After obtaining Dr Schroter’s (the CROQ author’s) written permission for adapting the 
CROQ into Greek, ethical approval to carry out the research studies was obtained from the 
University of Hertfordshire relevant institutional ethics committee, formerly the School of 
Psychology Ethics Committee with Devolved Authority (ECDA; Appendix 4.7). Afterwards the 
research protocol was submitted to five different general hospitals for consideration. 
Unfortunately, two out of the five hospitals approached denied access to their patients; both were 
private hospitals. Thus, approval from scientific committees of three hospitals located in Attica 
was obtained: Thriassio, Metropolitan and Attiko (Appendix 4.8).  
Before describing the whole procedure it should be clarified that of the 487 individuals 
recruited, 307 participants underwent PCI and 180 underwent CABG. Excluding 15 patients who 
had undergone CABG and took part solely in study 1 (the CROQ translation validity), the same 
sample of 472 participants participated in studies 1 and 2. Different subsets of the same 472 
individuals (307 who had undergone PCI and 165 who had undergone CABG) participated in 
different phases and completed different scales. The following paragraphs present a detail 
description.  
 
Data collection of patients recruited prior to CR  
Two set of patients was recruited prior to CR (n=405 either PCI (n=244) or CABG (n=161)). 
Recruitment of patients scheduled to undergo CABG was made one to two days before 
treatment, in their hospital rooms, as these patients enter the hospital for clinical examination 24-
48 hours prior to CR. The patients’ name and room number was provided by the clinic’s registrar 
office.  
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Recruitment of patients scheduled to undergo PCI or coronary angiography was carried out 
in the hemodynamic waiting room early on the same day prior to intervention. At this point it is 
essential to mention that often the PCI is administered ad hoc during coronary angiography. Thus 
patient recruitment was carried out mostly prior to the coronary angiography without the 
researcher being aware which patients would have a PCI until the evening when the head of the 
coronary intervention office would let the researcher know the name of patients who had 
undergone PCI.  
In both cases, a general call was made initially. This announcement included an introduction 
to the researcher, the aim of the study and the request for volunteers. It was highlighted that the 
decision regarding participation to the study would not affect medical care. Patients willing to 
participate were escorted to a private room provided by each hospital. There, the researcher both 
orally and in writing (Appendix 4.9.1) informed potential participants about the details and aim 
of the study, what was expected from them and the duration of their participation (both duration 
of the instrument administration and duration of participation in the overall studies). An 
information sheet was then given to each participant. Participants agreeing to participate signed 
the consent form (Appendix 4.10.1), being reminded that they could withdraw at any time 
without the need for providing an explanation and that this would not affect their medical care in 
any way. After that, the appropriate booklet was administered to participant. A 6-page booklet 
was administered as the vast majority of patients enrolled prior to treatment which consisted of 
the CROQ PCI or CABG pre-revascularization version, demographic and clinical information.  
A subset of patients was administered instead of the 6-page booklet, a 12-page booklet. This 
larger booklet included also the Short Form-36 (SF-36v2 Greek version). 
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The data of all these participants were used both in Study 1 and Study 2 (quantitative 
component).  
 
Data collection of patients recruited 2-5 months post CR  
Fifteen patients who had undergone CR 2-5 months earlier were recruited for the CROQ 
preliminary translation validity of Study 1. Patients were met prior to their follow-up meeting 
with their doctors. After providing introductory details, information and obtaining consent, data 
collection was carried out via face to face interviews. These individuals were required solely for 
that purpose and they were not contacted again (details for this part are presented in chapter 5).  
 
Data collection of patients recruited 3 months post CR  
Sixty-seven patients were recruited 3 months post treatment (PCI (n=63), CABG (n=4)), to 
increase the sample of post-CR versions. Patients were met prior to their follow-up meeting with 
their doctors. After providing introductory details, information and obtaining consent, they 
completed the 3-month post revascularization CROQ-Gr version (either PCI or CABG). The 
administration procedure was similar to the one mentioned for the procedure of patients recruited 
prior to CR.  
 
Data collection of patients followed up for Study 1 and Study 2 (Part 1) 
The follow-up was made 3 months and 12 months after treatment through telephone calls. An 
8-page booklet was administered both times which consisted of the CROQ PCI or CABG post-
revascularization version, and the four items of clinical information mentioned earlier (in the 
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Materials section p.120). The subset of patients recruited at 3 months post treatment was 
followed up at 12 months as well.  
The subset of patients who had completed both the CROQ and SF-36v2 Greek version prior 
to the coronary revascularization at 3 months follow up was administered a 14-page booklet 
which included again both questionnaires, at 12 months follow up only post CR 
revascularizations versions were administered.  
Also, another subset of patients, the first 20 patients (excluding those administered both the 
CROQ and SF-36v2) of each CR type (PCI or CABG) were recalled two weeks after the 3-
month phone call in order to collect data needed for CROQ-Gr validation (e.g. assessing 
reliability; an issue that will be discussed in chapter 5)   
At this point it is essential to clarify that the 3-month follow up data were used for both  
Study 1 (the CROQ-Gr validation) and Study 2 (Part 1, quantitative component) while the 12 
months follow up data were used only for Study 2.  
Also, it should be mentioned that the three-month post revascularization follow-up interval 
was selected based on the suggestions of the CROQ author who maintains that a three-month 
period is generally considered an average recovery period for the procedure. At this point only a 
minority of patients will still be experiencing adverse effects from the particular procedure 
(Schroter, & Lamping, 2004). 
  
Questionnaire administrations for Study 1 and Study 2 (Part 1)  
Sessions lasted approximately 15-30 minutes, depending on the booklet being administered 
and whether participants completed the SF-36v2 or not. The booklet with the SF-36v2 was 
administered 60 times. Initially, this was administered to every 10th patient recruited but due to 
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the amount of missing data and fear of not collecting the appropriate number in time, the SF-
36v2 was then administered to every 2nd patient. Moreover, in order to minimize order bias, half 
of the booklets first presented the CROQ and then the SF-36v2 while the other half presented the 
SF-36v2 first and then the CROQ. Furthermore, the majority of patients completed the 
questionnaire by themselves except for a few participants who asked the researcher to help them 
due to sight problems. 
All sessions were carried out by the same researcher using a standard procedure and 
standardised instructions. After the completion of the booklet, debriefing was provided both 
orally and in writing (Appendix 4.11.1), explaining the importance of the study and giving 
participants the opportunity to ask any relevant questions. All booklets were stored in a locked 
cupboard at the researcher’s office, except for the booklets completed by patients who, having 
completed the questionnaires, did not subsequently undergo PCI; these were destroyed the same 
evening after the meeting with the doctors.  
The follow up (3 and/or 12 months post treatment) of patients, as stated earlier, was made 
through telephone calls. Participants had been asked to provide their telephone number and 
suitable contact days and hours on the initial consent form. The follow-up calls were made to the 
phone number provided by the patients by a “call display” phone number where individuals 
could be aware of who is calling them, based on suggestions concerning telephone surveys 
(Streiner & Norman, 2008).  
Depending of the follow up (3 or 12 months) participants were debriefed and either were 
reminded that there would be a final telephone contact, approximately 9 months later (i.e. 12 
months post-CR), or if the call was the final one (12 months call) they were thanked for their 
participation.  
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Data collection for Study 2 (Part 2)  
Of those participating at all three time points (study 2, Part 1, quantitative component), 10 
participants were re-contacted to participate in Study 2, Part 2 (qualitative component). These 
were the first 5 CABG and the first 5 PCI patients that agreed to participate in the qualitative 
study. The main inclusion criteria were the time after revascularization, being current or ex-
smokers and the absence of other serious life threatening co-morbidities (e.g. cancer). Patients 
asked to participate should have undergone CR 12-15 months before the interview. At the 
scheduled appointment, either at the patient’s house or at the researcher’s office, patients were 
given a brief overview about the aims of the study, both orally and in writing (Appendix 4.9.2), 
and written consent was obtained (Appendix 4.10.2). All interviews were recorded upon 
participants’ approval and lasted from 45 minutes to 2 ½ hours. At the end of the interview 
patients were asked to comment on the interview (Appendix 4.12). After this, debriefing 
followed during which an information leaflet listing psychological support services (Appendices 
4.11.2 & 4.13) was given to the participants in case they felt distressed at any time. Finally, 
participants were thanked for their time, participation and willingness to share with the 
researcher their thoughts and opinions.  
4.2. Analysis  
Various analyses were for the purposes of the two studies. In the following sections, a brief 
overview of the strategies and methods of data analysis for each study will be presented.  
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4.2.1. Study 1 – Translation, adaptation and validation of the CROQ into Greek 
Concerning the translation stage a series of forward and backward translations of the 
questionnaire were conducted. Then, an expert panel revised the preliminary CROQ-Greek 
version. Afterwards, a preliminary draft of the CROQ - post CABG Greek version was piloted at 
two different hospitals prior to its wider use (details for this stage are presented in chapter 5). To 
evaluate the validity and reliability of the CROQ-Gr version, a range of analyses were performed 
following suggestions in the literature (Field, 2005). Briefly, a descriptive analysis was carried 
out in order to estimate instrument acceptability (missing data and response frequencies; ceiling 
and floor effects) and item variance. The reliability analysis was performed with the use of 
Cronbach’s α to estimate internal consistency and intraclass correlation coefficients (ICC) to 
estimate test-retest reliability. In order to check sample sufficiency, the Kaiser-Meyer-Olkin 
measure of sampling adequacy was used. Bartlett’s test of sphericity was carried out to 
determine whether the correlation matrix differed from the identity matrix (i.e. to check whether 
the correlations between items were non-zero and that therefore a factor analysis was feasible). A 
four-factor Principal Axis Factoring (PAF) extraction, set a priori, with Varimax rotation and 
coefficient suppression at 0.35 (appropriate criterion for a sample greater than 200 (Field, 2005)) 
was carried out for assessing instrument (internal) construct validity, as suggested by the CROQ 
developers (Schroter & Lamping, 2004). Zero-order correlation coefficients were calculated in 
order to test the equality of item-scale correlations and item discriminant validity. Correlations 
(Spearman’s rho) between the CROQ and SF-36 scale scores were calculated for assessing the 
CROQ’s external validity. The scoring of the SF-36 was carried out with the use of the Health 
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Outcomes Scoring Software 3.0. Statistical analyses were performed by using the Statistical 
Package for the Social Sciences (SPSS) version 20.0 (IBM, 2011).   
 
 
4.2.2. Study 2 – Part 1: Quantitative Component  
For the 2nd study, analysis was conducted with the use of mixed models and in particular, 
conditional growth models, a type of multilevel modeling (MLM) for longitudinal or repeated 
measures, in order to detect the effect of the type of CR treatment at the different time points on 
Health Related Quality of Life (HRQoL) as measured with the coronary revascularization 
outcome questionnaire (CROQ), controlling for several demographic, clinical and behavioural 
variables. Mixed models were selected because they permit detecting changes over a period of 
time (repeated measures) both within and between individuals without being affected by missing 
data in a longitudinal study due to loss of follow up or dropouts; unequal data per participant 
over time can be treated by flexible specification of the time variable and to produce aggregate-
level as well as individual-level growth curves (Kwok et al., 2008; Ntoumanis, 2014). Also, by 
treating “time” as a continuous variable instead of a discrete one can increase the statistical 
power for the detection of growth effects (Kwok et al., 2008).  
As suggested by Chen and Peace (2011) and Singer and Willett (2003) a series of models 
were tested to determine the best fitting model. All models were computed with maximum 
likelihood estimation (ML) and AR(1) (first-order autoregressive structure) where it is assumed 
that the data are continuous and the relationship between changes in variances is systematic) 
following experts guidelines (Curran, Obeidat, & Losardo, 2010; Kwok et al., 2008; Singer & 
Willett, 2003). Also, for comparative reasons, to detect the best fitting model, the Schwarz’s 
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Bayesian Information Criterion (BIC) was used (Schwarz, 1978). The BIC was selected as the 
most appropriate compared to the -2LL (negative log likelihood) criterion as it takes into 
consideration both the statistical goodness of fit and the number of parameters to estimate the 
degree of fit. When fitting models, it is possible to increase the likelihood by adding parameters, 
resulting in an overfitting model. BIC resolves this problem by introducing a penalty term for the 
number of parameters in the model (Nishii, 1984), so the conclusion based on the BIC index 
about the model fit is more conservative.  The smaller BIC value is the better the fit.  
The initial steps followed (prior to the analysis) was to calculate the Body Mass Index (BMI; 
weight/height2), restructure the data (discrete time points to become continuous; Field, 2013) and 
then change the coding of the time variable due to unequal time spacing (from 1-3 to 0-4 where 0 
represented baseline data (Time0), 1 represented 3-month follow-up (Time1) and 4 represented 
the 12-month follow-up (Time2)). To test the quadratic (nonlinear) trend over the measurement 
time points, the time variable was generated by squaring the linear term (i.e. time2=0 (baseline), 
time2=1 (3-month), time2=16 (12-month)). 
Concerning the statistical analysis, the first step was to determine the best fit for the time 
trend; time (level 1 variable) as predictor nested within individuals (level 2 variable) and within 
the response variable, CROQ Total scores. Thus, a series of mixed models were computed (this 
issue is discussed further in the quantitative study’s statistical section). The second step was to 
detect the CR type of treatment effects. The best fitted model for the Time trend was further 
investigated by adding the effect of the CR type (PCI, CABG; level 3 variable). Again a series of 
mixed models were computed to determine the best fitting model. The third step was to 
investigate further the best fitting model of step two by adding potential predictors, meaning all 
individual level covariates (time-invariant (e.g. gender, education, diabetes representing 
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individuals’ demographic and medical characteristics (as measured at a single time point) and 
time-varying (i.e. smoking and BMI representing individuals’ behavioural characteristics that 
have been updated in all three time points) with random intercept, linear and time terms. 
Included in the model were also all the two way interaction terms between those potential 
predictors with time and CR type of treatment.  
Next, the same analysis was repeated for each CROQ subdomain (symptoms, physical, 
psychosocial, cognitive functioning) as response variable. For adverse effects and satisfaction, as 
these were measured only at 3 months and 12 months post treatment, two new variables were 
created indicating the difference of each. Then multiple linear regression models were developed 
with response variables of difference in adverse effects and difference in satisfaction respectively 
in order to examine the fixed effects of all individual level covariates (time-invariant and time-
varying potential predictors).  
The level of significance was set at 0.05. Analyses were performed using SPSS 20.00 (IBM, 
2011) and the R package nlme (Baayen, 2008; Baayen, Davidson, Bates, 2008; Pinheiro & Bates 
2000; Pinheiro et al., 2016). R’s popularity has increased substantially in recent years especially 
for its graphic capability and utility for nonlinear mixed models analyses (Muenchen, 2016; 
Revelle, 2016).  
 
4.2.3. Study 2 – Part 2: Qualitative Component  
Regarding the 2nd study Part 2, the qualitative data were analysed using Interpretative 
Phenomenological Analysis (Smith et al., 2009). After the verbatim transcription of interviews, a 
four step procedure took place. The first step involved reading and re-reading the transcribed 
interviews, creating a list of words, ideas and comments in the left hand margin. The second step 
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focused on identifying emerging themes using a higher level of abstraction. At the right hand 
margin, extracted words and comments were transformed into themes. The third step involved 
listing the themes and then clustering themes that were similar or connected. At this stage, quotes 
related to each theme were attached to guarantee that the original meaning was not lost. The 
fourth step aimed to formulate super-ordinate themes that emerged from the clustering of themes. 
Then, a table of super-ordinate (master) themes was developed, followed by keywords from 
interview transcripts. After the analysis of the first interview, this process was repeated with data 
from all interviews (see in Appendix 4.14 the table of themes developed from analysis of the first 
interview). The tables of themes resulting from each transcript analysis were then compared and 
considered together for the development of an integrated table of themes (i.e. a Master table of 
themes). What is important to mention is that although all interviews were conducted in Greek, 
all analyses were conducted in English and relevant quotes have been translated as well. 
 
4.2.4. Study 2 – Part 3: Interpretation (Integration of Part 1 and 2 findings)   
In line with experts’ guidelines for mixed methods research (e.g. Hanson, Creswell, Plano 
Clark, Petska, & Creswell, 2005; Ivankova, Creswell, & Stick 2006; Onwuegbuzie & Teddlie, 
2003; Tashakkori & Teddlie 2003), the mixing occurred in two ways. The first occurred at the 
stage where quantitative results shaped the qualitative part (as shown in Figure 4.1) in terms of 
purposive selection of participants for the second part (a purposive subset of the sample) and of 
investigating in greater depth various issues that the researcher wanted to gain a greater 
understanding of. The second occurred at the integration of both quantitative and qualitative 
findings in part 3, the interpretation part, permitting to present converging, diverging and 
complementary insights (both in terms both new additional issues as well as explanation). The 
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interpretation of findings is organized in a way to address the Study 2 main research questions. 
Findings are presented within a set of themes addressing key aspects.   
 
 
4.3. Ethics  
4.3.1. Thesis  
Ethical approval was granted for the studies by the University of Hertfordshire Ethics Committee 
(ethics approval forms are presented in Appendix 4.7), and by the allied Hospitals (Attikon, Thriasio, 
Metropolitan; approval forms are presented in Appendix 4.8). This thesis has therefore considered 
and followed research ethics standards. Studies have been designed and conducted so as to respect 
participants’ dignity, privacy and autonomy and the researcher has followed specific steps for to 
protect participants’ identity, confidentiality, safety and kept the promises and agreements as stated 
both orally and in writing during the information phase. Patients were in no way misinformed nor 
was there any misconduct. The researcher has fully respected their right to refuse participation or to 
withdraw their participation without explanation and has shown due consideration to 
minimizing/dealing with patients’ potential distress or discomfort and avoiding sex and race 
discrimination. Data protection and transparency in all scientific communication (e.g. methods and 
procedures, data analysis, data report) has been handled in a rigorous manner.  
 
4.3.2. Participant information, consent and debriefing  
The first step for ensuring informed consent was made by informing potential participants about 
the aims and objectives of the research both orally and in written form by providing a Participant 
Information Sheet (Appendix 4.9). This information also included what taking part would involve, 
for how long, for how many times, how data would be stored and who would have access to it. This 
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information was provided as the basis for inviting participants to take part in the studies. After 
ensuring that participants had understood the contents of the information sheet, and agreed to 
participate they were given the consent form to read (Appendix 4.10). If they wanted to continue they 
were asked to give their written consent before the questionnaire pack was given. A signed copy of 
the consent form was given to the participant.  
To ensure that participants did not feel obliged to take part in the research, it was emphasized that 
they were under no obligation to do so and that, whether or not they decided to participate, it would 
not affect their treatment or quality of care. Participants were also informed that they could withdraw 
from the study at any point, without needing to provide reasons for doing so. Individuals unwilling to 
give informed consent were excluded from the study. Finally, they were reminded that any concerns 
they might have about their medical condition should be discussed with their doctor. 
At the end of data collection, debrief information regarding the research was provided, 
explaining the importance of the study and giving the opportunity to participants to ask any 
relevant questions. A debriefing sheet was also given in face-to-face administrations 
(Appendices 4.11). In cases of telephone contact, the standard debriefing was read. 
 
4.3.3. Confidentiality and safe storage of data 
Participants were fully informed about confidentiality and its limits. They were aware that their 
anonymised data (with pseudonyms), would be used in the write-up of the present thesis and journal 
publications. In particular, those participating in the qualitative study were informed that quotes of 
their utterances (translated versions) might be used. Moreover, they were informed that my 
supervisors would read the anonymised transcripts (with pseudonyms). Participants were also 
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informed of the limits of confidentiality, that is, that I would share information with their doctors if 
their scores indicated that they were at risk of significant distress.  
Also, participants were fully orally informed about the steps that would be taken to protect their 
data from third party access. All data were stored on a computer with restricted access protected by 
an 8-digit password at the researcher’s office. Any hard copies (consent forms or transcriptions) were 
locked separately in a cupboard at the researcher’s office accessible to the researcher only, with the 
key secured in a deposit box.  
 
4.3.4. Participants’ potential distress  
The extent of disturbance or discomfort caused by participation was expected to be minimal. 
Firstly, the content of the questionnaires mainly referred to symptoms and daily concerns related 
to heart disease, topics patients commonly discussed with health professionals when undergoing 
revascularisation. Secondly, the content of the interview schedule referred mainly to their 
perception of well being, symptoms (experienced before/now) and concerns related to everyday 
life.  
Additionally, patients were made aware that they could ask for a break at any time, had the 
right not to answer particular questions if they did not want to and withdraw at any time without 
having to give a reason for doing so.  
Also, due to my experience as a counselor and trainee health psychologist, I conducted the 
interviews (both structured and semi-structured) as sensitively as possible.  During the 
debriefing, I checked how participants were feeling, how their experience of being interviewed 
was and I advised them to discuss any concerns raised from our discussion with their doctors. 
Patients were under the care of the hospital and retained access to medical care. Also, an 
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information leaflet with daily care centers that provide psychological support services (free of 
charge) was given to patients in case they wanted to further discuss any emotional issues with an 
expert. Moreover, the local supervisor, a qualified health psychologist was at their disposal in 
case they needed psychological support. However, this never occurred.  
Given their medical status, specific actions were taken to ensure the safety and comfort of 
patients who visited the researcher’s office for interviews (study 2, Part 2). A private, air-
conditioned, fire and sound-proofed room with toilet services was available for conducting the 
interviews. In this way, patients’ security and privacy was ensured. The office was located near 
to bus and rail stations so easy access was ensured. Parking services were offered too, providing 
convenient access. During their visit, beverages and cookies were offered to patients in an effort 
to make them feel as comfortable as possible.  
4.3.5. The researcher’s safety and potential distress  
Specific consideration was given to the researcher’s safety, especially when she visited 
patients’ homes as part of data collection in Study 2, Part 2. Hospitals are protected 
environments with safeguards in place if any unusual or hazardous situation occurs. Patients’ 
home environments, however, were of unknown safety. Therefore an effort was made to 
emphasise the benefits of patients coming to the researcher’s office. Although most interviews 
did take place in the researcher’s office, in two cases participants insisted for the interviews to 
take place at their home. The researcher visited their homes, accompanied by her spouse who 
was aware of the procedure; he remained in a separate room, with closed doors, throughout the 
course of the interview and did not interfere in the process in any way. Both patients had ensured 
137 
 
there would be no distractions from other family members during the interview; they were very 
polite, friendly and tried to make the researcher feel comfortable.   
Considerations regarding any distress on part of the researcher were dealt with by discussing 
with supervisors any concerns, frustrations or distress as often as was needed or asked for. This 
did not happen often but there were times that the researcher became frustrated, for instance, 
when it was discovered that many participants had been “lost” at the yearly follow up. 
Supervisors guidance and support towards the researcher was provided and vital throughout the 
PhD.    
 
4.4. Summary of method  
This chapter provided details about the rationale for the methods used in order to achieve the 
thesis aim, namely to explore Greek individuals’ perspectives of their HRQoL after CR. Based 
on the data selected from a sample of 487 individuals, two studies were conducted and will be 
presented in the following chapters.  
After the validation of the four versions of the CROQ-Gr (Study 1) which is presented in the 
next chapter (chapter 5), a mandatory step since the study would be conducted with Greek 
patients, a mixed methods longitudinal study (actually a 3-part study) with a sequential 
explanatory research design (presented in Chapters 6,7 and 8) will help to address the study’s 
research questions. Part 1 (quantitative component), with data collection at three different time 
points and a rigorous statistical analysis (multilevel modelling) will allow to detect HRQoL 
changes as well as its pattern over a one-year period following CR with the use of the CROQ-Gr 
and exploring potential predictors. Part 2 (qualitative component) with data collected on a subset 
of 10 patients analysed using the Interpretative Phenomenological (IPA) approach may refine 
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and provide a deeper understanding by exploring participants’ point of view and experience and 
capturing their meaning-making process. Part 3, the integration of the findings for each 
component (quantitative and qualitative) at the interpretation stage, following an explanatory 
synthesis, thematically organized to present key aspects, will allow to address thesis research 
questions. 
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Chapter Five 
5. Translation, adaptation and validation of the Coronary 
Revascularization Outcome Questionnaire (CROQ) into Greek  
5.1. Introduction  
As stated in the previous chapters, in order to conduct the longitudinal mixed methods study 
with Greek patients the first step was to translate the Coronary Revascularization Outcome 
Questionnaire (CROQ) into Greek and validate its Greek version (CROQ- Gr); Part of this 
chapter is already published (Takousi et al., 2016). The CROQ is a patient-based scientific 
instrument, specifically designed for measuring HRQoL and health outcomes of patients 
undergoing coronary revascularization. This scientifically robust tool allows rigorous assessment 
of Health Related Quality of Life (HRQoL) and other health outcomes in clinical trials, 
responding to the need for specificity and sensitivity. The main objective of this chapter is to 
present and discuss the multi-step process followed for the adaptation and psychometric 
validation of the Greek version; CROQ-Gr. This chapter begins with reviewing the guidelines 
regarding a measure’s cultural adaptation and continues with presenting the CROQ English 
version.  
5.1.1. Cultural adaptation and validation of patient-based instruments  
An instrument which has already been developed, validated and thus widely used in one 
culture, is not necessarily valid and reliable in every language and culture.  Therefore, a simple 
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literal translation on the part of the researcher(s) is inadequate to achieve the goal of validation; a 
multi-step process is required. However, there is no consensus approach for the cultural adaption 
of an instrument (Acquadro, Conway, Hareendran, & Aaronson, 2008; Maneesriwongul & 
Dixon, 2004; Marquis et al., 2005; Wang, Lee, & Fetzer, 2006). The literature identifies at least 
17 methods for an instrument’s translation, cultural adaption and validation (Acquadro, Conway, 
Hareendran, & Aaronson, 2008). Among them, the most broadly discussed and followed 
guidelines are those of the American Association of Orthopedic Surgeons  (Beaton, Bombardier, 
Guillemin, & Ferraz, 2000; Guillemin, 1995; Guillemin, Bombardier, & Beaton, 1993), the 
World Health Organization (WHO (Ginieri-Coccossis et al., 2001; Nedjat, Montazeri, 
Holakouie, Mohammad, & Majdzadeh, 2008; Saxena et al., 2005; Skevington, 2002; WHO, 
2010)), the International Quality of Life Assessment (IQOLA (Bullinger et al., 1998; Gandek & 
Ware, 1998; Gandek et al., 1998; Leung et al., 2010; Li, et al., 2003; Montazeri, Goshtasebi, 
Vahdaninia, & Gandek, 2005; Montazeri, Vahdaninia, Mousavi, & Omidvari, 2009; SAC & 
Lohr, 2002; Wagner et al., 1998)), the Scientific Advisory Committee of the Medical Outcomes 
Trust (SAC (Lohr, 2002)), and finally, the Universalist Approach of  Herdman and colleagues 
(Herdman, Fox-Rushby, & Badia, 1997, 1998; Reichenheim & Moraes, 2007).  
Nevertheless, the majority of guidelines for the translation and validation of a measure agree 
upon a multi-stage procedure focusing on equivalence between the two versions (the original and 
the adapted one). It involves at least two forward translators, one or two back translators, a 
synthesis of findings, a review by an expert panel, pre-testing and a formal testing of the 
instrument’s reliability and validity (Acquadro et al., 2008). Briefly, the guidelines adopted in 
the present study are similar to the three-stage process suggested by IQOLA research team 
(Bullinger et al., 1998; Gandek et al., 1998; Ware & Gandek, 1998; Ware et al., 1995). The 
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decision for following these particular guidelines was made due to the fact that these guidelines 
were followed for the translation and validation of the SF-36 which is the most widely adapted 
instrument of HRQoL globally.  
Stage 1 involves forward and backward translations and pilot testing (Bullinger, et al., 1998; 
Gandek et al., 1998; Streiner & Norman, 2008).  
Stage 2 focuses on testing the scaling assumptions; five core assumptions should be 
explored: 1) equal item variance 2) missing data, 3) equality of item – scale correlations, 4) item 
discriminant validity and 5) reliability (DeVellis, 2003; Streiner & Norman, 2008; Ware & 
Gandek, 1998).  
Stage 3 focuses on validation, which refers to the degree to which a measure captures the 
concepts for which it was designed and ensures the uniqueness of the items’ contribution to the 
scale. Typically, three types of validity are assessed: content, construct and criterion (McDowell, 
2006; Streiner & Norman, 2008; Ware & Gandek, 1998). All types assess the degree of 
confidence that can be placed in inferences drawn from scores (Streiner & Norman, 2008).  
The relevant literature also highlights that an important aspect of a good instrument is its 
“sensitivity to change” and “responsiveness”. These terms are often used interchangeably. In 
general terms, they refer to an instrument’s ability to capture changes over time. However, there 
is a conceptual difference between these two notions (Corzillius, Fortin, & Stucki, 1999; Liang, 
2000). Responsiveness refers to a measure’s capacity to capture clinically meaningful changes 
that are important to patients or to physicians. Sensitivity to change refers to a measurement’s 
capacity to detect statistically significant change regardless of whether the change is meaningful 
to the decision-maker. This distinction is of importance because statistically significant change 
(difference) in state over time may not be synonymous with clinically important change and vice 
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versa (Kazis, Anderson, & Meenan, 1989; Pardasaney et al., 2012). A discussion of these 
guidelines can be found in Appendix 5.1  
In short, an instrument’s translation and testing its reliability and validity is a rather demanding 
procedure. The aim of this study is to detect the acceptability, reliability, and validity of the 
CROQ’s Greek versions. The following research questions will be addressed: 
1. Does the Coronary Revascularization Outcome Questionnaire Greek version (CROQ-
Gr) seem straightforward and relevant to Greek patients?  
2. Is there evidence to support the reliability of the CROQ-Gr? 
3. Is there evidence to support the validity (both internal and external) of the CROQ-Gr? 
4. Is there evidence to support that the CROQ-Gr is sensitive to change? 
 
5.2. Methods  
5.2.1. Participants 
An opportunity sample was recruited between March 2010 and September 2012 and followed 
for one year. Patients recruited were either candidates for coronary revascularization (PCI or 
CABG) or had undergone a revascularization during the study period. Details about recruitment 
can be found in chapter 4. 
5.2.2. Material 
Two instruments were used in this study: the CROQ and the Greek version of SF-36v2. Both 
of them were introduced in Chapter 4. 
Briefly, the CROQ consists of four versions; one pre-PCI, one post-PCI, one pre-CABG and 
one post-CABG. The two pre-operative versions are identical for the two procedures and capture 
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four domains containing 32 core evaluative items (symptoms, physical functioning, psychosocial 
functioning and cognitive functioning) and one descriptive item that is not taken into account 
when computing scale scores. The two post-operative versions consist of 44 (PCI) and 49 
(CABG) core evaluative items and three items that are not taken account of when computing 
scale scores. The two additional domains in the post-operative versions are adverse effects and 
satisfaction with outcome (Table 5.1). Total scores are reported on a 0-100 scale. Higher scores 
indicate higher HRQoL level. 
 
 
 
The SF-36v2TM consists of 36 questions focusing on eight areas: physical functioning (PF-10 
items), role limitations due to physical health problems (RP- 4 items), bodily pain (BP- 2 items), 
general health perceptions (GH-5 items), vitality (VT-4 items) tapping energy levels and fatigue, 
Table 5.1 CROQ- subdomains and number of items per scale 
Subdomain Number of items  
Common items in pre & post - versions  PCI† CABG‡ 
Symptoms (e.g. chest pain due to angina) 7 7 
Physical functioning (e.g. limited in moderate activities, such as 
making the bed?) 8 8 
Psychosocial functioning (e.g. family being overprotective toward 
you?) 14 14 
Cognitive functioning (e.g. have difficulty reasoning and solving 
problems ) 3 3 
Not classified (e.g. During the past 4 weeks, have you had chest pain, 
chest tightness or angina at rest? On exertion? Both?) 1 1 
Additional items in post - version    
Satisfaction (e.g. how satisfied are you with the Results of your heart 
operation  ) 6 6 
Adverse effects (e.g. sensitivity around the groin wound ) 6 11 
Not classified (e.g. Since your heart operation, have you been re-
admitted to hospital ) 2 2 
Total  47 52 
†PCI= Percutaneous Coronary Interventions  
‡CABG= Coronary Artery Bypass Graft Surgery 
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social functioning (SF-2 items), role limitations due to emotional problems (RE-3 items) and 
mental health (MH-5 items). Also it includes one item measuring health transition (Ware, 2008). 
The average score of PF, GH, RP, BP create the Physical Component Summary (PCS) while VT, 
SF, RE, MH create the Mental Component Summary (MCS). Higher scores indicate higher 
HRQoL level. Total scores are reported on a 0-100 scale. Higher scores indicate higher HRQoL 
level. 
 
5.2.3. Procedure 
A three stage procedure (described earlier) was followed in order to established the CROQ 
Greek version: 1) translation, 2) testing assumptions, 3) validation  
 
5.2.3.1. Stage I: translation  
Concerning the translation stage a series of forward and backward translations of the 
questionnaire were conducted. The CROQ was translated into Greek by two translators with 
English language qualifications, but having Greek as a mother tongue. In the forward translation 
into the Greek language, the translators were asked to focus on conceptual rather than on literal 
equivalence by considering the definition of the original term/wording and trying to translate it in 
the most appropriate way. Then, an expert panel was formed by the principal investigator, a BPS 
chartered psychologist (with English language qualifications) and an operational cardiologist 
who revised the preliminary CROQ-Greek version. Afterwards, a preliminary draft of the CROQ 
- post CABG Greek version was piloted at two different hospitals through an approximately 45-
minute face-to-face semi-structured interview in a hospital setting with patients who had 
undergone revascularization 2-5 months earlier and were having a follow-up appointment. 
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Participants were given the information sheet, which introduced the researcher and explained the 
purpose of the study emphasizing that the goal was to test the questionnaire’s suitability (Willis, 
2005). After giving their written consent, and being reminded that they could withdraw at any 
time, an interview took place with 15 patients (male 80%, n=12) with mean age M=65.73 years 
(SD=9.10), in order to evaluate the questionnaire format, the clarity of the instructions and items, 
appropriateness of wording, the content validity, and feasibility (regarding the burden on the 
respondent). 
Firstly, attention was given to the layout and appearance of the questionnaire because this 
can affect response rates (Jackson, & Furnham, 2000). For example, the colour of the 
questionnaire may influence response rates (Brennan, & Charbonneau, 2005). Therefore, an 
instrument identical to the original one was created (in terms of size, instructions, order, 
grouping of items, response categories), but in three different layouts: one printed on white paper 
with black letters and grey shading where appropriate (identical to the original one), a second 
one printed on a light purple paper with black letters and grey shading, and a third, printed on 
white paper with black letters but with coloured shading and box borders which grouped items. 
All three were presented to the participants in order to choose the most “attractive” one. 
Secondly, the clarity, relevance, and appropriateness of wording of the instructions for each 
subscale (domain), the items and their rating was investigated through verbal probing, a 
cognitive interviewing technique (Willis, 2005). 
Transcription was carried out using the Jeffersonian system (Atkinson & Heritage, 1984; 
Braun & Clarke, 2006; Jefferson 2004). This system refers to a standardized way (a coding 
scheme) of guiding verbatim transcription facilitating the conversion of oral language into 
written. Finally, the open question that the instrument contains was asked, “Is there anything else 
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you would like to tell us about your heart condition or heart operation that is not covered in this 
questionnaire?” Additionally, a brief demographic questionnaire and a short medical record 
were piloted as supplementary materials (concerning format, appropriateness of wording and 
clarity). For each participant’s answer the researcher completed a structured answer sheet as the 
literature recommends in order to make changes where items appeared difficult or misleading. 
After minor modifications by the expert panel based on the interviews’ qualitative analysis, the 
final translation back to English was conducted by two different individuals (a bilingual 
individual born in Greece backtranslated the PCI versions and a bilingual individual born in the 
USA backtranslated the CABG versions). Then it was sent to the developer in order to get her 
consent to proceed with the instrument’s psychometric evaluation.  
 
5.2.3.2. Stage II & III: testing of scaling assumptions and validation  
A total of 472 participants were given the information sheet, which introduced the researcher 
and explained the purpose of the study. After agreeing to participate in the survey, participants 
signed the consent form, being reminded that they could withdraw at any time without the need 
for an explanation. After that, participants proceeded with the tasks, depending on the procedure 
they were to undergo. The pre- PCI or CABG version was administered to the patients on a face-
to-face basis. The majority of patients completed the questionnaire by themselves except for a 
few participants that asked the researcher to help them due to sight problems. All administrations 
lasted approximately 15-30 minutes and were carried out by the same researcher using a standard 
procedure and standardised instructions. After the completion of the questionnaire, a brief 
medical record and some basic demographic data were obtained. Moreover, in order to ensure a 
high follow-up response rate where the data would be obtained by telephone, the researcher 
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followed Streiner and Norman’s (2008) suggestions regarding questionnaire administration. 
Based on these guidelines, participants who completed the questionnaire prior to their surgical 
procedure were asked to indicate contact hours that suited them.  
A few more points should be mentioned concerning the procedure of this phase. Firstly, the 
SF-36v2 (Ware & Gandek, 1998) was administered to every 2nd patient. Moreover, in order to 
avoid order bias, in half the administrations the SF-36v2 was presented first and in the other half 
the CROQ was presented first.   
Secondly, due to the fact that percutaneous coronary interventions (PCI) are administered 
mostly ad hoc during angiography, patient recruitment was made prior to the coronary 
angiography without the researcher being aware which patients would have heart surgery. Late in 
the afternoon of the same day, the head of the coronary interventional office let the researcher 
know the name of patients who underwent coronary revascularization. The questionnaires 
completed by patients who did not undergo heart surgery were destroyed on the same day.  
The first follow-up was carried out three months later by telephoning the number given by 
the patients through a “call display” phone number where individuals may be aware of who is 
calling them, based on suggestions concerning phone surveys (Streiner & Norman, 2008). The 3-
month post revascularization follow-up interval was selected based on the suggestions of  CROQ 
authors who maintain that a three-month period is generally considered as an average  recovery 
period for the procedure and only a minority of patients will still be experiencing adverse effects 
from the particular procedure (Schroter & Lamping, 2004). An update on medical record 
information was also obtained. Last but not least, the first 20 patients (excluding those 
administered both the CROQ (Schroter & Lamping, 2004) and SF-36v2 (Ware, & Gandek, 
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1998)) of each procedure (PCI or CABQ) were recalled two weeks after the 3-months procedure 
in order to collect data for checking test-retest reliability.  
 
5.2.4. Statistical analysis 
To evaluate the acceptability, reliability and validity of the CROQ-Gr, a range of analyses 
were conducted (Field, 2005; Ware et al., 1995). Tests and criteria are summarized in Table 5.2. 
 
5.2.4.1. Acceptability 
Descriptive analysis was carried out in order to estimate instrument acceptability (missing 
data and response frequencies - ceiling and floor effects) and equal item variance. Missing data 
was dealt with in line the CROQ developer’s guidance (Schroter, 2001) which is based on the 
algorithm recommended for scoring the SF-36v2 (Ware, 2007). If at least 50% of items in a scale 
were completed, a person-specific estimate (mean of the non-missing items) was substituted for 
the missing items. A missing scale score would be assigned if over 50% of the items in a scale 
were missing, as a result the case would be excluded from the analysis; however no such case 
was identified. What is important to mention is that the criterion of acceptability regarding 
ceiling/floor scores might be broken due to the fact that CR aims to increase patients’ condition; 
ceiling scores might be present.   
 
5.2.4.2. Reliability 
Scale reliability analysis was carried out with the use of Cronbach’s α for internal 
consistency and intraclass correlation coefficients (ICC) for test-retest reliability.  
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Table 5.2 Psychometric tests and criteria for the validation of the CROQ-Gr (PCI and 
CABG scales) 
Psychometric property Criteria for acceptability 
Acceptability  Missing data for scales <10% 
Low ceiling/floor values before revascularization (Streiner & 
Norman, 2008) 
Reliability  
Internal consistency 
 
 
 
 
Test-retest reliability  
 
Cronbach’s α for scales >.70 
Item-total correlations >.30  
Items discriminant validity = low to moderate zero 
correlations.  
 
ICC>.70 (Streiner & Norman, 2008; Field, 2005) 
Validity  
Content validity  
 
 
Construct validity(within scale) 
 
 
 
Construct validity (external 
criteria)  
 
Patients’ and experts opinion as well as literature review that 
items are representative of  impact of PCI/CABG 
 
Cronbach’s α for scales >.70 
Principal axis factor analysis (factor loadings≥ .35)  
Small intercorrelations between scales score 
 
moderate to strong correlations for similar constructs 
measured by each instrument 
r =.10 defined as small 
r =.30 defined as moderate  
r =.50 defined as large  (Field, 2005) 
Sensitivity to change   
 
 
Responsiveness  
Paired-t test; statistically significant change set at p<.05 
(Field,2005) 
 
Effect size (ES) calculated in accordance to Cohen’s d (post 
CR mean- prior CR mean divided by standard deviation of 
mean of prior CR  
d =.20 defined as small 
d =.50 defined as moderate  
d =.80 defined as large   
(Schroter and Lamping, 2004; Field, 2005) 
 
 
5.2.4.3. Validity 
In order to assess construct validity (within scale), beyond the Cronbach’s α, principal axis 
factoring extraction (PFA) with varimax rotation and coefficient suppression at 0.35 was carried 
out to identify the factor structure. Zero-order correlation coefficients were calculated to check 
equality of item-scale correlations and item discriminant validity.  
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In order to measure construct validity (against external criteria), correlation coefficients 
(Spearman’s rho) were calculated for assessing external discriminant and convergent validity 
between the CROQ and SF-36v2 scale scores. The scoring of the SF-36v2 was carried out with 
the use of the Health Outcomes Scoring Software 3.0 (Ware, 2007). 
 
5.2.4.4. Sensitivity to change and responsiveness 
Sensitivity to change was calculated with the use of paired t-tests. Significance level was set 
at p<0.05  
Responsiveness was detected through calculation of ES with the use of Cohen’s d index.  
Statistical analyses were conducted with the use of SPSS 20 (IBM, 2011). 
5.3. Results 
A total of 487 coronary patients were recruited between March 2010 and September 2012. 
Among them 15 patients participated only in the translation phase, whereas 472 patients 
participated in the psychometric phase. Patients’ mean age was M = 60.4 years (SD = 10.9) 
ranging from 32 to 89 and 76.1% (n = 371) were males.  Table 5.3 displays the participant 
demographic and medical features per coronary revascularization procedure.  
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Table 5.3 Demographic and medical characteristics of the study participants per CR type  
 N(%)/Mean(SD) 
(n=472) 
N(%)/Mean(SD) 
PCI* (n=307) 
N(%)/Mean(SD) 
CABG** (n=165)  
t/χ2 p Value 
Age (yr) 60.43(10.89) 59.68(11.44) 61.83(9.65) -2.16 0.031 
Sex (female %) 113(23.9) 72(23.5) 41(24.8) 0.12 0.736 
Place of residence (%) 
Athens 
Other big city 
Rural areas 
 
365(77.3) 
31(6.6) 
76(16.1) 
 
261(85.0) 
12(11.1) 
34(3.9) 
 
104(63.0) 
19(11.5)  
42(25.5) 
29,94 0.001 
Marital status(%) 
Unmarried/living alone 
Married  
 
87(18.4)  
385(81.6) 
 
62(20.2) 
245(79.8) 
 
25(15.2) 
140(84.8) 
1.82 0.213 
Educational status(%) 
6  years or less  
7-12 years (high school   
12+ years  
 
122(25.8) 
226(47.9) 
124(26.3) 
 
82(26.7) 
150(48.9) 
74(24.1) 
 
40(24.2) 
76(46.1) 
50(29.3) 
1.46 0.283 
Occupational status  
Unemployed 
Public/Private servant 
Freelance 
Pensioner  
 
69(14.6) 
123(26.1) 
97(20.6) 
183(38.8) 
 
47(15.3) 
89(29.0) 
56(18.2) 
115(37.5) 
 
22(13.3) 
34(20.6) 
41(24.8) 
68(41.2) 
5.58 0.129 
Risk factors (%) 
CHD family history  
Hypertension  
Cholesterol  
Diabetes 
Smoking 
BMI***(kg/m2) 
 
235(49.8) 
175(37.1) 
153(32.4) 
133(28.2) 
238(50.4) 
28.62(4.45) 
 
154(50.3) 
114(37.6) 
92(30.4) 
76(25.1) 
161(53.0) 
28.44(4.9) 
 
81(49.1) 
61(37.0) 
62(37.2) 
57(34.8) 
77(46.7) 
28.93(4.70) 
 
0.07 
0.04 
2.26 
4.89 
1.70 
1.13 
 
0.847 
0.505 
0.148 
0.032 
0.209 
0.260 
Methods of CR  
PCI 
Metal Stent  
Drug eluting Stent 
CABG 
Off Pump 
On Pump 
 307(65.0) 
 
117(38.1) 
187(60.9) 
 
 
 
165(35.0) 
 
 
 
 
41(24.8) 
123(75.5) 
42.7 
15.5 
 
 
41.8 
<0.001 
<0.001 
 
 
<0.001 
* PCI= Percutaneous Coronary Interventions **Coronary Artery Bypass Grafting 
***BMI Categories: Underweight = <18.5, Normal weight = 18.5–24.9, Overweight = 25–29.9, Obesity = BMI of 30 or  greater 
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5.3.1. Stage I: translation and cultural adaptation 
The translations of the two individuals with an English language qualification were almost 
identical. Two minor changes were made by the panel. The first one referred to the 2nd question 
“During the past 4 weeks how many times have you taken nitros (nitroglycerin tablets or spray) 
for chest pain, chest tightness or angina?” where the word spray was deleted as Greek 
cardiologists usually do not prescribe spray. The second change was made for the physical 
functioning domain. In this domain, it was agreed to adopt the wording of the items of the Greek 
version of the SF-36 (Papa, et al., 2006). It seemed a good solution partly because Dr Schroter 
(the author of the CROQ) had borrowed the items for this domain from the English version of 
the SF-36 and, partly, because some items appeared not to be relevant to the situation in Greece. 
For instance, it would not be appropriate to ask participants  “…has your heart condition limited 
you in your usual daily activity in moderate activities such as bowling and playing golf”, since 
the majority of Greeks do not play golf and rarely bowl.  
The preliminary questionnaire was completed by fifteen post CABG patients, with a mean 
age M = 65.73 years (S.D. = 9.10), the majority (80%, n=12) were males. This is an indication of 
the fact that more males than females undergo coronary artery bypass graft surgery. Concerning 
the questionnaire appearance, 87% of participants preferred the white-colored shading 
appearance and none chose the purple one. Regarding the CROQ’s clarity and appropriateness of 
wording 10 participants answered positively for all 52 items, 5 considered two instructions: 
“During the past 4 weeks how many times have you taken nitros for chest pain, chest tightness or 
angina?” and “During the past 4 weeks how much trouble has your heart condition caused?” as 
not clear enough. Furthermore, 5 participants suggested that two items were “not clear enough 
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and/or inappropriate”: “moderate activities (e.g. playing racquetball on the beach)” and 
“climbing several flights of stairs” from the physical functioning domain.  
All participants confirmed the clarity of the response scale. Concerning comprehension, 
analysis of the examined items showed that the majority of patients could give accurate 
synonyms indicating appropriate comprehension. Two items were misunderstood or 
misinterpreted by a few individuals. Misunderstanding appeared for the “nitros” item/question in 
the symptoms domain and “overprotection” in the psychosocial domain. Nitros were interpreted 
as ordinary pills for heart or hypertension by 7 patients. Overprotection was interpreted as a 
special care/interest from family members or friends by 8 participants.  
All these findings lead the scientific panel at its 2nd meeting to make some minor 
modifications to the questionnaire for which Dr Schroter gave her consent.  
 
5.3.2. Stage II to III: scaling assumption for PCI version  
Out of the 307 PCI patients, 76.5% (n=235) were males. At recruitment, participants’ mean 
age was M=59.68 years (SD=11.44) with a range of 32-89 years.  
 
5.3.2.1. Acceptability  
Concerning equal item variance, the SD of items in each scale was quite similar (Appendix 
5.1). Moreover, all PCI versions had good acceptability with little missing data per subscale 
(Table 5.4). With the exception of the physical functioning scale the total number of instances 
with missing data was quite small.  
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Table 5.4 Acceptability and Reliability of the CROQ-Gr PCI (pre and post versions) 
  Acceptability Reliability  
CROQ scale 
Score  
(range 0-100) 
mean (SD) 
Missing data 
(range) 
Floor / 
ceiling 
effects 
Internal 
consistency 
(Cronbach’s 
α) 
Test-retest 
(ICC) 
CROQ-PCI _pre(n=244) 
Symptoms   
(7 items) 
63.62(18.73) 2.3%(0.4-6.0) 0%/1.7% .71 -- 
Physical functioning 
 (8 items) 
56.29(28.24) 8.3%(0.8-19.0) 2.9%/20.2% .92 -- 
Psychosocial functioning  
(14 items) 
67.34(15.96) 1.1%(0.4-2.0) 2.5%/19.9% .91 -- 
Cognitive functioning 
(3 items) 
82.98(18.45) 0.5%(0.4-0.8) 0.5%/50.4% .88 -- 
CROQ-PCI _post (n=244) 
Symptoms   
(7 items) 
90.34(11.41) 0%(0-0.2%) 0%/35.3% .75 .80 
Physical functioning  
(8 items) 
89.08(14.96) 5.4%(0-18%) 1.3%/48.2% .83 .87 
Psychosocial functioning  
(14 items) 
84.51(12.13) 1.9%(0-3.6%) 0%/6.3% .84 .86 
Cognitive functioning 
(3 items) 
89.73(15.11) 1.1%(0-2.4%) 0.4%/51.8% .86 .96 
Adverse effects (6 items) 97.50(5.88) 0.6%(0.4-1.2%) 0%/77.3% .81 .89 
Satisfaction  
(6 items) 
85.99(3.85) 1.6%(0.4-5.1%) 2.8%/27.5% .77 .94 
 
The two items that demonstrated moderate to high levels of missing data were “climbing two 
or more flights of stairs” and “walking a kilometre”. This was partially expected as Greek 
individuals culturally prefer to use elevators and cars in daily life. Moreover, all subscales 
demonstrated low to moderate floor/ceiling effects with an exception of cognitive functioning 
and adverse effects. 
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5.3.2.2. Reliability  
Regarding reliability, in both pre and post PCI versions, subscales exceeded the criterion of 
≥0.70 for both internal consistency (Cronbach’s alpha) and temporal stability (test-retest, ICC; 
Table 5.3; Streiner & Norman, 2008). As for item-scale correlation (items are more strongly 
correlated with their own scale than with other scales) the criterion of correlation >0.30 was  
reached for both versions (Appendix 5.2). However, for the post procedure version a few 
symptom items demonstrated a low correlation with their subscale (r=0.17).  
 
5.3.2.3. Validity  
5.3.2.3.1. Content validity 
Content validity was evaluated during the development of the CROQ-Gr versions and in the 
preliminary and pilot studies. A review of the literature regarding patients’ quality of life and 
other health issues after coronary revascularization as summarised above, expert opinion and 
advice as well as the face-to-face interviews provided support for the content validity of CROQ-
Greek versions. In particularly, a literature overview was conducted on issues regarding coronary 
heart disease and its treatment in relation to the biopsychosocial model (BPS; Engel, 1980). Parts 
of that review are presented in chapter 1 and 2. Patients’ opinions regarding content validity were 
elicited through face to face interviews as presented in section 5.3.1. During those interviews 
individuals were asked to comment on each item regarding its relevance, clarity and simplicity. 
Furthermore, experts opinion and advice about the CROQ’s content validity was taken into 
account based on four criteria; relevance, clarity, simplicity, and ambiguity as suggested by 
Yaghmaie (2003) during two panel meetings. Specifically, the first panel meeting took place at 
Thriasio hospital prior to the patient interviews. It consisted of four individuals: an operational 
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cardiologist, a surgeon, a health psychologist and the researcher. The second panel meeting took 
place at Metropolitan hospital and consisted of six people; the same four persons as above plus a 
second operational cardiologist and another surgeon. As stated in section 5.3.1 during the first 
panel meeting relevance and clarity was discussed resulting in two changes: The first occurred in 
the 2nd question (“During the past 4 weeks how many times have you taken nitros (nitroglycerin 
tablets or spray) for chest pain, chest tightness or angina?” where the word spray was deleted as 
Greek cardiologists usually do not prescribe spray), while the he second was in relation to the 
physical functioning domain (“…has your heart condition limited you in your usual daily activity 
in moderate activities such as bowling and playing golf”; since the majority of Greeks do not 
play golf and rarely bowl, this was replaced by playing racquetball on the beach).  
The second panel meeting took place after analyzing the patient interviews. During this 
meeting each item was assessed based on the four criteria as stated above (Yaghmaie, 2003) with 
the following process: The researcher read clearly and loudly the question or the item and then 
asked panel members “do you believe that this item is a) very relevant? b) very clear? c) very 
simple? d) meaning is clear (i.e. in terms of ambiguity)?. If each member answered “yes” to each 
question then the next item was presented. In cases where one or more members of the panel 
replied “no” or raised any concerns, a brainstorming of suggestions took place with the best 
possible alternatives. When a mutually agreed change was established, the researcher made a 
note and proceeded to the next question/item. Special attention was given to items that appeared 
as not very clear from the patient  interviews even if they were very clear to panel. In these  
cases the researcher highlighted that the particular item was not very clear to patients and asked 
the panel to propose a common accepted alternative. It is important to state that the researcher 
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had the role of  meeting coordinator and kept notes; she was not involved in any decision 
making.  
Specifically, the following alterations were made as a result of the second panel meeting:  
A) Symptoms domain  
1) In the 2nd question, the word “nitros” was replaced by the word “sublingual” as 
suggested by some individuals and the cardiologist agreed.  
2) In the 4th question the word “suffering” was added in brackets as a clarification.   
B) Physical functioning domain 
1) In the 1st item the phrase “playing racquetball on the beach” was deleted as irrelevant 
2) In the 3rd item referring to “climbing several flights of stairs” the clarification “two or 
more” was added in brackets. 
C) Psychosocial functioning domain 
1) In the 1st item after the phrase “overprotective toward you” the clarification 
“overdoing” was added in brackets. 
Last but not least, both the demographic questionnaire and medical record questions were 
confirmed by all participants as clear.  
 
5.3.2.3.2. Construct validity (within scale) 
In addition to the high levels of internal consistency and intraclass correlation coefficients 
described above, additional support for the construct validity of the CROQ-Gr can be 
demonstrated from the findings of the factor analysis. A four factor solution following principal 
axis factoring (loadings ≥0.35) with Varimax rotation was selected a priori for the common 
items in the pre- and post-CR versions, as per the procedure described for the development of 
158 
 
the CROQ. For all versions, the Kaiser-Meyer-Olkin test verified sampling adequacy (KMO 
>.78) and Bartlett’s test confirmed sphericity (p<.001). Four factors had Eigen values that were 
greater than 1 and items loaded on their expected factor (Table 5.5). However, the four factor 
model of rotated squared loadings explained between 41.7% to 50.3% of the variance, depending 
on the version, implying a moderate explanatory power. Results were almost identical to the 
original English version. 
Following the original development of the CROQ, a separate PFA should be carried out in 
order to assess the construct validity of the two additional subdomains of the post-PCI version. 
Following developer instructions a second PFA was conducted (Table 5.6 shows the item 
loadings). Once again however, this only explained a relatively low percentage of variability. 
The two factor model explained 42.1% of the variance. Concerning the reliability of these two 
subdomains, a good level of internal consistency and test-retest reliability had been found (as 
demonstrated earlier in Table 5.3). 
 
Table 5.5 PFA* for CROQ-Gr PCI score items (pre and post versions)  
 Factors for pre-PCI  Factors for post-PCI 
  1 2 3 4  1 2 3 4 
Chest pain   .68    .37 .49  
Discomfort   .66     .58  
Shortness of breath   .45     .56  
Angina radiates   .54     .42  
Palpitations   .43     .48  
Sublingual per day   .19     .44  
Troubles  .51  .41     .50  
Moderate activities .59      .49 .35  
Lifting .70      .45   
Climbing two or more flights  .79      .67   
Climbing one flight .80      .61   
Bending .74      .67   
Walking a km .83      .68 .31  
Walking 100 m .85      .57   
Bathing .61      .58   
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Table 5.5 PFA* for CROQ-Gr PCI score items (pre and post versions)  
 Factors for pre-PCI  Factors for post-PCI 
  1 2 3 4  1 2 3 4 
Overprotective environment  .50    .42    
Burden on others  .38 .39   .35    
Restriction of social activities  .60    .47    
Go far from home  .55    .50    
Worried  about heart condition  .61    .65    
Worried about overdoing  .38    .54    
Worried about sudden attack  .52    .70    
Frightened by pain  .73    .65    
Uncertain about future  .69    .64    
Depressed  .61    .30    
Frustrated / impatient  .55    .48    
Enjoyment of life  .62    .69    
Positive outlook of health  .50    .64    
Plan ahead .36 .48    .31    
Reasoning and solving problems    .83     .75 
Forget    .93     .80 
Concentration    .80     .78 
*PFA=Extraction Method: Principal Axis Factoring.  Rotation Method: Varimax with Kaiser  
 
Table 5.6 PFA for CROQ-Gr PCI post version 
additional items 
 Factor 
 1 2 
Post pain in groin wound .50  
Post tenderness .55  
Post numbness or tingling .62  
Post bruising .78  
Post catheter point .57  
Post concern for bruises .80  
Post satisfaction about results .39 .41 
Post satisfaction about operation info  .78 
Post satisfaction about recovering 
info 
 .82 
Post heart condition after operation  .50 
Post recovery  .48 
Post results from heart operation  .54 
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5.3.2.3.3. Construct validity (against external criteria) 
Construct validity against external criteria was examined through the correlations between the 
CROQ-Gr and the SF-36v2 subscales (Table 5.7). Correlations between the CROQ-PCI and the 
SF-36v2 physical component summary score (PCS) at baseline were stronger for the Symptoms 
and Physical Functioning subscales than for the Psychosocial Functioning subscale. Conversely, 
correlations between the CROQ and the SF-36v2 mental component summary score (MCS) at 
baseline were stronger for the Psychosocial Functioning subscale than for the Symptoms and 
Physical Functioning subscales. The CROQ’s cognitive function domain was not expected to be 
correlated with any summary score as it is not measured by the SF-36v2.   
 
Table 5.7 Spearman rho correlation between CROQ-Gr PCI and SF-36v2 
 
CROQ –PCI scales SF-36v2  
PF RP BP GH V SF RE MH PCS MCS 
Baseline (N=50) 
Symptoms   .64** .40** .49** .50** .187 .09 .16 -.06 .64** .04 
Physical functioning  .86** .27 .48** .42** .41** .31* .26 .08 .72** .31* 
Psychosocial functioning  .27 .07 .40** .44** .70** .49** .37** .64** .36* .71** 
Cognitive functioning .16 .15 .17 .02 .17 .14 .08 .11 .18 .15 
Adverse effects  --- --- --- --- --- --- --- ---   
Satisfaction  --- --- --- --- --- --- --- ---   
3 months after heart surgery (N=45) 
Symptoms   .44** .39** .15 .26 .23 .11 -.04 .15 .42** .17 
Physical functioning  .80** .36* .26 .43** .10 .47** .08 .01 .67** .22 
Psychosocial functioning  .24 .25 .16 .42** .59** .52** .45** .76** .37* .77** 
Cognitive functioning -.16 -.28 -.12 .01 -.21 -.11 -.27 -.27 -.06 .30 
Adverse effects (chest) -.00 .33* .11 .16 .06 .08 -.06 -.06 .22 .06 
Adverse effects (leg/arm) .17 .06 -.06 -.2 -.06 .05 -.09 -.08 -.01 -.01 
Satisfaction  .44** .39** .15 .26 .23 .11 -.04 .14 .42** .17 
*Correlations between scales that purport to measure similar aspects of health related quality of life. Weak 
correlation (r ≤ 0.40); moderate correlation (0.40 < r < 0.70); strong correlation (r ≥ 70). -MCS, mental component 
summary score; PCS, physical component summary score; PCS & MCS are summaries of SF-36v2; PF=Physical 
Functioning, RP=Role Physical, BP=Bodily Pain, GH=General Health, V=Vitality, SF=Social Functioning, 
RE=Role Emotional, MH= Mental Health 
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5.3.2.4. Sensitivity to change  
A series of paired t-tests demonstrate the statistically significant difference between pre (T1) 
and post (T2) coronary intervention. As Table 5.8 demonstrates CR has a large size effect on 
PCI-CROQ scores.    
 
Table 5.8 Descriptive statistics and sensitivity to change as indicated by CROQ-Gr 
PCI between baseline and 3 months post treatment 
CROQ PCI subscales 
(n=195) 
T1 T2 t 0-
3mths 
d 
Symptoms   63.66(18.28) 90.29(12.17) 18.39** 1.46 
Physical functioning  54.84(26.96) 88.39(15.43) 17.05** 1.24 
Psychosocial functioning  62.33(16.62) 83.33(12.62) 16.45** 1.26 
Cognitive functioning 83.79(17.62) 91.08(15.09) 4.63* 0.41 
*p<0.05,  **p≤0.01 
 
 
5.3.3. Stage II to III : scaling assumption for CABG version  
Out of 165 CABG patients 75.15% (n=124) were males. Participants’ mean age was 
M=61.83 years (SD=9.65) with a range of 44-82 years.  
 
5.3.3.1. Acceptability  
Concerning equal item variance, the SD of items in each scale is quite similar. Moreover, 
both CABG versions had good acceptability with little missing data per subscale (Table 5.8). 
With exception of the physical functioning scale the total number of instances with missing data 
was quite small. The two items that demonstrated moderate to high levels of missing data are 
“climbing two or more flights of stairs” and “walking a kilometre”, as in the PCI versions. 
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Furthermore, all subscales in the pre-revascularization version demonstrated low to moderate 
floor/ceiling effects with the exception of cognitive functioning where the ceiling index is quite 
high (Table 5.9). In contrast, the post-revascularization version had elevated percentages 
suggesting ceiling effects for symptoms, physical functioning and adverse effects (leg/arm).  
 
 
5.3.3.2. Reliability  
Regarding reliability, in both the pre and post CABG versions, subscales exceeded the 
criterion of ≥0.70 for both internal consistency (Cronbanch’s alpha) and temporal stability (test-
retest, ICC; Table 5.9; Streiner & Norman, 2008). As for the item-scale correlation (items are 
Table 5.9. Acceptability and Reliability of CROQ-Gr CABG (pre & post versions) 
  Acceptability  Reliability  
CROQ scale 
Score (range 
0-100) mean 
(SD) 
Missing data 
(range) 
Floor / 
ceiling 
effects 
Internal 
 consistency 
(Cronbach’s α) 
Test-retest 
(ICC) 
CROQ-CABG _pre (n=161) 
Symptoms (7 items) 59.27 (16.84) 1.5%(0-4%) 0%/0% .80 -- 
Physical functioning (8 items) 41.36 (21.33) 7.8%(0-18%) 0.7%/0% .85 -- 
Psychosocial functioning (14 items) 71.41 (16.98) 3.5%(0-8.7%) 0%/0% .93 -- 
Cognitive functioning (3 items) 80.33 (14.97) 0%(0-0.6%) 0%/15.8% .83 -- 
CROQ-CABG _post (n=144)  
Symptoms  (7 items) 93.84 (7.95) 0%(0-0.7%) 0%/39.8% .83 .82 
Physical functioning (8 items) 89.08 (14.54) 6.4%(0-24%) 1.3%/47% .87 .97 
Psychosocial functioning (14 items) 84.95 (13.32) 1.9%(0-5.8%) 0%/6.3% .93 .95 
Cognitive functioning (3 items) 83.95 (17.13) 1.3%(0-2.6%) 0 %/7 % .92 .98 
Adverse effects (11 items)  84.19(12.74) 0.4%(0-2.6%) 0%/19.2% .84 .87 
Adverse effect chest (5 items) 76.67 (18.68) 0.4%(0-2.6%) 0%/10.7% .86  
Adverse effect leg/arm (6 items) 90.35 (13.71) 0.2%(0-2.2%) 0%/40% .87  
Satisfaction (11 items) 72.99 (22.23) 1.8%90-7.9%) 0%/5.5% .85 .94 
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more strongly correlated with their own scale than with other scales) the criterion of correlation 
>0.30 was reached for both versions (Appendix 5.2).  
 
5.3.3.3. Validity  
5.3.3.3.1. Content validity 
Content validity was assessed during the development of the CROQ-Gr versions and in the 
preliminary and pilot studies. A review of the literature regarding patients’ quality of life and 
other health issues after coronary revascularization as summarised above, expert opinion and 
advice as well as the face-to-face interviews provided support for the content validity of the 
CROQ-Greek versions. The process followed was the same as for the PCI version, as described 
in  section 5.3.2.3.1 
 
5.3.3.3.2. Construct validity (within scale) 
In addition to the high levels of internal consistency and intraclass correlation coefficients 
described above, additional support for the construct validity of the CROQ-Gr can be 
demonstrated from the findings of the factor analysis. A four factor solution following principal 
axis factoring (loadings ≥0.35) with Varimax rotation was selected a priori for the common 
items in the pre- and post-CR versions, as per the procedure described for the development of 
the CROQ. For all versions, the Kaiser-Meyer-Olkin test verified sampling adequacy (KMO 
>.80) and Bartlett’s test confirmed sphericity (p<.001). Four factors had Eigen values greater 
than 1 and items loaded on their expected factor (Table 5.10). However, the four factor model of 
rotated squared loadings explained only 50.3%-51.6% of the variance, depending on  
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Table 5.10 PFA for CROQ-Gr CABG core items (pre and post versions) 
 Factors pre- CABG  Factors post- CABG 
 1 2 3 4  1 2 3 4 
Factor 1: Symptoms           
Chest pain   .51     .64  
Discomfort   .48     .74  
Shortness of breath   .63     .53  
Angina radiates   .64     .51  
Palpitations   .47     .43  
Sublingual per day   .63 .51    .37  
Troubles    .54    .36 .65  
Factor 2: Physical functioning  
Moderate activities  .46     .69   
Lifting  .52     .56 .38  
Climbing two or more flights  .58     .80   
Climbing one flight  .66 .40    .77   
Bending  .66    .40 .50   
Walking  a km  .79     .77   
Walking 100 m  .54     .59   
Bathing  .54    .35 .60   
Factor 3: Psychosocial functioning  
Overprotective environment .63     .49    
Burden on others .62     .47    
Restriction of social activities .72     .63    
Go far from home .78     .61    
Worried  about heart condition .40     .63    
Worried about overdoing .66     .52    
Worried about sudden attack .68     .66  .37  
Frightened by pain .59     .82    
Uncertain about future .71   .39  .76    
Depressed .70   .44  .78    
Frustrated / impatient .79     .79    
Enjoyment of life .65   .46  .72    
Positive outlook of health .55   .35  .71    
Plan ahead .67     .74    
Factor 4: Cognitive functioning  
Reasoning and solving problems    .56     .86 
Forget    .68     .84 
Concentration    .80     .92 
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the version, implying a moderate explanation. For the post-CABG version, very low correlations 
were found for two items hypothesized to belong to the symptom scale; the “sublingual intake 
frequency” and “troubles”. However, these two items did not strongly correlate with other items 
belonging to a different conceptual domain. These two items were retained for clinical reasons. 
With the exception of those two items, results were almost identical to the original English 
version. 
As for the two additional scales of the post-CABG version, the Kaiser-Meyer-Olkin test 
verified sampling adequacy (KMO >.72) and Bartlett’s test confirmed sphericity (p<.001). 
However, the factor analysis did not confirm the original construct (Table 5.11).  
Table 5.11 PFA* for CROQ-Gr CABG- post version additional items  
Two factors analysis Factors  Three factors analysis  Factors  
 1 2   1 2 3 
Factor 1: adverse effects in chest    Factor 1: adverse effects in 
chest 
   
Pain in the chest wound .76   Pain in the chest wound .41  .74 
Infection in the chest wound .75   Infection in the chest wound .53  .75 
Tenderness around chest wound .67   Tenderness around chest wound   .69 
Numbness or tingling around chest 
wound 
.69   Numbness or tingling around 
chest wound 
  .84 
Bruising on chest .59   Bruising on chest   .72 
    Factor 2: adverse effects in leg 
& arms 
   
Pain in leg or arm wound   .78  Pain in leg or arm wound   .72 .54 
Any other pain in leg or arm   .59  Any other pain in leg or arm   .65  
Infection in leg or arm  .69  Infection in leg or arm  .76  
Numbness in leg or arm  .87  Numbness in leg or arm  .82 .37 
Bruising in leg or arm  .76  Bruising in leg or arm  .73  
Swollen feet or ankles   .66  Swollen feet or ankles   .64  
Factor2: satisfaction    Factor 3: satisfaction    
Satisfaction  about results .91   Satisfaction  about results .84  .40 
Satisfaction about operation info .87   Satisfaction about operation info .76  .46 
Satisfaction  about recovering info .76   Satisfaction  about recovering 
info 
.70  .36 
Heart  condition after operation .59   Heart  condition after operation .65   
Recovery  .41   Recovery  .49   
Results from heart operation .61   Results from heart operation .67   
*Extraction Method: Principal Axis Factoring. Rotation Method: Varimax with Kaiser Normalization. 
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A clear distinction between different adverse effects items was found. Therefore, a three factor 
model was carried out. In this factor analysis (Table 5.11), item loadings exceeded the criterion 
of ≥0.35. The majority of items were scaling successes. However, a probable scaling failure was 
found for an item of the adverse effects domain, the “infections to chest wound-10b” item, which 
strongly correlated with satisfaction items. The three factor model accounted for 63.7% of the 
variance. This index suggests a moderate to high explanation.  
 
5.3.3.3.3. Construct validity (against external criteria) 
Construct validity against external criteria was examined through the correlations between 
the CROQ and the SF-36v2 subscales (Table 5.12). Correlations between the CROQ-CABG and 
the SF-36v2 physical component summary score (PCS) at baseline were stronger for the 
symptoms and physical functioning subscales than for the psychosocial functioning subscale. 
Conversely, correlations between the CROQ and the SF-36v2 mental component summary score 
(MCS) at baseline were stronger for the psychosocial functioning subscale than for the symptoms 
and physical functioning subscales. CROQ’s cognitive functioning domain was not expected to 
be correlated with any summary score, as it is not measured by the SF-36v2.   
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Table 5.12 Spearman rho correlation between CROQ-Gr CABG and SF-36v2  
CROQ –CABG scales 
SF-36v2 
PF RP BP GH V SF RE MH PCS MCS 
 Baseline (N=52) 
Symptoms   .29* .56** .30* .16 .22 .28* .30* .20 .40** .29* 
Physical functioning  .71** .58** .80** .60** .21 -.01 .19 .12 .91** .15 
Psychosocial functioning  -.03 .05 .12 .06 -.10 .72** .77** .81** .05 .81** 
Cognitive functioning .23 .24 .22 -.07 .39** .40** .39** .42** .23 .54** 
Adverse effects  ---          
Satisfaction  ---          
 3 months after heart surgery (N=50) 
Symptoms   .01 -.13 .17 .42** -.06 -.15 -.22 .02 .10 -.14 
Physical functioning  .49** .20 .35* .44** .40** .21 .33* .28* .49** .37** 
Psychosocial functioning  .35* .38** .11 .03 .31* .34* .60** .38** .33* .54** 
Cognitive functioning .16 .20 .24 .03 -.03 -.10 -.06 -.23 .28* -.10 
Adverse effects (chest) -.01 .05 .11 -.07 .09 .14 .07 -.14 .04 .04 
Adverse effects (leg/arm) -.19 .17 -.08 -.12 -.02 -.07 -.14 -.36* -.03 -.17 
Satisfaction  .17 .14 .13 -.01 .16 .12 .09 .15 .17 .12 
*p<0.05    **p≤0.01 
-Correlations between scales that purport to measure similar aspects of health related quality of life. Weak correlation (r ≤ 
0.40); moderate correlation (0.40 < r < 0.70); strong correlation (r ≥ 70). 
 -MCS, mental component summary score; PCS, physical component summary score; PCS & MCS are summaries of SF-
36v2; PF=Physical Functioning, RP=Role Physical, BP=Bodily Pain, GH=General Health, V=Vitality, SF=Social 
Functioning, RE=Role Emotional, MH= Mental Health 
5.3.3.4. Sensitivity to change  
A series of paired t-test demonstrate the statistically significant difference between pre and 
post coronary intervention. As Table 5.13 shows CABG-CROQ post scores significantly differ 
from those pre revascularization. Also CABG-CROQ scores demonstrate that CR has a large 
positive effect on patients’ symptoms, physical functioning, psychosocial functioning and a low 
effect on cognitive functioning.   
 
 
 
168 
 
Table 5.13 Descriptive statistics and sensitivity to change as indicated by CROQ-Gr CABG between 
baseline and 3 months post treatment 
CROQ PCI subscales (n=119) T1 T2 t 0-3mths d 
Symptoms   60.36 (15.27) 94.29(6.83) 22.26** 2.16 
Physical functioning  41.39(19.61) 89.81(14.21) 24.62** 2.47 
Psychosocial functioning  71.46(16.13) 84.53(13.62) 6.29** 0.81 
Cognitive functioning 81.40(13.88) 84.42(17.34) 1.65 0.22 
**p≤0.01 
 
 
 
5.4. Discussion  
The aim of this study was to develop a Greek version of the CROQ (for both PCI and CABG 
procedures) and test it against rigorous scientific criteria in order to fill the gap in the literature. 
Both versions were examined at two time points: prior to coronary revascularization, and 3 
months after revascularization. 
 
5.4.1. Findings   
Results showed that the adapted Greek version of the CROQ is a practical and scientifically 
sound patient-based instrument able to measure health related quality of life and other health 
issues before and after coronary revascularization. Generally, results are promising, revealing 
that the CROQ-Gr is acceptable to patients and satisfies the majority of the rigorous 
psychometric criteria set regarding reliability, validity and responsiveness. Findings are in 
accordance with results reported by the CROQ developers (Schroter & Lamping, 2004) as well 
as with its other language adaptations; Italian (Pintor et al., 2002), Farsi (Shahali et al., 2008) and 
Japanese (Seki et al., 2010).  
However, a few issues should be highlighted in order to draw a clear conclusion regarding 
the instrument’s characteristics. These issues are related to cultural issues as well as to specific 
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psychometric aspects (acceptability, construct and concurrent validity and responsiveness) that 
may influence results. 
 
5.4.1.1. Cultural issues  
Overall, Greek people are willing to participate in a research study. Actually, occasionally 
patients perceived their inclusion in the study as a specific interest in their experience, and were 
very enthusiastic and detailed in their answers, especially during the follow-up where 
questionnaire administration was carried out over the phone.  
Moreover, when interpreting findings, cultural issues (Marquis et al., 2005) should be 
considered due to the fact they could influence the total scores obtained for each subscale, which 
in turn could influence conclusions about research questions.   
First of all, observing the scores obtained through the CROQ-Gr and by the English 
(original) version (Schroter & Lamping, 2004), scores obtained through the Greek PCI version 
were rather higher. This may be an indication of cultural discrepancy that has been reported 
before (Li, Wang, & Shen, 2003). Perhaps Greek patients do perceive their HRQoL to be rather 
“good” despite health issues. The literature indicates that patients in different cultures tend to 
selectively express symptoms as well as physical and/or psychological functioning in culturally 
acceptable ways. This is based on how people perceive, sense and articulate their physical and 
mental problems. For instance, regarding their culture, individuals might suppress upsetting 
thoughts while others might adopt a more active way of expressing and facing problems, rather 
than ignoring them (U.S. Department of Health and Human Services, 2001).  
Secondly, Greek people tend to systematically avoid physical activities. This claim can be 
supported by various studies suggesting that Greeks tend to be an inactive population. Research 
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findings reveal that the vast majority of Greeks demonstrate low physical activity and tend to 
avoid exercising, walking or running, preferring a sedentary lifestyle, driving and using the 
elevator, especially those living in urban areas (Athyros et al., 2005; Milias et al., 2006; Pitsavos, 
et al., 2006; Pitsavos, Panagiotakos, Lentzas, & Stefanadis, 2005). Between 2002 and 2005, a 
shift has been noted; many individuals, in an effort to maintain a healthy body, increase fitness or 
control their weight, have developed a more active lifestyle. This shift could be explained by the 
plethora of public educational interventions that support a “therapeutic” role of physical activity 
which took place in Greece right after its entry into the EU. However, this observation was 
mostly related to younger females (Athyros et al., 2005; Pitsavos et al., 2005) and higher income 
individuals (Tzormpatzakis & Sleap, 2007). 
Thirdly, concerning the psychological functioning scale, a few more issues should be 
considered, especially in items related to the impact of the heart condition on family and friends 
and the extent to which it has interfered with individuals’ social activities. The Greek population 
is more collectivist (Audickas, Davis, & Szczepańska, 2006), has tight family relationships and 
bonds and is more socially oriented than countries such as the UK. When a family member 
becomes ill, s/he becomes the family’s focus of attention and care. Thus the majority of 
respondents, especially male, responded automatically that they are “a lot” overprotected by 
family because the concept of overprotection seems to be the standard for family care. For 
instance, with this particular item, many participants added to their answer that the whole family 
showed intense care and concern about their heart condition, which is actually different from 
overprotection.  
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5.4.1.2. Psychometric aspects needing special attention  
5.4.1.2.1. Acceptability and Scoring  
Generally, the CROQ-Gr is an instrument that is easily completed and accepted by patients. 
However, regarding acceptability, a great number of missing values were observed for physical 
functioning in all versions, in all intervals. The most commonly missing items were related to 
“Climbing two or more flights of stairs”, “and “Walking 1 km”. This observation could be 
related to the complexity of the questions and/or cultural issues as discussed elsewhere. 
In terms of the complexity of the questions, an issue emerging from both the qualitative and 
quantitative parts of the study is whether the “walking” questions referred to walking on a flat 
surface or uphill. When the particular inquiry was made, the researcher suggested a flat surface. 
Nevertheless, fundamental problems may be present due to this uncertainty. When participants 
respond to these questions without clarification, having in mind one or the other situation, they 
may answer differently, creating inconsistency, or do not answer the question at all due to 
confusion and producing missing data. It essential to point out that when participants had the 
opportunity to ask, they stated limitations when walking uphill but not on a flat surface. These 
concepts suggest the need to reduce confusion. Upon resolving this problem instrument 
acceptability, content validity and sensitivity to change could become even stronger.  
Concerning the scoring, the CROQ scoring is time consuming, especially for missing data, 
compared with other instruments (e.g. SF-36v2). The development of software would resolve 
this difficulty. For instance, using the software for the SF-36v2 scoring and total score 
calculation is very easy; calculations and transformation are automatically done in a few minutes. 
Moreover, with the use of software, human errors in both data entry and scoring are minimized 
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as data are inserted in the data sheet through completing an electronic form (Saris-Baglama, et 
al., 2009).  
 
5.4.1.2.2. Construct validity  
Regarding construct validity, results should be interpreted keeping in mind that the four 
factor model at all time-points explained only a moderate variability in scores in both the PCI 
and CABG versions. In both the PCI and CABG versions, the most “problematic” item for both 
pre and post operation version was in the symptoms scale, “sublingual intake frequency”. One 
could suggest its exclusion (Zhang et al., 2013). However, it was retained for clinical reasons. 
Moreover, a few other “problematic” items with a probable scaling failure in the CABG version 
are related to “troubles faced due to the health condition” in the symptoms scale and “bending” 
in the physical functioning scale.   
The researcher made a great effort to recruit as many CABG patients as possible. However 
the mission became more and more difficult as fewer and fewer coronary surgical procedures are 
carried out in the allied hospitals.  This phenomenon might be partly explained by the financial 
crisis existing in Greece leading to cut in the public health system. In many cases hospitals do 
not have the resources or the necessary personnel to proceed with such operations (Efthimiadou, 
2012). In some others EOPYY (the national health insurance agency) cannot afford the cost 
(Efthimiadou, 2012). Another reason for the reduction in the number of bypasses might be 
related to the technological and scientific advances in the field of heart surgery. A great number 
of coronary bypasses are made through Minimally Invasive Direct Coronary Artery Bypass 
(MIDCAB; discussed elsewhere). Evidence based findings suggest that MIDCAB surgery is 
preferred when a bypass for one or two coronary arteries is required as it results in less pain after 
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surgery, a shorter hospital stay, a faster recovery, an earlier return to work and fewer 
complications while conventional CABG is indicated for bypassing three or more arteries (Eagle 
et al., 1999).  Therefore, coronary patients may decide to undergo MDDCAB instead of 
traditional CABG.   
Finally, another interesting finding was related to adverse effects. In the Greek CABG 
version a clear division was revealed between problems related to chest wounds and problems 
related to leg/arm wounds. However, for reasons of consistency with other CROQ adaptations it 
is kept as one.  
 
5.4.1.2.3. Construct validity based on external criteria 
Regarding validity based on external criteria, the present study showed that the PCS score of 
the SF -36 correlates with the CROQ scales symptoms and physical functioning, and that the 
MCS score of the SF-36v2 correlates with the CROQ’s psychological functioning scale. 
However, item-total correlations did not show strong correlations (e.g. for symptoms); an issue 
that was present also in the Japanese version (Seki et al., 2010). This raises various concerns and 
highlights the need for further testing. However, this problem might be present due to two crucial 
reasons. The first one is the small sample size (< 50). The second explanation may lie in the fact 
that these two tools do not measure exactly the same constructs. For instance, the CROQ 
symptoms or physical functioning scale is unlikely to correlate with the SF-36v2 Bodily Pain 
subscale as coronary revascularized individuals, especially those who undergo a PCI treatment, 
may experience angina or dyspnea over a one-year period, but they do not experience bodily 
pain. It is not unexpected that the biggest correlation between the two measures exists for the 
physical functioning scale which contains many similar items. Nevertheless both measures aim 
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to demonstrate quality of life, but the CROQ is a condition-specific measure while the SF-36v2 
is a generic measure. Thus, they emphasise different issues.  
 
5.4.2. Strengths and Limitations  
Concerning the study’s limitations, a few methodological issues should be highlighted. These 
issues are mostly related to the mode of administration, the sample size and the establishment of 
validity.   
 
5.4.2.1. Administration mode  
The present study used a different mode of administration compared to the original one. 
Instead of mailed or self administration, it used self-administration prior to revascularization and 
telephone administration in post-revascularization follow-up. The high response rate at both time 
points suggests that the particular mode is rather acceptable to the Greek population. As experts 
maintain (Bowling, 2005) a trained and friendly interviewer (although financially more costly 
relative to mail) is able to obtain a greater response rate, observe various issues to inform 
questionnaire improvement and rephrase a question when it is not comprehended as long as s/he 
uses the same vocabulary in all cases of rephrasing the same item. Of course, it should be 
pointed out that responses could be affected by interviewer biases, respondent social desirability 
biases (Bowling, 2005) or interviewer characteristics (e.g. age and sex (Moun, 1998)).  
 
5.4.2.2. Sample and analysis issues  
First of all, the results of the present study should be interpreted with caution and cannot be 
generalized (Streiner & Norman, 2008). The sample is not large and not random (<300 
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participants per measurement and the vast majority of them Attica residents). In some analyses 
for some versions the sample size was rather low. This may affect the results. Furthermore, 
another systematic error that may be present is selection biases. Selection biases refer to different 
characteristics of those who are selected and those who are not (Streiner & Norman, 2008; 
Sutton & French, 2004). For instance, severely ill individuals were excluded. Moreover, some 
individuals may have been more willing to participate as their doctor had informed them about 
the research during their last contact, so they had more time to consider their participation. Also, 
some patients were approached on the basis of clinician recommendations who believed that they 
might like to participate. The latter issue, in addition to the good level of response rate may raise 
concerns regarding social desirability bias (i.e. the tendency of participants to answer in a way 
that they can be viewed favourably by others; Miller, 2012). This in turn, may have influenced 
the validity of the results (Streiner & Norman, 2008). Furthermore, regarding content validity, 
although the researcher made an effort for the CROQ-Gr to be assessed by both patients and the 
expert panels, it might have been better to have kept a more detailed record in order to be able to 
measure and present judge agreement in a quantitative way too. The lack of such data may raise 
some concerns about the accurate assesssmnet of the content validity (Yaghamie, 2003; Waltz & 
Bausell, 1983) of the CROQ- Gr version.  
Concerning its strengths, it should be mentioned that the study has involved rigorous 
scientific criteria for the psychometric evaluation of the CROQ-Gr version highlighting few 
weaknesses which can influence questionnaire construct validity. Additionally, this study 
demonstrates that the CROQ-Gr can be administered in a different way referring to interviewer 
administration as well as mailed or self administration that were used in previous international 
studies. Finally, the present study has recruited patients with different ages, sexes and marital, 
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occupational and educational status. This implies that this disease-specific instrument, although 
not adjusted for demographic variables, is feasible and sensitive to detect improvement (if any) 
of HRQoL across a wide demographic. Finally, sensitivity analysis showed that the CROQ-Gr is 
somewhat more sensitive in detecting certain kinds of problems tailored to patients undergoing 
coronary revascularization compared to a generic measure of HRQoL. Thus, the use of the 
CROQ-Gr could allow researchers and clinicians to draw a more precise conclusion in relation to 
overall quality of life of this particular population.  
 
 
5.4.3. Implications/recommendations   
The findings of the present study have a number of important implications. From a 
theoretical point of view this study supports Schroter and Lambing’s (2004) findings that suggest 
that the HRQoL concept in CR can be measured through four different aspects (symptoms, 
physical, psychosocial and cognitive functioning). However, it should be borne in mind that the 
PFA of the CROQ-Gr was carried out on the same items as in the original CROQ and different 
factors may have emerged with the inclusion of different items. In other words, there may be 
other factors that are potentially important (e.g. emotional growth) that may have influenced the 
outcome but for which there are no relevant items in the CROQ. The measurement of these 
aspects could allow a clearer understanding of the effect of coronary revascularization and help 
to determine the impact of other factors (e.g. individual characteristics such as age and sex or co-
morbidities such as diabetes) on outcomes following interventions, thereby enhancing clinical 
interpretability. For instance, the literature suggests that males benefit more compared to females 
in terms of general HRQoL after PCI (Blankenship et al., 2013). However, since no other 
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disease/treatment-specific instrument incorporates symptoms, physical, psychosocial and 
cognitive functioning and detects post-treatment adverse effects, this conclusion might not be 
warranted. Thus, future research should include the CROQ in order to be more confident in 
conclusions that would enhance best practice. 
Regarding suggestions for further research, the development of a shorter version could be 
very helpful for reducing respondent burden and increasing data quality (Bowling, 2005),  
especially when research aims to explore many related issues (e.g. personality, mood) and thus 
may use many instruments. The adaptation of the CROQ-Gr to be relevant to other CR 
procedures such as MIDCAB or robotic CR would be in line with recent medical developments 
and thus would allow investigation of their impact on patients’ well-being. Also, the 
investigation of alternative modes of administration is needed in order to increase the utility of 
CROQ. The development and testing of different forms of administrations such as online or via 
smartphone might also be useful. An electronic online form may increase participation, 
especially in post-revascularization follow-ups of patients with physical or time restrictions, as 
an online form can be completed from any location and at any time as long as the patient has 
access to the internet. The expansion into smartphone administrations could help doctors get an 
instant picture of their patients’ HRQoL in everyday practice, avoiding time-consuming 
calculations, or else help researchers to get instant snapshots of each subdomain of HRQoL.  
Concerning practice, health professionals may use the CROQ for a number of reasons: a) for 
gaining a better understanding of the patient’s experience which in turn will facilitate doctor-
patient communication and promote the collaboration of doctor and patient in treatment 
decisions; b) for drawing a clear conclusion about a patient’s condition and disease burden; c) for 
measuring disease severity and to make decisions about whether a patient should be referred to 
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an interventional/surgery cardiologist for revascularization treatment; and d) for assessing 
effectiveness of rehabilitation. 
 
 
5.5. Conclusion 
As the Greek version of the CROQ (GROQ-Gr) is a practical and a scientifically rigorous 
instrument, its use in clinical trials could allow forming a clear and detailed picture about 
patients’ HRQoL and health outcomes after coronary revascularization. Therefore, it can be used 
in the data collection for exploring the quantitative research questions investigated in study 2. 
Furthermore, in health settings, it could be used as a single tool by cardiologists in order to 
capture and record their patients’ health outcomes following their operation. Finally, researchers 
with an interest in patients’ HRQoL undergoing coronary revascularization should be 
encouraged to make use of the CROQ either solely or in combination with generic measures for 
more appropriate monitoring.  
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Chapter Six 
6. Study 2, Part One, The influence of Coronary Revascularization on 
Patients’ Health Related Quality of Life over a one year period 
6.1. Introduction 
The systematic review with the meta-analysis (chapter 3) has revealed that people who have 
undergone CR experience greater improvement in their Quality of Life than those treated with 
medication. Taking health as a whole, it could be commented that CR would seem to maximise 
improvement in health. However, the heterogeneity in the findings and methods used by various 
studies did not allow the investigation of factors that positively or negative influence the 
outcome (e.g. demographic or clinical characteristics). One factor that contributed to the 
heterogeneity was the type of HRQoL instrument used. Most studies used a generic measure. 
However, as argued earlier, the use of a disease-specific instrument may provide more insightful 
results and, thus, allow drawing a more accurate conclusion. Therefore, one of the main goals of 
this study is to provide a longitudinal examination of the level of change of patients’ HRQoL 
after CR with the use of a disease-specific instrument, and discuss the results in relation to 
previous evidence.  
Furthermore, the duration of follow-up varies dramatically among studies. A great number of 
studies draw conclusions with a short or middle term follow-up (1-11 months). This however 
may affect conclusions about the level of change of patients’ HRQoL after CR.  Studies with a 
longer follow-up (e.g. 12 months or greater) demonstrate a lower level of improvement after CR 
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than those with a shorter one. This suggests that in order to be able to draw a more appropriate 
conclusion, at least a 12-month follow-up should be obtained. Moreover, due to the differences 
between short- and long-term follow-up) in the change in patients’ HRQoL after CR, a 
longitudinal study with data collection prior to treatment (missing for most of the studies) and 
more than 1 month follow-up could help predict the pattern of improvement over one year. 
Therefore, another goal of this study is to detect not only the extent of change at 3 months (a cut 
point for short-term measurement suggested by many researchers, e.g. Schroter et al., 2004), and 
at 12 months (long-term), but also to identify the pattern of change over 1 year period.   
Also, few published studies make comparisons regarding the extent of change of HRQoL 
(overall and its dimensions) between different types of CR; the majority of them focus either on 
the CABG or PCI procedure. This in turn, along with the great heterogeneity in design among 
them, does not allow health care professionals to draw confident conclusions about the beneficial 
or harmful aspects of each treatment, which is a crucial aspect for both doctors and patients (e.g. 
for making treatment suggestions, adequately inform patients about the pros and cons of 
treatment and allowing them to make informed decisions). Thus another aim is to investigate 
whether there are differences in levels of change in patients’ HRQoL (overall and its dimensions) 
between the two types of CR.  
Moreover, many studies only present the range of the sample’s demographic and clinical 
features; that is, they do not present any analysis or adequate data to determine whether these 
factors may influence the outcomes. Therefore, another goal is to investigate the effect of a 
variety of demographic and clinical features on the outcomes.   
To this end, the present study has incorporated a number of features discussed above to 
improve the research design, and addresses the following research questions:  
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1) What is the trajectory of change in HRQoL over a one-year period post CR? 
2) Does the type of CR influence the level of change? 
3) What are the predictors of change in HRQoL over a one-year period?  
4) What is the trajectory of change in HRQoL specific aspects (symptoms, physical, 
psychosocial, cognitive function) and what are the predictors of change in each 
subdomain?  
 
 
6.2. Methods  
6.2.1. Design 
A longitudinal design was employed for the aims of the present study. Data collection was 
carried out from March 2010 to September 2013 with data collected from each participant at 
three different time points; immediately prior to CR (PCI or CABG) and then 3 and 12 months 
post treatment.  
 
6.2.2. Participants 
In total, 472 (307 PCI and 165 CABG) coronary patients were recruited. In particular, 405 
participants were recruited prior to CR (baseline, T1) while 321 completed the 3 month follow-
up (T2, response rate 79.26%) and 291 completed the 12 month follow-up (T3, response rate 
71.85 %). Additionally, 67 participants who had had their CR 3 months prior to recruitment were 
included (T2) and, out of these individuals, 38 completed the 12 month follow-up (T3 response 
rate for this subsample 56.72%). Thus, T1 includes 405 individuals, T2 includes 388 individuals 
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and T3 includes 329 individuals. Figure 6.1 illustrates sample size per type of CR and 
measurement time point. 
 
 
Figure 6.1 Flow diagram showing research participants per CR type and measurement time 
point. T1= prior to treatment, T2= 3 months after treatment, T3= 12 months after treatment 
 
The demographic and clinical characteristics of participants per type of CR have been 
presented in chapter 5, Table 5.3. Briefly, the sample represents a normal proportion of smokers 
while there is higher proportion of diabetes and overweight individuals compared to the general 
population (WHOQOL group, 2008). Furthermore, the demographic clinical and behavioural 
features only significantly differ between individuals treated with CABG and PCI with respect to 
average age and diabetes condition. The mean age of individuals treated with CABG was a little 
bit higher compared to patients treated with PCI while a higher proportion of individuals with 
diabetes underwent PCI.  
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6.2.3. Materials 
For the present study as presented in the Methods chapter (Chapter 4) three questionnaires 
were used: the Greek version of the Coronary Revascularization Outcome Questionnaire (CROQ 
(Schroter & Lamping, 2004)), a questionnaire capturing demographic characteristics and a 
questionnaire capturing individuals’ clinical and behavioural features.  
As demonstrated in chapter 5 of the present thesis, the CROQ-Gr is a valid and reliable 
disease-specific questionnaire that evaluates HRQoL and health outcomes before and after the 
two common operational heart procedures; Percutaneous Coronary Interventions (PCI) and  
Coronary Artery Bypass Graft Surgery (CABG).   
 
6.2.4. Procedure 
After obtaining ethical approval to carry out the research by the University of Hertfordshire 
relevant institutional ethics committee, formerly the School of Psychology Ethics Committee 
with Devolved Accountability (ECDA; Appendix 4.7) potential participants were approached. 
Initially, a general call for participants was made in hospital settings (after obtaining ethical 
approval from the scientific committee of participating hospitals). This announcement included 
an introduction to the researcher, the aim of the study and the request for volunteers. It was 
highlighted that the decision regarding participation in the study would not affect their medical 
care. Patients willing to participate were escorted to a private room provided by each hospital. 
There, the researcher both orally and in writing (Appendix 4.9.1) informed potential participants 
about the details and aim of the study, what was expected from them and the duration of their 
participation. Participants agreeing to participate signed the consent form (Appendix 4.10.1), 
being reminded that they could withdraw at any time without the need for providing an 
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explanation and that this would not affect their medical care in any way. After that, the 
appropriate booklet was administered to participants. A 6-page booklet was administered to the 
vast majority of participants enrolled prior to treatment which consisted of the CROQ PCI or 
CABG pre-revascularization version, demographic and clinical and behavioural (e.g. smoking) 
information. A subset of participants were recruited 3 months post treatment. These patients 
were met prior to their follow-up meeting with their doctors. The procedure followed was 
identical to the one described above.  
The follow-up was made 3 months and 12 months after treatment through telephone calls. An 
8-page booklet was administered at both times consisting of the CROQ PCI or CABG post-
revascularization version, and questions regarding medical and behavioural information to 
update patient information.  Sessions lasted approximately 15-30 minutes, depending on the 
booklet being administered and were carried out by the same researcher using a standard 
procedure and standardised instructions. All booklets were stored in a locked cupboard in the 
researcher’s office, except from approximately 120 booklets completed by patients who did not 
subsequently undergo PCI; these booklets were destroyed the same evening after a meeting with 
doctors which clarified that these patients had not undergone the procedure. At the last follow-
up, participants were debriefed and thanked for their participation.  
For further information about the procedure followed please see the Method section in 
Chapter 4 where a detailed description of the recruitment and data collection process is 
presented.   
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6.2.5. Statistical analysis 
Analysis was conducted with the use of mixed models and in particular, conditional growth 
models, a type of multilevel modeling (MLM) for longitudinal or repeated measures, in order to 
detect the effect of the type of CR treatment on health related quality of life (HRQoL) as 
measured with the coronary revascularization outcome questionnaire (CROQ-Gr), for the 
different time points, controlling for several demographic and clinical variables. Mixed models 
were selected because they permit detecting changes over a period of time (repeated measures) 
both within and between individuals without being affected by missing data in a longitudinal 
study due to loss of follow-up or dropouts; unequal data per participant over time can be treated 
by flexible specification of the time variable and produce aggregate-level as well as individual-
level growth curves (Kwok et al., 2008; Ntoumanis, 2014). Also by treating “time” as a 
continuous variable instead of a discrete one can increase statistical power for the detection of 
growth effects (Kwok et al., 2008).  
A series of models were initially tested as suggested by Chen and Peace (2011) and Singer, 
& Willett (2003) in order to determine the best model. All models have been computed with 
maximum likelihood estimation (ML) and AR(1) (first-order autoregressive structure) where it is 
assumed that the data are continuous and the relationship between changes in variances is 
systemic) following guidelines reported in the literature (Curran, Obeidat, & Losardo, 2010; 
Kwok et al., 2008; Singer & Willett, 2003). Also, for comparative reasons, in order to detect the 
best fitting model, Schwarz’s Bayesian Information Criterion (BIC) was used (Schwarz, 1978). 
The BIC was selected as the most appropriate compared to -2LL (negative log likelihood 
criterion) as it takes into consideration both the statistical goodness of fit and the number of 
parameters to estimate the degree of fit. When fitting models, it is possible to increase the 
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likelihood by adding parameters, resulting in an overfitting. BIC resolves this problem by 
introducing a penalty term for the number of parameters in the model (Nishii, 1984), so 
conclusions based on the BIC index about the model fit are more likely to be accurate.  The 
smaller BIC value the better the fit.  
The initial steps followed (prior to the analysis) was to calculate the participants’ Body Mass 
Index (BMI; weight/height2), restructure the data (discrete time points to become continuous; 
Field, 2013) and then change the coding of the time variable due to unequal time spacing (from 
1-3 to 0-4 where 0 represents baseline data (Time0), 1 represents 3-month follow-up (Time1) 
and 4 represents the 12-month follow-up (Time2)). To test the quadratic (nonlinear) trend over 
the measurement time points, the time variable was defined by squaring the linear term (i.e. 
time2=0 (baseline), time2=1 (3-month), time2=16 (12-month)). 
Concerning the statistical analysis, the first step was to determine the best fit for the time 
trend; time (level 1 variable) as a predictor was nested with individuals (level 2 variable) and 
with the response variable CROQ Total scores. Thus, a series of mixed models were computed. 
In particular, six models were compared: (1) Model A represents ordinal linear least square 
regression with Time as a predictor, (2) Model B = Time as a predictor with random intercept, 
(3) Model C = Time and Time2 as predictors with random intercept, (4) Model D = Time and 
Time2 as predictors with random intercept and linear term, (5) Model E = Time and Time2 as 
predictors with random intercept and quadratic term, (6) Model F = Time and Time2 as predictors 
with random intercept, linear and quadratic terms. In all models the response variable was CROQ 
Total scores.  
The second step was to detect the CR type of treatment effects. Thus the best model 
regarding Time trend was further investigated by adding the effect of CR type (PCI, CABG; 
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level 3 variable). Again in order to detect the best  model 3 different models were computed and 
compared: (1) Model 1= Time, Time2 and CR type of treatment as predictors with random 
intercept, linear and quadratic terms (i.e. no interaction between Time and CR type of treatment 
or Time2 and CR type of treatment), (2) Model 2= Time, Time2, CR type of treatment and Time 
x CR type of treatment interaction as predictors with random intercept, linear and quadratic terms 
(i.e. an interaction term only between Time and CR type of treatment), (3) Model 3= Time, 
Time2 Type of treatment, Time x CR type of treatment interaction, and Time2 x CR type of 
treatment interaction as predictors with random intercept, linear and quadratic terms (i.e. an 
interaction term between Time and CR type of treatment and between Time2 x CR type of 
treatment). In all models the response variable was CROQ Total scores.  
The third step was to investigate further the best model of step two by adding potential 
predictors, meaning all individual level covariates (time-invariant (e.g. demographic and medical 
characteristics) and time-varying (i.e. smoking and BMI representing individuals’ behavioural 
characteristics that were updated in all three time points) with random intercept, linear and time 
terms.  Included in the model were also all the two way interaction terms between those potential 
predictors with time and CR type of treatment.  
Next, the same analysis was repeated for each CROQ subdomain (symptoms, physical, 
psychosocial, cognitive functioning) as the response variable. For adverse effects and 
satisfaction, as these were measured only at two time points, 3 months and 12 months post 
treatment, two new variables were created indicating the difference in each case. Then multiple 
linear regression models were developed with the response variables adverse effects difference 
and satisfaction difference respectively in order to examine the fixed effects of all individual 
level covariates (time-invariant and time-varying potential predictors). The level of significance 
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was set at 0.05. Analyses were performed using SPSS 20.00 (IBM, 2011) and the R package 
nlme (Baayen, 2008; Baayen, Davidson, Bates, 2008; Pinheiro, & Bates 2000; Pinheiro et al., 
2016). The popularity of R has increased substantially in recent years especially for its graphic 
capability and utility for nonlinear mixed models analyses (Muenchen, 2016; Revelle, 2016). 
Concerning reporting in relation to the best fitting model, for fixed effects beta values (B; the 
mean values of the coefficient) and standards errors (SE) are reported, while for random effects 
standard deviations (SD) are reported showing the level of variability. For the final growth 
models in addition to B and SE, t statistics, p values, and CI (95% confidence interval; lower-
upper) values are reported.  
 
6.3. Results  
Regarding behavioural changes, smoking status was reduced by 74.79% (178 individuals quit 
smoking) 3 months post treatment. McNemar’s test indicated that there was a significant 
difference in the percentage of participants who stopped smoking between CABG patients and 
PCI (p<0.001). A greater percentage of CABG (98%) patients compared to PCI patients (63%) 
quit smoking 3 months after treatment. However, at 12 months, a 17.5% (n=31) relapse in 
smoking cessation was observed one year post treatment. In fact, 27 individuals treated with PCI 
and 4 people treated with CABG started to smoke again between the 3rd and 11th month post 
treatment. Moreover, a minor increase in BMI was observed between baseline and 12 months 
post treatment (Mdifference=0.56, SD=3.36) with no essential difference between groups 
(approximately 100 grams). This observation suggests that participants were overweight prior to 
treatment (Table 5.3) and one year post treatment instead of losing weight they had gained a few 
grams.   
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Moreover, in the open ended questions in the CROQ where participants were asked “is there 
anything else you would like to tell us about your heart condition or heart operation that is not 
covered” 27.8% (n=131) of participants made a comment. The comments were related to 
concerns about various stressful issues and their effect on their heart condition. In fact, of those 
answering this question, 62.6% (n=82) mentioned financial issues and fear of unemployment, 
22.1% (n=29) mentioned family issues (e.g. problems in their relationship with a member of the 
nuclear family), and 15.3% (n=20) mentioned other health problems. Table 6.3 displays the type 
and frequency of issues (based on keywords) extracted from participants’ response to the CROQ 
open-ended question mentioned.  
 
 
Table 6.3. Participants’ responses to the CROQ open-ended question 
(n=131) 
Life stressors  Subtype  N (%) 
Financial stress 
Unemployment 13 (9.9) 
Low salary 15(11.5) 
Reduction in pension  19(14.5) 
Salary not paid on several occasions  31(23.6) 
Medical expenses  4 (3.1) 
Family issues 
Bad communication with offspring   6 (4.6) 
Bad communication with partner  11(8.4) 
Recent divorce  3 (2.2) 
Bad communication with parents  1 (0.8) 
Health problem of a family member 5 (3.8) 
Death of a member of the nuclear family  3 (2.3) 
Health related issues 
Diabetes 8 (6.1) 
Frozen shoulder  1 (0.8) 
Cholesterol  2 (1.5) 
Smoking  5 (3.8) 
Increased weight  4 (3.1) 
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6.3.1. CROQ Total scores over a one-year period 
The descriptive analysis of the CROQ Total scores indicated an increase over a one-year 
period. Table 6.3.1 displays participants’ mean scores on CROQ Total over a one-year period in 
overall and by the CR type of treatment for all individuals characteristics measured; the mean 
scores of all groups after CR treatment have increased.  
 
 
Table 6.3.1 Descriptive statistics for CROQ Total scores per CR type over a one-year period (n=472)    
CROQ Total 
Type of CR 
PCI   CABG 
index   index 
T1 T2 T3   T1 T2 T3 
Overall    Mean 67.56 88.42 86.62   63.09 88.18 88.93 
  SD 13.54 9.38 9.34   12.13 7.67 6.47 
Age group                              
Mean age (60.43) 
<60.43 Mean 68.32 89.63 86.42   66.86 89.45 90.14 
SD 14.31 8.60 9.80   8.19 7.44 5.17 
>60.43 Mean 66.63 87.23 86.84   59.56 86.74 87.63 
SD 12.55 9.98 8.82   14.07 7.73 7.46 
Sex male Mean 68.50 89.47 86.77   64.76 89.88 90.64 
SD 13.48 7.35 9.37   12.01 6.90 5.18 
female Mean 64.52 85.44 86.17   57.60 82.81 83.14 
SD 13.41 13.23 9.33   10.98 7.57 7.12 
Marital status unmarried/live 
alone 
Mean 67.74 87.47 87.52   58.10 86.94 81.62 
SD 15.82 11.06 13.27   14.83 9.49 10.23 
married Mean 67.51 88.64 86.44   63.94 88.37 89.75 
SD 12.91 8.97 8.38   11.46 7.37 5.38 
Educational status six years or 
less 
Mean 66.89 84.84 85.49   62.75 85.41 86.64 
SD 12.68 10.89 11.36   15.47 8.01 4.51 
7-12 years Mean 68.81 90.09 87.19   62.90 88.11 89.89 
SD 12.56 7.05 8.00   10.08 7.45 7.49 
12+  years  Mean 65.91 89.62 86.87   63.42 90.24 88.93 
SD 16.05 10.43 9.13   12.20 7.28 5.17 
Occupational status unemployed Mean 61.71 91.06 87.60   60.60 84.81 81.17 
SD 13.05 8.46 9.43   9.67 7.72 7.75 
public/private 
servant 
Mean 69.31 88.77 85.95   69.95 92.72 92.99 
SD 14.05 9.45 11.15   6.37 7.48 4.41 
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Table 6.3.1 Descriptive statistics for CROQ Total scores per CR type over a one-year period (n=472)    
CROQ Total 
Type of CR 
PCI   CABG 
index   index 
T1 T2 T3   T1 T2 T3 
free-lancer Mean 71.39 91.17 87.68   61.47 90.07 89.99 
SD 12.23 6.35 7.08   13.65 5.40 3.97 
pensioner Mean 67.06 85.94 86.11   61.26 85.36 88.66 
SD 13.22 10.19 8.76   12.94 7.59 6.18 
Family history CHD no Mean 66.18 87.68 87.03   63.26 87.42 88.69 
SD 12.43 9.83 7.85   12.28 8.11 5.15 
yes Mean 68.89 89.16 86.21   62.92 88.95 89.12 
SD 14.46 8.93 10.66   12.05 7.17 7.42 
Hypertension no Mean 66.68 88.22 85.96   61.42 88.84 90.91 
SD 12.96 9.48 10.05   13.19 6.91 5.52 
yes Mean 68.94 88.77 87.71   65.57 86.80 85.69 
SD 14.45 9.24 7.96   9.65 8.91 6.70 
Cholesterol no Mean 66.91 89.45 86.81   63.26 89.05 88.34 
SD 13.65 8.48 9.62   12.23 8.01 5.92 
yes Mean 68.94 86.11 86.22   62.53 86.29 90.27 
SD 13.15 10.85 8.80   11.98 6.67 7.66 
Diabetes no Mean 67.94 88.56 86.75   63.08 89.29 90.82 
SD 13.53 9.24 9.91   11.84 7.42 5.56 
yes Mean 66.02 88.05 86.23   62.84 85.79 85.72 
SD 13.47 9.81 7.58   12.68 7.75 6.75 
Smoking no Mean 66.12 89.00 89.06   61.33 88.66 89.69 
SD 12.05 9.18 7.83   13.62 7.50 5.37 
yes Mean 68.60 88.22 83.49   65.18 68.21 81.29 
SD 14.48 7.00 10.12   9.77   7.16 
BMI  
normal weight 
(18.5-24.9) 
Mean 66.27 87.11 85.93   62.48 90.83 90.60 
SD 13.24 7.95 7.66   12.95 7.70 5.85 
overweight 
(25.0-29.9) 
Mean 67.64 89.04 86.25   60.90 88.96 88.34 
SD 13.60 9.80 8.69   13.75 7.63 4.43 
obese (<29.9) Mean 68.41 88.47 86.93   65.24 86.08 88.45 
SD 14.08 10.27 10.74   10.13 7.40 4.43 
T1= prior to treatment, T2 = 3 months after treatment, T3= 12 months after treatment  
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6.3.1.1. Changes in CROQ Total scores : Time and type of CR treatment effects  
As described in the analysis section, the first step was to detect the best fitting model for the 
time trend. Table 6.3.2 shows the values of the six models compared, demonstrating based on the 
BIC index that the 6th model (model f, Time and Time2 as predictors with random intercept, 
linear and quadratic terms) was the best mixed model for describing the time trend of the CROQ 
Total scores.   
 
Table 6.3.2 Parameter estimates and model fit statistics for first and second order polynomials of CROQ Total score 
growth over a one-year period 
 Model a Model b Model c Model d Model e Model f 
Fixed effects B (SE) B (SE) B (SE) B (SE) B (SE) B (SE) 
Intercept 73.53(0.53)** 73.53(0.53)** 65.76(0.52)** 65.73(0.56)** 65.74(0.54)** 65.75(0.65)** 
Time  4.27(0.24)** 4.27(0.24)** 28.28(0.82)** 28.37(0.80)** 28.35(0.81)** 28.19(0.89)** 
Time2  NA NA -5.71(0.19)** -5.73(0.18)** -5.73(0.19)** -5.69(0.19)** 
Random effects  SD SD SD SD SD SD 
Residuals  13.14 13.12 8.80 8.43 8.57 5.46 
Intercept   NA 0.001 5.74 7.71 6.89 11.96 
Time  NA NA NA 1.16 NA 15.42 
Time2  NA NA NA NA 0.20 3.14 
Model fit        
BIC 9070.01 9084.07 8510.48 8493.06 8506.50 8385.14 
NA= not applicable; ML= maximum likelihood; BIC= Schwarz’s Bayesian Criterion 
Random covariate = AR1 heterogeneous 
Time= Linear, Time2= Quadratic 
Model a= Ordinal linear least square regression with Time as a predictor 
Model b= Time as a predictor with random intercept  
Model c= Time and Time2 as predictors with random intercept  
Model d = Time and Time2 as predictors with random intercept and linear term 
Model e= Time and Time2 as predictors with random intercept and quadratic term  
Model f= Time and Time2 as predictors with random intercept, linear and quadratic terms 
In all models response variable CROQ Total scores 
**p<0.001 
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The analysis demonstrated that the mean initial status (baseline) of the CROQ Total scores 
was 65.75 (β = 65.75, SE = 0.65, t=100.89, p < 0.01). Time had a significant positive linear 
effect on CROQ Total scores (β = 28.19, SE = 0.89, t= 31.69, p < 0.01), as well as a significant 
negative quadratic effect (β = -5.69, SE = 0.19, t= -30.13, p < 0.01). The acceleration (calculated 
based on Singer, & Willett, 2003) was 16.81 points [i.e. 28.19/ (2 (-5.69))]. According to these 
results, the CROQ Total scores increased at the beginning, but this trend slowed down later on. 
Compared to the linear change trajectory (28.19), the rate of quadratic growth (-5.69) was small, 
thus a positive change on CROQ Total following CR can be assumed.  
In order to detect the effect of the CR type on CROQ Total scores, the best model of the time 
trajectory was further investigated by adding the type of treatment (PCI/CABG) variable. The 
model with the smallest BIC value was the second (Time, Time2, CR type of treatment as 
predictors and the interaction term Time x CR type of treatment with random intercept, linear 
and quadratic terms) as Table 6.3.3 suggests.  
 
Table 6.3.3 Parameter estimates and model fit statistics for first and second order polynomials and 
treatment interactions of CROQ Total score growth over a one-year period  
 Model 1 Model 2 Model 3 
Fixed effects B (SE) B (SE) B (SE) 
Intercept 65.90(0.71)** 67.87(0.73)** 67.53(0.82)** 
Time 28.18(0.89)** 27.63(0.89)** 26.41(1.13)** 
Time2 -5.68(0.19)** -5.67(0.18)* -5.41(0.24)** 
Type of treatment† -0.40(0.74) -2.85(0.92)** -4.50(1.31)** 
Time x Type of treatment  NA 1.22(0.27)** -4.36(1.81) 
Time2 x Type of treatment  NA NA -0.67(0.39) 
Random effects SD SD SD 
Residual  5.46 5.37 5.37 
Intercept  11.93 11.83 11.80 
Time 15.40 15.44 15.39 
Time2 3.14 3.17 3.15 
Model fit     
BIC 8391.90 8379.16 8383.12 
NA= not applicable; ML= maximum likelihood; BIC= Schwarz’s Bayesian Criterion 
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Random covariate = AR1 heterogeneous, Time= Linear, Time2= Quadratic, †Type of treatment = CABG 
 
Model 1=Time, Time2 and CR type of treatment as predictors with random intercept, linear and quadratic term 
Model 2=Time, Time2, CR type of treatment as predictors and Time x CR type of treatment interaction term with 
random intercept, linear and quadratic terms 
Model 3=Time, Time2, CR type of treatment as predictors, Time x CR type of treatment interaction term, and Time2 
x CR type of treatment interaction term with random intercept, linear and quadratic terms 
In all models response variable CROQ Total scores 
**p<0.001, *p<0.05  
 
The results demonstrated that the average initial status (baseline) of CROQ Total scores for 
CABG patients was lower compared to PCI patients while a greater increase in CROQ Total 
scores for CABG patients was revealed in the rate of change in linear trends. The marginal 
means of CR type as a predictor for CROQ Total scores can be estimated by employing the 
following formulas:  
CROQ Total marginal means for 0 months (baseline) = β0, 3 months = β0 + β1 x Time1 + β2 x 
Time12 and 12 months = β0 + β1 x Time2+ β2 x Time22, where  
Time1 = 1 and Time2 = 4,  
CR type of treatment: PCI = 0 and CABG = 1, 
β0 = 67.87 (baseline mean score of CROQ Total) - 2.85 x type of treatment,  
β1 = 27.63 (linear mean change of CROQ Total) + 1.22 x type of treatment, 
β2 = -5.67 (quadratic mean change of CROQ Total). 
Thus, for PCI the marginal mean prior to treatment is 67.87 and at 3 months it is 89.83 
[(67.87 + (27.63 x 1) + (-5.67 x 12)], resulting in a mean change of 21.96 points from the 
baseline mean score (89.83-67.87). For CABG the marginal mean prior to treatment is 65.02 and 
at 3 months it is 88.20 [(67.87-2.85) + (27.63+1.22) x 1-5.67 x 12], resulting in a mean change of 
23.18 points from the baseline mean score (88.20-65.02).  
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Concerning the marginal mean for PCI at 12 months, this is 87.67 [(67.87 + (27.63 x 4) + (-5.67 
x 42)], resulting in a mean change of 19.80 points from the baseline mean score (86.67-66.87), 
while the marginal mean for CABG at 12 months is 89.70 [(67.87-2.85)+((27.63+1.22) x 4)) + (-
5.67 x 42)], resulting in a mean change of 24.68 points from the baseline mean score (88.70-
64.02), as Figure 6.2 illustrates.   
 
 
Figure 6.2 Marginal means of CROQ Total scores per CR type of treatment.  
Time0= baseline scores, Time1= 3 month mean scores, Time4=12 month mean  
scores.  
 
 
The variability of CROQ Total scores within individuals per CR type at the 3 measurement time-
point can be seen in Figure 6.3.  
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Figure 6.3 CROQ Total scores as a function of time for all patients by type of CR 
treatment. Time0= baseline scores, Time1= 3 month scores, Time4=12 month scores.  
 
Hence overall, it can be assumed that over one year period, on the CROQ Total, patients 
treated with CABG experienced a greater mean change compared to patients treated with PCI. 
However, CR type did not remain a significant predictor of the CROQ Total change after 
adjusting for all time invariant and time-varying predictors as the following section reveals.  
 
6.3.1.2. Predictors of CROQ Total score change over a one-year period 
In the final conditional growth model, the effects of all individual level covariates as well as 
well as the two time-varying predictors (i.e. smoking and BMI) were investigated. Included in 
the model were also all the two-way interaction terms of those potential predictors with time and 
CR type of treatment. The following Table 6.3.4 summarizes the fixed and random effects of the 
model.   
 
PCI CABG 
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Table 6.3.4 Growth model for changes in CROQ Total scores over a one-year period  
Fixed effects  B(SE) df  t p 
95% Confidence Interval  
Lower 
Bound 
Upper 
Bound 
Intercept  52.94(6.12) 530 8.65 0.00 41.22 64.66 
Time  31.75(2.25) 530 14.09 0.00 27.44 36.07 
Time2  -5.79(0.22) 530 -26.00 0.00 -6.21 -5.36 
Type of treatment (CABG)  5.43(9.45) 428 0.57 0.57 -12.67 23.54 
Place of residence (Rural Area)  -2.15(1.75) 428 -1.23 0.22 -5.50 1.20 
Age  0.06(0.07) 428 0.79 0.43 -0.08 0.20 
Sex (Female)  -3.98(1.22) 428 -3.26 0.00 -6.32 -1.64 
Marital status (Married)  -0.25(1.30) 428 -0.19 0.85 -2.73 2.23 
Educational status† 
3.11(1.32) 428 2.36 0.02 0.59 5.64                   7-12 years  
                  12+ years  1.26(1.53) 428 0.83 0.41 -1.66 4.19 
Occupational status‡ 
0.37(1.59) 428 0.23 0.82 -2.68 3.42                   Public/private servant 
                  Free lancer  3.90 (1.78) 428 2.18 0.03 0.48 7.32 
                  Pensioner   -2.10(1.76) 428 -1.19 0.23 -5.48 1.28 
CHD Family history  (yes)  1.68(1.01) 428 1.66 0.10 -0.26 3.61 
Hypertension    (yes)   1.37(1.04) 428 1.32 0.19 -0.63 3.37 
Cholesterol      (yes)   -2.98(1.10) 428 -2.71 0.01 -5.09 -0.88 
Diabetes           (yes)   -0.21(1.20) 428 -0.17 0.86 -2.51 2.10 
BMI  0.31(0.11) 530 2.75 0.01 0.09 0.53 
Smoking           (yes)   1.25(1.05) 530 1.19 0.23 -0.76 3.26 
Time x Type of treatment  0.50(0.43) 530 1.18 0.24 -0.32 1.32 
Time x Place of residence 0.69(0.48) 530 1.45 0.15 -0.22 1.60 
Time x Age  0.00(0.02) 530 0.00 1.00 -0.04 0.04 
Time x Sex  1.00(0.35) 530 2.84 0.00 0.33 1.67 
Time x Marital status  -0.24(0.41) 530 -0.59 0.55 -1.03 0.54 
Time x Educational status†   
0.03(0.40) 530 0.07 0.95 -0.73 0.79                  7-12 years 
                 12+ years 0.39(0.45) 530 0.86 0.39 -0.48 1.25 
Timex Occupational status‡ 
-0.51(0.49) 530 -1.05 0.29 -1.45 0.42                  Public/private servant 
                 Free lancer   -0.88(0.52) 530 -1.67 0.10 -1.88 0.13 
                 Pensioner  0.32(0.53) 530 0.59 0.55 -0.70 1.34 
Time x CHD Family history   -0.38(0.30) 530 -1.27 0.20 -0.95 0.19 
Time x Hypertension     -0.04(0.30) 530 -0.15 0.88 -0.62 0.53 
Time x Cholesterol        0.57(0.32) 530 1.75 0.08 -0.05 1.19 
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Table 6.3.4 Growth model for changes in CROQ Total scores over a one-year period  
Fixed effects  B(SE) df  t p 
95% Confidence Interval  
Lower 
Bound 
Upper 
Bound 
Time x Diabetes            -0.29(0.35) 530 -0.83 0.41 -0.96 0.38 
Time x BMI  -0.10(0.04) 530 -2.58 0.01 -0.17 -0.03 
Time x Smoking -1.58(0.36) 530 -4.40 0.00 -2.27 -0.89 
Type of treatment x Place of residence  0.60(2.21) 428 0.27 0.79 -3.64 4.84 
Type of treatment x AGE  -0.03(0.13) 428 -0.26 0.79 -0.28 0.21 
Type of treatment x Sex  -3.81(2.09) 428 -1.83 0.07 -7.81 0.19 
Type of treatment x Marital status  4.41(2.36) 428 1.87 0.06 -0.11 8.94 
Type of treatment x Educational status† 
-0.99(2.35) 428 -0.42 0.68 -5.50 3.53                   7-12 years  
                  12+ years 1.25(2.71) 428 0.46 0.65 -3.96 6.45 
Type of treatment x Occupational status‡ 
1.96(2.92) 428 0.67 0.50 -3.63 7.55                   Public/private servant  
                  Free lancer   -5.09(2.99) 428 -1.70 0.09 -10.82 0.65 
                  Pensioner  -2.06(3.16) 428 -0.65 0.51 -8.11 3.99 
Type of treatment x CHD Family history   -0.73(1.57) 428 -0.47 0.64 -3.73 2.27 
Type of treatment x Hypertension     -0.21(1.75) 428 -0.12 0.90 -3.57 3.15 
Type of treatment x Cholesterol        0.72(1.70) 428 0.43 0.67 -2.54 3.99 
Type of treatment x Diabetes            -1.05(1.75) 428 -0.60 0.55 -4.40 2.29 
Type of treatment x BMI  -0.22(0.16) 530 -1.35 0.18 -0.54 0.09 
Type of treatment x Smoking -1.46(1.89) 530 -0.77 0.44 -5.07 2.16 
Random effects  SD    
  Residuals  4.44    
  Intercept  11.74    
  Time  15.84    
  Time2 3.25    
  Model fit  
   
  BIC 7662.15    
  †Educational status compared to six years or less  
‡Occupational status compared to unemployed  
 
The above results demonstrate that after adjusting for potential predictors, the CROQ Total 
score initially increased with time and then decreased (β=31.75, SE=2.25, p<0.01 and β=-5.79, 
SE=0.22, p<0.01 respectively), though remaining much higher than baseline scores. The CR type 
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of treatment did not remain a significant predictor of CROQ Total scores either for the baseline 
scores, or for the mean change over the one year period (p>0.05).  
Concerning the effect of Time, taking into account also the significant interaction terms, due 
to the presence of the quadratic effect, interpretation should be based on specific time points. For 
example, if Time1 denotes the value of Time at a specific time and BMI the body mass index of 
the patient, then if time increases by one unit, the CROQ Total score will increase on average by 
(31.75-0.10 x BMI) -5.79 (2 x Time1 +1) units for male patients that do not smoke, by (32.75-
0.10 x BMI) -5.79 (2 x Time1 +1) units for female patients that do not smoke (where 32.75= 
time + female effect), by (30.17-0.10 x BMI) -5.79 (2 x Time1 +1) units for male patients that 
smoke (where 30.17= time – smoking effect) and by (31.17-0.10 x BMI) -5.79 (2 x Time1 +1) 
for female patients that smoke (where 31.71= time + female – smoking effect), if the other 
variables are kept constant.   
Females on average showed a lower score of CROQ Total by 3.98 units at the baseline 
compared to males. This reduction, however,  decreased by one unit every time that Time 
increased by one unit, leading to a slightly greater mean change of 0.02 units for females 
compared to males with the same features one year after CR. Specifically, female sex at Time0 = 
- 3.98, at Time1 =-2.98 (3.98-1; where 1 represents the value of the interaction term sex x time) 
and at Time2= 0.02 [(3.98-(1x4)); where 4 represents the value of Time2]. Taking into account 
that the positive change is tiny, an equal mean change between males and females after CR can 
be assumed.  
Also, a crossover interaction was revealed between smoking and Time. At the baseline 
smoking was not associated with differences in CROQ Total score (it had a positive non- 
significant effect on CROQ Total), but one year post CR smokers showed on average a 
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significant lower CROQ Total score by 5.07 units compared to non-smokers with the same 
features one year after CR, specifically smokers at Time0 = 1.25, at Time1 =-0.33 (1.25-1.58; 
where 1.58 represents the value of the interaction term smoking x time) and at Time2= -5.07 
[(1.25-(1.58x4)); where 4 represents the value of Time2].  
Regarding the remaining individual and time-varying covariates it should be noted that 
education, profession, cholesterol and BMI were statistically significant predictors of CROQ 
Total score at baseline when keeping the other variables constant; Patients with 7-12 years of 
education showed a higher score on average by 3.11 units compared to individuals with up to 6 
years of education. Patients with increased cholesterol levels showed a lower score on average 
by 2.98 units and patients working as free-lancers showed a higher score on average by 3.90 
units compared to those without a job, of when keep the rest of the variables fixed. The lack of 
significant time x educational or occupational status interactions imply that those differences do 
not significantly change after treatment. Finally, when BMI increases by 1 unit individuals 
demonstrated a higher CROQ Total score at baseline on average of 0.31 units; this increase, 
however, becomes lower by 0.10 units every time that time increases by 1 unit (b=-0.10, 
SE=0.04, p<0.001).  
 To sum up, based on the marginal means of the effect of Time, even after adjusting for 
treatment type (see Section 6.3.1.1), CHD patients following CR showed an increase, on 
average, in CROQ Total one year post CR. Furthermore (again see Section 6.3.1.1), individuals 
treated with PCI demonstrated a small decrease in the mean change between 3 and 12 months, 
while individuals treated with CABG demonstrated a small increase in the mean change between 
3 and 12 months. 
201 
 
After adjusting for potential predictors, results revealed that the CROQ Total score initially 
significantly increased with time and then significantly decreased, remaining however much 
higher to baseline scores. The type of treatment was not a significant predictor for CROQ Total 
anymore. Moreover, the effect of Time depended on sex, BMI and smoking; on average it 
seemed to be larger for females that did not smoke and had a low BMI. Moreover, as time 
increases, females show on average a significantly higher CROQ Total score compared to males 
and smokers show on average a significantly lower CROQ Total score compared to non-
smokers. Individuals with 7- 12 years of education compared to individuals with up to 6 years,  
patients without increased cholesterol levels compared to those with increased cholesterol levels 
and free-lancers compared to the those without a job showed a larger CROQ Total score 
following CR.  
 
6.3.2 The Symptoms subdomain 
The descriptive analysis of the CROQ’s symptoms scores indicated an increase over a one-
year period. Table 6.3.5 displays participants’ mean scores for the symptoms subdomain over a 
one-year period overall and by CR type of treatment for all individual characteristics measured; 
the mean scores after CR treatment increased for all groups.  
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Table 6.3.5 Descriptive statistics for Symptoms scores per CR type over a one-year period (n=472)     
Symptoms 
Type of CR 
PCI   CABG 
T1 T2 T3   T1 T2 T3 
Overall    Mean 63.62 90.35 87.17   59.27 93.85 97.85 
  SD 18.77 11.41 12.67   16.77 7.85 5.18 
Age group 
Mean age (60.43) 
<60.43 Mean 67.23 91.75 85.30   61.83 94.83 98.01 
SD 17.82 9.41 13.83   13.35 6.74 4.68 
>60.43 Mean 59.24 88.96 89.32   56.87 92.78 97.68 
SD 19.05 12.98 10.85   19.22 8.82 5.71 
Sex male Mean 65.40 91.21 87.13   61.36 94.66 98.74 
SD 17.91 10.54 13.18   16.73 7.39 3.59 
female Mean 57.86 87.90 87.28   52.39 91.18 94.84 
SD 20.46 13.39 11.17   15.16 8.80 8.01 
Marital status unmarried/live 
alone 
Mean 65.96 89.30 88.67   51.23 90.09 89.88 
SD 16.26 14.11 12.83   14.05 13.79 10.86 
married Mean 63.00 90.59 86.87   60.63 94.44 98.75 
SD 19.38 10.73 12.65   16.86 6.32 3.08 
Educational status six years or 
less 
Mean 60.34 88.04 87.29   63.55 91.99 99.26 
SD 19.41 13.73 12.27   20.88 11.06 2.10 
7-12 years Mean 66.28 91.66 86.97   59.39 93.32 97.93 
SD 16.41 10.09 12.08   14.32 6.93 4.41 
12+  years  Mean 61.92 90.93 87.39   55.49 96.34 96.54 
SD 21.77 10.09 14.47   16.18 5.21 7.63 
Occupational status  unemployed Mean 62.71 92.38 88.10   55.88 94.25 92.86 
SD 18.96 10.19 11.64   12.22 6.14 9.19 
public/private 
servant 
Mean 65.97 90.90 85.44   65.17 94.70 98.71 
SD 18.59 10.23 14.08   13.18 5.45 2.70 
free-lancer Mean 68.09 93.94 86.67   53.94 96.89 98.97 
SD 18.37 8.41 13.27   16.16 4.86 2.18 
pensioner Mean 59.92 87.61 88.42   60.54 91.23 98.40 
SD 18.58 13.14 11.63   18.92 10.01 5.03 
Family history CHD no Mean 63.49 90.13 89.31   60.13 93.21 97.64 
SD 17.61 12.25 9.81   17.51 9.61 5.10 
yes Mean 63.75 90.64 85.07   58.38 94.52 98.02 
SD 19.90 10.58 14.75   16.03 5.39 5.28 
Hypertension no Mean 61.45 90.41 86.62   57.40 93.13 98.07 
SD 18.19 11.46 12.89   17.98 7.38 4.48 
yes Mean 67.44 90.23 88.07   62.01 95.09 97.62 
SD 
 
19.10 11.39 12.33   14.21 8.62 6.19 
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Table 6.3.5 Descriptive statistics for Symptoms scores per CR type over a one-year period (n=472)     
Symptoms 
Type of CR 
PCI   CABG 
T1 T2 T3   T1 T2 T3 
Cholesterol no Mean 63.10 91.15 87.26   60.53 96.43 98.06 
SD 18.62 11.03 12.82   15.95 6.03 4.68 
yes Mean 64.72 88.54 86.98   56.64 88.89 97.48 
SD 18.98 12.11 12.45   18.00 8.62 6.31 
Diabetes no Mean 63.91 90.20 86.95   58.79 93.83 97.95 
SD 18.05 10.45 13.18   16.43 6.52 4.53 
yes Mean 62.40 90.75 87.78   59.81 93.82 97.81 
SD 20.74 13.78 11.21   17.45 10.03 6.17 
Smoking no Mean 61.21 90.92 90.35   58.73 94.71 98.32 
SD 17.30 10.62 10.50   18.17 6.20 4.60 
yes Mean 65.36 90.32 83.22   59.91 82.14 91.96 
SD 19.64 10.35 13.68   15.06 14.13  9.39 
BMI normal weight  
(18.5-24.9) 
Mean 63.90 88.42 85.85   56.19 93.65 99.64 
SD 20.06 11.11 11.79   15.72 5.55 1.13 
overweight 
(25.0-29.9) 
Mean 61.26 90.72 88.12   56.54 96.33 99.60 
SD 18.23 11.46 13.40   17.77 4.79 1.68 
obese (<29.9) Mean 66.59 90.99 86.35   62.86 91.47 97.62 
SD 18.04 12.00 12.64   16.08 8.80 1.84 
T1= prior to treatment, T2 = 3 months after treatment, T3= 12 months after treatment  
 
 
6.3.2.1 Changes in the Symptoms subdomain: Time and Type of CR treatment effects 
As described in the analysis section, the first step was to detect the best fitting model for the 
time trend. Table 6.3.6 shows the values for the six models compared. According to the BIC 
index the 6th model (model f, Time and Time2 as predictors with random intercept, linear and 
quadratic terms) was the best mixed model for describing the trend for symptoms scores.   
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Table 6.3.6 Parameter estimates and model fit statistics for first and second order polynomials of Symptoms score 
growth over a one-year period 
 Model a Model b Model c Model d Model e Model f 
Fixed effects B (SE) B (SE) B (SE) B (SE) B (SE) B (SE) 
Intercept 72.09(0.70)** 72.08(0.70) ** 61.85(0.69) ** 61.76(0.75) ** 61.80(0.72) ** 61.79(0.90) ** 
Time  5.78(0.31) ** 5.78(0.31) ** 37.27(1.19) ** 37.37(1.11) ** 37.33(1.15) ** 37.33(1.22) ** 
Time2  NA NA -7.50(0.25) ** -7.51(0.25) ** -7.50(0.27) ** -7.50(0.25) ** 
Random effects  SD SD SD SD SD SD 
Residuals  17.39 17.38 12.93 11.79 12.39 8.29 
Intercept   NA 0.01 5.14 9.82 7.62 16.10 
Time  NA NA NA 2.56 NA 19.81 
Time2  NA NA NA NA 0.37 3.94 
Model fit        
BIC 9706.33 9720.40 9207.77 9178.20 9203.46 9076.60 
NA= not applicable; ML= maximum likelihood; BIC= Schwarz’s Bayesian Criterion 
Random covariate = AR1 heterogeneous 
Time= Linear, Time2= Quadratic 
Model a= Ordinal linear least square regression with Time as a predictor 
Model b= Time as a predictor with random intercept  
Model c= Time and Time2 as predictors with random intercept  
Model d = Time and Time2 as predictors with random intercept and linear term 
Model e= Time and Time2 as predictors with random intercept and quadratic term  
Model f= Time and Time2 as predictors with random intercept, linear and quadratic terms 
In all models response variable symptoms scores 
**p<0.001 
 
The analysis demonstrated that the mean initial status (baseline) of the symptoms scores was 
61.79 (β = 61.79, SE = 0.90, t=68.69, p < 0.01). Time had a significant positive linear effect on 
the symptoms scores (β = 37.33, SE = 1.22, t= 30.58, p < 0.01), as well as a significant negative 
quadratic effect (β = -7.50, SE = 0.25, t= -28.93, p < 0.01). The acceleration (calculated 
according to Singer, & Willett, 2003) was 22.33 points [i.e. 37.33/ (2 (-7.50))]. These results 
suggest that the, symptoms scores increased at the beginning, but this trend slowed down later on. 
Overall, a positive effect on the symptoms subdomain following CR can be assumed.  
To examine the effect of the CR type on the symptoms scores, the best model of time 
trajectory was further investigated by adding the CR type of treatment (PCI/CABG) variable. 
Based on the BIC index, the best model describing symptoms trends was the second (Time, 
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Time2, CR type of treatment as predictors and the interaction term Time x CR type of treatment 
with random intercept, linear and quadratic terms) as Table 6.3.7 suggests.  
 
Table 6.3.7 Parameter estimates and model fit statistics for first and second order polynomials and 
treatment interactions of Symptoms score growth over a one-year period  
 Model 1 Model 2 Model 3 
Fixed effects B (SE) B (SE) B (SE) 
Intercept 59.53(0.97)** 62.13(1.01)** 63.58(1.14)** 
Time 37.47(1.22)** 36.22(1.22)** 33.75(1.54)** 
Time2 -7.53(0.25)** -7.49(0.26)** -6.96(0.33)** 
Type of treatment† 4.88(0.82)** -0.75(1.18) -4.39(1.83)* 
Time x Type of treatment  NA 2.84(0.43)** 9.16(2.46)** 
Time2 x Type of treatment  NA NA -1.38(0.53)* 
Random effects SD SD SD 
Residual  8.48 8.27 8.25 
Intercept  16.51 16.07 15.95 
Time 20.18 19.65 19.46 
Time2 4.03 3.98 3.94 
Model fit     
BIC 9052.89 9019.73 9020.01 
NA= not applicable; ML= maximum likelihood; BIC= Schwarz’s Bayesian Criterion 
Random covariate = AR1 heterogeneous, Time= Linear, Time2= Quadratic, †Type of treatment = CABG 
 
Model 1=Time, Time2 and CR type of treatment as predictors with random intercept, linear and quadratic term 
Model 2=Time, Time2, CR type of treatment as predictors and Time x CR type of treatment interaction term with 
random intercept, linear and quadratic terms 
Model 3=Time, Time2, CR type of treatment as predictors, Time x CR type of treatment interaction term, and Time2 
x CR type of treatment interaction term with random intercept, linear and quadratic terms 
In all models response variable symptoms scores 
**p<0.001, *p<0.05  
 
Results showed that CABG patients scored slightly lower compared to PCI patients in terms 
of mean initial status (baseline) for the symptoms subdomain but the rate of change in linear 
trends was greater for CABG patients. The marginal means for the CR type as a predictor for the  
symptoms subdomain can be estimated by employing the following formulas:  
Symptoms marginal means at 0 months (baseline) = β0, 3 months = β0 + β1 x Time1 + β2 x Time12 
and 12 months = β0 + β1 x Time2+ β2 x Time22, where  
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Time1 = 1 and Time2 = 4,  
CR type of treatment: PCI = 0 and CABG = 1, 
β0 = 62.13 – 0.75 x type of treatment, 
β1 = 36.22 + 2.84 x type of treatment, 
β2 = -7.49 
For PCI the marginal mean prior to treatment was 62.13 and at 3 months was 90.86, resulting 
in a mean change of 28.73 points from the baseline mean score. For CABG the marginal mean 
prior to treatment was 61.38 and at 3 months was 92.95, resulting in a mean change of 31.57 
points from the baseline mean score.  
Concerning the marginal mean for PCI at 12 months this was 87.17, resulting in a mean 
change of 25.04 points from the baseline mean score, while the marginal mean for CABG at 12 
months was 97.78, resulting in a mean change of 36.40 points from the baseline mean score, as 
Figure 6.4 illustrates.   
 
Figure 6.4 Marginal means of the Symptoms subdomain scores per CR type of treatment.  
Time0= baseline scores, Time1= 3 month mean scores, Time4=12 month mean  
scores.  
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Hence overall, it can be assumed that over one year period, in the symptoms subdomain, patients 
treated with CABG experienced a greater mean change compared to patients treated with PCI.  
The variability of Symptoms subdomain scores within individuals per CR type at the 3 month 
measurement time points can be seen in Figure 6.5.  
 
Figure 6.5 Symptoms subdomain scores as a function of Time for all patients by type of 
CR treatment. Time0= baseline scores, Time1= 3 month scores, Time4=12 month scores.  
 
 
6.3.2.2.Predictors of Symptoms subdomain change over a one-year period  
In the final conditional growth model, the effects of all individual level covariates as well as 
well as the two time-varying predictors (i.e. smoking and BMI) were investigated. Included in 
the model were also all the two-way interaction terms of these potential predictors with Time and 
CR type of treatment. The following Table 6.3.8 summarizes the fixed and random effects of the 
model. 
 
PCI CABG 
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Table 6.3.8 Growth model for changes in Symptoms scores over a one-year period  
Fixed effects Est (SE) df t p 
95% Confidence 
Interval  
Lower 
Bound 
Upper 
Bound 
Intercept  64.07(8.07) 530 7.94 0.00 48.61 79.52 
Time  36.91(3.67) 530 10.06 0.00 28.98 43.93 
Time2  -7.64(0.30) 530 -25.11 0.00 -8.22 -7.06 
Type of treatment (CABG)  -1.08(11.25) 428 -0.10 0.92 -22.63 20.47 
Place of residence (Rural Area)  -1.54(2.20) 428 -0.70 0.48 -5.76 2.67 
Age  -0.16(0.10) 428 -1.66 0.1 -0.34 0.02 
Sex (Female)  -4.22(1.56) 428 -2.70 0.01 -7.21 -1.23 
Marital status (Married)  -0.86(1.68) 428 -0.51 0.61 -4.09 2.37 
Educational status† 
                        7-12 years  0.81(1.69) 428 0.48 0.63 -2.43 4.05 
                  12+ years  -2.42(1.96) 428 -1.24 0.22 -6.18 1.33 
Occupational status‡ 
                        Public/private servant -0.93(2.06) 428 -0.45 0.65 -4.88 3.01 
                  Free lancer  2.25(2.30) 428 0.98 0.33 -2.15 6.65 
                  Pensioner   -2.65(2.27) 428 -1.17 0.24 -6.99 1.70 
CHD Family history  (yes)  -0.63(1.29) 428 -0.49 0.62 -3.09 1.83 
Hypertension    (yes)   2.25(1.33) 428 1.69 0.09 -0.3 4.81 
Cholesterol      (yes)   -2.12(1.41) 428 -1.51 0.13 -4.82 0.58 
Diabetes           (yes)   1.86(1.53) 428 1.21 0.22 -1.07 4.79 
BMI  0.32(0.15) 530 2.07 0.04 0.02 0.61 
Smoking           (yes)   2.19(1.45) 530 1.51 0.13 -0.58 4.97 
Time x Type of treatment  2.13(0.72) 530 2.94 0.00 0.74 3.52 
Time x Place of residence 0.24(0.81) 530 0.29 0.77 -1.31 1.78 
Time x Age  0.08(0.04) 530 1.96 0.06 0.00 0.15 
Time x Sex  1.14(0.61) 530 1.86 0.06 -0.03 2.31 
Time x Marital status  -0.19(0.71) 530 -0.27 0.78 -1.55 1.17 
Time x Educational status†   
                       7-12 years 0.66(0.69) 530 0.96 0.34 -0.65 1.98 
                 12+ years 1.53(0.78) 530 1.96 0.06 0.04 3.03 
Timex Occupational status‡ 
                       Public/private servant -0.40(0.85) 530 -0.47 0.64 -2.02 1.23 
                 Free lancer   -0.71(0.91) 530 -0.78 0.44 -2.45 1.04 
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Table 6.3.8 Growth model for changes in Symptoms scores over a one-year period  
Fixed effects Est (SE) df t p 
95% Confidence 
Interval  
Lower 
Bound 
Upper 
Bound 
                 Pensioner  0.06(0.92) 530 0.07 0.95 -1.71 1.84 
Time x CHD Family history   -0.27(0.51) 530 -0.53 0.60 -1.25 0.71 
Time x Hypertension     -0.54(0.52) 530 -1.04 0.30 -1.54 0.46 
Time x Cholesterol        0.23(0.56) 530 0.41 0.68 -0.84 1.29 
Time x Diabetes            -0.41(0.60) 530 -0.68 0.50 -1.55 0.74 
Time x BMI  -0.14(0.06) 530 -2.21 0.03 -0.26 -0.02 
Time x Smoking -2.06(0.59) 530 -3.48 0.00 -3.19 -0.93 
Type of treatment x Place of residence  0.59(2.54) 428 0.23 0.81 -4.27 5.46 
Type of treatment x AGE  0.04(0.15) 428 0.27 0.79 -0.25 0.33 
Type of treatment x Sex  -1.94(2.41) 428 -0.8 0.42 -6.55 2.68 
Type of treatment x Marital status  3.57(2.81) 428 1.27 0.20 -1.81 8.96 
Type of treatment x Educational status†             
                  7-12 years  -0.74(2.75) 428 -0.27 0.79 -6.02 4.53 
                  12+ years 1.23(3.17) 428 0.39 0.70 -4.85 7.30 
Type of treatment x Occupational status‡             
                  Public/private servant  -0.90(3.39) 428 -0.26 0.79 -7.39 5.59 
                  Free lancer   -3.49(3.48) 428 -1.00 0.32 -10.15 3.18 
                  Pensioner  0.09(3.65) 428 0.02 0.98 -6.91 7.09 
Type of treatment x CHD Family history   1.11(1.80) 428 0.62 0.54 -2.34 4.56 
Type of treatment x Hypertension     2.23(2.04) 428 1.09 0.28 -1.68 6.15 
Type of treatment x Cholesterol        -4.40(1.96) 428 -2.24 0.02 -8.16 -0.64 
Type of treatment x Diabetes            -0.59(1.99) 428 -0.3 0.77 -4.4 3.23 
Type of treatment x BMI  -0.08(0.21) 530 -0.4 0.69 -0.48 0.31 
Type of treatment x Smoking -3.73(2.60) 530 -1.44 0.15 -8.7 1.24 
Random effects  SD 
     Residuals  7.28 
     Intercept  15.47 
     Time  20.42 
     Time2 4.20 
     Model fit 
 
     BIC 8253.57 
     †Educational status compared to six years or less ‡Occupational status compared to unemployed 
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The above results demonstrate that after adjusting for potential predictors, the symptoms 
mean score initially increased with time and then decreased (β=36.91, SE=3.67, p<0.01 and β=-
7.64, SE=0.30, p<0.01 respectively), although remaining much higher than the baseline scores.   
Concerning the effect of Time, taking into account also the significant interaction terms, due 
to the presence of the quadratic effect, interpretation should be based on specific time points. For 
example, if Time1 denotes the value of Time at a specific time and BMI the body mass index of 
the patient, then if Time increases by one unit, the symptoms score will increase on average by 
(36.91-0.14 x BMI) -7.64 (2 x Time1 +1) units for PCI patients that do not smoke, by (39.04-
0.14 x BMI) -7.64 (2 x Time1 +1) units for CABG patients that do not smoke (where 39.04=time 
+ time x type of treatment), by (34.85-0.14 x BMI) -7.64 (2 x Time1 +1) units for PCI patients 
that do smoke (where 34.85= time – time x smoking) and by (36.98-0.10 x BMI) -7.64 (2 x 
Time1 +1) for CABG patients that do smoke (where 36.98= time = time x type of treatment - 
time x smoking), if the other variables are kept constant.  
The CR type of treatment was not associated with differences in symptoms score at baseline; 
it had a negative non-significant effect (p>0.05). A crossover interaction effect between Time 
and CR type of treatment on symptoms score (p<0.01) was revealed, suggesting that as time 
increased, patients treated with CABG showed a significantly higher symptoms score on 
average. Specifically, for individuals with the same characteristics one year after CR, patients 
treated with CABG demonstrated a greater mean change of 7.47 units compared to patients 
treated with PCI;  CABG treatment  at Time0 = - 1.08, at Time1 = 1.05 (1.08-2.13; where 2.13 
represents the value of the interaction term CABG x Time) and at Time2= 7.47 [(1.08-(2.13x4)); 
where 4 represents the value of Time2].  
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Females scored lower on the symptoms subdomain by 4.22 units (p=0.01) at baseline 
compared to males when keeping the other variables constant. This reduction, however, tended 
to decrease as time increased at an almost significant level (p=0.06), resulting in a slight greater 
mean change of 0.34 units for females compared to males with the same features. Specifically, 
female sex at Time0 = - 4.22, at Time1 =-3.08 (4.22-1.14; where 1 represents the value of the 
interaction term sex x time) and at Time2= 0.34 [(4.22-(1.14x4)); where 4 represents the value of 
Time2].  
Also, a crossover interaction was revealed between smoking and Time. At  baseline smoking 
was not associated with differences in symptoms score (it had a positive non-significant effect on 
symptoms, p>0.05) keeping the other variables constant, but one year post CR smokers showed 
on average a significant lower symptoms score (indicating more symptoms) by 6.05 units 
compared to non-smokers with the same features. Specifically smokers at Time0 = 2.19, at 
Time1 =-0.13 (2.19-2.06; where 2.06 represents the value of the interaction term smoking x 
time) and at Time2= -6.05 [(2.19-(2.06x4)); where 4 represents the value of Time2].  
BMI was revealed as an independent significant predictor of the symptoms score at baseline. 
When BMI increases by one unit individuals demonstrated a better symptoms scores at baseline 
on average by 0.32 units, when keeping the other variables constant; this increase, however, 
decreases by 0.10 units every time that time increases by one unit (p=0.04).  
Briefly, the results suggest that CHD patients following CR experienced significantly fewer 
heart-related symptoms one year after CR (section 6.3.2.1); After adjusting for potential 
predictors the symptoms score initially increased with time and then decreased, although 
remaining much higher compared to baseline scores.  Moreover, the effect of time depended on 
the CR type of treatment, BMI and smoking; on average, it seemed to be larger for individuals 
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treated with CABG, who did not smoke and had a low BMI. Finally, as time increased patients 
treated with CABG compared to those treated with PCI and females compared to males on 
average showed a better symptoms score, while smokers compared to non-smokers on average 
showed a significantly worse symptoms score.  
 
 
6.3.3 The Physical functioning subdomain 
The descriptive analysis of the Physical functioning scores indicated an increase over a one-
year period. Table 6.3.9 displays participants’ mean scores in the physical functioning 
subdomain over a one-year period overall and by CR type of treatment for all individual 
characteristics measured; the mean scores after CR treatment increased for all groups.  
 
Table 6.3.9 Descriptive statistics for Physical functioning scores per CR type over a one year period 
(n=472)  
  
Type of CR 
PCI   CABG 
T1 T2 T3   T1 T2 T3 
Overall    Mean 56.29 89.08 85.40   41.35 89.09 92.29 
  SD 28.30 14.97 17.16   21.15 14.54 10.93 
Age group  
Mean age (60.43) 
<60.43 Mean 57.22 91.07 85.65   48.05 90.05 94.04 
SD 29.22 13.23 16.26   21.66 13.89 10.39 
>60.43 Mean 55.15 87.12 85.11   35.06 88.04 90.36 
SD 27.22 16.31 18.23   18.71 15.26 11.27 
Sex male Mean 57.91 91.19 86.29   44.01 91.61 93.55 
SD 27.98 12.84 17.35   21.57 12.51 10.75 
female Mean 51.04 83.08 82.84   32.60 80.88 88.33 
SD 28.93 18.66 16.49   17.25 17.61 10.73 
Marital status unmarried/live 
alone 
Mean 57.28 86.61 88.47   35.87 89.80 85.42 
SD 30.85 18.14 16.04   25.23 10.67 16.71 
married Mean 56.02 89.64 84.79   42.28 88.99 93.02 
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Table 6.3.9 Descriptive statistics for Physical functioning scores per CR type over a one year period 
(n=472)  
  
Type of CR 
PCI   CABG 
T1 T2 T3   T1 T2 T3 
SD 27.65 14.14 17.36   20.34 15.07 9.95 
Educational status six years or 
less 
Mean 54.81 83.13 84.80   37.66 87.13 90.63 
SD 27.14 18.30 19.46   24.01 16.13 13.42 
7-12 years Mean 58.55 92.00 85.24   42.57 88.13 92.19 
SD 27.39 11.13 16.25   21.24 14.79 9.86 
12+ years  Mean 53.87 90.99 86.46   41.94 92.19 95.16 
SD 31.25 14.89 16.18   18.11 12.48 8.02 
Occupational status unemployed Mean 46.87 91.77 85.98   40.46 83.33 87.50 
SD 26.24 12.22 17.56   20.24 19.05 12.30 
public/private 
servant 
Mean 60.74 90.22 83.10   57.17 94.15 96.50 
SD 29.98 14.20 17.88   21.55 12.49 7.01 
free-lancer Mean 62.46 93.01 89.33   39.79 93.11 94.08 
SD 26.77 10.86 10.85   17.22 9.27 10.77 
pensioner Mean 54.20 85.53 84.94   34.33 85.42 90.20 
SD 27.62 17.24 18.95   19.49 15.55 11.47 
Family history CHD no Mean 50.83 88.89 86.55   44.21 89.27 93.01 
SD 25.27 15.73 17.19   21.74 13.11 8.46 
yes Mean 61.57 89.28 84.38   38.38 88.91 91.63 
SD 30.12 14.30 17.20   20.24 15.99 12.80 
Hypertension no Mean 54.73 88.27 84.10   42.79 89.58 94.47 
SD 26.90 15.48 18.24   22.12 13.36 6.90 
yes Mean 59.16 90.51 87.57   38.85 88.24 88.89 
SD 30.59 13.99 15.06   19.57 16.71 14.95 
Cholesterol no Mean 56.51 89.13 85.20   43.20 91.45 93.00 
SD 28.62 15.45 17.14   22.25 13.21 10.39 
yes Mean 55.69 88.97 85.81   37.83 84.57 91.25 
SD 27.54 13.89 17.32   18.86 16.14 11.82 
Diabetes no Mean 56.44 89.43 85.03   40.32 89.28 92.41 
SD 28.43 14.24 17.51   20.34 15.05 11.79 
yes Mean 55.78 88.13 86.45   43.08 88.78 92.47 
SD 27.99 16.87 16.27   22.79 13.80 9.10 
Smoking no Mean 54.95 90.56 91.60   39.10 89.74 92.87 
SD 26.22 14.04 14.52   20.25 14.21 10.67 
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Table 6.3.9 Descriptive statistics for Physical functioning scores per CR type over a one year period 
(n=472)  
  
Type of CR 
PCI   CABG 
T1 T2 T3   T1 T2 T3 
yes Mean 57.25 86.18 76.72   44.01 37.50 86.25 
SD 29.75 14.76 16.87   22.01 13.15 12.02 
BMI normal weight 
(18.5-24.9) 
Mean 51.99 87.73 85.46   46.88 85.42 98.75 
SD 29.57 14.94 19.44   26.54 16.61 3.95 
overweight 
(25.0-29.9) 
Mean 57.62 89.67 83.97   38.19 92.36 91.78 
SD 29.28 15.68 16.52   21.50 13.11 8.60 
obese (<29.9) Mean 57.62 88.57 86.22   41.32 86.1 89.38 
SD 27.41 14.72 17.17   17.13 15.64 11.80 
 
 
6.3.3.1.Changes in Physical functioning: Time and Type of CR treatment effects 
As described in the analysis section, the first step was to detect the best fitting model for the 
time trend. Table 6.3.10 shows the values for the six models compared. Based on the BIC index 
the 6th model (model f, Time and Time2 as predictors with random intercept, linear and quadratic 
terms) was the best mixed model for describing the time trend of the physical functioning scores.   
 
Table 6.3.10  Parameter estimates and model fit statistics for first and second order polynomials of Physical 
functioning score growth over a one-year period 
 Model a Model b Model c Model d Model e Model f 
Fixed effects B (SE) B (SE) B (SE) B (SE) B (SE) B (SE) 
Intercept 63.67(0.98) ** 63.67(0.98) ** 50.39(0.99) ** 50.35(1.10) ** 50.36(1.05) ** 50.38(1.32) ** 
Time  7.44(0.43) ** 7.44(0.44) ** 48.57(1.69) ** 48.88(1.56) ** 48.81(1.61) ** 48.45(1.76) ** 
Time2  NA NA -9.79(0.39) ** -9.86(0.36) ** -9.76(0.37) ** -9.76(0.37) ** 
Random effects  SD SD SD SD SD SD 
Residuals  24.21 24.18 18.18 16.45 17.16 10.83 
Intercept   NA 0.01 8.46 15.28 12.50 24.38 
Time  NA NA NA 3.58 NA 29.88 
Time2  NA NA NA NA 0.58 5.91 
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Table 6.3.10  Parameter estimates and model fit statistics for first and second order polynomials of Physical 
functioning score growth over a one-year period 
 Model a Model b Model c Model d Model e Model f 
Model fit        
BIC 10455.66 10469.62 10024.43 9977.63 10008.16 9838.82 
NA= not applicable; ML= maximum likelihood; BIC= Schwarz’s Bayesian Criterion 
Random covariate = AR1 heterogeneous 
Time= Linear, Time2= Quadratic 
Model a= Ordinal linear least square regression with Time as a predictor 
Model b= Time as a predictor with random intercept  
Model c= Time and Time2 as predictors with random intercept  
Model d = Time and Time2 as predictors with random intercept and linear term 
Model e= Time and Time2 as predictors with random intercept and quadratic term  
Model f= Time and Time2 as predictors with random intercept, linear and quadratic terms 
In all models response variable physical functioning scores 
**p<0.001 
 
The analysis demonstrated that the mean initial status (baseline) for the physical functioning 
scores was 50.38 (β = 50.38, SE = 1.32, t=38.05, p < 0.01). Time had a significant positive linear 
effect (β = 48.45, SE = 1.76, t= 27.39, p < 0.01), as well as a significant negative quadratic effect 
(β = -9.76, SE = 0.37, t= -26.38, p < 0.01). The acceleration was 28.93 points [i.e. 48.45/ (2 (-
9.76))] (Singer, & Willett, 2003). According to the results, physical functioning scores increased 
at the beginning, but this trend slowed down later on. Overall, a positive change on physical 
functioning scores following CR can be assumed.  
To investigate the effect of CR type on physical functioning scores, the best model of the 
time trajectory was further investigated by adding the CR type of treatment (PCI/CABG) 
variable.  The best model describing the trend of the physical functioning scores, having the 
lowest BIC value, was the third (Time, Time2, CR type of treatment as predictors, and Time x 
CR type of treatment and Time2 x CR type of treatment interaction terms with random intercept, 
linear and quadratic terms) as Table 6.3.11 suggests.  
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Table 6.3.11 Parameter estimates and model fit statistics for first and second order polynomials and 
treatment interactions of Physical functioning score growth over a one-year period  
 Model 1 Model 2 Model 3 
Fixed effects B (SE) B (SE) B (SE) 
Intercept 50.46(1.41)** 52.97(1.43)** 56.31(1.63)** 
Time 48.44(1.76)** 46.99(1.76)** 41.35(2.20)** 
Time2 -9.76(0.37)** -9.72(0.37)** -8.52(0.46)** 
Type of treatment† -0.19(1.25) -6.67(1.67)** -15.08(2.61)** 
Time x Type of treatment  NA 3.37(0.56)** 17.84(3.51)** 
Time2 x Type of treatment  NA NA -3.11(0.74)** 
Random effects SD SD SD 
Residual  10.83 10.77 10.71 
Intercept  24.36 23.64 23.32 
Time 29.85 29.29 28.65 
Time2 5.90 5.89 5.75 
Model fit     
BIC 9845.83 9820.05 9809.91 
NA= not applicable; ML= maximum likelihood; BIC= Schwarz’s Bayesian Criterion 
Random covariate = AR1 heterogeneous, Time= Linear, Time2= Quadratic, †Type of treatment = CABG 
 
Model 1=Time, Time2 and CR type of treatment as predictors with random intercept, linear and quadratic term 
Model 2=Time, Time2, CR type of treatment as predictors and Time x CR type of treatment interaction term with 
random intercept, linear and quadratic terms 
Model 3=Time, Time2, CR type of treatment as predictors, Time x CR type of treatment interaction term, and Time2 
x CR type of treatment interaction term with random intercept, linear and quadratic terms 
In all models response variable physical functioning scores 
**p<0.001, *p<0.05  
 
Results demonstrated that the mean initial status (baseline) of the physical functioning scores 
for CABG patients was lower compared to PCI patients, a greater increase, however, was 
revealed for CABG patients in the rate of change in both linear and quadratic trends. The 
marginal means for CR type as predictor can be estimated by employing the following formulas:  
Physical functioning marginal means at 0 months (baseline) = β0, 3 months = β0 + β1 x Time1 + 
β2 x Time12 and 12 months = β0 + β1 x Time2+ β2 x Time22, where  
Time1 = 1 and Time2 = 4, 
CR type of treatment: PCI = 0 and CABG = 1, 
β0 = 56.32-15.09 x type of treatment, 
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β1 = 41.36 + 17.84 x type of treatment, 
β2 = -8.52+3.11 x type of treatment. 
For PCI the marginal mean prior to treatment was 56.32 and at 3 months it was 89.16, 
resulting in a mean change of 32.84 points from the baseline mean score. For CABG the 
marginal mean prior to treatment was 41.23 and at 3 months it was 88.80, resulting in a mean 
change of 47.57 points from the baseline mean score.  
Concerning the marginal mean for PCI, at 12 months this was 85.44, resulting in a mean 
change of  29.12 points from the baseline mean score, while the marginal mean for CABG at 12 
months was 91.95, resulting in a mean change of 50.72 points from the baseline mean score, as 
Figure 6.6 illustrates. Hence overall, it can be assumed that over a one year period, in the 
physical functioning subdomain patients treated with CABG experienced a greater mean change 
compared to patients treated with PCI.  
 
Figure 6.6 Marginal means of the Physical functioning subdomain scores per CR type of 
treatment. Time0= baseline scores, Time1= 3 month mean scores, Time4=12 month 
mean scores. 
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The variability of the physical functioning scores within individuals per CR type at the 3-
month measurement time po can be seen in Figure 6.7.  
 
Figure 6.7 Physical functioning subdomain scores as a function of Time for all patients 
by type of CR treatment. Time0= baseline scores, Time1= 3 month scores, Time4=12 
month scores.  
 
 
6.3.3.2.Predictors of Physical functioning change over a one-year period 
In the final conditional growth model, the effects of all individual level covariates as well as 
the two time-varying predictors (i.e. smoking and BMI) were investigated. Included in the model 
were also all the two-way interaction terms for these potential predictors with time and CR type 
of treatment. The following Table 6.3.12 summarizes the fixed and random effects of the model. 
 
 
 
 
PCI CABG 
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Table 6.3.12 Growth model for changes in Physical functioning scores over a one-year period  
 Fixed effects  Est (SE) df  t p 
95% Confidence 
Interval  
Lower 
Bound 
Upper 
Bound 
Intercept  26.25(11.46)  529 2.29 0.02 4.31 48.20 
Time  48.17(4.81) 529 10.02 0.00 38.97 57.67 
Time2  -8.52(0.52) 529 -16.53 0.00 -9.51 -7.53 
Type of treatment (CABG)  -7.03(17.08) 428 -0.41 0.68 -39.73 25.67 
Place of residence (Rural Area)  -2.63(3.17) 428 -0.83 0.41 -8.70 3.43 
Age  0.22 (0.14) 428 1.61 0.11 -0.04 0.47 
Sex (Female)  -8.49 (2.23) 428 -3.81 0.00 -12.75 -4.22 
Marital status (Married)  0.41 (2.39) 428 0.17 0.86 -4.18 4.99 
Educational status†             
                  7-12 years  6.20 (2.41) 428 2.57 0.01 1.58 10.82 
                  12+ years  3.47 (2.79) 428 1.24 0.21 -1.88 8.82 
Occupational status‡             
                  Public/private servant 2.10 (2.92) 428 0.72 0.47 -3.49 7.70 
                  Free lancer  5.21 (3.27) 428 1.59 0.11 -1.05 11.48 
                  Pensioner   -5.07 (3.23) 428 -1.57 0.12 -11.25 1.12 
CHD Family history  (yes)  2.90 (1.84) 428 1.58 0.12 -0.62 6.42 
Hypertension    (yes)   2.66 (1.90) 428 1.40 0.16 -0.98 6.30 
Cholesterol      (yes)   -2.35 (2.01) 428 -1.17 0.24 -6.20 1.49 
Diabetes           (yes)   -1.56 (2.19) 428 -0.71 0.48 -5.75 2.63 
BMI  0.50 (0.22) 529 2.30 0.02 0.08 0.91 
Smoking           (yes)   -0.08 (2.06) 529 -0.04 0.97 -4.03 3.86 
Time x Type of treatment  17.48 (4.46) 529 3.92 0.00 8.94 26.01 
Time 2 x Type of treatment  -3.36 (0.94) 529 -3.58 0.00 -5.16 -1.56 
Time x Place of residence 0.49 (0.99) 529 0.49 0.62 -1.41 2.39 
Time x Age  -0.02 (0.05) 529 -0.52 0.61 -0.12 0.07 
Time x Sex  1.57 (0.74) 529 2.11 0.04 0.15 2.99 
Time x Marital status  -1.51 (0.86) 529 -1.75 0.08 -3.16 0.14 
Time x Educational status†               
                 7-12 years 0.50 (0.95) 529 0.53 0.60 -1.32 2.32 
                 12+ years -0.78 (1.03) 529 -0.75 0.45 -2.74 1.19 
Timex Occupational status‡             
                 Public/private servant -0.78 (1.03) 529 -0.75 0.45 -2.74 1.19 
                 Free lancer   0.07 (1.11) 529 0.06 0.95 -2.05 2.19 
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Table 6.3.12 Growth model for changes in Physical functioning scores over a one-year period  
 Fixed effects  Est (SE) df  t p 
95% Confidence 
Interval  
Lower 
Bound 
Upper 
Bound 
                 Pensioner  0.75 (1.12) 529 0.67 0.50 -1.40 2.91 
Time x CHD Family history   -0.19 (0.62) 529 -0.31 0.76 -1.39 1.00 
Time x Hypertension     -0.11 (0.64) 529 -0.17 0.86 -1.32 1.11 
Time x Cholesterol        0.82 (0.68) 529 1.20 0.23 -0.48 2.11 
Time x Diabetes            0.60 (0.73) 529 0.83 0.41 -0.79 2.00 
Time x BMI  -0.12 (0.08) 529 -1.46 0.15 -0.27 0.04 
Time x Smoking -3.34 (0.74) 529 -4.49 0.00 -4.77 -1.92 
Type of treatment x Place of residence  3.30 (3.80) 428 0.87 0.39 -3.98 10.58 
Type of treatment x AGE  0.28 (0.22) 428 1.25 0.21 -0.15 0.71 
Type of treatment x Sex  -6.74 (3.60) 428 -1.87 0.06 -13.64 0.16 
Type of treatment x Marital status  4.39 (4.19) 428 1.05 0.29 -3.63 12.41 
Type of treatment x Educational status†             
                  7-12 years  -4.87 (4.11) 428 -1.18 0.24 -12.75 3.01 
                  12+ years 0.45 (4.73) 428 0.10 0.92 -8.61 9.52 
Type of treatment x Occupational status‡             
                  Public/private servant  3.13 (5.07) 428 0.62 0.54 -6.58 12.85 
                  Free lancer   -6.40 (5.21) 428 -1.23 0.22 -16.38 3.58 
                  Pensioner  -6.03 (5.48) 428 -1.10 0.27 -16.52 4.47 
Type of treatment x CHD Family history   -6.12 (2.70) 428 -2.27 0.02 -11.30 -0.95 
Type of treatment x Hypertension     -4.04 (3.06) 428 -1.32 0.19 -9.90 1.82 
Type of treatment x Cholesterol        -1.10 (2.94) 428 -0.37 0.71 -6.73 4.53 
Type of treatment x Diabetes            4.23 (2.99) 428 1.42 0.16 -1.50 9.97 
Type of treatment x BMI  -0.69 (0.30) 529 -2.32 0.02 -1.26 -0.12 
Type of treatment x Smoking 0.97 (4.29) 529 0.23 0.82 -7.23 9.18 
Random effects  SD    
  Residuals  9.18    
  Intercept  22.72    
  Time  30.71    
  Time2 6.20    
  Model fit 
 
   
  BIC 8947.48    
  †Educational status compared to six years or less ‡Occupational status compared to unemployed  
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The above results demonstrate that after adjusting for potential predictors, the physical 
functioning score initially increased with time and then decreased (β=48.17, SE=4.81, p<0.01 
and β=-8.52, SE=0.52, p<0.01 respectively), although remaining much higher than baseline 
scores.  
Concerning the effect of Time, taking into account also the significant interaction terms, due 
to the presence of the quadratic effect, the interpretation should be based on specific time points. 
For example, if Time1 denotes the value of Time at a specific time, then if time increases by one 
unit physical functioning will increase on average by 48.17-8.52 (2 x Time1 +1) units for PCI 
male patients that do not smoke, by 65.65-11.88 (2 x Time1 +1) units for CABG male patients 
that do not smoke (65.55= time + time x type of treatment interaction) and 11.88= time2 + time2 
x type of treatment interaction, by 49.74-8.52 (2 x Time1 +1) units for PCI female patients that 
do not smoke (where 49.74=time + time x sex interaction), by 67.22-11.88 (2 xTime1 +1) units 
for CABG female patients that do not smoke (where 67.22= time + time x type of treatment 
interaction + time x sex interaction) , by 44.83-8.52 (2∙x Time1 +1) units for PCI male patients 
that smoke (where 44.83= time - time x smoking interaction), by 46.40-8.52 (2 x Time1 +1) 
units for PCI female patients that smoke (where 46.40= time + time x sex interaction - time x 
smoking interaction), by 62.31-11.88 (2 x Time1 +1) units for CABG male patients that smoke 
(where 62.31= time + time x time of treatment interaction - time x smoking interaction) and by 
63.88-11.88 (2 x Time1 +1) units for CABG female patients that smoke (where 63.88= time + 
time x type of treatment interaction + time x sex interaction - time x smoking interaction), if the 
other variables are kept constant.  
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The CR type of treatment was not associated with differences in physical functioning score at 
baseline; it had a negative non-significant effect (p>0.05). The crossover interaction between 
Time and CR type of treatment revealed on the physical functioning score (p<0.01) suggests that 
as the time increases, patients treated with CABG on average show a significantly higher 
physical functioning score. Specifically, for individuals with same the characteristics one year 
after CR, patients treated with CABG demonstrated a greater mean change of 9.13 units 
compared to patients treated with PCI;  CABG treatment at Time0 = - 7.03, at Time1 = 7.09 [((-
7.03+17.48-3.36); where 17.48 represents the value of the interaction term CABG x Time and 
3.36 represents the value of the interaction term CABG x Time2] and at Time2= 9.13[(-
7.03+(17.48x4)- (-3.36x16); where 4 represents the value of Time2 and 16 represents the value 
of Time22].  
Females scored lower on the physical functioning subdomain by 8.49 units (p=0.01) at 
baseline compared to males keeping the other variables constant. This reduction, however, 
tended to decrease as time increased at an almost significant level (p=0.06), resulting in a lower 
mean change of 2.21 units for females compared to males with the same features. Specifically, 
female sex at Time0 = - 8.49, at Time1 =-6.92 ((-8.49+1.57); where 1 represents the value of the 
interaction term sex x time) and at Time2= -2.21. [(-8.49+(1.57x4)); where 4 represents the value 
of Time2].  
Also, a crossover interaction was revealed between smoking and Time. At baseline smoking 
was not associated with differences in physical functioning score (it had a negative non- 
significant effect on physical functioning, p>0.05) keeping the other variables constant.  One 
year post CR, however, smokers showed on average a significantly lower score on physical 
functioning by 13.44 units compared to non-smokers with the same features. Specifically 
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smokers at Time0 = -8.08, at Time1 =-3.42 ((-0.08+(-3.34)) where 3.34 represents the value of 
the interaction term smoking x time) and at Time2= -13.44 [(-0.08+(-3.34x4)); where 4 
represents the value of Time2].  
Furthermore, individuals treated with CABG with a CHD family history will have a lower 
score on physical functioning by 6.12 units if the remaining variables are kept constant.  When 
BMI increases by one unit a PCI patient will have a higher score of physical functioning on 
average by 0.50 but a CABG patient will show a lower score of physical functioning on average 
by 0.19 units, keeping the other variables constant. Patients with 7-12 years of education scored 
higher on physical functioning at baseline by 6.2 units on average, and this difference seems to 
not change significantly after CR, due to a lack of a significant interaction between these two 
variables. 
Briefly, the results suggest that CHD patients following CR experience a significant increase 
in physical functioning subdomain scores one year post CR (section 6.3.3.1). After adjusting for 
potential predictors, the physical functioning score initially increased with time and then 
decreased, remaining much higher compared to baseline scores however. Moreover, the effect of 
time on physical functioning depended on CR type, sex and smoking status; on average it seemed 
to be larger for females treated with CABG who did not smoke. As the time increased, patients 
treated with CABG on average showed a significantly greater physical functioning score 
compared to those treated with PCI. Females compared to males demonstrated a significantly 
worse physical functioning score which tended to become smaller. Smokers compared to non-
smokers showed on average a significantly worse physical functioning. Also patients treated with 
CABG with a CHD family history compared to patients treated with CABG without CHD family 
history on average scored lower on physical functioning following CR.  Individuals with 7-12 
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years of education compared to those with up to 6 years of education on average scored lower on 
physical functioning following CR. 
 
 
6.3.4 The psychosocial functioning subdomain 
The descriptive analysis of the CROQ psychosocial functioning scores indicated an increase 
over a one-year period. Table 6.3.13 displays participants’ mean psychosocial functioning scores 
over a one-year period overall and by CR type of treatment for all individual characteristics 
measured; the mean scores after CR treatment increased for all groups.  
 
 
 
Table 6.3.13 Descriptive statistics for Psychosocial functioning scores per CR type over a one-year period (n=472)    
Psychosocial functioning  
Type of CR 
PCI   CABG 
Prior to 
treatment 
3-month 
post 
treatment 
12-
month 
post 
treatment   
Prior to 
treatment 
3-month 
post 
treatment 
12-
month 
post 
treatment 
Overall    Mean 67.34 84.51 84.03   71.42 84.97 87.23 
  SD 15.97 12.13 13.35   16.79 13.32 10.23 
Age group Mean age 
(60.43) 
<60.43 Mean 66.91 82.82 81.23   71.15 82.52 87.88 
SD 17.59 11.11 13.96   13.86 15.46 10.01 
>60.43 Mean 67.85 86.18 87.28   71.67 87.74 86.50 
SD 13.80 12.88 11.88   19.23 9.76 10.50 
Sex male Mean 67.62 84.98 83.92   72.69 86.87 90.20 
SD 16.31 10.22 13.23   16.50 12.09 8.26 
female Mean 66.41 83.20 84.36   67.23 78.99 77.92 
SD 14.89 16.41 13.83   17.29 15.30 10.33 
Marital status unmarried/ 
live alone 
Mean 68.61 85.52 84.52   65.61 87.41 78.42 
SD 18.16 12.99 14.44   18.61 12.03 11.05 
married Mean 67.00 84.29 83.93   72.40 84.59 88.17 
SD 15.36 11.94 13.17   16.34 13.51 9.73 
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Table 6.3.13 Descriptive statistics for Psychosocial functioning scores per CR type over a one-year period (n=472)    
Psychosocial functioning  
Type of CR 
PCI   CABG 
Prior to 
treatment 
3-month 
post 
treatment 
12-
month 
post 
treatment   
Prior to 
treatment 
3-month 
post 
treatment 
12-
month 
post 
treatment 
Educational status six years or 
less 
Mean 65.84 84.78 84.63   71.84 88.31 85.57 
SD 13.68 14.33 13.55   20.47 10.90 8.62 
7-12 years Mean 70.64 84.46 85.30   69.91 85.58 89.00 
SD 16.21 10.27 13.03   15.06 11.26 10.24 
12+  years  Mean 62.56 84.21 80.72   73.29 81.25 84.68 
SD 16.56 12.98 13.48   16.26 17.33 11.03 
Occupational status unemployed Mean 61.92 88.24 84.86   64.66 80.56 73.74 
SD 16.50 10.90 12.32   16.01 7.17 7.16 
public/private 
servant 
Mean 65.58 82.03 81.15   71.38 91.07 90.07 
SD 18.04 10.82 15.24   12.67 10.90 7.05 
free-lancer Mean 72.21 82.48 82.07   69.73 81.44 91.31 
SD 14.21 10.38 11.93   19.06 17.76 9.68 
pensioner Mean 68.89 85.61 87.10   74.48 85.42 87.30 
SD 13.95 13.68 12.39   17.01 11.27 8.98 
Family history CHD no Mean 67.27 84.40 84.59   68.87 83.25 86.32 
SD 16.56 12.52 13.09   17.11 15.88 9.76 
yes Mean 67.40 84.67 83.49   74.06 86.71 88.05 
SD 15.43 11.81 13.71   16.14 9.89 10.65 
Hypertension no Mean 66.48 83.18 82.68   67.67 86.47 89.31 
SD 16.01 12.76 14.11   17.62 10.64 10.38 
yes Mean 68.47 86.87 86.28   77.32 81.85 83.37 
SD 16.12 10.58 11.73   13.55 17.08 8.86 
Cholesterol no Mean 66.07 85.61 84.07   68.79 85.32 86.49 
SD 16.42 11.41 13.14   16.80 14.27 10.44 
yes Mean 70.04 82.04 83.95   75.99 84.01 88.48 
SD 14.75 13.36 13.87   15.97 11.27 9.75 
Diabetes no Mean 68.52 83.89 83.28   73.23 84.31 88.47 
SD 15.99 12.26 14.09   15.78 14.50 9.17 
yes Mean 62.93 86.22 86.12   67.89 86.06 84.74 
SD 15.60 11.65 10.87   18.21 10.58 11.62 
Smoking no Mean 65.08 85.57 86.34   70.89 84.60 88.12 
SD 14.98 11.83 12.36   19.05 13.51 9.52 
yes Mean 68.97 82.70 81.30   72.04 73.21 81.43 
SD 16.50 9.73 13.65   13.77 12.11 7.53 
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Table 6.3.13 Descriptive statistics for Psychosocial functioning scores per CR type over a one-year period (n=472)    
Psychosocial functioning  
Type of CR 
PCI   CABG 
Prior to 
treatment 
3-month 
post 
treatment 
12-
month 
post 
treatment   
Prior to 
treatment 
3-month 
post 
treatment 
12-
month 
post 
treatment 
BMI normal weight 
(18.5-24.9) 
Mean 66.63 85.03 80.99   67.61 89.09 87.32 
SD 15.83 9.43 11.20   15.43 8.79 10.22 
overweight 
(25.0-29.9) 
Mean 68.06 84.05 84.30   71.59 87.62 87.88 
SD 15.84 14.20 13.25   18.23 11.12 9.68 
obese (<29.9) Mean 66.82 85.09 84.81   73.11 77.94 87.14 
SD 16.81 11.75 14.37   16.23 15.94 10.57 
T1= prior to treatment, T2 = 3 months after treatment, T3= 12 months after treatment  
 
 
6.3.4.1 Changes in Psychosocial functioning: Time and type of CR treatment effects 
As described in the analysis section, the first step was to detect the best fitting model for the 
time trend. Table 6.3.14 shows the values for the six models compared. Based on the BIC index 
the 6th model (model f, Time and Time2 as predictors with random intercept, linear and quadratic 
terms) was the best mixed model for describing the time trend of the psychosocial functioning 
scores.   
 
Table 6.3.14  Parameter estimates and model fit statistics for first and second order polynomials of Psychosocial 
functioning scores growth over a one-year period 
 Model a Model b Model c Model d Model e Model f 
Fixed effects B (SE) B (SE) B (SE) B (SE) B (SE) B (SE) 
Intercept 74.22(0.61) ** 74.32(0.62) ** 69.04(0.69) ** 69.04(0.69) ** 69.04(0.69) ** 69.02(0.81) ** 
Time  3.29(0.27) ** 3.28(0.25) ** 19.69(1.13) ** 19.69(1.13) ** 19.69(1.13) ** 19.45(1.25) ** 
Time2  NA NA -3.89(0.26) ** -3.89(0.26) ** -3.89(0.26) ** -3.83(0.27) ** 
Random effects  SD SD SD SD SD SD 
Residuals  14.99 13.85 12.11 12.10 12.10 7.66 
Intercept   NA 5.68 6.94 6.94 6.95 14.47 
Time  NA NA NA 0.01 NA 20.83 
227 
 
Table 6.3.14  Parameter estimates and model fit statistics for first and second order polynomials of Psychosocial 
functioning scores growth over a one-year period 
 Model a Model b Model c Model d Model e Model f 
Time2  NA NA NA NA 0.01 4.32 
Model fit        
BIC 9369.47 9365.06 9178.87 9192.94 9192.94 9096.21 
NA= not applicable; ML= maximum likelihood; BIC= Schwarz’s Bayesian Criterion 
Random covariate = AR1 heterogeneous 
Time= Linear, Time2= Quadratic 
Model a= Ordinal linear least square regression with Time as a predictor 
Model b= Time as a predictor with random intercept  
Model c= Time and Time2 as predictors with random intercept  
Model d = Time and Time2 as predictors with random intercept and linear term 
Model e= Time and Time2 as predictors with random intercept and quadratic term  
Model f= Time and Time2 as predictors with random intercept, linear and quadratic terms 
In all models response variable psychosocial functioning scores 
**p<0.001 
 
The analysis demonstrated that the mean initial status (baseline) for the psychosocial 
functioning scores was 69.02 (β = 69.02, SE = 0.81, t=84.88, p < 0.01). Time had a significant 
positive linear effect (β = 19.45, SE = 1.25, t= 15.57, p < 0.01 as well as a significant negative 
quadratic effect (β = -3.83, SE = 0.27, t= -14.22, p < 0.01). The acceleration (Singer, & Willett, 
2003) was 11.79 points (i.e. 19.45/ (2 (-3.83)) = 16.81). According to the results, the 
psychosocial functioning scores increased at the beginning, but this trend slowed down later on. 
Overall, a positive change on psychosocial functioning scores following CR can be assumed.  
To investigate the effect of CR type on psychosocial functioning scores, the best model of the 
time trajectory was further investigated by adding the CR type of treatment (PCI/CABG) 
variable. The best model describing the data trends, having the lowest BIC value, was the first 
(Time, Time2, CR type of treatment as predictors with random intercept, linear and quadratic 
terms) as Table 6.3.15 illustrates.  
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Table 6.3.15 Parameter estimates and model fit statistics for first and second order polynomials and 
treatment interactions of Psychosocial functioning scores growth over a one-year period  
 Model 1 Model 2 Model 3 
Fixed effects B (SE) B (SE) B (SE) 
Intercept 68.22(0.89)** 68.55(0.93)** 67.51(1.04)** 
Time 19.31(1.25)** 19.27(1.26)** 21.44(1.58)** 
Time2 -3.84(0.27)** -3.84(0.27)** -4.31(0.34)** 
Type of treatment† 2.08(0.99)* 1.24(1.16) 3.88(1.65)** 
Time x Type of treatment  NA 0.53(0.37) -5.13(2.56)* 
Time2 x Type of treatment  NA NA 1.23(0.55)* 
Random effects SD SD SD 
Residual  7.65 7.60 7.58 
Intercept  14.37 14.43 14.37 
Time 20.91 21.01 20.81 
Time2 4.33 4.34 4.30 
Model fit     
BIC 9098.97 9103.99 9106.03 
NA= not applicable; ML= maximum likelihood; BIC= Schwarz’s Bayesian Criterion 
Random covariate = AR1 heterogeneous, Time= Linear, Time2= Quadratic, †Type of treatment = CABG 
 
Model 1=Time, Time2 and CR type of treatment as predictors with random intercept, linear and quadratic term 
Model 2=Time, Time2, CR type of treatment as predictors and Time x CR type of treatment interaction term with 
random intercept, linear and quadratic terms 
Model 3=Time, Time2, CR type of treatment as predictors, Time x CR type of treatment interaction term, and Time2 
x CR type of treatment interaction term with random intercept, linear and quadratic terms 
In all models response variable psychosocial functioning scores 
**p<0.001, *p<0.05  
 
Results demonstrated that the mean initial status (baseline) for the psychosocial functioning 
scores for CABG patients were higher compared to PCI patients. However, no significant  time x 
treatment interaction was revealed for psychosocial functioning. The marginal means of CR type 
as predictor can be estimated by employing the following formulas:  
Psychosocial functioning marginal means at 0 months (baseline) = β0, 3 months = β0 + β1 x 
Time1 + β2 x Time12 and 12 months = β0 + β1 x Time2+ β2 x Time22, where  
Time1 = 1 and Time2 = 4, 
CR type of treatment: PCI = 0 and CABG = 1, 
β0 = 68.22 + 2.08  x type of treatment, 
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β1 = 19.51 x type of treatment, 
β2 = -3.84 
For PCI the marginal mean prior to treatment was 68.22  and at 3 months it was 83.89, 
resulting in a mean change of 15.67 points from the baseline mean score. For CABG the 
marginal mean prior to treatment was 70.3 and at 3 months it was 86.90, resulting in a mean 
change of 15.67 points from the baseline mean score.  
Concerning the marginal mean for PCI at 12 months this was 84.82, resulting in a mean 
change of  16.60 points from the baseline mean score, while the marginal mean for CABG at 12 
months was 86.90, resulting in a mean change of 16.60 points from the baseline mean score, as 
Figure 6.8 illustrates. Hence overall, it can be assumed that over a one year period, in the 
psychosocial functioning subdomain, patients treated with PCI or CABG experienced a similar 
change as Figure 6.8 illustrates.  
 
 
Figure 6.8 Marginal means of the Psychosocial functioning subdomain scores per CR 
type of treatment. Time0= baseline scores, Time1= 3 month mean scores, Time4=12 
months mean scores. 
 
230 
 
The variability of  the psychosocial functioning scores within individuals per CR type at 
the 3-month measurement time point can be seen in Figure 6.9.  
 
 
Figure 6.9 Psychosocial functioning subdomain scores as a function of Time for all 
patients by type of CR treatment. Time0= baseline scores, Time1= 3 month scores, 
Time4=12 month scores.  
 
 
6.3.4.2 Predictors of Psychosocial functioning change over a one-year period 
In the final conditional growth model, the effects of all individual level covariates as well as 
the two time-varying predictors (i.e. smoking and BMI) were investigated. Included in the model 
were also all the two-way interaction terms for these potential predictors with time and CR type 
of treatment. The following Table 6.3.16 summarizes the fixed and random effects of the model. 
 
 
 
PCI CABG 
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Table 6.3.16 Growth model for changes in Psychosocial functioning scores over a a one-year period  
Fixed effects Est (SE) df t p 
95% Confidence 
Interval  
Lower 
Bound 
Upper 
Bound 
Intercept  46.72 (8.39) 531 5.57 0.00 30.64 62.80 
Time  20.69(3.27) 531 6.32 0.00 14.41 26.96 
Time2  -4.11 (0.31) 531 -13.20 0.00 -4.71 -3.52 
Type of treatment (CABG)  3.09 (12.94) 428 0.24 0.81 -21.72 27.89 
Place of residence (Rural Area)  0.65 (2.36) 428 0.27 0.78 -3.88 5.18 
Age  0.23 (0.10) 428 2.36 0.02 0.04 0.43 
Sex (Female)  -2.14 (1.66) 428 -1.29 0.20 -5.33 1.04 
Marital status (Married)  -3.07 (1.75) 428 -1.75 0.08 -6.43 0.29 
Educational status† 
                        7-12 years  2.88 (1.79) 428 1.61 0.11 -0.55 6.31 
                  12+ years  -0.31 (2.06) 428 -0.15 0.88 -4.27 3.65 
Occupational status‡ 
                        Public/private servant -1.51 (2.15) 428 -0.70 0.48 -5.63 2.61 
                  Free lancer  1.56 (2.42) 428 0.64 0.52 -3.08 6.19 
                  Pensioner   -0.91 (2.38) 428 -0.38 0.70 -5.48 3.65 
CHD Family history  (yes)  1.40 (1.37) 428 1.02 0.31 -1.23 4.03 
Hypertension    (yes)   4.50 (1.42) 428 3.18 0.00 1.78 7.22 
Cholesterol      (yes)   -2.35 (1.50) 428 -1.57 0.12 -5.21 0.52 
Diabetes           (yes)   -1.71 (1.64) 428 -1.04 0.30 -4.85 1.44 
BMI  0.27 (0.16) 531 1.72 0.09 -0.03 0.57 
Smoking           (yes)   1.20 (1.44) 531 0.84 0.40 -1.55 3.95 
Time x Place of residence 0.89 (0.67) 531 1.32 0.19 -0.40 2.17 
Time x Age  0.03 (0.03) 531 0.82 0.41 -0.04 0.09 
Time x Sex  0.42 (0.52) 531 0.80 0.42 -0.58 1.42 
Time x Marital status  0.86 (0.61) 531 1.43 0.15 -0.30 2.03 
Time x Educational status†   
                       7-12 years 0.91 (0.59) 531 1.55 0.12 -0.21 2.03 
                 12+ years 0.59 (0.67) 531 0.88 0.38 -0.69 1.86 
Timex Occupational status‡ 
                       Public/private servant -0.39 (0.72) 531 -0.54 0.59 -1.77 0.99 
                 Free lancer   -0.33 (0.78) 531 -0.42 0.67 -1.81 1.16 
                 Pensioner  0.06 (0.79) 531 0.08 0.94 -1.44 1.57 
Time x CHD Family history   -0.56 (0.44) 531 -1.26 0.21 -1.40 0.29 
232 
 
Table 6.3.16 Growth model for changes in Psychosocial functioning scores over a a one-year period  
Fixed effects Est (SE) df t p 
95% Confidence 
Interval  
Lower 
Bound 
Upper 
Bound 
Time x Hypertension     -0.39 (0.45) 531 -0.88 0.38 -1.25 0.47 
Time x Cholesterol        -0.58 (0.48) 531 -1.22 0.22 -1.50 0.33 
Time x Diabetes            0.04 (0.51) 531 0.08 0.94 -0.94 1.02 
Time x BMI  -0.08 (0.06) 531 -1.34 0.18 -0.18 0.03 
Time x Smoking -0.86 (0.50) 531 -1.71 0.09 -1.82 0.10 
Type of treatment x Place of residence  -6.61 (3.02) 428 -2.19 0.03 -12.39 -0.82 
Type of treatment x AGE  -0.02 (0.17) 428 -0.13 0.90 -0.35 0.31 
Type of treatment x Sex  -5.58 (2.83) 428 -1.97 0.06 -11.00 -0.15 
Type of treatment x Marital status  4.14 (3.18) 428 1.30 0.19 -1.95 10.23 
Type of treatment x Educational status† 
                        7-12 years  -0.20 (3.18) 428 -0.06 0.95 -6.31 5.91 
                  12+ years 1.81 (3.67) 428 0.49 0.62 -5.22 8.84 
Type of treatment x Occupational status‡ 
                        Public/private servant  7.63 (3.96) 428 1.93 0.06 0.05 15.22 
                  Free lancer   -1.35 (4.07) 428 -0.33 0.74 -9.14 6.44 
                  Pensioner  1.48 (4.28) 428 0.34 0.73 -6.73 9.68 
Type of treatment x CHD Family history   2.31 (2.13) 428 1.09 0.28 -1.77 6.40 
Type of treatment x Hypertension     -2.79 (2.37) 428 -1.18 0.24 -7.34 1.76 
Type of treatment x Cholesterol        3.67 (2.32) 428 1.58 0.11 -0.77 8.12 
Type of treatment x Diabetes            0.37 (2.38) 428 0.15 0.88 -4.20 4.94 
Type of treatment x BMI  -0.20 (0.23) 531 -0.89 0.37 -0.65 0.24 
Type of treatment x Smoking 2.27 (2.48) 531 0.92 0.30 -2.48 7.02 
Random effects  SD    
  Residuals  6.80      
Intercept  14.37      
Time  21.43      
Time2 4.47      
Model fit       
BIC 8341.18      
†Educational status compared to six years or less ‡Occupational status compared to unemployed 
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The above results demonstrate that after adjusting for potential predictors, the psychosocial 
functioning scores initially increased with time and then decreased (β=20.69, SE=3.27, p<0.01 
and β=-4.11, SE=0.31, p<0.01 respectively), although remaining much higher than baseline 
scores. The type of treatment is not a significant predictor for psychosocial functioning (p>0.05). 
Concerning the effect of Time, taking into account also the significant interaction terms, due 
to the presence of the quadratic effect, the interpretation should be based on specific time points. 
For example if TIME1 denotes the value of Time at a specific time then if time increases by one 
unit psychosocial functioning will be increased by 20.69-4.11(2 x Time1 +1) units, keeping all 
remaining covariates constant. Moreover, for each additional year older that participants were at 
baseline, there was a 0.23 increase in their psychosocial functioning over the 12 months; the lack 
of a time x age interaction demonstrates that this relationship did not change significantly after 
CR treatment. Interestingly, patients with hypertension scored on average higher on psychosocial 
functioning by 4.5 units; the lack of a time x hypertension interaction demonstrates that this 
relationship did not change significantly after CR treatment. Finally, the significant interaction 
effect between CR type of treatment and place of residence highlights that CABG individuals 
living in rural areas showed a lower score by 6.61 units, keeping the other variables constant. 
This finding suggests that CABG patients living in Attica demonstrated a higher score on 
average by 3.09 units on psychosocial functioning compared to patients living in Attica treated 
with PCI, keeping the other variables constant. On the other hand, CABG patients living in rural 
areas had a lower score on average in this subdomain by 3.52 (i.e. type of treatment-type of 
treatment x place of residence) units compared to PCI patients living in rural areas.   
Briefly, the results suggest that CHD patients following CR experience a significant increase 
in psychosocial functioning one year post CR (section 6.3.4.1). After adjusting for potential 
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predictors the psychosocial functioning score initially increased with time and then decreased, 
remaining however much higher compared to baseline scores. The type of treatment was not a 
significant predictor of psychosocial functioning.  In this subdomain only age and hypertension 
were revealed as individual predictors of the outcome. As the age of the patient increased the 
psychosocial functioning scores increased too. Also patients with hypertension had a greater 
level of psychosocial functioning prior to CR and this difference remained after CR. Finally, 
CABG individuals living in rural areas demonstrated a lower level in psychosocial functioning.  
 
 
 
6.3.5 The Cognitive functioning subdomain 
The descriptive analysis of the cognitive functioning scores as shown in Table 6.3.17 
indicated that participants’ mean scores on cognitive functioning over a one-year period varied. 
Patients treated with CABG seemed to experience a decline in this subdomain.  
 
 
Table 6.3.17 Descriptive statistics for Cognitive functioning scores per CR type over a one-year period 
(n=472)     
Cognitive functioning 
Type of CR 
PCI   CABG 
T1 T2 T3   T1 T2 T3 
Overall    Mean 82.98 89.74 89.87   80.34 83.95 78.55 
  SD 18.45 15.12 15.07   14.98 17.31 14.86 
Age group Mean 
age (60.43) 
<60.43 Mean 81.93 92.86 93.52   86.41 90.70 80.82 
SD 17.80 13.76 12.63   12.21 12.70 13.36 
>60.43 Mean 84.26 86.67 85.65   74.63 76.52 76.05 
SD 19.21 15.80 16.56   15.16 18.70 16.10 
Sex male Mean 83.05 90.50 89.76   80.98 85.11 80.14 
SD 19.04 13.70 15.96   14.49 16.74 14.47 
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Table 6.3.17 Descriptive statistics for Cognitive functioning scores per CR type over a one-year period 
(n=472)     
Cognitive functioning 
Type of CR 
PCI   CABG 
T1 T2 T3   T1 T2 T3 
female Mean 82.76 87.58 90.19   78.20 80.20 73.56 
SD 16.57 18.51 12.31   16.53 18.82 15.21 
Marital status unmarried/live 
alone 
Mean 79.10 88.44 88.43   79.71 78.25 72.78 
SD 19.54 12.08 19.72   17.23 20.35 19.58 
married Mean 84.02 90.03 90.15   80.44 84.81 79.17 
SD 18.06 15.73 14.02   14.63 16.73 14.24 
Educational status six years or 
less 
Mean 86.56 83.42 85.22   77.95 70.98 71.11 
SD 17.99 17.55 19.64   13.78 18.12 13.28 
7-12 years Mean 79.77 92.24 91.23   79.73 85.90 80.49 
SD 18.36 12.25 13.71   12.16 15.87 16.74 
12+  years  Mean 85.29 92.36 92.92   82.96 91.17 79.35 
SD 18.48 15.32 8.74   19.36 13.02 8.67 
Occupational status unemployed Mean 75.35 91.87 91.48   81.40 81.11 70.59 
SD 21.11 13.95 10.64   13.26 12.37 17.33 
public/private 
servant 
Mean 84.95 91.92 94.11   86.08 90.97 86.67 
SD 16.51 15.32 14.48   10.30 12.36 11.39 
free-lancer Mean 82.81 95.24 92.63   82.44 89.40 75.61 
SD 16.42 8.87 10.83   20.64 12.02 12.33 
pensioner Mean 85.23 85.00 83.99   75.69 77.31 79.55 
SD 18.81 16.31 17.62   11.87 21.19 15.64 
Family history 
CHD 
no Mean 83.14 87.31 87.69   79.84 82.88 78.31 
SD 18.08 16.14 14.73   15.02 20.53 13.48 
yes Mean 82.83 92.03 91.91   80.85 85.07 78.77 
SD 18.88 13.75 15.22   15.02 13.21 16.11 
Hypertension no Mean 84.08 91.03 90.44   77.82 86.52 81.54 
SD 18.99 13.04 15.27   16.04 14.07 13.80 
yes Mean 80.71 87.46 88.92   84.11 79.08 72.89 
SD 17.55 18.06 14.77   12.09 21.46 15.00 
Cholesterol no Mean 81.95 91.89 90.73   80.52 83.30 75.82 
SD 18.97 11.83 14.82   13.71 17.77 13.72 
yes Mean 85.29 84.87 88.14   79.64 85.03 83.67 
SD 17.26 19.95 15.53   17.08 16.64 15.69 
Diabetes no Mean 82.86 90.70 91.76   80.00 90.04 84.22 
SD 18.19 14.46 14.53   16.52 12.79 12.41 
yes Mean 82.99 87.11 84.57   80.60 71.97 67.88 
SD 19.71 16.61 15.42   11.67 18.90 12.88 
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Table 6.3.17 Descriptive statistics for Cognitive functioning scores per CR type over a one-year period 
(n=472)     
Cognitive functioning 
Type of CR 
PCI   CABG 
T1 T2 T3   T1 T2 T3 
Smoking no Mean 83.24 88.96 87.93   76.59 84.96 79.50 
SD 19.13 15.25 15.49   16.00 17.15 14.00 
yes Mean 82.80 93.67 92.71   84.75 80.00 72.00 
SD 18.01 11.48 14.08   12.40 13.22 21.81 
BMI normal weight 
(18.5-24.9) 
Mean 82.56 87.27 91.43   79.26 95.19 76.67 
SD 14.95 13.01 10.30   12.32 9.65 18.66 
overweight 
(25.0-29.9) 
Mean 83.62 91.72 88.62   77.28 79.54 73.68 
SD 18.85 15.37 14.61   17.06 17.27 10.99 
obese (<29.9) Mean 82.62 89.24 90.34   83.68 87.35 84.00 
SD 20.01 16.73 17.22   14.04 17.12 11.42 
T1= prior to treatment, T2 = 3 months after treatment, T3= 12 months after treatment  
 
 
6.3.5.1 Changes in Cognitive functioning: Time and type of CR treatment effects 
As described in the analysis section, the first step was to detect the best fitting model for the 
time trend. Table 6.3.18 shows the values for the six models compared. Based on the BIC index 
the 3rd model (model c, Time and Time2 as predictors with random intercept) was the best mixed 
model for describing the time trajectory of the cognitive functioning scores.   
 
Table 6.3.18  Parameter estimates and model fit statistics for first and second order polynomials of Cognitive 
functioning score growth over a one-year period 
 Model a Model b Model c Model d Model e Model f 
Fixed effects B (SE) B (SE) B (SE) B (SE) B (SE) B (SE) 
Intercept 84.10(0.67) ** 83.98(0.70) ** 81.82(0.81) ** 81.82(0.81) ** 81.82(0.81) ** 81.88(0.85) ** 
Time  0.59(0.30) * 0.63(0.26) * 7.26(1.31) ** 7.26(1.31) ** 7.26(1.31) ** 7.25(1.40) ** 
Time2  NA NA -1.57(0.31) ** -1.57(0.31) ** -1.57(0.31) ** -1.58(0.31) ** 
Random effects  SD SD SD SD SD SD 
Residuals  16.62 14.37 14.12 14.12 13.91 10.58 
Intercept   NA 8.40 8.54 8.54 8.54 13.54 
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Table 6.3.18  Parameter estimates and model fit statistics for first and second order polynomials of Cognitive 
functioning score growth over a one-year period 
 Model a Model b Model c Model d Model e Model f 
Time  NA NA NA 0.01 NA 20.17 
Time2  NA NA NA NA 1.57 4.25 
Model fit        
BIC 9603.79 9567.85 9549.01 9563.06 9563.06 9553.01 
NA= not applicable; ML= maximum likelihood; BIC= Schwarz’s Bayesian Criterion 
Random covariate = AR1 heterogeneous 
Time= Linear, Time2= Quadratic 
Model a= Ordinal linear least square regression with Time as a predictor 
Model b= Time as a predictor with random intercept  
Model c= Time and Time2 as predictors with random intercept  
Model d = Time and Time2 as predictors with random intercept and linear term 
Model e= Time and Time2 as predictors with random intercept and quadratic term  
Model f= Time and Time2 as predictors with random intercept, linear and quadratic terms 
In all models response variable cognitive functioning scores 
**p<0.001 
 
The analysis demonstrated that the mean initial status (baseline) for the cognitive functioning 
scores was 81.82 (β = 81.88, SE = 0.81, t=100.28, p < 0.01). Time had a significant positive 
linear effect (β = 7.26, SE = 1.31, t= 5.50, p < 0.01) as well as a significant negative quadratic 
effect (β = -1.57, SE = 0.31, t= -5.13, p < 0.01). The acceleration (Singer, & Willett, 2003) was 
4.12 points [(i.e. 7.26/ (2 (-1.57))]. According to the results, the cognitive functioning scores 
increased at the beginning, but this trend slowed down later on. Overall, a positive small change 
on cognitive functioning scores following CR can be assumed.  
To investigate the effect of the CR type on cognitive functioning scores, the best model of the 
time trajectory was further investigated by adding the CR type of treatment (PCI/CABG) 
variable. Based on the BIC lowest value, the model describing better the cognitive functioning 
trends was the second (Time, Time2, CR type of treatment as predictors and the interaction term 
Time x CR type of treatment with random intercept) as Table 6.3.19 shows.  
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Table 6.3.19 Parameter estimates and model fit statistics for first and second order polynomials and 
treatment interactions of Cognitive functioning scores growth over a one-year period  
 Model 1 Model 2 Model 3 
Fixed effects B (SE) B (SE) B (SE) 
Intercept 84.16(0.92)** 82.83(0.96)** 82.61(1.02)** 
Time 7.11(1.32)** 8.11(1.32)** 8.76(1.66)** 
Time2 -1.54(0.31)** -1.57(0.31)** -1.73(0.38)** 
Type of treatment† -6.20(1.17)** -2.90(1.41)** -2.36(1.64) 
Time x Type of treatment  NA -2.24(0.53)** -3.95(2.67) 
Time2 x Type of treatment  NA NA 0.41(0.62) 
Random effects SD SD SD 
Residual  14.15 13.94 13.93 
Intercept  7.92 8.14 8.15 
Time NA NA NA 
Time2 NA NA NA 
Model fit     
BIC 9529.09 9518.35 9524.95 
NA= not applicable; ML= maximum likelihood; BIC= Schwarz’s Bayesian Criterion 
Random covariate = AR1 heterogeneous, Time= Linear, Time2= Quadratic, †Type of treatment = CABG 
 
Model 1=Time, Time2 and CR type of treatment as predictors with random intercept, linear and quadratic term 
Model 2=Time, Time2, CR type of treatment as predictors and Time x CR type of treatment interaction term with 
random intercept, linear and quadratic terms 
Model 3=Time, Time2, CR type of treatment as predictors, Time x CR type of treatment interaction term, and Time2 
x CR type of treatment interaction term with random intercept, linear and quadratic terms 
In all models response variable cognitive functioning scores 
**p<0.001, *p<0.05  
 
Results showed that CABG patients scored lower compared to PCI patients at the mean 
initial status (baseline) of the cognitive functioning subdomain and had a lower increase in linear 
trends.  In quadratic trends, however, patients treated with CABG demonstrated a great decline. 
The marginal means of CR type as a predictor for cognitive functioning subdomain can be 
estimated by employing the following formulas:  
Cognitive functioning marginal means at 0 months (baseline) = β0, 3 months = β0 + β1 x Time1 + 
β2 x Time12 and 12 months = β0 + β1 x Time2+ β2 x Time22, where  
Time1 = 1 and Time2 = 4,  
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CR type of treatment: PCI = 0 and CABG = 1, 
β0 = 82.83 - 2.90  x type of treatment, 
β1 = 8.11 - 2.24 x type of treatment 
β2 = -1.57 
For PCI the marginal mean prior to treatment was 82.83 and at 3 months it was 89.37, 
resulting in a mean change of 6.54 points from the baseline mean score. For CABG the marginal 
mean prior to treatment was 79.93 and at 3 months it was 84.23, resulting in a mean change of 
4.30 points from the baseline mean score.  
Concerning the marginal mean for PCI at 12 months this was 90.15, resulting in a mean 
change of  7.32 points from the baseline mean score, while the marginal mean for CABG at 12 
months was 78.29, resulting in a mean change of -1.64 points from the baseline mean score, as 
Figure 6.10 illustrates.  Overall, it can be assumed that patients treated with CABG experience a 
decline in cognitive functioning one year after CR, while patients treated with PCI experience an 
increase in this subdomain as illustrated by Figure 6.10.  
 
Figure 6.10 Marginal means of the Cognitive functioning subdomain scores per CR type 
of treatment. Time0= baseline scores, Time1= 3 month mean scores, Time4=12 months 
mean scores. 
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The variability of the cognitive functioning scores within individuals per CR type at the 3 
month measurement time point can be seen in Figure 6.11.  
  
Figure 6.11 Cognitive functioning subdomain scores as a function of Time for all patients by 
type of CR treatment. Time0= baseline scores, Time1= 3 months scores, Time4=12 months 
scores. 
 
 
6.3.5.2 Predictors of Cognitive functioning change over a one-year period 
In the final conditional growth model, the effects of all individual level covariates as well as 
well as the two time-varying predictors (i.e. smoking and BMI) were investigated. Included in 
the model were also all the two-way interaction terms for these potential predictors with time and 
CR type of treatment. The following table 6.3.20 summarizes the fixed and random effects of the 
model. 
 
 
PCI CABG 
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Table 6.3.20  Growth model for changes in Cognitive functioning scores over a one year period  
 Fixed effects  Est (SE) df  t p 
95% Confidence 
Interval  
Lower 
Bound 
Upper 
Bound 
Intercept  81.88(10.32) 530 7.93 0.00 62.11 101.65 
Time  11.97(4.49) 530 2.67 0.01 3.38 20.56 
Time2  -1.79(0.35) 530 -5.12 0.00 -2.46 -1.12 
Type of treatment (CABG)  3.08(15.54) 428 0.20 0.84 -26.70 32.85 
Place of residence (Rural Area)  -3.89(2.81) 428 -1.39 0.17 -9.27 1.49 
Age  -0.11(0.12) 428 -0.87 0.38 -0.34 0.13 
Sex (Female)  0.94(2.06) 428 0.46 0.65 -3.00 4.88 
Marital status (Married)  3.69(2.14) 428 1.72 0.09 -0.42 7.80 
Educational status† 
                        7-12 years  -2.08(2.21) 428 -0.94 0.35 -6.32 2.16 
                  12+ years  1.27(2.54) 428 0.50 0.62 -3.59 6.13 
Occupational status‡ 
                        Public/private servant 5.95(2.67) 428 2.23 0.03 0.84 11.07 
                  Free lancer  7.82(2.98) 428 2.62 0.01 2.11 13.53 
                  Pensioner   5.29(2.93) 428 1.80 0.07 -0.33 10.90 
CHD Family history  (yes)  1.33(1.68) 428 0.79 0.43 -1.88 4.54 
Hypertension    (yes)   -4.44(1.74) 428 -2.55 0.01 -7.78 -1.10 
Cholesterol      (yes)   -1.08(1.84) 428 -0.59 0.56 -4.60 2.44 
Diabetes           (yes)   1.26(2.01) 428 0.63 0.53 -2.59 5.12 
BMI  0.04(0.19) 530 0.20 0.85 -0.33 0.40 
Smoking           (yes)   -0.00(1.72) 530 0.00 1.00 -3.30 3.29 
Time x Type of treatment  -2.09(0.92) 530 -2.26 0.02 -3.86 -0.32 
Time x Place of residence 1.31(1.00) 530 1.31 0.19 -0.60 3.22 
Time x Age  -0.04(0.05) 530 -0.85 0.39 -0.14 0.05 
Time x Sex  0.06(0.77) 530 0.08 0.94 -1.41 1.54 
Time x Marital status  -0.47(0.89) 530 -0.52 0.60 -2.17 1.24 
Time x Educational status†   
                       7-12 years 1.41(0.86) 530 1.63 0.10 -0.24 3.06 
                 12+ years 0.64(0.98) 530 0.65 0.52 -1.24 2.51 
Timex Occupational status‡ 
                       Public/private servant -1.53(1.06) 530 -1.43 0.15 -3.57 0.51 
                 Free lancer   -2.50(1.14) 530 -1.93 0.06 -4.69 -0.31 
                 Pensioner  -1.50(1.16) 530 -1.29 0.20 -3.72 0.73 
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Table 6.3.20  Growth model for changes in Cognitive functioning scores over a one year period  
 Fixed effects  Est (SE) df  t p 
95% Confidence 
Interval  
Lower 
Bound 
Upper 
Bound 
Time x CHD Family history   0.18(0.64) 530 0.27 0.78 -1.05 1.41 
Time x Hypertension     0.64(0.66) 530 0.98 0.33 -0.61 1.90 
Time x Cholesterol        0.31(0.70) 530 0.45 0.65 -1.02 1.65 
Time x Diabetes            -2.05(0.75) 530 -2.72 0.01 -3.49 -0.61 
Time x BMI  0.01(0.08) 530 0.16 0.87 -0.14 0.17 
Time x Smoking 0.20(0.73) 530 0.28 0.78 -1.20 1.60 
Type of treatment x Place of residence  5.76(3.50) 428 1.64 0.10 -0.95 12.48 
Type of treatment x AGE  -0.27(0.20) 428 -1.33 0.18 -0.66 0.12 
Type of treatment x Sex  -1.58(3.29) 428 -0.48 0.63 -7.89 4.73 
Type of treatment x Marital status  -0.27(3.69) 428 -0.07 0.94 -7.35 6.81 
Type of treatment x Educational status† 
                        7-12 years  4.10(3.70) 428 1.11 0.27 -2.99 11.20 
                  12+ years 0.98(4.30) 428 0.23 0.82 -7.25 9.21 
Type of treatment x Occupational status‡ 
                        Public/private servant  -2.42(4.71) 428 -0.51 0.61 -11.44 6.60 
                  Free lancer   -8.45(4.82) 428 -1.75 0.08 -17.69 0.78 
                  Pensioner  -5.74(5.02) 428 -1.14 0.25 -15.35 3.88 
Type of treatment x CHD Family history   1.84(2.50) 428 0.74 0.46 -2.95 6.63 
Type of treatment x Hypertension     8.29(2.75) 428 3.02 0.00 3.03 13.57 
Type of treatment x Cholesterol        1.20(2.73) 428 0.44 0.66 -4.04 6.44 
Type of treatment x Diabetes            -4.81(2.81) 428 -1.71 0.09 -10.20 0.57 
Type of treatment x BMI  0.31(0.27) 530 1.12 0.26 -0.22 0.83 
Type of treatment x Smoking 2.78(2.73) 530 1.02 0.31 -2.46 8.02 
Random effects  SD      
Residuals  13.77      
Intercept  5.94      
Time  NA      
Time2 NA      
Model fit       
BIC 8668.79      
†Educational status compared to six years or less ‡ Occupational status compared to unemployed 
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The above results demonstrate that after adjusting potential predictors, the cognitive 
functioning score initially increased with time and then decreased (β= 11.97, SE=4.49, p<0.05 
and β= -1.79, SE=0.35, p<0.01, respectively).  
Concerning the effect of Time, taking into account also the significant interaction terms, due 
to the presence of the quadratic effect, the interpretation should be based on specific time points. 
For example, if Time1 denotes the value of Time at a specific time then if time increases by one 
unit cognitive functioning will increase by 11.97-1.79(2 x Time1 +1) units for the PCI patients 
without diabetes, by 9.88-1.79(2 x Time1 +1) units for the CABG patients without diabetes 
(where 9.88= time - time x treatment interaction), by 9.92-1.79(2 x Time1 +1) units for the PCI 
patients with diabetes (where 9.92= time- time x diabetes interaction) and by 7.83-1.79(2∙x 
Time1 +1) units for the CABG patients with diabetes (where 7.83=time - time x type of 
treatment interaction - time x diabetes interaction).  
The CR type of treatment was not associated with differences in cognitive functioning scores 
at baseline; it had a positive non-significant effect (p>0.05). A crossover interaction effect 
between Time and CR type of treatment was revealed on the cognitive functioning score 
(p<0.01) suggesting that as time increased, patients treated with CABG on average showed a 
significantly lower value on the cognitive functioning. Specifically, for individuals with 
otherwise the same characteristics one year after CR, patients treated with CABG demonstrated 
on average a significant lower cognitive functioning score by 5.28 units compared to patients 
treated with PCI;  CABG treatment at Time0 = 3.08, at Time1 = 0.99 (3.08-2.09; where 2.09 
represents the value of the interaction term Time x Type of treatment) and at Time2= -5.28 
[(3.08-(2.09x4)); where 4 represents the value of Time2].  
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Also, a crossover interaction was revealed between diabetes and Time. At  baseline diabetes 
was not associated with differences in the cognitive functioning score (it had a positive non-
significant effect on the cognitive functioning score, p>0.05) keeping the rest of the variables 
fixed. However, as time increased, patients with diabetes showed on average a significant lower 
value on the cognitive functioning score. Specifically, individuals with diabetes on average 
showed a lower score on cognitive functioning by 6.94 units compared to patients without 
diabetes with similar features one year post CR; individuals with diabetes at Time0 = 1.26, at 
Time1 =-0.79 (1.26-2.05; where 2.05 represents the value of the interaction term time x diabetes) 
and at Time2= -6.94 [(1.26-(2.05x4)); where 4 represents the value of Time2].  
Also, PCI patients with hypertension on average showed a lower score on cognitive 
functioning by 4.44 units compared to PCI patients with no hypertension, while CABG patients 
with hypertension scored higher, on average by 3.85 units (i.e. type of treatment – type of 
treatment x hypertension) compared to CABG patients with no hypertension prior to CR keeping 
the other variables constant.  
Finally, patients working in the public/private sector on average scored higher on cognitive 
functioning by 5.95 units compared to those without a job and patients working as free-lancers 
on average scored higher by 7.82 units compared to the those without a job prior to CR keeping 
the other variables constant. The lack of significant interaction between time and occupational 
status suggests that the above differences remained the same post CR, in this subdomain. 
Briefly, results suggest that CHD patients following CR experienced a significant increase in 
cognitive functioning one year post treatment (section 6.3.5.1), but this increase was not 
experienced by all patients. After adjusting for potential predictors, the cognitive functioning 
score initially increased with time and then decreased, remaining however, much higher 
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compared  to baseline scores. Moreover, the effect of time depended on CR type of treatment and 
diabetes. The time effect was greater for patients treated with PCI without diabetes.  Moreover, 
as time increased, PCI patients on average showed a significantly higher cognitive functioning 
score compared to CABG patients. Individuals with diabetes on average showed a significantly 
lower cognitive functioning score compared to patients without diabetes. Also, CABG patients 
with hypertension on average showed a significantly greater cognitive functioning score 
compared to CABG patient without hypertension. Individuals working in the public or private 
sector or free-lancers compared to those without a job on average showed a greater cognitive 
functioning score following CR.  
6.3.6 Adverse effects  
The descriptive analysis of adverse effects scores indicated fewer adverse effects between 3 
and 12 months after CR (Table 6.3.2.1); the mean scores for all groups increased, revealing a 
reduction in adverse effects experienced. 
 
 
Table 6.3.21 Descriptive statistics for Adverse effects scores per CR type  
 Adverse effects   
Type of CR 
PCI   CABG 
T2 T3   T2 T3 
Overall    Mean 97.46 99.37   84.46 97.31 
  SD 5.92 3.69   12.54 4.39 
Age group  
Mean age (60.43) 
<60.43 Mean 97.84 99.55   86.69 97.69 
SD 5.28 2.35   10.75 4.07 
>60.43 Mean 97.08 99.17   81.92 96.88 
SD 6.50 4.81   13.96 4.72 
Sex male Mean 97.89 99.23   87.73 97.87 
SD 5.26 4.16   10.56 4.17 
female Mean 96.22 99.76   73.55 95.53 
SD 7.43 1.72   12.60 4.64 
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Table 6.3.21 Descriptive statistics for Adverse effects scores per CR type  
 Adverse effects   
Type of CR 
PCI   CABG 
T2 T3   T2 T3 
Marital status unmarried/live 
alone 
Mean 97.07 100.00   83.25 95.27 
SD 6.26 0.00   19.89 5.85 
married Mean 97.54 99.24   84.64 97.52 
SD 5.86 4.03   11.11 4.18 
Educational status six years or 
less 
Mean 96.93 98.82   79.55 95.45 
SD 6.52 5.95   14.27 5.73 
7-12 years Mean 97.39 99.40   84.48 97.86 
SD 5.84 2.62   12.43 3.55 
12+  years  Mean 98.20 100.00   88.18 97.43 
SD 5.36 0.00   10.13 4.69 
Occupational status unemployed Mean 98.48 99.65   75.88 95.86 
SD 3.93 2.08   11.95 4.12 
public/private 
servant 
Mean 97.92 99.79   87.98 98.36 
SD 5.70 1.61   11.40 4.47 
free-lancer Mean 97.52 99.67   88.23 98.62 
SD 4.70 2.03   8.32 3.15 
pensioner Mean 96.68 98.71   82.60 96.13 
SD 7.09 5.70   14.23 4.96 
Family history CHD no Mean 97.15 99.05   84.00 97.00 
SD 6.53 4.89   12.73 4.61 
yes Mean 97.74 99.68   84.95 97.59 
SD 5.30 1.91   12.42 4.19 
Hypertension no Mean 96.76 99.09   84.48 97.84 
SD 6.63 4.53   13.82 4.01 
yes Mean 98.70 99.84   84.28 96.31 
SD 4.14 1.42   9.93 4.90 
Cholesterol no Mean 97.60 99.48   83.95 97.45 
SD 5.79 2.45   13.78 4.48 
yes Mean 97.13 99.14   85.35 96.93 
SD 6.24 5.41   9.78 4.26 
Diabetes no Mean 97.27 99.42   88.18 97.90 
SD 6.07 3.85   11.12 3.85 
yes Mean 97.98 99.23   77.04 96.18 
SD 5.51 3.25   12.08 5.11 
Smoking no 
 
 
Mean 97.57 99.40   85.22 97.47 
SD 5.60 4.26   11.32 4.34 
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Table 6.3.21 Descriptive statistics for Adverse effects scores per CR type  
 Adverse effects   
Type of CR 
PCI   CABG 
T2 T3   T2 T3 
yes Mean 98.19 99.32   93.18 95.00 
SD 4.56 2.78     5.18 
BMI normal weight 
(18.5-24.9) 
Mean 96.65 100.00   92.55 96.82 
SD 6.42 0.00   10.48 5.38 
overweight 
(25.0-29.9) 
Mean 97.17 98.94   84.94 98.09 
SD 6.52 5.40   11.32 4.30 
obese (<29.9) Mean 98.39 99.43   80.03 96.59 
SD 4.74 2.63   13.94 2.88 
T2= 3 months after treatment, T3= 12 months after treatment  
 
 
The variability of adverse effects scores within individuals per CR type at the 2 measurement 
time points can be seen in Figure 6.12.  
 
Figure 6.12 Adverse effects subdomain scores as a function of time for all patients by 
type of CR treatment. Time1= 3 month scores, Time4=12 month scores.  
 
PCI CABG 
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6.3.6.1 Predictors of adverse effects  
In order to investigate predictors of adverse effects, as described in the analysis section, a 
new variable was created calculating the difference between the 3 and 12 month scores. The 
following Table 6.3.22 summarizes the results of the linear regression model for the adverse 
effects difference between 3 and 12 months after CR.  
 
Table 6.3.22  Regression model for mean difference in adverse effects between 3 and 12 months  
 Fixed effects  Est (SE) t p 
95% Confidence 
Interval  
Lower 
Bound 
Upper 
Bound 
Intercept  4.63(5.45) 0.85 0.40 -6.1 15.35 
Type of treatment (CABG)  6.88(11.62) 0.59 0.55 -15.99 29.75 
Place of residence (Rural Area)  3.34(2.32) 1.44 0.15 -1.22 7.92 
Age  -0.08(0.08) -0.97 0.33 -0.25 0.08 
Sex (Female)  -2.14(1.37) -1.56 0.12 -4.83 0.56 
Marital status (Married)  0.01(1.56) 0.01 0.99 -3.07 3.09 
Educational status†           
                  7-12 years  -0.76(1.53) -0.50 0.62 -3.76 2.24 
                  12+ years  -1.10(1.72) -0.64 0.52 -4.49 2.29 
Occupational status‡           
                  Public/private servant -1.24(1.79) -0.69 0.49 -4.76 2.28 
                  Free lancer  -1.84(2.02) -0.91 0.36 -5.82 2.13 
                  Pensioner   -1.42(2.07) -0.69 0.49 -5.49 2.65 
CHD Family history  (yes)  -0.20(1.21) -0.17 0.87 -2.60 2.19 
Hypertension    (yes)   1.42(1.20) 1.19 0.24 -0.94 3.78 
Cholesterol      (yes)   -0.59(1.29) -0.46 0.65 -3.13 1.95 
Diabetes           (yes)   1.81(1.38) 1.31 0.19 -0.91 4.52 
Type of treatment x Place of residence  -2.51(2.97) -0.85 0.40 -8.36 3.33 
Type of treatment x AGE  -0.15(0.18) -0.83 0.41 -0.51 0.21 
Type of treatment x Sex  -4.89(2.69) -1.82 0.07 -10.2 0.41 
Type of treatment x Marital status  -8.46(3.73) -2.27 0.02 -15.79 -1.12 
Type of treatment x Educational status†           
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Table 6.3.22  Regression model for mean difference in adverse effects between 3 and 12 months  
 Fixed effects  Est (SE) t p 
95% Confidence 
Interval  
Lower 
Bound 
Upper 
Bound 
                  7-12 years  1.79(3.55) 0.50 0.61 -5.19 8.77 
                  12+ years 0.52(3.85) 0.13 0.89 -7.06 8.10 
Type of treatment x Occupational status‡           
                  Public/private servant  1.07(3.73) 0.29 0.77 -6.28 8.42 
                  Free lancer   2.90(3.75) 0.77 0.44 -4.49 10.29 
                  Pensioner  3.80(4.07) 0.93 0.35 -4.22 11.82 
Type of treatment x CHD Family history   0.71(1.98) 0.36 0.72 -3.19 4.61 
Type of treatment x Hypertension     0.35(2.45) 0.14 0.89 -4.46 5.17 
Type of treatment x Cholesterol        -0.13(2.25) -0.06 0.95 -4.56 4.30 
Type of treatment x Diabetes            -9.85(2.20) -4.47 0.00 -14.18 -5.51 
 
The multiple linear regression analysis demonstrated two significant interactions: a) type of 
treatment x marital status and b) type of treatment x diabetes. Married patients treated with 
CABG showed a larger decrease in adverse effects score by 8.46 units compared to patients 
treated with CABG who lived alone keeping the remaining variables constant.  Furthermore 
patients with diabetes treated with CABG showed a larger decrease in the adverse effects score 
by 9.85 units compared to CABG patients without diabetes when keeping the remaining 
variables constant. Briefly, married individuals and people with diabetes treated with CABG 
demonstrated a larger decrease in adverse effects.  
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6.3.7 Satisfaction 
The descriptive analysis of satisfaction scores indicated an increase between 3 and 12 months 
after CR (Table 6.3.23); the mean scores for all groups increased. However, patients treated with 
PCI demonstrated a greater level of satisfaction shortly after treatment compared to patients 
treated with CABG.  
 
Table 6.3.23 Descriptive statistics for Satisfaction scores per CR type  
 Satisfaction 
Type of CR 
PCI   CABG 
T2 T3   T2 T3 
Overall    Mean 85.99 86.44   72.45 86.60 
  SD 14.58 16.18   22.74 12.61 
Age group  
Mean age (60.43) 
<60.43 Mean 82.48 82.49   76.33 89.15 
SD 15.07 17.02   21.81 12.68 
>60.43 Mean 89.44 91.01   67.80 83.87 
SD 13.27 13.89   23.16 12.05 
Sex male Mean 87.59 87.19   78.59 88.77 
SD 13.42 13.85   18.33 10.07 
female Mean 81.42 84.30   53.84 79.95 
SD 16.77 21.53   24.93 16.86 
Marital status unmarried/live 
alone 
Mean 84.57 84.38   71.76 81.60 
SD 14.33 20.92   30.13 17.43 
married Mean 86.31 86.85   72.57 87.15 
SD 14.66 15.10   21.38 11.95 
Educational status six years or 
less 
Mean 87.98 90.42   67.42 84.66 
SD 14.36 16.16   23.01 8.84 
7-12 years Mean 85.68 85.38   69.94 84.60 
SD 14.19 15.55   22.87 13.48 
12 years + Mean 84.03 83.60   81.90 92.82 
SD 15.69 16.83   20.18 11.60 
Occupational status unemployed Mean 83.54 84.11   59.31 70.02 
SD 14.58 21.56   26.94 17.62 
public/private 
servant 
Mean 85.92 84.49   88.51 88.44 
SD 14.71 14.85   13.62 9.12 
free-lancer Mean 80.23 84.65   81.70 95.06 
SD 13.51 13.09   7.11 6.88 
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Table 6.3.23 Descriptive statistics for Satisfaction scores per CR type  
 Satisfaction 
Type of CR 
PCI   CABG 
T2 T3   T2 T3 
pensioner Mean 89.46 90.23   64.94 85.04 
SD 14.16 15.21   24.44 8.58 
Family history CHD no Mean 86.71 87.11   69.15 87.55 
SD 13.97 15.26   24.85 11.09 
yes Mean 85.26 85.70   76.29 85.77 
SD 15.23 17.13   19.54 13.84 
Hypertension no Mean 85.44 86.14   70.27 85.90 
SD 14.55 16.60   24.49 13.75 
yes Mean 86.94 86.94   75.72 87.56 
SD 14.68 15.55   19.63 10.26 
Cholesterol no Mean 86.51 85.82   77.71 86.66 
SD 13.57 17.08   18.99 13.91 
yes Mean 84.80 87.69   61.67 86.15 
SD 16.69 14.21   26.12 9.55 
Diabetes no Mean 85.93 85.77   77.95 89.47 
SD 13.70 16.37   23.26 9.81 
yes Mean 86.13 88.33   61.59 81.28 
SD 16.89 15.62   17.69 15.15 
Smoking no Mean 87.57 90.37   73.61 88.39 
SD 13.40 13.26   21.76 11.26 
yes Mean 82.18 81.29   84.72 68.33 
SD 15.59 18.24   17.23 9.23 
BMI normal weight 
(18.5-24.9) 
Mean 86.66 86.00   75.93 82.08 
SD 10.70 15.55   25.15 15.80 
overweight 
(25.0-29.9) 
Mean 84.53 85.75   76.82 86.48 
SD 16.37 15.89   17.09 10.95 
obese (<29.9) Mean 87.43 86.63   64.97 88.73 
SD 15.32 17.22   24.99 9.83 
T2 = 3 months after treatment, T3= 12 months after treatment  
 
The variability of satisfaction scores within individuals per CR type at the 2 measurement time 
points can be seen in Figure 6.13.  
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Figure 6.13 Satisfaction subdomain scores as a function of time for all patients by type of CR 
treatment. Time1= 3 month scores, Time4=12 month scores. 
 
6.3.7.1 Predictors of Satisfaction  
To investigate potential predictors of satisfaction scores, as described in the analysis section, 
a new variable was created calculating the difference between the 3 and 12 month scores. The 
following Table 6.3.24 summarizes the results of the linear regression model for the satisfaction 
difference between 3 and 12 months after CR.  
 
Table 6.3.24  Regression model for mean difference in satisfaction between 3 and 12 months 
 Fixed effects  Est (SE) t p 
95% Confidence 
Interval  
Lower 
Bound 
Upper 
Bound 
Intercept  -0.05(11.00) 0.00 1.00 -21.71 21.62 
Type of treatment (CABG)  -35.43(28.73) -1.23 0.22 -92.01 21.16 
PCI CABG 
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Table 6.3.24  Regression model for mean difference in satisfaction between 3 and 12 months 
 Fixed effects  Est (SE) t p 
95% Confidence 
Interval  
Lower 
Bound 
Upper 
Bound 
Place of residence (Rural Area)  3.48(4.68) 0.74 0.46 -5.73 12.69 
Age  0.00(0.17) 0.00 1.00 -0.34 0.34 
Sex (Female)  -0.92(2.75) -0.33 0.74 -6.33 4.49 
Marital status (Married)  -2.67(3.16) -0.84 0.40 -8.89 3.56 
Educational status†           
                  7-12 years  3.07(3.07) 1.00 0.32 -2.97 9.11 
                  12+ years  2.48(3.47) 0.71 0.48 -4.36 9.31 
Occupational status‡           
                  Public/private servant 1.69(3.61) 0.47 0.64 -5.42 8.79 
                  Free lancer  -2.21(4.08) -0.54 0.59 -10.25 5.82 
                  Pensioner   1.25(4.16) 0.30 0.76 -6.95 9.45 
CHD Family history  (yes)  -1.92(2.44) -0.79 0.43 -6.93 2.89 
Hypertension    (yes)   1.82(2.41) 0.76 0.45 -2.92 6.57 
Cholesterol      (yes)   -1.58(2.59) -0.61 0.54 -6.69 3.53 
Diabetes           (yes)   0.76(2.78) 0.27 0.79 -4.71 6.22 
Type of treatment x Place of residence  -12.23(6.25) -1.96 0.06 -24.53 0.07 
Type of treatment x AGE  1.00(0.46) 2.19 0.03 0.10 1.90 
Type of treatment x Sex  -10.97(6.00) -1.83 0.07 -22.79 0.85 
Type of treatment x Marital status  -11.70(7.76) -1.51 0.13 -26.99 3.58 
Type of treatment x Educational 
status†           
                  7-12 years  -2.06(7.77) -0.27 0.79 -17.36 13.23 
                  12+ years 2.22(9.33) 0.24 0.81 -16.16 20.60 
Type of treatment x Occupational 
status‡           
                  Public/private servant  -2.16(8.66) -0.25 0.80 -19.23 14.90 
                  Free lancer   -14.09(8.18) -1.72 0.09 -30.20 2.02 
                  Pensioner  -24.75(8.81) -2.81 0.01 -42.09 -7.40 
Type of treatment x CHD Family 
history   11.63(4.41) 2.63 0.01 2.94 20.32 
Type of treatment x Hypertension     -5.16(6.11) -0.85 0.40 -17.20 6.87 
Type of treatment x Cholesterol        -14.56(5.21) -2.79 0.01 -24.82 -4.30 
Type of treatment x Diabetes            -13.95(4.91) -2.84 0.00 -23.61 -4.29 
†Educational status compared to six years or less ‡Occupational status compared to unemployed 
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The multiple linear regression analysis demonstrated five significant interactions: a) type of 
treatment x age; when the age of a CABG patient increased by 1 year, the satisfaction score after 
12 months on average increased by one unit compared to the satisfaction score after 3 months, b) 
type of treatment x occupational status; retired patients treated with CABG showed a larger 
decrease in satisfaction score between 3 and 12 months by 24.75 units compared to the CABG 
patients without a job, c) type of treatment x cholesterol; CABG patients with high cholesterol 
levels demonstrated a larger decrease in satisfaction score between 3 and 12 months on average 
by 14.56 units compared to patients without high cholesterol levels treated with CABG, d) type 
of treatment x diabetes; CABG patients with diabetes showed a larger decrease in satisfaction 
score between 3 and 12 months by 13.95 units compared to individuals without diabetes treated 
with CABG, and e) type of treatment x CHD family history; patients with a previous CHD 
history treated with CABG showed a larger increase in satisfaction score between 3 and 12 
months by 11.63 units compared to individuals without CHD family history treated with CABG, 
when keeping the remaining variables constant. Briefly, as time increased, a larger increase in 
satisfaction level showed by retired patients, patients with high cholesterol levels or diabetes 
treated with CABG.  
 
 
 
6.4 Discussion  
6.4.3 Findings  
The present study aimed to detect the extent to which CR affects the HRQoL level of CHD 
patients over a one-year period, what might be the pattern of change, whether the type of CR 
treatment influences the outcome as well as to investigate the predictive value of various 
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individual characteristics (demographic, medical and behavioural) on the change in HRQoL over 
a one-year period.  
Results demonstrated that the overall HRQoL level increases dramatically after treatment. 
One year post treatment, for most individuals the gain remains large but somewhat lower than 
the one experienced three months post treatment. Concerning the effect of type of CR treatment 
on the overall HRQoL over one year, patients treated with CABG experienced a greater mean 
change compared to patients treated with PCI, but this difference did not remain significant after 
controlling for individual characteristics. In fact, the final growth model showed that the benefit 
experienced by patients with either treatment did not significantly differ. However it should be 
noted that the effect of CR type on subdomains is mixed. Thus the effect of type of CR treatment 
remains a challenging issue.  
Moreover, results revealed that the effect of Time depends mainly on sex, BMI and smoking. 
Females and individuals who do not smoke and have close to normal BMI seem to experience 
the greatest improvement. These findings are in line with the literature (e.g. Blankenship, et al., 
2013; Soo Hoo, Gallagher, & Elliott, 2014) and the meta-analysis (Chapter 3) suggesting that 
these factors (e.g. smoking; Blankenship, et al., 2013; Rumsfeld et al., 2004; Taira et al., 2000) 
have a stronger influence on the outcome than type of treatment. Also the findings of the present 
study support research evidence highlighting that females do not benefit less from CR compared 
to males and that the differences observed in studies comparing solely post-CR scores may be 
due to the poorer preoperative HRQoL (e.g. Lansky et al., 2005; Hartman et al., 2014). An 
explanation of such variability in research findings may be related to the statistical analysis used 
(e.g. lack of investigation of interaction effects) or reflect differences in CHD adjustment and 
level of “positive growth” following CR or being a CHD survivor. As the literature suggests, 
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individuals after experiencing a traumatic event such as heart surgery or surviving a heart attack, 
often experience post-traumatic growth (e.g. greater appreciation of life, motivation to change 
leading to personal growth; Bluvstein, Moravchick, Sheps, Schreiber, & Bloch, 2013; Waight, 
Strodl, Sheridan, & Tesar, 2015) which influences their perspective and evaluation of HRQoL. 
This phenomenon tends to be experienced more strongly females (Leung et al., 2012).      
Also the results support recent studies suggesting that smokers demonstrate poorer HRQoL 
outcome compared to non-smokers following CR (e.g. Jang et al., 2015) but are contrary to 
studies suggesting that BMI is not related to HRQoL outcome  (e.g. Jarvinen et al., 2007). 
Concerning the symptoms subdomain, results showed that individuals experience a positive 
change after coronary revascularization. However, the largest effect of CR on this domain was 
experienced during the first three months. At 12 months, it still remained much greater than the 
baseline level, but lower than at three months post treatment. Moreover, the results revealed that 
the effect of time depends on CR type of treatment, BMI and smoking; it seems to be larger for 
individuals who are treated with CABG, do not smoke and have low BMI.  For the 12 month 
follow up, fewer symptoms were reported by patients treated with CABG compared to ones 
treated with PCI, by females compared to males and by non-smokers compared to smokers. It 
may be that the relapse in smoking cessation between 3 and 12 months, which is much greater 
among PCI patients, reflects the reporting of more symptoms at 12 months post-CR by 
individuals treated with PCI. In any case, the literature highlights that smokers experience 
increased CHD symptoms post operation compared to quitters (e.g. Rumsfeld et al., 2004).  
Regarding physical functioning, similar to the symptoms subdomain, results showed that 
individuals experience a positive change after coronary revascularization. However, the largest 
effect of CR on this domain was during the first three months. At 12 months it still remained 
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much greater than at baseline level, but lower than at 3 months.  Moreover, the effect of time on 
physical functioning interacts with CR type, sex and smoking status. Females, those treated with 
CABG and non-smokers seem to benefit most. Existing research evidence (e.g. Martin et al., 
2012; Peric et al., 2010) found that female sex and smoking are independent predictors of lower 
physical functioning after CABG compared to males and to non-smokers, although no interaction 
effects were reported.  
In relation to the psychosocial functioning results suggest that CHD patients following CR 
experience a significant increase in this subdomain. Similar to other HRQoL subdomains the 
largest effect of CR on this domain was during the first three months. At 12 months it remained 
much greater than at baseline, but reduced after 3 months. In this subdomain only age and 
hypertension predicted the outcome. Patients with hypertension had a greater level of 
psychosocial functioning prior to CR and this difference remained after CR. Also, older patients 
reported greater increases in their psychosocial functioning. Existing research evidence (Kurfirst 
et al., 2004) suggests either that age is not a valid predictor of HRQoL following CR, or  that 
younger patients benefit more after heart surgery especially in cognitive components of HRQoL 
(e.g. Hokkanen, Järvinen, Huhtala, & Tarkka, 2014). The findings of the present study contradict 
both these claims. An explanation might be the instrument used. As discussed elsewhere, data 
the present study used the CROQ which is a disease/treatment specific instrument and thus more 
sensitive when capturing change. Finally, CABG individuals living in rural areas demonstrated 
less improvement in psychosocial functioning compared to individuals treated with PCI living in 
rural areas or individuals treated with CABG and living in urban areas. This observation may be 
explained by the fact that CABG is a more “severe” heart operation compared to PCI, as 
involving a general anesthesia, sternotomy, removal of a vein usually from a leg or arm, and 
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involving a longer hospital stay and recovery in general, as well as greater level of complications 
(e.g. wound infections, atrial fibrillation (Halonen et al., 2007; Salehi-Omran et al., 2007; 
Toumpoulis, Anagnostopoulos, Derose, & Swistel, 2005), implying the need for good healthcare 
(well-equipped hospital and qualified surgeon at very least).  In Greece, rural areas have only 
small hospitals (known as hospital health care centres; Kontodimopoulos, Nanos, & Niakas, 
2006), lacking the necessary equipment and doctors for such surgeries. Demanding surgeries are 
carried out in big cities (Siskou, Kaitelidou, Papakonstantinou, & Liaropoulos, 2008). Thus rural 
dwellers need to temporarily move to a big city, such as Athens and often seek private health 
care due to an understaffed public health care system (Siskou, Kaitelidou, Papakonstantinou, & 
Liaropoulos, 2008). Taking into consideration moving, operation expenses and follow up visit to 
doctors which in and of themselves are factors associated with high level of distress, those 
individuals may lose their sense of control and balance in their life, factors eliciting further 
distress (Helman, 2007).    
Regarding cognitive functioning, results showed that many CHD patients following CR 
experience a significant increase in this subdomain. This observation though was not similar for 
all individuals undergoing CR; the effect of time seems to depend on CR type of treatment and 
diabetes. Patients treated with PCI without diabetes experienced higher cognitive functioning 
compared to PCI individuals with diabetes or CABG patients (with or without diabetes). 
Independently, one year after CR, individuals treated with CABG seemed to experience a decline 
in cognitive functioning while individuals treated with PCI seemed to experience an 
improvement. These findings are aligned with some previous research evidence (e.g. Phillips-
Bute et al., 2006; McKhann et al., 2009) but contradict other evidence suggesting no difference 
in cognitive functioning between patients treated with different revascularization treatments (e.g. 
259 
 
Kennedy et al., 2013; Währborg et al., 2004) especially when co-morbidities are controlled for 
(Cormack et, 2012; Sun et al., 2012). Moreover, the results are in line with previous research 
findings suggesting worse cognitive functioning for individuals with diabetes after CABG (e.g. 
Krannich et al., 2012). Finally, having hypertension seems to be an independent predictor of 
lower increase in cognitive functioning compared to individuals without hypertension after CR. 
Research evidence demonstrates similar results (Selnes & McKhann, 2005).   
Concerning adverse effects and satisfaction, patients treated with PCI seem very satisfied and 
show low levels of adverse effects at 3 months post treatment compared to patients treated with 
CABG.  These findings are in line with the literature (e.g.  Salehi-Omran et al., 2007; Sellier, 
2007). However, the results showed that at 12 months individuals who underwent CABG 
demonstrated a greater improvement reaching the same level as those treated with PCI. This 
observation seems to be in line with the greater increase of CABG patients in physical 
functioning between 3 and 12 months; as individuals experience a reduction in adverse effects 
their physical functioning increases more strongly. Significant predictors of the mean difference 
were marital status and diabetes; married patients and patients with diabetes treated with CABG 
showed a greater improvement in adverse effects. In terms of satisfaction, significant predictors 
of the mean difference were retired patients treated with CABG, patients with high cholesterol 
levels or diabetes treated with CABG; these patients suggested a greater increase in satisfaction 
with treatment. The findings are in line with the limited literature in these areas (i.e. adverse 
effects and satisfaction with coronary revascularization treatment; Shroter, 2001).  
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6.4.4 Strengths and limitations 
The current study has several strengths. First of all it adds to the existing knowledge about 
individuals’ different experience and changes in HRQoL over one year after treatment. It is one 
of the few longitudinal studies that makes use a CR-specific HRQoL instrument with a 12 month 
follow-up. Moreover, it follows recommendations (Pragodpol & Ryan, 2013) for detecting 
factors that predict the trajectory of HRQoL in cardiac patients since the concept of HRQoL may 
change over time, but the majority of predictors are usually constant (fixed); the  study tested a 
number of demographic, medical and behavioural characteristics demonstrating significant 
predictors regarding HRQoL level at different time points over a one-year period. Furthermore, 
the present study demonstrates the changes in total HRQoL level after coronary revascularization 
as well as the effect of each CR type both on total HRQoL and its subdomains providing the 
required data for calculation of effect sizes. These are important issues because as the meta-
analysis revealed, the literature has a dearth of studies that examine HRQoL in both procedures 
simultaneously and there is lack of studies that provide adequate data (e.g. Mean scores and SD) 
per HRQoL subdomain. All these issues covered increase study quality which, based on the 
criteria used in the meta-analysis, can be rated with a 7.5 which puts it up near the top of the 
studies reviewed.  
On the other hand, there are a few limitations that should be mentioned. First the sample size 
was  not large (especially for CABG treatment with fewer than 200 participants) and not random. 
This limits generalizability. Moreover, the majority of individuals were residents of Athens with 
a higher proportion of overweight participants compared to the general population. Another 
limitation is the lack of a detailed medical profile for each patient. Various factors related to 
patients’ medical characteristics (e.g. severity of angina) were not controlled for and thus the 
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results may be misleading. Research evidence demonstrates that individuals with multi-vessel 
CHD have fewer symptoms and greater HRQoL post CABG compared to those treated with PCI 
(Abdallah et al., 2013). Therefore the results should be interpreted with caution. 
Furthermore, many patients treated with CABG were recruited from a private hospital in 
contrast to PCI who were recruited from public ones. This might imply differences in financial 
status, another variable that was not measured, and possibly differences in stress e.g. about costs, 
as the majority of patients treated in private hospitals have private health insurance. Empirical 
research shows that people on a low income tend to have poor HRQoL and increased 
psychological distress (Ackerman, Graves, Wicks, Bennell, & Osborne, 2005). Also a number of 
individuals who underwent CABG reported having at least one session with a health 
professional, usually a health or clinical psychologist prior to hospital discharge. This may have 
created differences in individuals’ perceptions which in turn may have influenced their scoring. 
As the literature highlights, even a single structured supporting session may influence 
individuals’ perception of HRQoL (Phillips et al., 2004).  
Furthermore, there are a number of researchers (e.g. Walters, 2009) who suggest that 
longitudinal studies should use both disease specific and generic HRQoL instruments for more 
accurate results, especially when the research sample may have multiple morbidities. Moreover, 
a challenge that remains to be addressed is whether a disease specific HRQoL measure is more 
sensitive to a generic one in the long-term. As HRQoL is a dynamic concept that changes over 
time and individual shifts are present, a generic instrument could capture essential aspects not 
addressed via the disease-specific one (e.g. psychological distress not immediately related to the 
health condition).  
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Finally, issues such as response shift (Schwartz et al., 2007) or adjustment processes (e.g. 
Taylor, 1983; discussed in Chapter 2) that may influence individuals’ evaluation of their HRQoL 
over time were not investigated. Thus the increase in HRQoL level following CR treatment or 
the lack of CR type effect in some subdomains (i.e. psychosocial functioning) observed might be 
challenged in terms of whether it reflects a “true” estimation of CR effect or interferes with 
changes of individuals’ internal standards, values and the conceptualization of quality of life. 
 
6.4.5 Implications for theory, research and practice 
The present study is a vivid illustration of the dynamic process of HRQoL. As results have 
shown, individuals’ subjective evaluation of HRQoL changes between three and twelve months 
after CR treatment.  
Findings highlight the importance of examining HRQoL level across multiple time points (at 
least 3) to capture HRQoL changes over time as well as detect factors that might influence the 
outcome. The use of multilevel modelling provides an opportunity to examine both the effect of 
time over several measurement points and develop growth models examining various predictors 
without restrictions such as the assumption of homogeneity of regression slopes, and excluding 
cases due to missing data (i.e. excluding participants that have not participated in all measured 
timepoints). Measurement of HRQoL over multiple timepoints would help health professionals 
construct a less ambiguous picture of change trends and related factors and, in turn, would allow 
them to target interventions at a time point that would benefit patients most. Moreover, further 
research should be carried out investigating whether the type of diabetes is related to the 
outcome. The limited research that has been carried out in this area in relation to CR outcome 
suggests that the issue with cognitive deficits observed following CABG may be related only to 
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insulin-dependent individuals (Kadoi, Saito, Fujita, & Goto, 2005; Kubal, Srinivasan, Grayson, 
Fabri, & Chalmers, 2005). Furthermore, for researchers aiming to investigate the influence of 
treatment on the pattern of HRQoL over several time points, it might be beneficial to explore 
some additional factors that may interfere with subjective evaluations over time. For instance, 
measuring response shift (Ahmed, Mayo, Wood-Dauphinee, Hanley, & Cohen, 2004) or 
exploring adjustment (Foxwell, Morley, & Frizelle, 2013) that may influence individuals’ 
evaluations of their HRQoL over time (Hamidou, Dabakuyo, & Bonnetain, 2011) and may allow 
to draw more robust conclusions concerning the estimated effect of treatment over time.  
Health providers should take into consideration that smoking and BMI are two negative 
predictors of HRQoL outcome after CR and that it would be helpful to facilitate their patients’ 
behaviour modification. Also, cardiologists should consider diabetes mellitus when deciding on 
the type of CR treatment; although there is a tendency to suggest CABG treatment more often to 
individuals with diabetes compared to PCI (NICE team guidelines, 2012), individuals with 
diabetes tend to demonstrate a decline in cognitive functioning after CABG. However, women 
experience a similar increase in HRQoL after CR as men, especially when BMI and smoking are 
controlled for. Thus sex should not be considered when making decisions about CR treatment, at 
least in relation to HRQoL.  
Finally, policies regarding equal access to health services in rural areas should be 
implemented, especially for patients needing cardiac surgery; improving health care in rural 
areas may contribute positively to psychosocial well-being particularly in CABG patients. 
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6.5 Conclusion  
Individuals treated with CR experience an increase in their HRQoL level after treatment. One 
year post treatment, the gain remains large for most individuals but it is somewhat lower than the 
one experienced three months post treatment. Moreover, individuals treated with CABG tend to 
experience a larger increase compared to PCI patients in the subdomains of symptoms and 
physical functioning but a decline in the subdomain of cognitive functioning. This contradiction 
may account for there being no significant difference in the effect of type of treatment on overall 
HRQoL. Smoking and BMI were the most prominent negative predictors of low mean change in 
most HRQoL subdomains. Patients with diabetes when treated with CABG experience a 
cognitive decline.   
The results of the present study regarding the positive effect of CR on individuals’ HRQoL 
based on their subjective evaluation might be challenged without a greater insight into 
individuals’ understanding and making meaning process.  If taking into consideration that CHD 
is a chronic disease, an adjustment process to CHD may interfere with the positive effect on 
measured HRQoL. Thus a further in-depth exploration of the patient experience would be helpful 
to draw more robust conclusions. The next qualitative study (the second component of the mixed 
methods study) aims to capture individuals’ understanding of their disease and CR treatment and 
its influence on their perspective of HRQoL as well as adjustment related issues. In order to do 
so an Interpretative Phenomenologcal approach (IPA; Smith et al., 2009) was selected which 
guides researchers to focus more on the patients’ meaning-making process. Also this approach 
would allow the researcher to explore concerns about lifestyle modifications, especially in 
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relation to smoking, which was identified as a negative predictor of improvement in HRQoL 
level following CR.   
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Chapter Seven 
Study 2, Part Two. Individuals making sense of HRQoL one year 
after CR: An Interpretative Phenomenological Analysis 
7.1 Introduction  
The quantitative part of the present mixed methods study (Chapter 6) shows an overall 
improvement in Health Related Quality of Life (HRQoL) following coronary revascularization 
(CR). The quantitative results showed various factors as being influential to the pattern of overall 
HRQoL change and its subdomain over a one-year period following CR; among the most 
influential factors were CR type, smoking status, BMI and diabetes mellitus. Concerning female 
sex, an individual feature mostly suggested in the literature as a predictor of lower improvement 
following PCI or CABG, especially in the physical functioning domain (Martin et al., 2012; 
Yeng, Gallagher, & Elliott, 2016), the results showed that females experienced greater 
improvement following CR when do not smoke and are not overweight. As previously discussed, 
these findings are important and build upon previous research. However, they do not provide the 
scientific community with a deeper understanding of how coronary heart disease (CHD) patients 
make sense of HRQoL, how they view themselves and their life after CR. Such understanding 
could provide a complimentary insight. Thus the present qualitative component of the mixed 
methods study aims to capture individuals’ understanding of their disease and CR treatment and 
its influence on their perspective of HRQoL exploring adjustment related issues. Also, it puts a 
special emphasis on exploring concerns about life style modifications, especially in relation to 
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smoking which was identified as a predictor of a lower increase in HRQoL following CR. 
Specifically the qualitative part intends to: 1) explore further the relevance and meanings of the 
main domains of quality of life, as defined in the coronary revascularization outcome 
questionnaire (CROQ); 2) contribute qualitative insights into quality of life after CR, including 
both patients who have undergone coronary artery bypass graft surgery (CABG) and those who 
have been treated with percutaneous coronary intervention (PCI); 3) examine the way individuals 
adopt behaviour change and consider the implications of this for practice. This chapter begins 
with an overview of the literature on qualitative research related to HRQoL after CR, then 
presents the methods and procedure followed in the course of data collection and data analysis. 
The main part of this chapter provides an extensive presentation and discussion of the qualitative 
findings.  
 
7.1.1 Overview of qualitative literature; patients experience of quality of life after CR 
The literature on the quality of life of patients after CR is largely dominated by quantitative 
studies that assess the impact of the therapeutic intervention on patients’ everyday life through 
measurements of pre-defined items. Starting from the recognition that, quality of life is a multi-
dimensional and fluid concept, there has been an increasing number of qualitative studies in the 
last two decades that aim to capture the meaning and variability of lived experience beyond the 
researchers’ pre-defined constructs. This section will review the literature on qualitative studies 
of patients’ experience of quality of life after CR in order to move towards defining the 
conceptual context and aims of the current study. 
The vast majority of qualitative studies have focused on patients who have undergone 
CABG, exploring patients’ lived experience after CABG or  patients’ perception of factors that 
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influence lifestyle changes after CABG (e.g. Abbasi, Mohammadi, Nasrabadi, Fuh, & Sadeghi, 
2014; Angus, 2001; Goldsmith, Lindholm, & Bute, 2006; Leegaard, Nåden, & Fagermoen, 2008; 
Leegaard, Rustøen, & Fagermoen, 2010; Tolmie, Lindsay, & Belcher, 2006; Tung, Hunter, & 
Wei, 2008). Only few studies have explored PCI patients’ experience and factors that may 
influence their behaviour change (Astin, Closs, McLenachan, Hunter, & Priestley, 2009; 
Peterson et al., 2010).   
An interesting synthesis (Leegaard & Fagermoen, 2008) of 19 qualitative studies published 
between 1991-2006 that had used either thematic analysis or grounded theory, aimed to explore 
patients’ experience after CABG and highlighted several important themes. In short, this review 
applied thematic analysis and demonstrated that many individuals experience fears (e.g. of the 
unknown future, being a burden), losses (reduced independence, mandatory life changes), as well 
as the paradox of feeling alone while being supported by others. Furthermore, a very recent 
article (Abbasi, Mohammadi, Nasrabadi, Fuh, & Sadeghi, 2014), to date the only study on the 
topic using IPA, focused on understanding the lived experience of 11 patients at least six months 
post CABG. The study findings revealed that patients perceive their experience as a “re-birth”, 
especially in terms of bodily sensation and function.   
Qualitative research on PCI (Astin, Closs, McLenachan, Hunter, & Priestley, 2008; Astin, et 
al., 2009; Peterson, et al., 2010) highlights that PCI patients, similar to CABG patients, 
experience a fear of the unknown future. Many patients perceive PCI as a turning point to make 
life changes (re-prioritizing). They make changes in their stance towards life (e.g. quit work, 
spend more time with the family, and enjoy simple everyday things). Some others, however, do 
not experience PCI in the same way. The absence of bodily evidence (e.g. lack of a scar) and the 
feeling of being healthy (lack of symptoms) result in perceiving the health condition to be of 
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minor importance. This perception, accompanied by the lack of adequate and correct information 
provided by the medical services, reduces their effort to make lifestyle changes (e.g. in terms of 
diet, physical activity) in both the short- and long-term.   
With respect to all previous published studies, although they reveal important findings and 
provide cumulative knowledge in the area of cardiac health, there are a few issues that need to be 
addressed. The findings do not build a complete picture of the phenomenon under investigation. 
With very few exceptions (these exceptions concern studies with patients after CABG (e.g. 
Abassi et al., 2014; Tomie et al., 2006), the aim of most qualitative studies has been the 
exploration of individuals’ lived experience shortly after CR, exploring some aspects of QoL 
(e.g. Lindsay, Smith, Hanlon, & Wheatley, 2000; Peterson et al., 2010). However, as QoL is a 
fluid multi-dimensional notion, a qualitative study using in-depth individual interviews exploring 
people's lived experience after a longer follow-up post treatment could provide greater insights. 
Interviewing patients at a greater temporal distance to the experience of treatment can inform us 
further of the process that individuals follow in order to make sense of their life, potential shifts 
over time in their points of view regarding the meaning of living a good life, their persistent 
concerns and their interpretation, as well as the strategies that they adopt in order to practise (or 
not) everyday lifestyle modifications.  
Furthermore, in most studies, the methods used for data analysis focus on demonstrating 
either the most important themes in participants’ accounts by using thematic analysis, or 
categories revealing similarities and differences by using grounded theory. These methods imply 
limited interpretation of the phenomenon through participants’ viewpoints as, especially in the 
latter case, the aim is to develop theories to generate concepts which may provide an explanation 
of individual ways to resolve their main concerns focusing mainly on social processes. Thus they 
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lose important idiographic elements as well as individual processes that may be of primary 
concern, particularly when this knowledge can form the foundation for tailored interventions 
aiming to foster an individual’s sense of a good life. Also, they do not provide a deeper 
understanding of the process that individuals follow in order to adopt and justify various 
modifications in their lifestyle. For instance, Peterson et al. (2010) highlight that patients 
unsuccessfully treated with PCI quit smoking but they do not provide the reader with any insight 
into why successfully treated patients are less willing to quit smoking. Tomie et al. (2006) 
demonstrate that individuals acknowledge that stress has a negative impact on their health and 
try to avoid it as a coping strategy. Yet, the authors do not explain the process that individuals 
undergo in order to gain such an understanding and how an individual sense of self as well as 
behaviour is influenced as a result of this understanding. As Smith (2010) underlines, illness 
experience might be better understood within an IPA framework. He considers this approach 
more insightful as it focuses on exploring the unique human experience as it is perceived and 
interpreted by individuals themselves.  In turn, this can facilitate more effective interventions 
aiming to promote living a good life.  
To this end, this study, by using IPA aims to gain a deeper understanding of patients’ 
subjective meanings of what constitutes a good life in the context of their experience of heart 
disease and CR treatment that might be helpful in designing more effective programmes for 
rehabilitation, secondary prevention and promotion of long lasting behavioural/life-style 
changes. In order to achieve the study’s aim the following research questions will be addressed: 
 
1) How does having been diagnosed with CHD and undergone CR influence CHD 
patients’ perspectives regarding QoL?  
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2) How do CHD individuals experience life changes after CR and what might be the 
adjustment process that follows? 
3) What concerns do CHD individuals have about life style modifications, in particular 
smoking cessation?  
 
 
7.2 Methods 
7.2.1 Participants  
In total, 13 people were contacted from two lists compiled in the course of the quantitative 
studies; the first included individuals treated with PCI and the second individuals treated with 
CABG, who had participated in all three quantitative assessment points and were smokers or ex-
smokers. One participant never replied, one declined to participate and one was excluded after 
she cancelled the interview appointment three times. Thus, a purposive sample of 10 individuals 
participated in this study (5 from each CR procedure), 6 males and 4 females. Their ages ranged 
between 42-70 years. All of them were Greek, in terms of ethnicity, and the majority were high 
school or university graduates.  Table 7.1 displays the participants characteristics. As the 
developer of IPA argues, a very small number of interviews between four and ten (even, a single 
case study) could be enough for developing a deep understanding of an experience (Smith et al., 
2009). For a greater discussion about sample sizes in qualitative studies please see appendix 7.1 
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Table 7.1 Participant Profile 
Name* Age Sex Marital status 
Time after 
CR in 
months 
Type of CR Smoking status  
Joanna  46 Female Married 13 CABG Smoker  
Nathan 70 Male Married 12 CABG Ex-smoker** 
Giannis 63 Male Married 12 CABG Ex-smoker 
Nasos 63 Male Married 13 CABG Ex-smoker 
Dina  65 Female Married 14 CABG Ex-smoker 
Illianna  42 Female Married 11 PCI Ex-smoker 
Petros  54 Male Married 12 PCI Smoker 
Charis  50 Male Married 12 PCI Smoker 
Maria  47 Female Married 13 PCI Smoker 
Gerassimos 64 Male Divorced 15 PCI Smoker 
*pseudonyms  ** prior to CR  
 
7.2.2 Data collection 
In-depth semi-structured interviews were carried out for data collection. According to the 
recommendation of IPA experts (Smith, Flowers, & Larkin, 2009; Smith & Osborn, 2003), this 
type of interview can provide rich data for analysis as it is guided by a flexible interview 
schedule. This also allows researchers to investigate other important issues related to the subject 
under investigation mentioned by each participant. The particular interview schedule consists of 
ten open-ended questions (Appendix 4.6). The development of the questions was based on two 
aspects of quality of life (physical and psychosocial well-being) examined in the quantitative 
component of the study and highlighted in the relevant literature. In addition, it included 
questions on changes in attitude, behaviour and lifestyle, as well as other questions that allowed 
participants to discuss issues related to quality of life that had not been directly asked about or 
covered. Also, prompting questions were used to allow better exploration and understanding of 
issues revealed during discussion. The interview schedule was reviewed and approved by the 
supervisors and tested for relevance and clarity in a mock interview.  
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Participants could choose the place where the interview would take place; either the 
researcher’s office (8) or their own homes (2). The interviews lasted between 45 and 150 
minutes. All interviews were audio-recorded and then transcribed verbatim by the researcher 
based on Silverman’s (2000) guidelines. At the transcription stage all information that could 
identify participants was removed. Ethical approval was granted for the study by the University 
of Hertfordshire Ethics Committee (Appendix 4.7.1), and all participants gave their oral and 
written consent (a detailed discussion about ethical considerations is presented in Chapter 4: 
Methods).    
 
 
7.2.3 Analysis  
The methodological approach adopted in the design of the qualitative interviews and analysis 
of the interview data was in accordance with Interpretative Phenomenological Analysis 
guidelines, for which a small number of participants is adequate since emphasis is on 
understanding subjective experience rather than identifying similarities and differences between 
individuals. Interpretative Phenomenological Analysis (IPA; Smith, 2009) was chosen as the 
most appropriate approach for the analysis of interviews in the present study among other 
qualitative analyses for reasons discussed in Chapter 4. First of all, IPA best suits the research 
aims as it was developed to explore individuals’ understanding and sense making of various 
phenomena as expressed in their own words. Secondly, it is interpretative with a double 
hermeneutic heuristic. In other words, the researcher makes an effort to understand and make 
sense of individuals’ points of view and their understanding of the particular experience. Thirdly, 
IPA is idiographic in nature. It treats each case as a case study and afterwards explores 
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convergence and divergence across themes from the analysis of different interviews (Larkin, 
Watts, & Clifton, 2006; Smith et al., 2009). Finally, it is useful in the field of health psychology 
research as it is able to give "voice" to the individual experience of disease/illness as well as 
reveal the individual meanings attributed to it. This insight has been shown to be very useful in 
improving best clinical practice (Curry, Nembhard, & Bradley, 2009), and shaping health care 
policy (Cassidy, Reynolds, Naylor, & De Souza, 2011).  
The exact steps followed for IPA are described in the Method chapter. 
 
 
7.2.4 Strategies to ensure quality  
The assessment criteria for the quality of qualitative research differ dramatically from those 
for quantitative research. According to Smith et al. (2009), the developer of the IPA approach, 
Yardley’s (2000) guidelines are most appropriate. Those guidelines place emphasis on four main 
principles: a) sensitivity to context, b) commitment and rigour, c) transparency and coherence, 
and d) impact and importance. 
Sensitivity to context refers to four different aspects of sensitivity that should be 
demonstrated by the researcher: presentation of the theoretical and empirical background of the 
literature related to the research; being sensitive to participants’ points of view and their socio-
cultural stance; being sensitive to ethical issues; being sensitive in the data analysis. In the 
present study, sensitivity to the context has been established partly in the introductory chapters 
(Chapter 1 & 2) and partly in the introduction to this chapter. Sensitivity to participants has been 
established by asking them open-ended questions as well as by using prompting questions to 
encourage them to speak about essential aspects of their experience. Moreover, interviews 
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conducted in the researcher’s office were made in a calm and safe environment with minimal 
decor. All interviews were conducted at a mutually agreed time between the researcher and 
participant. Furthermore, the researcher’s genuine interest in individuals’ points of view and non-
critical attitude (i.e. unconditional positive regard; Rogers, 1962) also ensured sensitivity towards 
participants and reduced social desirability biases (Silverman, 2013). Active listening, mirroring 
and summarizing techniques were used to help the researcher gain  confirmation from the 
participants of their understanding of their utterances. Sensitivity to ethical issues was 
established by ensuring participants’ anonymity (using pseudonyms) and by respecting their 
rights. Sensitivity in data analysis was established by supporting the analysis and interpretation 
with participant quotes and trying to be as open-minded as possible to avoid my own biases, 
based on existing knowledge.   
Commitment and rigour refers to the demonstration of the researcher’s systematic 
engagement with the topic, competence and skill in the method followed, thorough data 
collection and in-depth data analysis.  Participants’ openness was also encouraged by the fact 
that, due to the longitudinal nature of the research for this thesis, an previous relationship had 
been established between participants and the researcher. Also, an interview debriefing schedule 
was presented at the end of the discussion allowing participants to comment on the interview 
procedure and make recommendations for improvement (Appendix 4.12). Researcher 
engagement with the topic and related skills were obtained by attending seminars on IPA, 
practicing a mock interview prior to data collection and having constant supervision by an expert 
in IPA during data collection as well as during data analysis.   
Transparency and coherence refers to a clear and coherent description of the process 
followed and how the methodological principles underlying IPA have been accomplished during 
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both data collection and analysis. Moreover, it refers to the relevance between interpretation and 
supporting quotes from the interviews as well as to the researcher’s reflexivity about her own 
influence on data analysis and interpretation.  Concerning my influence on data analysis and 
interpretation, first of all I acknowledge that, due to lack of prior experience with IPA research, 
some aspects of the participants’ experience may have not received the attention that participants 
would like. Moreover, as a Greek middle-aged individual with a congenital heart disease, 
interpretation of individuals’ accounts may have been influenced by my own projections and 
experience of the impact of the disease on quality of life. Also, due to my training in two 
psychological disciplines, health and counseling, my professional background may have 
prejudiced the way the data have been interpreted trying to find a deeper meaning in simple, 
straightforward issues. In an effort to avoid possible misconceptions, transparency and coherence 
in this study have been established in part by the detailed description of the steps followed and 
their relevance to IPA as described in the Method chapter. In the course of the analysis, an 
experienced researcher in IPA was involved in reviewing the data and considering individual 
interpretations. This involved, firstly, discussions of coding of themes and sub-themes with 
reference to the transcript in the course of analysis of the first interview and, secondly, 
comparisons and clarifications of the themes derived from all interviews to confirm the 
consistency and validity of analysis. The thesis supervisors also revised the interview schedule 
(as stated in previous paragraphs), monitored the analysis process and reviewed the data and the 
table of themes constructed from all interviews. In that way, leading questions and interpretation 
bias (Silverman, 2013) were reduced.  
Finally, impact and importance refers to the importance of a research study regarding novelty 
and usefulness. The present qualitative study can be argued to provide readers with a unique 
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knowledge in the field of coronary disease about how individuals who have undergone CR (both 
CABG and PCI) make sense of their quality of life one year after treatment, using IPA. Efforts 
have been made to understand the constructive nature of individuals’ experience, the meaning 
that they give to this experience and how this affects their perception of quality of life. This 
understanding in turn can inform professional understanding of  individuals’ needs and thus what 
is required for effective interventions aiming to improve individuals’ sense of quality of life. 
 
 
7.3 Findings  
Four superordinate themes were extracted from the ten semi-structured interviews by making 
use of Interpretative Phenomenological Analysis (IPA). These four superordinate themes are:   
 
Modes of patienthood: “Your psychology is everything”    
The self in the body: “I am a new person now”  
Self and others: “So what if they see it differently…relax…you cannot control everything”   
Towards living a good life: “Pull the sheet that blurs your mind” 
 
In this section, the superordinate themes, ,themes and subthemes (Table 7.2; Appendix 7.2 
with text examples) will be shaped by the narrative of findings and will be supported by quotes, 
verbatim extracts, from the interviews.  
The reader should note that some minor changes in verbatim extracts have been made in 
order to improve readability as these quotes represent conceptual translations from Greek. 
Moreover, dotted lines within brackets (...) indicate that some material is not presented, while 
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words in square brackets [ ] represent added material in order to give a more explicit sense of 
what interviewees were referring to. The names of participants presented in the narratives are 
pseudonyms to ensure anonymity.  
 
Table 7.2 Master table of themes  
Superordinate 
themes 
Themes Subthemes 
Modes of 
Patienthood  
Experiencing disease &its treatment: 
“it’s scary… many thoughts come to your 
mind” 
Confrontation with the diagnosis & 
treatment     
Clinical interactions 
Receiving medical treatment          
Feeling helpless                               
Living a post-CR life: “I have quality of 
life, but there are other things that you 
can’t amend” 
Defying patienthood                         
Other concerns gaining primacy       
Differences of stage of life                 
Searching for understanding: “I had a lot 
to time to think about it… why …why all 
this happened” 
Perception of disease causality  
Self-responsibility  
The self in the 
body  
Sensing the altered body:  “I feel 
different now…but sometimes troubles 
me what tomorrow will bring” 
The body becomes visible 
Fear of the unknown future                           
Experiencing a new me: “It's not that 
you do not stress yourself out but the 
intensity is different” 
Developing psychological self              
My body-my self                                 
Self and others You are alone: “and I was left alone, all 
alone” 
Being alone hurts                                  
Feeling disappointed                                 
In need of support: “I felt as if they 
wanted to help” 
Receiving practical  support                 
What you really need                            
Changes in relating with others: “You 
should see things differently” 
Thinking in a different way                   
Behaving in a different way                
Towards living a 
good life 
Positive growth: “If I didn’t go through 
this I wouldn’t realize… life is too short” 
Increased appreciation of life  
Personal growth  
Strengthening relationships 
Strategies to regaining control: “I felt so 
good that I was alive … there are so 
many things that I would like to do 
Setting boundaries                                      
Minimizing the impact of the disease  
Avoiding emotional expression                  
Using humor                                               
Making comparisons with others 
Challenges in living a new life style: “I 
want to change but…” 
Getting expert’s support                            
Persuading the self                                     
Quitting smoking                                        
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7.3.1  “Your psychology is everything”: Modes of patienthood   
This superordinate theme demonstrates how interviewees have experienced their patienthood 
(condition of being/becoming a patient, moving into another social category from being a healthy 
person to being an ill person; Aujoulat, Marcolongo, Bonadiman, & Deccache, 2008; Helman, 
2007). This includes reflections on how they experienced diagnosis and treatment, a year before 
the interview, and how their life and perceptions have evolved during the last 12 months post 
CR. 
 
7.3.1.1 Experiencing disease and its treatment: “It’s scary … many thoughts come to your 
mind” 
Reflecting on their illness experience, most participants explained that the diagnosis of 
coronary heart disease and their clinical experience of the treatment they received played a key 
role in how they identified as cardiac patients. Their narratives primarily refer to feelings and 
emotional shifts that they experienced; feeling disturbed at being treated as a medical case, being 
annoyed at aspects of care as a hospital patient and feeling scared in confronting the possible 
outcome of treatment. 
For some, the absence of sufficient information on the therapeutic procedure increase 
feelings of discomfort or lack of control and this may enhance fear of death. Petros describes 
how he felt in his initial encounters with the doctor and his diagnosis, emphasizing how the 
limited information provided by his doctor raised feelings of fear of the “unknown” procedure of 
treatment. 
 
"You get a fright… that’s exactly how you feel [because] no one 
tells you anything… and that’s the worst because you imagine 
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different things. The doctor simply told me “don’t be scared, it’s 
nothing, it has become a routine operation now”. [But] you don’t 
know, does this thing hurt? [and] that they whisper… oh that 
scares you… the doctor and his assistant speaking in whispers… 
that whispering sound killed me… at some point I felt that I might 
not get out [of hospital] ever again. I mean I believed it… [and 
then] many thoughts come to mind. You [imagine] your kids 
passing in front of you, you think of your father, your mother… 
"(Petros) 
 
 
For many participants negative feelings related to the process of surgical treatment are 
reduced as a sense of control is gradually regained, highlighting the important role of the sense 
of control in emotional adjustment. For instance, Petros (among many others) describes how the 
anxiety he experienced during the therapeutic intervention was replaced by tears of happiness 
when he realized that it was over and he was alive and able to re-experience simple every day 
things implying a re-appreciation of life. Also, from his perspective, being prepared in the sense 
of having received some information beforehand would have given at least some comfort.  
 
"when they brought me out, they took me [to a room] next to the 
window, and I saw the street and the cars passing by, and my 
eyes got wet. I mean I couldn’t believe it [that I was alive]. Your 
psychology is everything. When someone goes into the surgery 
room you have to tell him some things… that he has to keep calm 
and he’ll be able to see his loved ones again in a few hours" 
(Petros) 
 
 
Although all participants described their experience regarding the CR procedure as 
“nothing”, many expressed intense post-treatment suffering, mostly emotional, as a result of poor 
interactions with medical staff.  
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Some interviewees describe their impressions of the indifferent or rude behaviour of the 
medical staff during their stay in hospital. Even though participants did not always directly 
describe it in their narratives, this may be related to feeling disempowered and being in need of 
the best care that one can get. As the quotes below show, Illianna experienced various negative 
emotions such as anger and indignation during her short stay in the hospital as a result of the  
inappropriate attitude of nurses.  
 
“The girl who just finished her studies and who’s doing her 
practical training, does she have the right to speak rudely to you, 
to make fun of or ignore the patient’s calls?” (Illianna) 
 
 
Some others suggest that being in need of medical care during hospitalization could be 
stressful as they have to cope with novel and unfamiliar situations. Individuals may experience 
lack of privacy and distressing feelings resulting from sharing other patients’ experiences, as in 
the case of Charis. 
 
"The intensive care is a bit tiring… you can’t find peace and 
quiet… it would be better if not so many people were together in 
the intensive [care unit]. Old ones, young ones, all together (…) 
We happened to have this case of a man who had a heart attack 
and almost died… and that almost brought everyone else 
down…" (Charis) 
 
 
Although for these participants distressing feelings are related to the hospital context and 
their worry about medical care, when individuals have to cope with medical uncertainty about 
appropriate treatment of side effects, such feelings are intensified. Joanna, for instance, who 
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underwent CABG and had a long hospital stay due to several side effects, explains how she felt 
when doctors did not know how to treat her. She emphasises how overuse of drugs produced 
various side effects and made her feel insecure and desperate: “I had become a guinea pig”, she 
emphatically described.    
 
I was drinking a handful of pills and swallowed them all together 
(…) they were doing experiments… All those things that happened 
to me were not because of the heart but pharmaceutical [side-
effects] in reality (…) [and they kept saying] “we don’t know what 
else to do to you”. When they tell you that it makes you feel 
insecure (…) and I was saying what do I do now, do they want me 
to kill myself?” (Joanna) 
 
 
Feeling frustrated and humiliated may also be triggered by a prolonged stay in hospital or 
repeated treatment for side effects. As Joanna further highlights, doctors’ attitudes towards her as 
if she had nearly died, a delay in getting physical support from hospital staff as well as the 
limited facilities for personal hygiene, raised her feelings of shame and loss of dignity. 
 
Because ok, it’s not so nice looking at someone with terror… 
looking at him as if saying “I wonder how can you be alive”, [nor] 
calling for the nurse and have her say “coming now…  coming 
now” and you want to go to the bathroom since that morning and 
end up going in the afternoon… that brings you to a point that 
you’re embarrassed of what you have… it’s the absolute 
humiliation (…) and this thing in the hospitals, that they provide 
almost nothing, that you can’t wash yourself, that’s like uncivilized 
life on  mountains. It deprives you of your dignity. It tears you 
down from the beginning”(Joanna) 
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7.3.1.2 Living a post-CR life:“I have quality of life, but there are other things that you can’t 
amend”  
Participants’ accounts demonstrate that the treatment outcome is linked with the maintenance 
(or not) of a stage of patienthood. Those who experienced various side effects due to surgery 
(CABG treatment) or hospitalization as in the cases of Joanna, Nasos and Dina describe the 
previous year of their life as a life of continuing suffering “full of pain and hardship” and 
identify themselves as patients due to post-treatment complications. As Dina and Nasos 
explained  
 “I don’t have angina anymore, in that way I feel all right… The 
pain chest due to surgery disappeared three-four months after the 
surgery, but, my leg… it hurts (...).  It started from the area of the 
wound from which they [doctors] took the graft.  It never fully 
recovered. Now, a year after surgery and it still numbs, sometimes 
so badly that hurts … Many times I cannot walk without my walking 
stick (Dina). 
 
“My whole troubles are because of the bacterial infection I caught 
in the hospital. If I didn’t have that, I would have been fine (…) The 
[chest] inflammation was so bad that anti-inflammatory drugs did 
nothing, and the infection spread. I was going  to the doctor,  he  
recommended hospitalization (…) part of the treatment was to cut a 
piece in order to clean the wound (…) a few weeks later the same 
was repeated… don’t say much, this process was repeated eight 
times. During those episodes I’ve experienced terrible 
pain”(Nasos) 
 
 
For many participants, the scary experience of treatment or diagnosis soon became less 
important, described “like a bad nightmare”. Many individuals who had no side effects, focus on 
an interpretation of their condition based on heart symptoms and any concerns are related to the 
maintaining the treatment’s positive outcome as in the case of Giannis, Charis, Petros, Nathan, 
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Gerassimos and Grigoris. For instance, participants who “feel all right” may not identify as a 
cardiac patient defying the chronic aspect of the disease. As Grigoris said: 
 
“To be honest I don’t feel any symptoms, and after treatment (…)  
I don’t view myself as having a health problem, the surgery 
“fixed” that problem.” (Grigoris) 
 
 
 
Many participants who seem to defy patienthood tend to place a focus on other issues, on 
other coexisting problems and perceive them as more influential on their life. For some 
participants other coexisting problems are related to health problems, especially that of diabetes 
(Nathan and Petros), while for some others coexisting problems refer to financial and family 
problems. For instance, Petros’s account demonstrates how he perceives that, since his heart 
problem was diagnosed and treated, he is done with it, while it is diabetes that has affected his 
everyday functioning.  
 
The sugar [diabetes] is troubling me more than the heart. I mean I 
measure my blood sugar two or three times a day… I’ve never 
really bothered about the heart (…) Sugar is a more devious 
disease it’s not something you can fix, you say will it affect my 
kidneys? My feet? (Petros) 
 
 
Others including Gerassimos, Giannis, Charis, and Maria perceive critical life events to have 
primacy over cardiac patienthood. Although these individuals acknowledge that health is an 
essential factor for living a good life, they emphasise ongoing life issues that already existed in 
their life previous to CR. Thus, they interpret the disease and its clinical management as an 
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interruption of pre-existing concerns, to which they turned their attention again after treatment.  
For example, within Charis’s account, the major theme was financial problems. His 
unemployment status has made him feel inadequate to take care of his family’s needs which are 
more important than personal health.  
 
“It’s not that it doesn’t play a role [your health] but your finances 
come first in any case. When you have obligations and you can’t 
cover them, your life sucks. It doesn’t matter if you have some 
health problem or not (…) think of me, I came from my village 
when I was 17 and I’ve always worked, I’ve stayed at home 
[unemployed] for over a year now?” (Charis)  
 
In Maria’s account the major theme was the loss of her husband and the responsibilities that 
were automatically transferred to her.  The absence of “his support”, having to raise two children 
alone and being in charge of the family business, leaves her limited time for attending to her 
personal health.  
 
“My priority is taking care of my children and since my husband 
died I have to be both a father and a mother (…) I took over the 
family business too.  I run all day long and since I don’t have any 
obvious problem …  I don’t have time for such things [medical 
examinations]”(Maria) 
 
Moreover, a number of interviewees suggest that the stage of life has influenced how they 
understand and view their lives approximately one year post diagnosis and CR. The heart disease 
may be seen as just another problem expected with older age, or else its impact on their vitality 
and functioning which have already diminished with age may not be so great. For instance, Dina, 
similar to Nathan and Giannis, said: 
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“I’m not some youngster anymore (...) not that I think of me as old 
(...) any way you look at it I’m not as robust as I was when I was 
young (...) we grow up and health problems are expected… some 
sugar [diabetes], some [high] blood pressure” (Dina) 
 
 
7.3.1.3 Searching for understanding:“I had a lot to time to think about it… why …why all 
this happened”  
All participants described efforts to understand why that “problem” (the disease and its 
treatment) appeared. Many interviewees borrow meanings from the medical discourse on the 
development of heart disease emphasise heredity and stress. For instance, similar to other 
participants, Joanna said 
 
“Out of the 50 doctors I have been to, statistically everyone asked 
me if I have stress, everyone. The first thing they asked was if you 
have inherited it and second if you have stress, thus it plays a very 
big role.”(Joanna) 
 
 
This in turn, initiates a self-reflection process about disease manifestation in an effort to gain a 
better understanding of what aspects of self may have contributed to disease development. 
Female interviewees mostly explained that the stress experienced is related to internal factors, 
putting emphasis on their tendency for “perfectionism”. As Illianna, by adopting the prevailing 
medical discourse, explains, her efforts to have everything under control as soon as possible and 
as well as possible might have caused the disease. 
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“It was stress [that caused my heart problem]. As they told me at 
the hospital, I am a perfectionist. I am a person who wants to have 
everything under control, I am a bit demanding, impatient and I 
want to do what can be done, or what I judge has to be done now, 
to do it immediately now! Whatever I turn my hand to, I want it to 
be perfect or at least as good as possible. That’s the reason why I 
didn’t want a woman coming to help me with the housework. Once 
or twice that I tried, I ended up doing the housework again on my 
own, that [housework] I had paid a Romanian woman to do (...) 
My perfectionism caused all this.” (Illianna) 
 
 
Joanna, in addition to perfectionism, emphasises her tendency to suppress her own emotions. She 
perceives that her difficulty to express how she felt increased the levels of stress.     
 
It’s the stress… because I was a perfectionist, and my introversion. 
I will get furious and I don’t express it … I keep it inside and tell 
myself it doesn’t matter, it will pass … of course this is not the 
right way to deal with it” (Joanna) 
 
 
On the other hand, many male participants explained their stress as a cause of the disease, but 
attributed it to external factors. Most of the time increased stress, before as well as after 
diagnosis, concerned uncontrollable issues related to financial restrictions that damaged their 
self-perception and lead them to experience discrepancies from the masculine role of the 
provider. For instance, Charis describes how essential it is to earn money in order to provide for 
his family and how the absence of work makes him experience stressful feelings of inferiority as 
he has had to carry out household chores and activities traditionally connected with the female 
role.  
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It’s the stress… [struggling] to earn money and support your 
family... Can you imagine me now (…) While I should be taking 
care of my children now, I’m playing the happy housewife instead” 
(Charis) 
 
Similarly for Giannis, although he acknowledges that stress is damaging to health, he perceives it 
as inevitable sometimes. His job problems increase his stress as he feels that he is not able to 
offer his family simple things and regrets his spending behaviour 
 
“Stress is a bad thing… but when you have financial problems, or 
your business is going worse and worse, what can you do, can you 
not stress out? And as time passes you stress our even more… do 
you know what it’s like to not be able to take your wife and kid for 
a day out, get them an ice-cream, when in the past I would spend a 
bulk of money on foolish things?” (Giannis) 
 
 
Depending on people’s attributions about the sources of their stress, concerns about 
responsibility and self-blame may arise. For instance, although Nathan is troubled with his 
difficulty to provide financial assistance to his children, he considers this is due to external 
factors and thus feels less responsible and stressed about it. As he said: 
 
“I feel sad… I’m stressing out, I would like to help to my children 
more … but what can I do, fight God?” (Nathan) 
 
 
Others, such as Gerassimos, exert severe self-criticism and blames himself for both 
overwhelming levels of stress and unhealthy behaviours that affect his body.  
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“The blame is all mine. It’s my fault, my wrong behavior brought us 
to this point…  I was smoking, drinking, working exhaustively…. 
And here are the results.” (Gerassimos) 
 
 
The above quotes demonstrate that self-reflection is part of an explanatory process whereby 
people come to consider what caused their heart disease and whether their behavioural patterns 
contributed to it.  
Overall, this superordinate theme encapsulates people’s experiences of becoming a medical 
case and how they faced up to having to undergo an urgent medical procedure. For some, 
uncertain treatment of CR side effects and long periods of hospitalization made them feel 
helpless in the face of a life-threatening disease. For others, whose negative experience was 
restricted to interactions with medical staff, becoming cardiac patients was less scary and 
frustrating. In effect, participants connected their perceptions about their life one year post 
diagnosis and CR to the presence or absence of adverse effects as well as other life concerns. 
Whether and how they identify themselves as patients or attempt to defy patienthood affects their 
response to everyday life adjustments that is variously explained as making compromises and 
living a balanced life. Participants trying to gain a sense of understanding about the reasons for 
CHD development, borrow meanings from the related medical discourse and emphasise stressful 
aspects of self and their own unhealthy behaviours and responsibility.  
People’s causal attribution of the disease as well as the fear of the re-occurrence of a cardiac 
event, emerge as an attention to the embodied self and constant efforts to change aspects of their 
individual and relational self in an effort to find ways of mastering. In effect, many participants 
experience a positive adjustment as the following superordinate themes describe.   
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7.3.2  “I am a different person now”: The self in the body  
This superordinate theme captures how interviewees experience themselves one year post 
diagnosis and treatment focusing on the individual body-self. Overall, this includes reflections 
and considerations such as that they experience a different sensation of their body after 
treatment, that the treatment was a turning point, a trigger for rethinking their self and stance to 
life, and how these have in turn made them experience a different sense of self. 
 
7.3.2.1 Sensing the altered body:“I feel different now… but it sometimes worries  me what 
tomorrow will bring” 
Participants, reflecting on their body sensation after CR, explain how they perceive their 
body and how this sensation makes them feel. Within all interview accounts, there are 
descriptions explaining that the body becomes more “visible” after treatment and for some it is at 
this point that they pay attention to their bodies for the first time. As in the case of Gerassimos:   
 
“I didn’t pay any attention to my body. I didn’t take care of it. I 
took it as self-evident that I was young and strong. (…) I think I 
was a different person coming out of the hospital. Maybe it was the 
first time I really looked at myself.”(Gerassimos) 
 
 
Many interviewees (including Gerassimos, Illiana, Petros, Charis, Maria, Nathan and 
Giannis) have experienced a bodily restoration. For instance, Giannis’ account demonstrates how 
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he has visualized his heart before and after treatment, emphasising how the revascularizated 
heart gives life to the whole body and makes him feel revitalized. 
  
“I imagine my heart, as if it was into the mire, sort of crumbled 
and black, and now I see it glowing. And thereafter your whole 
being glows… let’s not forget that the heart is like the carburetor 
of the motorbike… now I have a new carburetor and the 
speedometer is starting off from zero… even though I’m an old 
BMW, I can beat new cars”(Giannis) 
 
 
Others experience a detachment from their body as a result of CR. Three of the interviewees 
who were treated with CABG (Dina, Joanna, Nasos) experienced a body-self discrepancy.  They 
compared their body at present to their body before CR and perceive it as less efficient, 
inadequate, placing restrictions on their freedom. For instance, Dina’s account points out how 
her body does not help her be fully functional in everyday tasks and how this makes her feel as 
half a woman. 
     
“My body does not help me anymore (…) I have become half a 
person” (Dina) 
 
 
Nasos’ account is in line with Dina’s describing a general loss in bodily function. 
 
  
“We get minus in everything (…) Before, it was fine, I was going 
wherever I wanted, did whatever I wanted, hard work, now… now 
this is out of the question. There is no strength… even though I say 
I will do this I will do that, then I can’t come up to that.” (Nasos)  
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Joanna explains how she feels that her body has lost part of its femininity and vitality, saying 
that it “doesn’t rock as it used to do”. Her account highlights how she feels about her body, 
emphasizing that she is free from heart symptoms but she faces problems with her legs, 
sometimes experiencing herself as paralyzed.   
   
 “My feet hurt, I can’t go up and down the stairs as I used to do 
before (…) I don’t get tired, I don’t get short of breath, I mean, as 
a heart it may have its problems but I know what bothers me today 
is my feet, I can’t take good steps. There are times I feel as if I’m 
paralysed.” (Joanna) 
 
 
Among those participants’ sensing their body as renewed, feelings of insecurity and fear are 
experienced as a result of considering an unknown future; some individuals are afraid that the 
positive health outcomes may be temporary. Many participants explain that, to some extent, they 
have thoughts and worries about “what tomorrow will bring” and the consequences of this 
change on their lives. For example, Illianna, Giannis, and Maria describe how, even though they 
feel well at present, they still have concerns about how their bodies may turn in the future and 
what the consequences of bodily reactions or a potential death might be. 
 
 
“My body is fine. The examinations prove it, but if I tell you the bare 
truth… I’m afraid that my heart might stop, or that its condition may 
get worse and I get to lose all I have and all the things I want to do in 
the future. That is, having a child, travelling to distant destinations 
(…) but I don’t know how long my body will last.”(Illianna)  
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“I feel fine, but it’s the heart, I am afraid I may not be here to see my 
child grow up.” (Giannis)  
 
 
“I feel strong like a bull… but still sometimes  I’m afraid I may die 
and what will happen to my children?” (Maria)  
 
 
As the above quotes demonstrate many participants experienced a kind of bodily 
revitalization following treatment, but the fear of the unknown future seems to have an adaptive 
value as it empowers individuals to make positive changes to aspects of the individual self as the 
following themes describe.   
 
7.3.2.2 Experiencing a new me: “It's not that you do not stress yourself out but the intensity 
is different” 
As evident in participants’ accounts, changes in body sensations and the self-reflection 
process may create shifts in the psychological self and sense of the body-self.  
Many participants experienced a change in aspects of the self. Their accounts emphasise 
changes in the psychological self. For example, Petros describes how he became more easy-
going when he understood that life is too short to pay attention to trivial details and damage 
yourself. 
 
“In the beginning I was getting angry with them [family] for the 
slightest little thing. Now I don’t steam up… life is too short to 
bother with trivial things and ruin your calmness.”(Petros) 
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Joanna describes how her detachment from everyday activities made her realize that things 
can be done “well” without her interference. 
 
“I am more relaxed, more distanced… you think you do things 
perfectly and that’s the only way things work… I have now seen a 
lot of things can be done properly, and function well without me 
interfering at all.” (Joanna) 
 
 
Μaria also experiences this change as she describes herself as tougher.   
 
“I’m not as mushy as I used to be… I have become tougher and I 
don’t easily forgive mistakes… and [I am] more bitter and 
sarcastic.” (Maria) 
 
A few participants explain how the experience of CR and self-reflection have impacted their 
body-self sensation; the realization of what really matters make them consider their bodily 
strength and limit unnecessary bodily activities. For instance, Petros illustrates how irascible and 
ready to get into fights he was prior to treatment and how calm he has become after realizing his 
exaggerated response to others’ behaviour.   
 
“Look, I don’t get into arguments now, I see things differently, I 
keep much calmer. Before, I was short-tempered over little things. 
I took everything personally.”(Petros) 
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Giannis recounts how the new self avoids getting stressed  
 
“In the past, I would flip out for no reason. I would easily lose my 
temper. Now, I don’t steam up, I don’t get into arguments at all 
(…) And with my colleagues too, I don’t quarrel whereas I did 
before (…) Before… we could even end up coming to blows.” 
(Giannis) 
 
 
Another issue voiced by a few participants who are emphasizing the importance of not 
stressing yourself, concerns the diminished bodily strength in relation to maintaining an active 
sexual life. Also, Giannis describes:  
 
“Having sex with your wife is important… it’s not that you neglect 
her if you don’t do it, but how can I say… you feel good 
too.”(Giannis) 
 
 
Charis also places particular emphasis on his sexual self, perceiving it as an integral aspect of 
the self. The vitality of this subject is demonstrated within his accounts by describing how he 
experienced feelings of overwhelming discomfort as a result of his wife’s restraint, and how he 
coped with it by discussing this subject with his doctors.  
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“During the first months the situation was intolerable… my wife 
wouldn’t let me touch her for fear something might happen to me. 
In a doctor’s appointment, I asked him what I can and what I 
cannot do… I don’t say we do the acrobatics but… we’re still 
young, our blood is warm.”(Charis) 
 
 
Joanna’s accounts also show how essential a sexual life is for one’s identity, by highlighting 
the vital importance of sexual satisfaction and equating it to a survival need similar to food. As 
Joanna said:  
“Sex is of vital importance! Just like food, so it was with sex too…I 
don’t have a physical problem, but then again the sensation, the 
pleasure is not the same (…) I’m ruined in that respect.”(Joanna) 
 
 
Joanna does not communicate this to her doctor in the face of serious health problems, as she 
considers “this was the least important in the midst of all those problems I had” and, in contrast 
to Charis, she feels that the problem remains unresolved. Using a past tense in her description 
implies that she has accepted the loss of a vital aspect of herself, while this adjustment has been 
facilitated by focusing on staying alive.    
Overall, it is the experiential and meaning-making process that refers to how participants 
perceive and reflect on their body-self that comes to the core in this superordinate theme. 
Participants begin to have a different relationship to their bodies after CR which, for some, is 
positive while it has a negative meaning for others. Experiencing bodily changes and fear of the 
unknown mobilizes them to develop new aspects of self. While some behavioural changes are 
welcomed and more easily adopted, other aspects of the self, especially those concerning 
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sexuality, may be viewed as more vital and yet more difficult to deal with in the face of life 
threatening issues, as in Joanna’s accounts.   
 
 
7.3.3 “So what if they see it differently ... relax ... you cannot control everything”: Self and 
others 
This superordinate theme illustrates individuals’ feelings and attitudes concerning the 
relational aspects of the self. In particular, the issues of interest and reference here have included 
how individuals feel about the way they have been treated by others during the last year, what 
kind of support, if any, they have received and how a comparative consideration of their own 
behaviour towards others prior to the disease has made them start relating with others in a 
different way. 
 
7.3.3.1 You are alone “and I was left alone, all alone” 
Another key aspect of the individuals’ experience concerns how they view the self in relation 
to the way they have been treated by others. Many of the participants report having experienced 
feelings of loneliness and some of them were hurt by the responses and attitudes of their family 
members. For instance, Joanna describes how she felt alone in the hospital and explains how the 
attitude of people close to her, especially their behaviour towards her children, had disappointed 
her.  
 
“I was very much hurt by the fact that I was alone. Do you know 
how it feels like when your own people don’t stand by you? Those 
you considered your own? Very much [hurt]… and all this has to 
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do with my children. Because … er ... I was expecting they would 
support my children. Do you know what it is like when your kid 
calls you at the hospital  and tells you “ask aunt not to bring those 
foods again because, they bring us,  for five days now, five days of 
lentil soup.” I mean is this possible? You shouldn’t give so much 
worth to others around you, and invest emotionally, because that 
hurts you.” (Joanna) 
 
 
Joanna, among others, realized that she was alone while being in hospital and explains that 
her feeling of being disappointed arose mostly from the fact that people whom she counted on 
did not meet her needs and expectations. Some others become hurt by their friends. Charis’s 
account demonstrates how annoyed and disappointed he  felt because of the absence of his 
“supposed friends”, in his own words, emphasising their lack of attention to his wife’s financial 
needs. 
 
 
“Do you know what bothered me most? That they didn’t care to 
ask if my wife needed anything. If we have the money… I hadn’t 
got the retirement compensation and most people around me 
knew.”(Charis) 
 
 
In contrast, some other interviewees had felt satisfied and supported by others as their friends 
have met their expectations. As Petros says:  
 
“They are good friends. They came to see me, they asked my wife if 
we needed anything … and then … how can I say, they stood by us. 
I believe they would go into fire for me. It’s not that my brothers 
are bad people but see…I’m closer to these few friends.” (Petros) 
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The above quotations demonstrate that many interviewees felt alone, in the course of 
hospitalization and recovery as well as in their life as CHD survivours. The intensity of 
loneliness initiated a re-evaluation of their relationships, highlighting the need for closer bonds 
and emotional support. 
 
 
7.3.3.2 In need of support: “I felt as if they wanted to help” 
Many participants, although they received some kind of support, may also have felt alone in 
that the support experienced may not have been consistent over time or in line with their needs. 
For instance, Maria describes how supported she felt by getting practical aid and how those 
feelings disappeared and she felt alone when this support diminished over time.  
 
“I felt as if they wanted to help, each in their own way, and even 
more on financial matters of the company. But you know after a 
while everyone goes back to their problems and they forget you.” 
(Maria) 
 
 
Joanna placed particular emphasis on the kind of support that she received from a friend who 
took her on car trips or went out for coffee with her. 
 
“It was Olga only… only she was strong, a good friend… she took 
me on car trips, took me out for coffee… She really helped me a 
lot.”(Joanna) 
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Joanna implied that going out with her friend helped her temporarily escape from being a 
patient and her health or life concerns and, thus, made her feel emotionally supported. The 
emphasis that she put on her words demonstrates that she perceived the emotional support as 
more important and valuable than the practical one.  
Also, within Gerassimos’ accounts, he highlights that the only support that he experienced 
from his family was financial assistance for payments to the doctor, private nurse and hospital 
stay. In his terms, the lack of emotional support reflected his own previous behaviour towards 
them; he perceived their attitude as a paying back for his own emphasis on material support.  
 
“They paid for the doctor, the hospital, the private duty nurse... 
How can I complain that they didn’t support me enough? They 
gave back to me what I was giving them all those years… money.” 
(Gerassimos) 
 
Gerassimos brings to light another aspect regarding the absence of the required emotional 
support by maintaining that one cannot expect to get without giving. Self-reflection about his 
relationship with others allowed him to realize that the practical support that he used to offer to 
his family is less precious than the emotional one. In such ways many participants, like 
Gerassimos, report that feelings of being alone have forced them to reflect on various aspects of 
the relational self.  
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7.3.3.3 Changes in relating with others “You should see things differently”  
Interviewees’ reflections about their relational self may have affected how they have related 
to others. For many their re-evaluation had a determining impact on the manifestations of the 
relational self.   
Some become detached from their extended family. For instance, Joanna explains how the 
realization that “I was left alone” throughout the difficult phases of hospitalization and post-
treatment experience, have mobilized her to alter her behaviour and become more detached from 
members of her family of origin.  
 
“And I say wait a minute, why do I have to invest emotionally, to 
suppress my emotions and the others… have him saying I was 
squandering my money, and that I was insensitive, hey there, why 
not behave accordingly too, why do I have to swallow it, at the end 
of the day it’s my money I’m wasting not his. I should at least 
behave the way that makes me feel good. Isn’t that so? Why do I 
have to feel oppressed? I was suppressing what I wanted to say, 
my whole life, to avoid provoking others, and so what? This has 
changed (…) I responded to their behaviour and I 
changed.”(Joanna) 
  
 
The experience of the disease has also led her to become less protective towards her children, 
recognizing that things can be done without her contribution. 
 
“Why do I have to do everything? When there is someone else who 
can do it, why do you have to do everything on your own? You 
think that only you can do things perfectly and that’s the only way 
they work well. Kids can do things on their own and detach from 
me.” (Joanna) 
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In contrast, for Gerassimos, his experience and self re-evaluation resulted in becoming more 
attached to his nuclear family members. His accounts show that he perceives a new relational 
self and he tries to enhance emotional bonds through various activities.  
 
“I now do more constructive things… I will cook, even though not 
often, and I will invite [the family] over for dinner all together, and 
[we will] play some games. I will ask my sons to come over to 
watch football together… and give my partner a hug while 
watching a movie together” (Gerassimos)  
 
 
Others have become detached from their social network. For example, Charis explains how 
he became detached from his ex-colleagues as a result of the disappointment he had experienced 
due to their lack of support, highlighting that real friendship is tested in hard times. As Charis 
said:  
 
“The truth is, most of them, I pushed them away…A friend in need 
is a friend indeed. In joy and parties, everyone is a friend.” 
(Charis) 
 
 
Yet others become more balanced in their interactions, as in the case of Maria. Her account 
highlights the positive impact of the re-evaluation of her relational self. Maria describes how she 
perceives herself as more clever and explains how strong she feels at present as a result of this 
change.  
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“You can’t fool me anymore. And I can tell you this, I think with 
all this I’ve grown stronger” (Maria)  
 
 
Overall, this superordinate theme demonstrates how the CHD and CR experience makes 
many people realize that they are alone and how this realization generates feelings of 
disappointment and the need for re-evaluation of multiple aspects of the self in relation to others. 
All participants referred to practical support. However, even those who received it suggested that 
this was not enough as they emphasized that they felt alone during disease management and 
recovery. Thus, even though the need for emotional support is implied, it is not directly 
described in most participants’ narratives.  This, in turn, mobilizes a self-talk in which 
participants consider their self before and after their disease experience as well as engage in a 
dialogue with multiple aspects of their relational self. The outcome of this kind of re-thinking 
concerns changes in the way they relate to others. Individuals who recognize that they used to be 
detached from significant others attempt to establish closer relationships, as in the case of 
Gerassimos, whereas others have suggested the need to distance oneself when being 
disappointed by friends, as in the case of Charis, or by family, as in the case of Joanna.   
 
 
7.3.4 “Pull the sheet that blurs your mind”: Towards living a good life  
This superordinate theme captures individuals’ new stance towards life as CHD survivors 
highlighting a positive growth and bringing to light coping strategies as well as perceived needs, 
and practices. Specifically, individual accounts vividly describe what kinds of positive growth 
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they have experienced in effect to their disease-related experiences; what strategies individuals 
have developed and/or adopted for regaining control of their life and regain self-esteem; what 
challenges they have had to address in order to live in accordance with a healthy lifestyle. 
 
7.3.4.1 Positive growth: “ If I didn’t go through this I wouldn’t realize… life is too short”  
All participants’ narratives demonstrate evidence that through survival a positive growth 
emerged. The strong feelings of being alive elicited an increased appreciation of life, a 
willingness for personal growth and an effort to establish meaningful relationships.  
In many participants’ accounts it was highlighted that after being diagnosed with CHD and 
surviving the coronary revascularization they started to gradually appreciate living, enjoying 
small everyday things, “beauties of life”, which they rarely enjoyed before diagnosis. For 
instance, Nathan and Petros said:  
 
“I feel all right, but you never know what tomorrow could bring. 
Why lose precious time by focusing on pointless issues? … I prefer 
to make enjoyable things … things I couldn’t do before … sitting in 
my balcony early in morning hearing the song of birds.” (Nathan)  
 
 
“Nothing is as in the past. I enjoy everything I do (…) even having 
my breakfast. Few months ago I was always in rush … I swallowed 
my food … I had never paid attention to the nice smell of fried eggs 
and fresh butter.” (Petros)  
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Many narratives show that participants perceive their CHD diseases experience as “a life lesson”, 
enabling them to gain some personal strength. Some, as in the case of Maria, Giannis, Nathan, 
and Illianna, experienced emotional growth by becoming “tougher", “stronger”, “self-
controlled”, “less stressed”. Some interviewees explained further that this emotional growth 
initaly developed in an effort to prevent disease progression also helps them with dealing more 
efficiently with difficult situations.  As Illianna describes, being able to manage her stress levels 
resulted in more efficient coping with demanding situations in her workplace 
 
“Prior to it [diagnosis], I couldn’t cope very efficiently with 
difficult situations (…) especially, with parents of kids with special 
needs. It needs a lot of calm and patience to persuade them to seek 
expert help. After the diagnosis where I have to calm down for my 
own sake, I’ve realized that I could deal better with those 
parents.” (Illianna) 
 
Many participants highlighted that surviving CHD and CR was perceived as a “second 
chance” in life giving rise also to a willingness for self-development, a need to learn new 
things and acquire new skills. For some this willingness was motivated by the need for 
personal progress as in the case of Nathan.  
 
“For many years I was static, after recovering from CABG I’ve 
decided to go change that. As I said earlier I love gardening… 
recently I enrolled in a local free of charge gardening seminar.” 
(Nathan) 
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However, for others as in the case of Gerassimos, their willingness was motivated by the 
new way of relating with significant others. As Gerassimos explained 
 
 
“I try to be closer to my loved ones (…) I cook for them at least 
once a week, (….) I went to a cookery school… I am not yet a very 
good cook but as they say [family members] I am on the right path 
(…) it is valuable to me to dine all together where we can relax 
and share our news…” (Gerassimos)  
 
 
Gerassimos’ account highlights the acquisition of a new skill, that of cook, but also reveals his 
effort to build a strong meaningful relationship with his family members after his understanding 
of their superficial relationship triggered by how he felt in hospital and shortly after discharge. 
He alludes to the fact that cooking is the route for showing them that he cares and the gathering 
and sharing on the occasion of cooked lunch or dinner helps in developing and establishing 
emotional bonds.  
 
 
7.3.4.2 Strategies to regain control: “I felt so good that I was alive…there are so many 
things that I would like to do” 
Considering a good life in the course of the year following CR, participants’ accounts are 
different in two ways. Those who have positively adjusted and use active coping strategies (e.g. 
setting boundaries, and suppressing self-expression) and those who, under the influence of 
persisting health problems, consider their post-CR life trajectory as an ongoing project adopting 
strategies that may minimize the impact of the disease and treatment in their lives in an effort to 
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regain control. In both cases the use of self-enhancement strategies was vivid in many 
participants’ narratives.  
Many of those adopting more active coping explained the importance of putting limits on 
“self exaggeration” or other exaggerated demands. For instance, Dina describes how for her this 
meant withdrawal from responding to her husband’s constant demands. 
“I just don’t get myself to do whatever he asks for… Dina bring my 
slippers, Dina bring me a glass of water… if he wants water he can 
go and get it himself.” (Dina) 
 
Charis, among others, explains that he has adopted restricted expression as a strategy to control 
others’ insistence on identifying him as a patient.  For instance, Charis describes how he has 
become more introverted as a way to cope with his family overprotective attitude.  As he said: 
“There are many times I catch them [nuclear family member] 
talking secretly to each other (…) I tell them, why don’t you guys 
tell me too, and they answer “you don’t worry, we’ll take care of 
things on our own”…with that kind of behavior on their part 
[excluding me], they make me not tell them, even when I do have 
something, I’m thinking that since they treat me like that when I 
feel well, imagine what they will do if I tell them I’m in pain or 
something’s bothering me.” (Charis) 
 
Some participants may use humour to minimize the impact of the disease on the body-self; it 
was often not mentioned directly in participants’ narratives but both coping strategies seem to 
facilitate control over negative feelings. For example, Joanna tries to adjust to her sense of loss 
of her sexual self after CR treatment by using humour. As she said laughing,“Greece has lost a 
sexy woman”. 
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Others avoid reference to their body sensation in an effort to suppress negative feelings, 
which facilitates acceptance of their current condition and adjustment maintenance. As Dina 
said, “I can’t go on discussing the symptoms over and over again”.   
Some may give a temporal dimension to their condition in order to gain a sense of control 
over their life. As Nasos said,“things will get better over time”. Yet, others deny their 
patienthood by downplaying both the severity of their heart disease as well as its chronic nature 
and describing it as something that was present in the past and now has gone. As Nathan said “It 
was nothing, it’s gone now”. 
 
For some others strategies to regain control over their life involve the rebuilding of their 
challenged self-esteem. These individuals explained how comparisons with other people of their 
age may help them to feel better, allowing them to rebuild their self-esteem and challenge the 
sense of the body experienced after CR. For example, Nasos similar to Dina and Petros 
compared himself with other individuals of his social group assessing his own situation 
positively and in effect, feeling enhanced. As he said: 
 
“look every Sunday when I go to the church I see many people of 
my age and while they have not undergone a bypass they use a 
stick to move… and I tell to myself …   you see Nasos you are 
much better than they are” (Nasos) 
 
 
Although participants developed various coping strategies to regain control over their life as 
presented in the previous paragraphs, highlighting once more the adaptive value of control, 
various challenges still remain to be addressed as the following theme suggests.  
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7.3.4.3 Challenges in living a new life style: “I want to change but…” 
Participants explain the difficulty of making and maintaining the necessary changes in their 
everyday lifestyle. Common challenges mentioned relate to making the required changes when 
they do not have expert support, persuading themselves to make changes and quitting smoking in 
particular. 
Many interviewees explain how helpful it may be to get expert support in managing various 
necessary changes. For instance, Illianna describes how useful it would be to get in writing all 
the relevant information and guidance from doctors and hospitals. As to this, she emphasized her 
own experience of difficulty and suffering in the effort to quit smoking without help, which 
instead could have been facilitated by the hospital’s smoking cessation clinic.  
 
“it would be useful if they gave you their [medical] directives in 
written form as well as the different referrals[to medical 
examinations] you potentially need. Similarly, since there are 
different departments in the hospitals, they should make sure you 
get all the information and advice you need in order to do the 
changes you should, not only after surgery but in general. For 
example, I got into so much trouble in quitting smoking whereas 
later on I found out that I could have got some help from within 
[the hospital].”(Illianna) 
 
 
Illianna’s account suggests that individuals’ adjustment to new lifestyles might be facilitated 
if the existing health system was better organized. The lack of patient-centered approaches in 
health care and poor organization of health services in those terms may lead to unnecessary 
suffering for the patient and lack of adherence to doctors’ advice. In effect, participants’ accounts 
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indirectly express concerns about unsuccessful secondary prevention and fear of future 
recurrence.     
Other participants explain that the greater challenge they have experienced is the lack of 
motivation to adopt or maintain the lifestyle changes recommended by doctors. For instance, 
Charis describes how he feels bored at following doctors’ advice in relation to walking on a 
regular basis, and how his daughter and family push him to go walking at the weekends.   
 
“Just as the doctor had told me, I have to go walking, but I’m 
bored going on weekdays, except when my daughter or my wife 
drags me along for a walkabout.”(Charis) 
 
 
Charis’s account suggests that walking is boring, implying that it may be important but he 
does not enjoy it. This attitude can be explained by his unwillingness to identify himself as a 
patient and thus to acknowledge walking as an important self-care practice which may promote 
his health. At the same time he highlights the importance of social support in following doctors’ 
advice. Similarly, Giannis explains the importance of social support for maintaining a change but 
also considers will power as an essential aspect for accomplishing a necessary change. As he 
said: 
  
“Sometimes those around you are of great help. Look, let’s say, I 
have stopped walking as I used to. But if my wife came along to 
keep me company maybe I wouldn’t quit… Of course the most 
important thing is your will. If you have sheer will, everything is 
possible.”(Giannis) 
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Also Giannis explains how his will power may be influenced by the perceived necessity of a 
change. His accounts describe how he mostly followed doctors’ advice, highlighting the crucial 
role of self-evaluation of the damaging impact of a habit on health. 
 
“[my doctor said] I have to be attentive to my diet, go walking, 
give up smoking and drinking… I’ve done that! Not 100% but 
about 70% of it. I quit smoking! I quit it cold turkey. I quit drinking 
cold turkey. Those things that I can’t give up, I don’t find them so 
very bad for me that’s why I don’t give up.”(Giannis) 
 
 
The above quotes imply that individuals’ motivation for life adjustment and decision towards 
a behaviour change may be increased if their awareness of the beneficial effect of that change is 
enhanced.  
Other participants perceive it as very challenging to quit addictive behaviour; smoking is the 
key example in this case. Quitting smoking as one of the main behavioural changes expected 
from CR patients is related to a sense of gaining control and minimizing its negative impact on 
health. On the other hand, the value of quitting smoking is debated in participants’ narratives 
(e.g. Maria, Joanna, Gerassimos) as they suggest that smoking, even a couple of cigarettes only, 
is important for keeping emotional control in certain situations, as for example, when you have 
to deal with stress. 
 
“My little [son] Kostas had an epileptic episode. I said that if I 
managed to survive seeing this… because I can bear anything but 
not when it comes to my children. I mean I had numb arms and by 
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the time I felt worried… I couldn’t feel my feet and felt like 
fainting. So I thought since I could hold on through this, I told  
 
 
myself that I do have a strong heart after all. But there it was, as 
soon as this was over, I lit a cigarette.”(Joanna) 
 
 
Also, smoking a cigarette may be seen as extremely helpful towards achieving other kinds of 
behaviour change. Maria as a few other participants (e.g. Petros, Joanna) connects smoking to 
controlling eating.  
 
“I remember when I had quit I wanted to put something in my 
mouth all the time… while the cigarette covers for that” (Maria)  
 
 
For those participants who were smokers, smoking is related to notions of pleasure and 
freedom versus living a life of restrictions.  Even if they acknowledge that it is an unhealthy 
habit, they perceive it as a way to get some pleasure in life after CR. As Petros among others 
(Maria, Charis, Gerassimos, Joanna) pointed out:   
 
“I know it’s bad for me [my health], but we’ve given up far too 
many things now to quit smoking too.”(Petros) 
 
 
Overall, this superordinate theme demonstrates how being a CHD survivours may elicit a 
positive growth and how individuals make an effort to to live a good life. Some aspects of 
positive growth that many participants experienced were related to a greater appreciation of life, 
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personal growth and need to develop meaningful relationships. Furthermore, some individuals 
set boundaries against social conventions and exaggerated expectations of the self and others use 
mechanisms such as humor, suppression of emotion and denial to accept the impact of the 
disease in their life as coping strategies to regain control over their lives. People’s sense of 
control may be compromised by the absence of expert support as some individuals may 
experience difficulty achieving and maintaining necessary lifestyle modifications. In turn, 
although not directly expressed, this may increase feelings of low self-efficacy. Some people 
reduce the inner conflict of unaccomplished changes in lifestyle by defying patienthood, as in the 
case of Charis, by minimizing their significance due to a lack of awareness, as in the case of 
Giannis, or by consciously choosing to maintain  pleasure in life, as in the case of Petros. 
 
 
 
7.4  Discussion  
Employing an IPA framework, this part of the study aimed to explore subjective meanings of 
HRQoL among 10 individuals one year after CR in order to gain a deeper understanding of how 
surviving CHD has influenced individuals’ sense of self and their life, the process by which 
individuals make sense of their experience, and what concerns they may have about life style 
modifications.     
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7.4.1 Findings  
Four superordinate themes have been revealed: Modes of patienthood, The self in the body, 
Self and others, Towards living a good life. Overall, these themes reflect individuals’ lived 
experience concerning CR and the year that follows as CHD survivors as well as the meaning 
making process of their experience that has elicited shifts in ways the view themselves, social 
relationships and life.  
Regarding the influence of CHD on individuals’ perspectives regarding QoL, participants’ 
accounts showed that after undergoing CR many CHD patients experienced changes in their 
embodied self as well as in the way they view life. Many individuals after CR experienced 
feelings of happiness and gratefulness at being alive. They reported strong emotions 
accompanied by a different bodily sensation, shifts in their perspectives regarding QoL leading 
to a greater appreciation of bodily autonomy, a willingness for personal growth, an effort to re-
build or strengthen their relationships with their loved ones and a re-appraisal of life.  
These findings are consistent both with various theoretical frameworks and research 
evidence. Participants’ narratives reflected how people with CHD make sense of themselves and 
their QoL in line with the biopsychosocial model (focusing on physical, psychological and social 
aspects as described by Engel (1980) and suggested by the WHO (1948)) and the fundamental 
aspects of self that shape identity (i.e. the individual self which reflects one’s unique 
characteristics, the relational self which reflects dyadic bonds that are shared with close others 
(family, friends) and the collective self which reflects similarities and identification with social 
groups (Sedikides, Gaertner, & O’Mara, 2011)).   
Furthermore, participants’ quotes provided evidence that the concept of quality of life is a 
continuously changeable notion over the life-span which is influenced by people’s experiences. 
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Their perspectives regarding QoL can shift as their points of view and standards change as 
Response Shift theory suggests (Sprangers & Schwartz, 1999). Briefly, this theory states with 
regard to the QoL concept that the phenomenon of the “meaning” of an individual’s self-
assessment can alter with time as a result of a change in the individual’s internal standards, a 
change in the components that comprise QoL, and redefinition of QoL (Schwartz et al., 2007; 
Sprangers & Schwartz, 1999; Schwartz & Sprangers, 1999; Visser et al., 2013). 
Moreover, participants’ narratives provide support for Tedeschi & Calhoun’s (1996) post 
traumatic growth model (PTG) which suggests that after experiencing a traumatic event or life 
crisis, individuals experience positive changes and emotional growth as a response to it. It is not 
the traumatic event itself, but rather the experience that motivates individuals to “re-build” their 
lives (Tedeschi & Calhoun, 2004). PTG’s most evident manifestations are related to increased 
life appreciation, increased sense of personal strength, changing priorities, more meaningful 
interpersonal relationships, and a richer spiritual life (Tedeschi & Calhoun, 2004). Research 
evidence indicates that PTG is related to better HRQoL in various chronic diseases (Arpawong, 
Richeimer, Weinstein, Elghamrawy, & Milam, 2013; Kahana, Feeny, Youngstrom, & Drotar, 
2006; Minkin, 2014). The findings of a recent qualitative study (Waight, Strodl, Sheridan, & 
Tesar, 2015) exploring post-traumatic growth in post-surgical coronary artery bypass graft 
(CABG) patients revealed that patients experienced two types of growth following CABG; 
‘greater appreciation of life’ (living in the moment instead of focusing on what the future may 
bring) and ‘new possibilities’ as they view surgery as the route that helped them to improve their 
physical functioning.  
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These issues suggest that reaching conclusions about the true effect of CR based on 
individuals’ subjective perceptions regarding their QoL might be biased if such issues are not 
taken into consideration.   
Regarding individuals’ experience about life changes and adjustment, participants suggested 
that they experienced patienthood from the moment they were diagnosed with heart disease but 
one year later they have returned to their everyday life. Many people perceive the state of being a 
patient as ending shortly after treatment and hospital discharge. Participants reflecting on their 
experience perceive treatment as a simple process, but many of them highlight medical care as a 
traumatic, distressing experience raising feelings of fear, frustration, loss of dignity and 
helplessness. This they consider to be a result of poor doctor-patient communication in terms of 
the limited amount of information given and inappropriate treatment by the medical/nursing 
staff. These findings are in line with the literature. A recent systematic review of 46 studies (both 
quantitative and qualitative (Parker et al., 2007) show that patients feel less stressed when health 
professionals show empathy, encourage questions and provide clarifying information aligned to 
their needs. However, it should be noted that, among those studies reviewed, there was a study 
carried out in Greece (Iconomou, Viha, Koutras, Vagenakis, & Kalofonos, 2002), in which 
authors the claimed that the need for information was not related to emotional distress. Research 
evidence from other chronic diseases (e.g. cancer) also highlights the beneficial impact of 
offering information to patients as it engenders a sense of control that can in turn help to reduce 
distress and increase self-efficacy (Chan, Webster, & Bennett, 2009). Moreover, previous 
research shows that staff behaviour and the hospital environment have an important impact on 
patients’ dignity; the lack of privacy in hospitals, staff being curt and authoritarian can threaten 
patients’ dignity (Baillie, 2009).  
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Shortly after hospital discharge, identifying as a patient or not is strongly related to the side 
effects experienced post treatment (as highlighted by CABG patients). Individuals with no 
symptoms feel healthy and defy patienthood and other pre-existing stressful issues (health or 
social) become the focus of the individual’s attention. Similarly, the literature (Astin, Closs, 
McLenachan, Hunter, & Priestley, 2009; Peterson, et al., 2010) indicates that individuals 
experiencing CR as a simple process, with absence of bodily evidence (e.g. surgery scar) and 
lack of symptoms, perceive this particular disease as acute instead of chronic. 
To recap, many individuals think of their CR experience as rather frightening, not merely due to 
the process but due to interactions with medical staff. A year after hospital discharge they recall it as 
a past nightmare which allowed them to have “fixed” the problems and return to their everyday life.    
After giving an overview of their experience in relation to their CHD diagnosis and CR, and 
perceiving disease as controlled due to CR with no serious consequences in their everyday life, 
individuals tried to gain a sense of understanding its cause. Adopting the medical discourse 
related to the causality of heart disease, in particular stress and unhealthy habits (e.g. smoking, 
unhealthy diet), all participants reflected on their attitude and behaviour prior to diagnosis in an 
effort to evaluate their own responsibility. This understanding helped them to develop various 
strategies in order to gain a sense of mastery over their life. Research evidence (Lin, Wang, 
Tung, & Furze, 2012), similar to this study’s findings, shows that many cardiac patients hold 
inaccurate beliefs about heart disease, while others may hold accurate illness beliefs but 
intentionally minimize the problem in order to reduce distress level and gain a sense of control. 
All these are in line with Leventhal’s (1992) Self Regulation Model (SRM) and cognitive 
adaptation theory (CAT; Taylor, 1983).  Both theories, SRT (Leventhal, Meyer, & Nerenz, 1980; 
Meyer, Leventhal, & Gutmann, 1985) and CAT (Taylor, 1983) agree upon the assumption that 
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understanding disease and causality allows individuals to develop coping strategies (either 
approaching or denying the problem) in order to re-gain control (a sense of mastery; Taylor, 
1983) or re-build/re-establish their state of normality (Meyer, Leventhal, & Gutmann, 1985) that 
was disrupted through the disease-related experiences. 
After reflecting on their responsibility for causing the disease, participants’ focus of attention 
becomes their bodily sensation. Individuals suggest that in the absence of side-effects, they 
experience a bodily revitalization. Previous research findings similarly reveal that individuals 
experience a bodily “reincarnation” after CR (Abbasi, et al., 2014; Astin, Closs, McLenachan, 
Hunter, & Priestley, 2008) and a sense of improved quality of life (Tolmie, Lindsay, & Belcher, 
2006). However, there are individuals, especially after CABG, who experience a negative impact 
due to the treatment's side-effects and make efforts to adjust to a continual changing embodied 
self, highlighting the restrictions that persisting problems pose on motivation As bodily self is a 
core aspect of the individual self, for those people adjustment may be more difficult, requiring 
more time to be achieved. In either case,  the experience of a fear, the fear of re-occurrence or 
disease progression and the impact that it may have on their embodied self and their overall life 
emerges in participants’ narratives.  
The positive feeling of being alive on the one hand and the negative feeling of fear of re-
occurrence or disease progression on the other, combined with self-responsibility for disease 
development, motivates individuals to work on aspects of the self, both the psychological and 
relational self.  Individuals tend to demonstrate a dramatic shift, a unique shift based on self-
responsibility attributions; they become calmer, less perfectionist, emotionally tougher. These 
findings are consistent with those of Peterson et al. (2010) and Abassi et al. (2014) who 
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suggested that many patients treated either with PCI or CABG perceive the treatment as a 
turning point provoking changes in their self-perception and behaviour.  
Many participants discussing changes in aspects of the embodied self described another 
aspect, just as important but less often discussed in the literature, that of the sexual self.  
Individuals discussing the changes they experienced in that aspect of self suggested that it may 
be unwelcome as other changes and that they face difficulties in adjusting to these changes and 
ask for expert help as individuals. Especially females tend to be more reluctant to discuss sexual 
issues with their doctors, believing that others (e.g. doctors, partners) may perceive their sexual 
life as a secondary issue with minor importance when dealing with a life-threatening disease. 
Recent research shows that very few females receive counselling or discussion about sexual 
concerns and most of the time this is only at their request (Abramsohn et al., 2013). Research 
further supports these claims indicating that both doctors (Doherty, Byrne, Murphy, & McGee, 
2011; Nicolai et al., 2013) and nurses (Goossens et al., 2011; Jaarsma et al., 2010) in cardiology 
practice rarely address sexual issues with the patients either due to lack of time and training to 
discuss sexual issues (Nicolai et al., 2013) or lack of adequate knowledge and a fear of 
provoking embarrassment in patients (Goossens et al., 2011). In light of these findings, when 
QoL is explored, sexuality should be included as it is an essential aspect of the self.  
Participants also experienced shifts in the relational self. As in the present study, qualitative 
research findings show that heart disease patients often experience feelings of loneliness despite 
the existence of supportive relationships (Leegaard et al., 2008). Feeling distanced from 
significant others initiates a self-talk with multiple aspects of their relational self in an effort to 
gain understanding of the reasons for such experience. Individuals who recognize that they used 
to be detached from significant others attempt to establish closer relationships, whereas others 
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experience a need to distance themselves from people who have disappointed them. According to 
the interpersonal social-cognitive theory (Andersen & Chen, 2002), the repertoire of relational 
selves is shaped by the interaction with significant others and this has an impact on self-
definition and behaviour. As research evidence demonstrates, the maintenance of strong 
relational bonds with significant others is fundamental for people’s well-being (Baumeister & 
Leary, 1995).   
In terms of changes in everyday life, individuals with CHD may develop various strategies, 
including denial in order to minimize the impact of disease and internal conflict, and comparison 
with others in order to re-gain or increase their self–esteem.  
To reiterate, the meaning making process of CHD survivors as suggested by participants 
embraces representations of disease and its impact on current and future life. Many individuals 
acknowledging their responsibility in disease development make conscious efforts for mastering 
disease progression and gaining a sense of control over themselves and their life. In effect, they 
work towards changing those aspects perceived as maladaptive.   
This process seems to be aligned with Leventhal and colleagues’ (1980) Self-Regulation 
Model (SRM) which provides a framework for understanding how individual symptoms and 
emotions experienced during a health threat or diagnosis can influence illness perception (illness 
beliefs) and guide subsequent coping behaviour, as discussed elsewhere (Chapter 2).  
Regarding the concerns that CHD individuals have about life style modifications, challenges 
are attributed to both external and internal factors. People may experience low self-efficacy when 
expert support is limited. As research demonstrates, self-efficacy is a key component in CHD 
self-management (Katch & Mead, 2010). Other concepts related to low adherence to doctors’ 
advice seem to be patienthood denial, lack of awareness of the significance of a change, lack of 
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support from significant others, or efforts to maintain certain kinds of pleasure in their lives. 
These findings are in line with research evidence in the field of heart diseases. Based on a recent 
review (Murray, Fenton, Honey, Bara, Hill, & House, 2013), social support, education and 
knowledge, as well as beliefs and emotions were the main issues related to making lifestyle 
changes and maintaining a healthy lifestyle.  
Concerning smoking cessation, one of the most challenging lifestyle modifications among 
CHD patients, three themes emerged from the participants’ accounts; a lack of accurate 
knowledge regarding smoking and CHD, a lack of support (by experts or family members) and a 
conscious refusal to quit smoking as a way to cope with anxiety and stress as well as a way to 
maintain pleasure in everyday life. In the latter case, as participants who continue to smoke one 
year post CR suggested, they felt that the damage (the consequence) of smoking cessation would 
be greater than continuing to smoke. Some participants’ quotes suggested that the value of 
emotional well-being might be of greater importance than physical well-being and health, while 
some other narratives implied that smoking may have a positive effect by helping them to control 
and reduce high stress which can cause problems with their heart. Research evidence, coming 
mostly from patients with cancer who continue to smoke, supports these findings (Duffy, 
Louzon, & Gritz, 2012).  
In light of these findings, these aspects may be helpful if included in interventions aiming to 
increase CHD self-management and in particular, smoking cessation.  
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7.4.2 Significance of the study and limitations 
The present study provides the fields of heart disease and health psychology with a deeper 
understanding of how individuals who underwent CR make sense of their experience and life one 
year after treatment. This study seems to be the first study in this area using IPA to capture the 
points of view of individuals who have undergone both CR types (CABG and PCI). In other 
words, it could be claimed that it is the first study that explores and captures the complex process 
that individuals undergo in order to make sense of their lives one year after CR, enlightening the 
multi-dimensional nature of quality of life as well as the interaction of multiple selves that may 
lead individuals to interpret their lives differently over time. Moreover, the findings of the 
present study in relation to the positive growth experienced by CHD survivors provide further 
insight and support for the Post-traumatic growth model (PTG- Tedeschi & Calhoun, 1996) in 
the field of heart disease.   
Some of the themes revealed in the present study are adding novel insights (e.g. interaction 
of multiple selves, belief that CHD is curable) to existing knowledge in the heart disease 
literature while some others (e.g. minimization of disease impact) support previous research in 
the field. However, the uniqueness relies on peoples’ interpretations and explanations of the 
process they undergo in order to make sense of their life one year after treatment. Thus, it can be 
argued that one major contribution of this study in the field of heart disease is that, by employing 
IPA, it has been revealed that many individuals after CR, especially those who received PCI 
treatment, perceive their disease as an acute condition which occurred and was treated in the 
past, bearing no more concern to the present. Although CHD is a life-threatening condition, 
many participants perceive it as less damaging compared to other medical conditions (e.g. 
diabetes) and less important to other life issues (e.g. financial). They come to pay less attention 
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to it as long as it does not affect their independence and dignity. As a result, they gradually deny 
its presence in order to return to a state of “normality”. However, as they adopt the medical 
discourse of CHD causality, they develop various cognitive and problem-focused coping 
strategies in order to prevent having to reface such a challenging condition. These coping 
strategies are developed after undergoing a re-evaluation of their multiple selves and can lead 
individuals to modify all aspects of the self that are linked with their attribution of disease 
causality. These strategies, whether maladaptive or not, lead in most cases to an inner growth 
resulting in positive psychological changes, meaningful relationships and appreciation of life.  
Another essential finding is that individuals perceive the self as being a multidimensional 
interrelated self; when one aspect is affected, all aspects are influenced. Sexual self is an integral 
part of the self and thus its well-being is a critical aspect of one’s life.  
Finally, an essential finding of the present study is that individuals give priority to the 
psychological self compared to the bodily self, especially when it comes to behaviour 
modifications. For instance, although they acknowledge that smoking is harmful for their bodily 
health they do not quit this unhealthy habit if they perceive it as a way to improve emotional 
status. Thus, the present study also illuminates further the area of patients’ adherence/non-
adherence to doctors’ advice by revealing a deeper understanding of the motives, the challenges 
as well as the cognitive processes that individuals undergo in order to decide, make and maintain 
lifestyle changes. This understanding may be particularly helpful to health care practice as it can 
guide multidisciplinary teams both in primary and secondary health settings to develop tailored 
interventions to increase patients’ adherence to lifestyle modifications.  
However, a few notable limitations are present in the current study. It could be claimed that 
as individuals underwent different types of CR, the sample violates the rule of homogeneity. The 
324 
 
decision to treat the participants as one group serves the purpose of avoiding a pre-defined 
differentiation of experiences of quality of life in terms of CR procedure. Furthermore, data 
collection, analysis, as well as interpretation of the accounts might be influenced by the fact that 
this study is the researcher’s first attempt at employing IPA. In other words, although the 
research followed specific guidelines to safeguard the study’s quality as described earlier, the 
researcher’s lack of experience may have influenced aspects of data collection and data analysis. 
For a researcher with some work experience that focuses on evidence-based practice it is 
extremely hard to distance themselves from the pre-existing theoretical perspective as well as 
ignore the existing literature on the topic. It was for this reason that an external researcher was 
involved in reviewing and commenting on the analysis process, in an attempt to control 
individual weakness and possible misconceptions. Moreover, the lack of triangulation on data 
collection could be another limitation of the present study; only semi-structured face-to-face 
interviews were employed for data collection. Thus, the reader could argue that findings may be 
biased due to the limited richness of the data. Smith (2003), however, suggests that the use of 
focus groups should be carefully considered within the IPA framework because the group 
discussion may fend off the idiographic aspect of IPA. Thus, it might reduce one of the basic 
notions of IPA, the in-depth exploration of individuals’ experience.   
 
7.4.3 Implications for theory, practice and research  
The findings of the present study are in agreement with the biopsychosocial framework of 
quality of life. However, based on participants’ accounts, quality of life is not a stable concept; it 
should be perceived as a continually changeable notion that is influenced by individuals’ stage of 
life, identity processes, experiences and context. Also, in the field of quality of life, theoretical 
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perspectives should incorporate sexuality as a key aspect both in terms of functioning and 
satisfaction (physical and psychological dimensions). Furthermore, findings provide support for 
adjustment theories (SRM, Cameron, & Leventhal, 2003; CAT, Taylor, 1983) as well as  PTG as 
conceptualized by Tedeschi & Calhoun (1996). 
Regarding clinical practice within hospitals, the communication skills of medical staff should 
be reviewed and improved. The findings of the current study highlight the importance of this in 
order to minimize individual distress and feelings of loss of dignity.  
Special attention should be given to establishing multidisciplinary teams in cardiac health 
care settings. The role of a health psychologist, sex therapist and dietician could boost best 
practice and quality of patients’ care. Health professionals should also place particular emphasis 
on exploring individuals’ process of adjustment and help them to accept the chronic nature of 
their disease as well as enhance their motivation to adopt a healthier lifestyle. 
In short, tailored motivational interventions based on the findings of the present study should 
include psychoeducation (Janssen, De Gucht, van Exel, & Maes, 2013), focus on enlarging self-
efficacy (Katch & Mead, 2010) and motivational interviewing (Rollnick, Miller, & Butler, 
2008), targeting minimally physical exercise (e.g. walking) and smoking cessation. Interventions 
aiming to increase patients’ social support can also be beneficial as support seems to have a 
reinforcing power on individuals’ maintenance of a lifestyle change. 
Concerning research, the present study highlights that quality of life cannot be captured 
solely by standardized self-report measures as each individual may experience the same 
phenomenon in a different way; the qualitative research paradigm should be espoused too. Also, 
researchers should pay attention to the disease adaptation process and the positive growth that 
individuals may experience when exploring changes in HRQoL after treatment, as these concepts 
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seem to affect the outcome. Lack of such considerations may lead to biased results. Furthermore, 
as the present study’s findings show, in the absence of side-effects individuals focus on other 
pre-existing problems. Consequently, exploring lived experience and quality of life over time, 
other stressful events should be investigated as well since they seem to have an influential effect 
on individuals’ understanding and perceptions about their overall quality of life. Future research 
may include attention to retrospective accounts of how people define and experienced a good life 
before CR as well as after CR, as this study has focused on the latter only. 
Researchers also should pay attention to the stage of life that individuals are at. Older adults 
may experience good adjustment  not due to the beneficial effect of CR upon their life but due to 
their view that heart disease or side-effects of treatment are only problems to be expected with 
older age (Hendry & McVittie, 2004). Nevertheless, further qualitative research focusing on 
exploring individuals’ coping strategies and challenges that they may face one year post CR 
treatment is needed in order to gain a greater insight into this topic, which in turn will allow the 
development of more advanced tailored interventions.     
 
7.5 Conclusion  
The present study aimed to explore how individuals make sense of a good life in relation to 
their health disease condition, one year after CR. Findings demonstrate that many individuals 
one year post treatment suggest that they do live a good live. This is considered in terms of 
continuation, where they perceive that the disease experience has not substantially affected their 
life, or is seen as an achievement, as long as they have managed to regain a sense of balance and 
purpose in life post treatment. Overall, individuals describe their experience as a life lesson.  
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Participants perceiving their disease as controllable or curable due to CR treatment, and 
fearing reoccurrence, try to gain a sense of understanding of disease causality. Individuals, in 
adopting the medical discourse regarding causes of CHD development and progression, place 
particular emphasis on stress and start a critical re-assessment of multiple aspects of self in 
accordance with Engel’s biopsychosocial model. In order to controltheir  disease and gain a 
sense of mastery they make a constant effort to change aspects of their self resulting in shifts in 
their attitude, behaviour and understanding of the essence of living a good life, eliciting a 
positive growth in terms of increased life appreciation, personal growth and development of 
meaningful relationships.   
Furthermore, participants face various challenges in living a healthier lifestyle and attribute 
this to both external and internal factors. Smoking cessation is difficult as smoking seems to be 
viewed as a way to control other related factors (e.g. weight) as well as a way of maintaining 
some sense of emotional well-being.  
Having gained a greater insight into individuals’ understanding, meaning-making process 
and concerns regarding lifestyle modifications, the next step is the interpretation, the integration 
of the findings of the quantitative and qualitative components in order to address the research 
questions of the mixed methods study.  
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Chapter Eight 
 
8 General discussion 
8.1  Introduction  
This thesis aimed to investigate CHD patients’ perspectives of the influence of coronary 
revascularisation (CR) on their health related quality of life (HRQoL) as defined by the World 
Health Organization (WHOQoL team, 1993), since health issues like CHD can be more 
efficiently addressed if viewed in a holistic, biospychosocial approach (Blankenship, et al., 2013; 
Engel, 1980). CR is one of the main treatments of CHD consisting of two types: percutaneous 
coronary intervention (PCI) and coronary bypass graft surgery (CABG)).  In order to achieve this 
aim a series of study were conducted.  
Initially an in-depth examination of the relevant research evidence has been carried out by 
conducting a systematic review with meta-analytic techniques of the influence of CR on patients’ 
HRQoL. The findings of the review based on 34 studies demonstrated that patients experience a 
moderate improvement in their HRQoL level after CR treated with either type (PCI or CABG). 
The length of a study (on average, studies with longer follow-up demonstrated lower effect 
sizes), the measurement used (studies using disease-specific instruments demonstrated higher 
effect sizes) and its quality (on average, as quality increases, effect size decreases) seem to be the 
main  factors influencing outcomes. The limited research, however, on the one hand and the lack 
of adequate data on the other, did not allow for a full understanding and identification other 
potential predictors of the outcome.  
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Taking into consideration the findings of the systematic review, the extremely limited 
research in this field in Greece (where the incidence of CHD has been constantly increasing over 
the last decades, and where CR treatment is mostly applied) as well as  the author’s advocacy of 
the mixed methods stance (where the advantages of quantitative and qualitative research methods 
can be combined to draw a clearer picture; Creswell, 2014),  two studies were carried out: (1) 
The translation, adaptation and validation of the Coronary Revascularization Outcome 
Questionnaire (CROQ; a disease/treatment specific instrument) into Greek, and (2) The 
longitudinal mixed methods study.  The latter was the main research study following a sequential 
explanatory design and refers to a 3-part study; two research parts (a quantitative component 
focusing on patients’ subjective ratings of and a qualitative component focusing on patients’ 
lived experience of HRQoL), and an interpretation part (the integration of the findings for the 
different research components) which aimed to address the  main research questions of this 
thesis:  
 
1) How do Greek individuals with CHD conceptualize HRQoL?  
2) How do aspects of the disease experience after CR and meaning-making processes 
inform individuals’ perspectives on their HRQoL?   
 
In this final Discussion chapter, the key findings of each of these studies are firstly 
summarized. Then, an explanatory synthesis of the main study’s research component findings, 
thematically organized to address key aspects of the main research questions, is presented. 
Following the in-depth understanding of CHD patients’ perspectives on their HRQoL one year 
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after CR, an extensive discussion on the implications of the findings is presented, providing 
recommendations for theory, future research and clinical applications.  
 
8.2 Summary of the findings  
8.2.1 The validity and reliability of the CROQ - Gr 
The validity and reliability study of the Greek version of the Coronary Revascularization 
Outcome Questionnaire (CROQ (Schroter & Lamping, 2004)) showed that the CROQ-Gr is 
acceptable to patients and satisfies the majority of the rigorous scientific criteria set in terms of 
reliability, validity and sensitivity to change.  
In particular, the acceptability of the measure was rather good, with a high response rate 
which was greater than 0.70 and a low level of missing data which was lower than 10% for 
almost all subscales; with the exception of the Physical functioning subscale where the missing 
data ranged between 0 and 24%. The CROQ-Gr also demonstrated a good level of reliability; 
with an internal consistency greater than 0.70 and intraclass correlation coefficients (ICC) 
greater than 0.80 for all subscales.  Regarding validity, the content validity was detected to be 
very good, firstly through face-to-face interviews of fifteen patients, and secondly, through 
expert opinion expressed during two panel meetings. Construct validity within scale was 
satisfactory. The four factor model of rotated squared loadings explained between 41.7% and 
50.3% of the variance, depending on the version. The construct validity against external criteria 
(compared to the SF-36v2 subscales) was shown to be adequate. The Symptoms and Physical 
functioning subscales of the CROQ-Gr correlated more strongly with the Physical Component 
Summary of the SF-36v2 than with the Mental Component Summary. Conversely, the 
Psychological Functioning subscale of the CROQ-Gr correlated more strongly with the Mental 
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Component Summary of the SF-36v2 than with the Physical Component Summary. Finally, the 
CROQ-Gr was demonstrated to be sensitivity to change (post-CR scores significantly differed 
from those pre CR).   
 
8.2.2 The mixed methods study 
8.2.2.1 Quantitative results  
The longitudinal quantitative component aimed to detect changes in patients’ HRQoL (both 
overall and in subdomains) following CR over a 12-month period based on individuals’ 
subjective evaluation as captured by the CROQ-Gr, exploring as well various clinical, 
behavioural and demographic predictors.  
Results demonstrated that the majority of people with CHD report an increase in their 
HRQoL following CR. The trajectory of change, however, is not constant; initially it increases 
with time, and then decreases, though remaining at a higher level compared to prior to CR . 
Regarding the influence of CR treatment type on patients’ HRQoL level a year after CR, the 
mixed findings do not allow a clear conclusion. Main predictors of the mean change were related 
to sex, BMI and smoking; females with low BMI that did not smoke tended to demonstrate a 
larger increase in HRQoL after CR.  
Regarding the subdomains, the pattern of change was similar to the one reflected in overall 
HRQoL. Concerning the influence of CR treatment type, an interaction between Time and CR 
treatment type in three HRQoL subdomains was found. Specifically, in the Symptoms and 
Physical functioning subdomains as time increased, individuals treated with CABG seemed to 
experience a greater mean change compared to individuals treated with PCI even after 
controlling for individuals’ biological, medical and behavioural characteristics.  On the other 
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hand, in the Cognitive functioning subdomain individuals treated with CABG seemed to 
experience a negative mean change compared to individuals treated with PCI who seemed to 
experience a positive mean change, even after controlling for individuals’ biological, medical 
and behavioural characteristics. The main predictors of mean change in the Symptoms subdomain 
seemed to be CR treatment type, BMI and smoking; individuals treated with CABG with a low 
BMI who did not smoke tended to demonstrate a greater increase after CR in this subdomain.  
Main predictors of the mean change in Physical functioning seem to be CR treatment type, 
sex and smoking status; female non-smoking individuals treated with CABG tended to show the 
greatest increase in this subdomain after CR.  The main individual characteristic predictors of the 
Psychosocial functioning outcome were age and hypertension; increasing age and no 
hypertension predicted greater level of functioning in this subdomain after CR. Main predictors 
of the mean change Cognitive functioning were CR treatment type and diabetes; patients treated 
with PCI without diabetes tended to demonstrate a greater increase in this subdomain after CR. 
At this point it is essential to highlight that individuals treated with CABG with diabetes tended 
to demonstrate a negative mean change (a decline in cognitive functioning level compared to 
prior to CR). Regarding adverse effects, the results suggested that patients treated with CABG 
three months post treatment experienced more side effects but at 12 months the condition of 
most participants had improved. In terms of Satisfaction, patients treated with CABG especially 
retired individuals and individuals with co-morbidities (e.g., diabetes, high cholesterol) tended to 
show low level of satisfaction with the treatment.  In contrast individuals with a family history of 
CHD tended to indicate a greater level of satisfaction with CABG treatment.     
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8.2.2.2 Qualitative findings   
The qualitative data and analysis using an Interpretative Phenomenological (IPA) approach 
aimed to refine and provide a deeper understanding of the perspectives of individuals with CHD, 
by exploring participants’ point of view and experience, placing particular emphasis on 
understanding and explaining issues revealed in the quantitative results (e.g. smoking-related 
issues). In terms of individuals’ lived experience, participants, reflecting on their experience one 
year after treatment, perceived CR as a simple process and their negative experience was mostly 
related to medical care. Many participants with no symptoms or adverse effects tended to 
misperceive CHD, viewing their health condition as an acute disease treated with CR. Trying, 
however, to understand disease causality they tended to adopt a medical discourse especially in 
relation to stress, as a factor that can be controlled by themselves and reflected on their own 
responsibility for causing the disease. Feeling grateful for being alive, sensing a different body, a 
“revitalized body” as many participants suggested, but also having a fear of re-occurrence or 
disease progression, motivated individuals to work towards aspects of self in an effort to regain 
control over their life, which had been disturbed by the  CHD diagnosis. In effect, dramatic 
changes in their views of self and life were observed highlighting a positive growth; a greater 
appreciation of life, personal growth and an effort to build more meaningful relationships. 
Challenges that participants faced in making lifestyle changes were attributed to both external 
and internal factors. Concerning smoking, there emerged a lack of accurate knowledge regarding 
the link between smoking and CHD, a lack of support (by experts or family members) and 
conscious denial as a way to cope with every day anxiety and stress on the one hand, and 
obtaining pleasure in everyday life from smoking on the other.  
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8.3 Integration and interpretation of findings (Part Three) 
8.3.1 How do Greek individuals with CHD conceptualize HRQoL? 
Findings provide support for the notion that HRQoL is a multi-dimensional concept;  
participants’ reports suggested that they espouse a view of HRQoL consistent with the 
biopsychosocial model (Engel, 1980; WHO, 1948). In fact, individuals make sense of their 
HRQoL by evaluating their symptoms, physical, psychological and social well-being, which are 
perceived not as discrete concepts but as being interconnected. Changes in one aspect provoke 
changes in another and vice versa. In other words, this critical re-assessment of different aspects 
of their selves resulted in a shift in their attitude, behaviour and understanding of the essence of 
living a good life. 
Moreover, as participants highlighted, sexuality is an important aspect of their life. Thus, in 
the field of the HRQoL related to coronary disease, sexuality should be incorporated as a key 
aspect both in terms of functioning and satisfaction (physical and psychological dimensions). 
Also, based on participants’ perspectives and the shifts indicated, QoL, with or without a 
health related aspect, is not a stable concept; it should be perceived as a continuously changeable 
notion that is influenced by individuals’ experiences, context and stage of life. These findings 
are in agreement with the suggestions by many scholars (e.g. Beeken, Eiser, & Dalleys, 2011) 
that HRQoL is a dynamic concept and it may change over time as human beings adjust to their 
life conditions and alter their internal standards, expectations, needs and values.  
A final important issue is that individuals, especially those who attempt to move beyond the 
identification as patients, no longer suffer symptoms and perceive CHD as a distant experience 
of no grave importance to their current life. They reduce emphasis on the health condition in 
their attempts to make meaning of quality of life at 12 months; in other words they focus on the 
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broader concept of QoL rather on the narrower notion of HRQoL. This points out that they do 
not necessarily conflate HRQoL and QoL, suggested in the literature, but redirect attention to 
other broader issues.  
 
 
8.3.2 How do aspects of the disease experience after CR and meaning-making processes 
inform individuals’ perspectives on their HRQoL? 
8.3.2.1 Individuals’ experiences of CR treatment and satisfaction 
Some individuals through their subjective evaluations especially those treated with CABG 
demonstrated a low level of satisfaction with treatment and medical care compared to patients 
treated with PCI. Individuals’ accounts support these findings by expressing that CR might be a 
simple process, but, being in need of and receiving medical care can be a very traumatic 
experience. Feelings of fear, frustration, loss of dignity and helplessness can arise due to distant 
and/or insensitive treatment by the medical/nursing staff (e.g. limited or absent information, lack 
of empathy). For patients treated with PCI, whose hospital stay is only a few hours or a day and 
interaction with hospital staff is limited, negative feelings and dissatisfaction are of short 
duration. For CABG patients whose treatment is more complicated and who need more hospital 
care the negative feelings might be long lasting, influencing their experience and level of 
satisfaction negatively. These findings are consistent with earlier research showing that limited 
information, poor communication (Shiloh et al., 2014) and authoritarian or cruel behaviour on 
the part of medical staff can elicit unpleasant feelings and challenge patients’ emotional well-
being as well as levels of satisfaction with medical care (Baillie, 2009; Lekidou, Trivellas & 
Ipsilandis, 2007; Parker et al., 2007; Thorne et al., 2013).  
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On the other hand, as the quantitative results indicated, patients with a family history of CHD 
especially those treated with CABG indicated increased satisfaction with treatment. This may 
reflect a reduced attention to communication aspects as they may view CABG as a more 
appropriate treatment due to their CHD history, which is a risk factor for disease progression and 
likelihood of a heart attack as mentioned in their narratives; an issue that due to lack of further 
research evidence needs greater exploration.   
 
8.3.2.2 Individuals’ views of their overall HRQoL one year after CR 
Most individuals’ subjective evaluations suggested a better overall HRQoL 12 months after 
CR compared to that prior to treatment. This claim is supported by both the quantitative and 
qualitative studies reported in this thesis, providing further support for existing research evidence 
(e.g. Blankenship et al., 2013). 
The qualitative findings suggested that this change, however, is not solely connected with the 
CR treatment, but also with the cognitive process that people underwent as a result of their 
experience (both disease and treatment). Their experience triggered a shift in the way they view 
themselves and life. In effect, they experience changes in aspects of self and the meaning of 
living a good life, leading to positive growth. Based on individuals’ accounts they experienced 
an increased appreciation of life and every day simple things, a sense of personal strength, and a 
willingness to build more meaningful interpersonal relationships.  
These points are in line with other research findings demonstrating that many patients view 
CR treatment as a turning point in their lives (Höfer, Doering, Rumpold, Oldridge, & Benzer, 
2006; Peterson, et al., 2010) because it triggers many changes in individuals’ understanding of 
living a good life and personal strength (Abbasi et al., 2014; Tolmie et al., 2006; Waight, Strodl, 
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Sheridan, & Tesar, 2015). In terms of theory, all these positive changes are in line with the Post–
Traumatic Growth model (PTG) which suggests that, after facing a life threatening event, people 
tend to experience positive changes (Tedeschi & Calhoun, 1996). The positive growth concept 
may also provide some explanation of female non-smokers’ overall greater increase in their 
perceptions of HRQoL. A recent meta-analysis (Vishnevsky, Cann, Calhoun, Tedeschi, & 
Demakis, 2010) showed that females after a crisis (e.g. surviving CHD) tend to experience 
greater positive growth compared to males. Taking into consideration the suggestions in the 
literature that PTG is positively related to individuals’ HRQoL, this implies a potential adaptive 
value (Barskova & Oesterreich, 2009). However, the finding of this thesis regarding the 
predictive value of female sex on HRQoL level of change should be considered with caution 
until further research clarifies the degree to which sex influences the effect of PTG on HRQoL 
following CR.   
Nevertheless, as the quantitative results showed, also supported by the meta-analysis, the 
increased functionality following CR tended to decline slightly over the one-year period, 
although it still remained greater than the baseline level. One possible explanation might be the 
lack of adherence to doctors’ recommendations regarding lifestyle changes, especially regarding 
physical activity and smoking cessation, which can reduce the effectiveness of treatment 
(Levesque, Li, & Pahal, 2012). The quantitative analysis showed that few patients quit smoking 
or, if they do, few maintain smoking cessation, especially when treated with PCI. Results also 
revealed smoking as a negative predictor of the HRQoL outcome, an issue which is well 
documented in literature (e.g. Jang et al., 2015). The qualitative findings supported the 
quantitative results indicating that a number of patients failed to adhere to doctors’ suggestions 
about lifestyle modifications after treatment. The accounts of many individuals highlighted their 
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unwillingness to quit smoking (an issue that will be discussed in greater depth later) or increase 
their physical activity (e.g. walking). Empirical research demonstrates that individuals without 
symptoms may perceive their disease as less severe and are less likely to adhere to doctors’ 
advice resulting in a reduction in health (DiMatteo, 2004); issues that will be further elaborated 
on in the following sections.  
 
8.3.2.2.1 CHD symptoms and physical wellbeing  
Individuals’ evaluations of their symptoms and physical wellbeing indicated that their CHD 
related symptoms were improved as well as their physical functioning. This improvement was 
greater for patients treated with CABG. Many participants’ accounts supported the quantitative 
results and provided further explanation of this finding. As individuals explained, being a CHD 
survivor elicited a special attention to their body, resulting in a different relationship to it. For 
many this increased bodily awareness was positive as they experienced a revitalized body while 
for some others it was negative, mostly due to treatment side effects; as side effects decreased 
over time their physical functioning increased. Similarly, the literature shows that people 
experience a bodily rebirth after CR (Abbasi et al., 2014; Astin et al., 2008). However, it should 
be noted that the accounts of some older participants suggested that individuals may experience a 
deterioration of their body which might be related to the treatment, but is viewed as a 
“consequence” that is expected with older age. Thus particular attention should be given to older 
adults and the influence of the CR on their physical functioning. These findings are in line with 
previous research evidence (e.g. Hendry & McVittie, 2004; Kleinspehn-Ammerlahn, Kotter-
Grühn, & Smith, 2008).  
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8.3.2.2.2 Psychosocial wellbeing 
Participants’ evaluations of their psychosocial wellbeing indicated that their psychosocial 
functioning increased following CR. Many accounts supported these findings, highlighting the 
interconnection with physical well-being; as participants experienced a bodily revitalization their 
psychosocial wellbeing increased too. Again participants’ narratives suggested that their 
experience triggered a shift in their prerception of psychological and social aspects of the self. 
Specifically, individuals modified themselves by becoming more easygoing and consciously 
avoiding health damaging, pointless, or stressful situations (e.g. easily getting into arguments). 
Consequently, they modified their relational self by becoming more attached or detached from 
significant others. As the interpersonal social-cognitive theory (Andersen & Chen, 2002) 
suggests, the repertoire of relational selves is shaped by the interaction with significant others 
which, in turn, has an impact on self-definition and behaviour. The path that individuals chose to 
follow depended mostly on their evaluation of the support offered toward others prior to 
diagnosis and the way that the others have behaved towards them when they were in need. In line 
with other research findings (Leegaard & Fagermoen, 2008) many participants mentioned that 
they felt alone even in the presence of practical support, implying indirectly the lack of 
emotional support. Most of them, however, may minimize the importance of this need (as they 
did not state it directly) because of another important need, fundamental to humans, that of 
maintaining relational bonds (Baumeister & Leary, 1995).  
 
8.3.2.2.3  Sexual wellbeing 
A complementary issue that emerged from the qualitative findings was related to individuals’ 
sexual wellbeing. Many participants’ accounts suggested that this aspect of self is a vital part of 
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the overall HRQoL for both males and females; an issue rarely explored or measured. Female 
participants, however, seemed to be more reluctant to discuss issues of sexuality with their 
doctors. The literature reveals that a healthy sex life is an essential factor in someone's overall 
quality of life (Steinke & Patterson-Midgley, 1998). Many individuals after a Myocardiac 
Infarction  may experience concerns about sex (e.g. fears related both to sexual functioning and 
satisfaction (Mosack & Steinke, 2009)) but often are embarrassed to discuss them with their 
doctors. Furthermore, recent research findings show that very few patients (Mosack et al., 2009), 
especially females, receive counseling or discuss sexual concerns with medical staff and this is 
usually a result of their own preference (Abramsohn et al., 2013).  Empirical evidence further 
supports these claims indicating that both doctors (Doherty et al., 2011; Nicolai et al., 2013) and 
nurses (Goossens et al., 2011; Jaarsma et al., 2010) in cardiology practice rarely address sexual 
issues with patients. This is either due to lack of time and training in discussing sexual issues 
(Nicolai et al., 2013) or lack of adequate knowledge and a fear of  provoking embarrassment in 
patients (Goossens et al., 2011).  
 
 
8.3.2.3 Individuals’ understanding of CHD; adjustment and lifestyle modifications  
8.3.2.3.1 CHD 
Shortly after discharge, many individuals who don’t have symptoms or adverse effects deny 
patienthood and misinterpret their CHD. Participants’ accounts suggested that they viewed CR as 
a permanent treatment of CHD. Thus it could be claimed that they held various inaccurate beliefs 
regarding their heart condition; as being acute and cured. The findings support research previous 
evidence suggesting that CHD individuals after CR in the absence of any bodily evidence (e.g. a 
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surgery scar) and lack of symptoms perceive the heart disease as an acute treatable disease 
denying its chronic nature (Peterson et al., 2010; Astin et al., 2009). 
These views on the hand may indicate inaccurate knowledge regarding CHD that should be 
dealt with tailored interventions aiming to increasing accurate knowledge of CHD. On the other 
hand, this denial may be an avoidance coping strategy in an effort to minimize disease severity 
and its impact on the individual’s life. In effect this strategy helps patients regain control over 
their life and reach a sense of equilibrium, as many researchers espousing the Self-Regulation 
theory would suggest (Cameron & Leventhal, 2003; Leventhal, Leventhal, & Contrada, 1998). 
This claim, however, needs further exploration as this study did not directly measure individuals’ 
illness representations.  
Research evidence (Lin, Wang, Tung, & Furze, 2012) shows that there are many cardiac 
patients who hold misconceptions (inaccurate beliefs) while some other may hold accurate 
illness beliefs but intentionally minimize the problem in order to reduce distress level (Platt, 
Green, Jayasinghe, & Morrissey, 2014).  
 
8.3.2.3.2 Surviving CHD  
The majority of patients, in either case (misinterpretation of CHD or a strategy to regain a 
sense of control), have concerns regarding a re-occurrence of their disease or disease 
progression. As an overall prevention strategy, they understate the reasons for why the disease 
may have developed in the first place and then they work towards aspects of self and develop 
various coping strategies to prevent re-occurrence. Specifically, many participants influenced by 
the medical discourse on the causes of heart disease, especially that of stress and overwhelming 
anxiety, were critical of their past attitudes and behaviours.  
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They mainly identified aspects of the self that had caused stress and anxiety and made a 
constant effort to change demonstrating a remarkable shift in those aspects as mentioned in the 
previous sections. Some essential everyday coping strategies that were captured in individuals’ 
accounts, relevant to people’s adjustment process to regain a sense of control over their lives, 
were setting boundaries, repressing negative thoughts and emotions, minimising disease 
influence and comparing their functioning to others with a similar profile (e.g. in terms of age).  
These findings support research evidence in the CHD field regarding positive adjustment 
(Abbasi et al., 2014; Helgeson, 2003; Helgeson, 1999, Helgeson & Fritz, 1999; Peterson et al., 
2010; Schröder, Schwarzer, & Konertz, 1998; Tolmie et al., 2006.) as well as Taylor’s (1983) 
cognitive adaptation theory (CAT). As this theory suggests, the adjustment process involves 
searching for meaning (e.g. what caused the disease? why did this happen to me?), making 
efforts to regain mastery over the situation (e.g. what I can do to prevent recurrence?) and efforts 
to restore self-esteem through self-enhancement (i.e. comparison with others of the same status).  
This research evidence raises concerns regarding the “pure” influence of CR on the life of 
individuals with CHD without acknowledging the influence of adjustment and positive growth 
(as mentioned elsewhere).   
 
8.3.2.3.3 Lifestyle modifications; an emphasis on smoking   
Challenges that participants face in lifestyle modifications are attributed to both external and 
internal factors. People may experience low self-efficacy when the support of experts is limited. 
As research demonstrates, self-efficacy is a key component in CVD self-management (Katch & 
Mead, 2010). Other concepts related to low adherence to doctors’ advice seem to be patienthood 
denial, lack of awareness of the significance of a change, lack of support from significant others, 
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or efforts to maintain certain kinds of pleasure in life. These findings are in line with research 
evidence in the field of heart disease. Based on a recent review (Murray, Fenton, Honey, Bara, 
Hill, & House, 2013), social support, education and knowledge, as well as beliefs and emotions 
were the main issues related to making lifestyle modifications and maintaining a healthy 
lifestyle.  
Regarding smoking the quantitative results indicated that smoking is a valid predictor of 
lower HRQoL change after CR. However, a great number of individuals did not make any effort 
to stop smoking and many individuals that tried to quit shortly after treatment, twelve months 
later experienced a relapse, especially those treated with PCI. Empirical evidence further 
supports these findings (Tolmie et al., 2006). In fact, individuals after CABG tend to quit 
smoking permanently while PCI patients are less willing to make or maintain this behaviour 
modification (Hammal, Ezekowitz, Norris, Wild, & Finegan, 2014). The qualitative findings 
suggested that smoking cessation is one of the most challenging lifestyle modifications among 
CHD patients due to lack of accurate knowledge regarding the relationship between smoking and 
CHD, and lack of support (by experts or family member) as well as due to a conscious decision 
not to quit their smoking habit not only as a way to cope with anxiety and stress but also as a 
way to maintain a kind of pleasure in everyday life. In the latter case, as participants who 
continued to smoke one year post CR suggested, they felt that smoking cessation would be more 
damaging compared to maintaining their habit. Some participants’ quotes alluded that emotional 
wellbeing might be of greater importance than physical wellbeing and health, while others’ 
narratives implied that smoking may have a positive effect by helping them to control and reduce 
high stress which can cause problems to their heart muscle. Research evidence in the CHD field 
(e.g. Kärner, Tingström, Abrandt-Dahlgren, & Bergdahl, 2005) and other chronic diseases (e.g. 
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cancer; Duffy, Louzon, & Gritz, 2012) support these findings. In light of this evidence, these 
aspects may be helpful if included in interventions aiming to increase CHD self-management and 
in particular, smoking cessation.  
 
 
8.4 Novelty and clinical importance  
This thesis contributes new insights of clinical and research importance to the field of cardiac 
health and health psychology in a number of ways. First of all it provides an updated systematic 
review with a meta-analysis. This is the first meta-analysis in the field investigating the impact of 
CR on individuals’ HRQoL as well as comparing the impact of different CR treatments (CABG 
and PCI).  
Furthermore, it fills a gap in the Greek literature by validating a robust and scientifically 
valid and reliable instrument to detect HRQoL and health outcomes after coronary 
revascularization. Currently the CROQ-Gr is the only disease-specific instrument in the field.  
Moreover, the main study, the longitudinal mixed methods study, enables researchers to 
build a more complete picture about and an in-depth understanding of the HRQoL of individuals 
with CHD who are treated with CR as well as helps gain a greater understanding of predictors 
and issues related to the outcome.  
Firstly, the quality of evidence is enhanced by combining the strengths of quantitative and 
qualitative research methods and at the same time, minimizing the weakness of each (Curry et 
al., 2009) and by using robust methods for data collection (e.g. use of a valid and reliable 
disease/treatment specific instrument, with data collected at multiple time points) and data 
analysis (e.g. multilevel modelling and interpretative phenomenological analysis). Secondly, the 
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final integration and interpretation of findings helped not only to portray more holistically 
patients’ perspectives of their HRQoL following CR, but also gain complementary insight by a) 
revealing factors rarely investigated (e.g. sexual issues) or issues rarely explored (e.g. positive 
growth) in the CHD field, b) providing possible explanations and highlighting various issues 
detected in the quantitative component (e.g. the true effect of CR on individuals’ perspectives of 
their HRQoL), c) capturing the complex process that individuals undergo in order to make sense 
of their life, d) demonstrating some of the process of decision-making about everyday life style 
modification (e.g. smoking), and e) portraying some needs that should be addressed either by 
further research or tailored interventions. 
Overall, the present thesis informs the fields of heart disease and health psychology by 
building upon the existing literature and offering a deeper understanding of how individuals who 
undergo CR assess and make sense of their lives one year after treatment. It is the first study in 
this area capturing individuals’ points of view following both CR types (CABG and PCI) one 
year post treatment with mixed methods. The findings can help health professionals to promote 
the best therapeutic regimen in daily practice and facilitate transition, rehabilitation, as well as 
secondary prevention.   
 
8.5 Limitations  
Even though the researcher made efforts to enhance quality, a number of limitations should 
be considered.  
Regarding design, in the present thesis a sequential explanatory mixed methods design was 
employed. However, taking into consideration the variation of individuals’ HRQoL at baseline, 
the incorporation of a qualitative study at baseline could be useful to better understand illness 
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representations as findings already suggest that perceptions of illness affect how individuals 
identify as patients and consider their quality of life. Also, the use of focus groups in the CROQ 
translation phase could provide some sense of consensus on the topics, which could supplement 
individual input and would be  less time-consuming.  
Concerning the participants, the sample is not very large (<300 participants per type of CR) 
and not random. The majority of individuals were residents of Athens. This may have affected 
the results as people living in rural areas may have demonstrated different HRQoL levels at 
baseline or 12 months post treatment, affecting the overall effect size and thus conclusions. A 
recent review (Smith et al., 2008) of many developed countries all over the world has shown that 
rurality in and of itself is not directly related to rural-urban disparities, but may be a sign of 
individuals’ greater levels of unhealthy behaviours, a lower tendency to look after their health 
(especially due to lack of confidence) or access to health services. Also, although efforts were 
made to reduce biases, due the nature of the study social desirability bias might be present 
(Streiner & Norman, 2008).  
None of the patients participated in a rehabilitation programme, so this variable cannot have 
affected the findings. However, many patients treated with CABG in contrast to PCI had at least 
one session with a health professional, usually a health or clinical psychologist, prior to hospital 
discharge. This may have created differences in individuals’ meaning-making of their 
experience, adjustment and lifestyle modification. Thus, this might have caused variation in 
individuals’ evaluation of HRQoL one year post treatment. Even a 60 minute well-structured 
psychoeducational session may positively influence QoL (Phillips et al., 2004).  
Also, for the qualitative study it could be claimed that as individuals underwent different 
types of CR, the sample violates the rule of homogeneity. The decision to treat the participants as 
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one group served the purpose of avoiding a pre-defined differentiation of experiences of quality 
of life in terms of CR procedure. Furthermore, the lack of triangulation (using more than one 
method, e.g. focus group) during data collection could be mentioned as another limitation of the 
present study; only in depth semi-structured face-to-face interviews were employed for data 
collection. However, this claim can be challenged since triangulation in data collection might 
violate the idiographic aspect of IPA, which primarily aims to explore an individual’s experience 
(Smith et al., 2009).   
Regarding measurement issues, a full clinical record of how many arteries had been 
revascularized was not obtained. This information was requested from patients. However, as 
there were instances where patients didn’t know, this information was not included in the 
analysis. The literature suggests that individuals with multi-vessel coronary heart disease have 
fewer symptoms and greater HRQoL post CABG compared to those treated with PCI (Abdallah 
et al., 2013). Furthermore, the clinical record questionnaire used in this study cannot be viewed 
as rigorous and might be challenged in terms of its accuracy as it makes use of a single 
dichotomous item for capturing relevant information. Single and/or dichotomous items, as the 
literature suggests are not the best way to capture such information (Gregory & Radovinsky, 
2012; Streiner & Norman, 2008). Moreover, time since diagnosis was not captured. Although 
such information might not be always known (e.g. for individuals undergoing PCI), a record 
would be helpful in order to investigate its predictive value. Finally, response shift (Schwartz et 
al., 2007) was not measured. An effort to capture changes in the way that CHD individuals 
evaluate their HRQoL would be beneficial; as the study’s findings revealed various factors 
related to adjustment and positive growth may influence their interpretation and would allow to 
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build a clearer picture of the contribution of CR to CHD individuals’ perspectives regarding their 
HRQoL. 
The literature highlights that important factors may be ignored and can influence the true 
effect size of a treatment (Ring, Hofer, Heuston, Harris, & O'Boyle, 2005). In order to address 
such issues, a number of scholars suggest that quantitative researchers should make use of both 
disease-specific and generic measures (e.g. Walters, 2009) for more accurate results especially 
when the research sample may have multiple morbidities. Thus, it might be beneficial, in 
addition to the CROQ-Gr, to use a generic measure such the WHOQOL-BREF (Ginieri-
Coccossis, Triantafillou, Tomaras, Soldatos, Mavreas, & Christodoulou, 2011) which captures 
the broader (global) QoL as it measures environmental, spiritual, independence and sexual 
aspects of QoL beyond the physical and psychosocial ones. After all, as the findings of the mixed 
methods study suggest many individuals one year after CR tend to focus more on their QoL 
rather on their HRQoL.  
Finally, regarding the qualitative analysis, as this was the first attempt by the researcher to 
employ IPA (Smith et al., 2009), her lack of prior experience may have affected the findings. 
However, the researcher’s commitment to IPA guidelines on the one hand and the constant 
supervision and the involvement of an external researcher in reviewing the analysis process on 
the other, minimized the researcher’s weakness and possible misinterpretations.  
 
8.6 Implications  
8.6.1 For theory 
The thesis findings support the notion that HRQoL can be defined by the biopsychosocial 
approach as described by Engel (1980) and the World Health Organization (WHOQOL group, 
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1993). Individuals make sense of their quality of life by evaluating their physical, psychological 
and social wellbeing all of which are interrelated. Furthermore, HRQoL cannot be perceived as a 
static concept but rather as fluid. People tend to change their point of view in an effort to adjust 
to their life conditions and alter their internal standards, values, and needs as well as 
expectations. Finally, HRQoL in the field of CR should include sexuality. In fact, as the WHO 
group (2006) suggests, sexuality is a core aspect of human life and is interconnected with 
physical, psychological, mental and social well-being. Thus, sexuality should not be viewed as a 
distinct concept but rather as an aspect of quality of life (Steinke et al., 2013) and so it should to 
be included in research of both HRQoL and QoL. 
Furthermore, the findings of this thesis provide some support that HRQoL is related to 
Leventhal’s Self-Regulation Model (SRM  (Leventhal, et al., 1980)); although illness perceptions 
are not directly measured, the qualitative findings support such claims. Briefly, the model 
suggests that when a threatening event is present (in this case the presence of CHD) individuals’ 
“status quo” becomes unbalanced and, therefore, they are internally motivated to undergo a 
problem-focused procedure in order to regain a sense of balance. The first stage is to make sense 
of a problem (interpretation of threat’s representation; “illness beliefs”), the second one is to find 
ways to deal with it (coping) and the final is to assess the effectiveness of coping. As has been 
captured in the qualitative study, one aspect of making sense of their lives is the evaluation of the 
disease. This evaluation includes its causality, its time line (acute vs chronic), the severity of 
consequences, its curability and their control over it. Based on this evaluation patients maintain 
or deny their patient identity as well as develop strategies to prevent disease re-occurrence and to 
gain a sense of equilibrium. This process is aligned to the self-regulatory theory. Research 
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evidence, in the field of CR suggests that positive illness perceptions are significantly correlated 
to and predict better QoL (Foxwell, Morley, & Frizelle, 2013). 
Moreover the findings of this thesis support the concepts of perceived benefits and post-
traumatic growth (PTG) following heart disease and revascularisation. These concepts refer to 
individuals’ experience of positive changes in response to challenging traumatic events or life 
crises. PTG is an ongoing rather than a static process influenced by life span wisdom (Tedeschi 
& Calhoun, 1996). It is not the traumatic event itself, but rather the experience that motivates 
individuals to “re-build” their lives (Tedeschi & Calhoun, 2004). PTG’s most evident 
manifestations are related to increased life appreciation, increased sense of personal strength, 
changing priorities, more meaningful interpersonal relationships, and a richer spiritual life 
(Tedeschi & Calhoun, 2004). Although perceived benefits and PTG are understudied in heart 
disease, the limited literature, mostly with patients after a heart attack (Affleck, Tennen, Croog, 
& Levine, 1987; Garnefski, Kraaij, Schroevers, & Somsen, 2008; Hassani, Afrasiabifar, 
Khoshknab, & Yaqhmaei, 2009; Petrie, Buick, Weinman, & Booth, 1999; Bluvstein, 
Moravchick, Sheps, Schreiber, & Bloch, 2013; Leung et al., 2010; Sheikh, 2004), reveals that 
individuals experience positive changes after the challenging event. Waight et al. (2015), 
exploring PTG in fifteen post-CABG patients found that individuals experience cognitive growth 
following CABG. Patients’ accounts revealed a greater appreciation of life (i.e. living the 
moment without worrying about the future) and recognition of new possibilities for adopting a 
healthier lifestyle. Research findings (Barskova & Oesterreich, 2009) of studies on people with 
chronic disease including heart disease demonstrate a positive association between HRQoL and 
PTG. The limited research in the field of cardiac patients treated with coronary revascularization 
shows evidence about the relationship between PTG and HRQoL. For instance, Leung et al. 
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(2010, 2012) found that individuals who experience PTG have a greater psychological 
functioning, and females experience a greater PTG compared to men. Also Ai et al.’s (2013) 
findings demonstrated that CABG survivors with an increased spirituality (an aspect of PTG) 
had better HRQoL.  
8.6.2 For practice  
Regarding practice, this study provides novel findings, it also adds weight to the field of 
cardiac health.  
Regarding clinical practice within hospitals, the communication skills of medical staff should 
be enhanced. The findings of the thesis suggest that being in medical care might be very 
frustrating. Participants complain about inappropriate confrontation by staff (doctors and nurses) 
as well as limited interaction which results in feelings of helplessness and loss of dignity. A more 
patient-centered approach would be helpful to overcome such issues. According to research 
(Frankel, 1995; Ha & Longnecker, 2010), the most essential skills to promote hospital staff-
patient communication are active listening, empathy and support. Active listening to individuals’ 
concerns and needs for information to increase control, satisfaction, self-efficacy; Appropriate 
genuine interest and cognitive understanding to enhance trust and commitment to treatment; 
Attending to concerns over shame and humiliation to minimize loss of dignity. 
Regarding practice after discharge, rehabilitation teams should keep in mind that individuals 
try to adjust by re-evaluating the self. This process can be extremely difficult raising a variety of 
negative feelings. As patients give primacy to the psychological self, they develop various 
coping strategies to minimize the impact of the disease. This in turn may result in denying 
patienthood and conscious avoidance of changes in behaviour, especially those they may 
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perceive as a threat to their emotional well-being. Therefore, health professionals should place 
particular emphasis on exploring  individual adjustment processes based on the SRM (Cameron, 
& Leventhal, 2003) and CAT (Taylor, 1983). 
Furthermore, emphasis should be given to interventions based on the SRM (particularly in 
relation to adherence) and to test the extent that they are effective. According to participants, 
illness beliefs may shape their attitudes and behaviours. Thus, interventions based on this model 
are likely to be effective. In fact, a recent study (Duncan et al., 2014) aiming to improve middle 
aged males’ physical activity and healthy eating demonstrated that simple smartphone 
interventions based on SRM (e.g. messages addressing inaccurate beliefs) are effective to 
achieve their goals. 
Also, the findings regarding CHD individuals’ positive growth might be useful to health 
professionals in promoting PTG (Tedeschi & Calhoun, 1996) in order to reduce distress and 
promote well-being in individuals with a cardiac disease.  
Moreover, social support, especially the emotional aspect seems to have a reinforcing power 
on individuals maintaining a change, as suggested by participants’ accounts. Thus specific 
interventions targeting family members should include coaching on emotional support and then 
examine their effectiveness. 
Findings also demonstrate the need to establish a multidisciplinary team in cardiac health 
care settings. The role of a health psychologist, sex therapist and dietician will boost best 
practice and quality of patients care. As many participants stated “psychology is the a and z” (the 
be-all and end-all), health psychologists trained in health communication and qualified in 
behaviour change could help to reduce both pre-operative and post-operative negative feelings. 
This is especially the case for sexual activity which, as stated by participants, is an important 
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aspect of life and is often influenced by the fear that sexual activity may damage the heart and 
provoke recurrent events. According to a literature review by Steinke (2015) of 20 published 
studies between 2000 and 2011 sexual intercourse is poorly associated with myocardial 
infarction (MI) or arrhythmia, and sexual counselling can assist patients to maintain (or regain if 
lost) their quality of sexual life.  
Additionally, health professionals supporting smoking cessation in cardiac patients should 
include cognitive and behavioural techniques that decrease anxiety and stress. Based on the 
findings of the present study, individuals after CR continue or restart smoking to control anxiety 
and maintain a kind of pleasure in their life. Also, interventions for smoking cessation in CR 
populations should include a long-term follow-up as many individuals relapse after the first 3 
months of cessation. As researchers suggest, cigarette smoking should be perceived as a chronic 
relapsing behaviour, and cessation may need a long-term approach (Rennard, & Daughton, 
2014).  
 
8.6.3 For research  
Concerning research, the present study highlights that quality of life cannot be captured 
solely by quantitative measures as each individual may experience the same phenomenon in a 
different way; the qualitative research paradigm should be adopted too. Thus, in the field of 
HRQoL research mixed methods studies should be conducted to maximize insight.    
The CROQ-Gr was rigorously validated and should be used in the field of coronary 
revascularization. However, the development of a shorter version could be very helpful for 
reducing respondent burden and increasing data quality (Bowling, 2005), especially when 
research aims to explore many related issues (e.g. personality, mood) and thus may use many 
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instruments. As has been observed in the present study, participants, although willing to give 
their opinion and participate, did not like to devote a lot of time to it. For instance, when they had 
to complete more than one questionnaire (e.g. for concurrent criterion related validity), a large 
number of individuals left the second instrument incomplete. Even with phone contact, when 
contact exceeded twenty minutes their reluctance and tension was obvious by giving sharp and 
monotonous replies (e.g. “not at all, not at all, not at all”). Furthermore, adapting the CROQ-Gr 
to be relevant to other CR procedures such as MIDCAB or robotic CR would allow investigation 
of the impact of these treatments on patients’ well-being in line with recent medical 
developments. Also, an investigation of alternative modes of administration is needed in order to 
increase the utility of the CROQ. The development and testing of different forms of 
administrations such as online or via a smartphone might be useful. An online form could 
increase participation, especially in post-revascularization follow-ups, of patients with physical 
or time restrictions, as an online form can be completed from any location and at any time as 
long as the patient has access to the internet. The expansion into smartphone administrations 
could help doctors get an instant picture of their patients’ HRQoL in everyday practice, avoiding 
time-consuming calculations, or else help researchers to get instant snapshots of each subdomain 
of HRQoL.  
Moreover, more high quality longitudinal studies including patients form both CR types with 
large samples using disease-specific instruments are needed in order to draw confident 
conclusion about predictors of HRQoL following CR. As suggested by experts (Downs & Black, 
1998; CASP, 2013; Noyez et al., 2011), researchers should design and conduct their study 
meeting a variety of criteria such as address a clearly focused issue; use valid and reliable 
measures; consider confounding factors; make efforts to minimize bias; take into account losses 
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of patients to follow-up; use appropriate statistical tests to assess the main outcomes; and obtain 
a long enough follow up (at least 12 months in CR). 
Furthermore, longitudinal studies should use both disease-specific HRQoL instruments and 
generic instruments. As individuals tend to deny patienthood in the long term and consider QoL 
that is not “health related”, a generic instrument could capture broader aspects of QoL.  
Also, in order for longitudinal studies to allow a clear conclusion about predictors of short 
and long term HRQoL after treatment, more potential moderators should be examined. For 
instance, medical (e.g. angina severity, number of vessels revascularized, type of diabetes), 
behavioural (e.g. adherence to medication, diabetes management, obesity, alcohol use) and 
psychological (e.g. personality, illness representations, mood, stress) factors could be assessed to 
identify their predictive value. 
Moreover, as the present study’s findings show, in the absence of side effects individuals 
focus on other pre-existing problems. Consequently, other stressful events should be investigated 
since they also seem to have an influence on individuals’ understanding and perceptions about 
their quality of life. Future research may include attention to retrospective accounts of how 
people define and experienced a good life before CR as well as after CR as this study focused on 
the latter only. This would provide a greater insight into changes in subjective experience.  
Researchers should pay attention to the individual’s stage of life. Although quantitative 
research evidence about changes in HRQoL following CR suggest no effect of age (Barolia et 
al., 2012; Gjeilo et al., 2012; Merkouris et al., 2009; Li et al., 2012), the qualitative study’s 
findings demonstrate that age may play an important role in individuals’ perception about their 
quality of life. They may experience living a good life not due to the beneficial effect of CR 
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upon their life but due to their view that heart disease or side effects of treatment are life 
problems and are to be expected with older age (Hendry & McVittie, 2004). 
Yet, as the qualitative study findings revealed HRQoL might be tied up with illness 
representation. Future research might usefully include a questionnaire measuring individuals’ 
illness beliefs and their change over a one-year period to detect changes in HRQoL. 
Another related topic that would be useful to be investigated is the relation between SRM 
(Cameron & Leventhal, 2003), PTG (Tedeschi & Calhoun, 1996) and HRQoL in patients after 
coronary revascularization as present thesis findings imply some connection, though not directly 
measured or explored. To date, there is a dearth of literature on this topic. Among the very few 
researchers that investigated such a connection were Leung, and colleagues (2010). Their 
findings suggested that PTG was related to increased psychosocial functioning and lower 
physical functioning. Also PTG was greater for CHD individuals’ holding positive illness 
perceptions and a sense of control over it. Thus further research on this area would be helpful to 
build a better understanding.     
Further qualitative research should be carried out focusing on exploring individuals’ coping 
strategies, challenges in post-CR life (especially in terms of adopting a healthy lifestyle) as well 
as PTG as these aspects are poorly explored in CR. These efforts might be very rewarding as 
they can guide health professionals in designing and implementing tailored interventions that 
would prolong the beneficial effect of CR on individuals’ quality of life.    
Finally, an interesting issue to be investigated would be how well prepared health 
professionals working in smoking cessation are to cope with smokers with heart disease that 
deny patienthood, or those who believe that continuing to smoke is better than being stressed.  
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8.7 Final conclusion  
The current thesis aimed to explore Greek CHD patients’ perspectives of their HRQoL 
following CR (Coronary Artery Bypass Grafting (CABG) or Percutaneous Coronary 
Interventions (PCI)), as well as detect and explain individual disparities. In order to achieve these 
aims a series of studies were conducted. The main study of the thesis was a longitudinal mixed 
methods study, following a sequential explanatory design. The synthesis of findings highlighted 
the benefits of using a mixed methods longitudinal design in exploring HRQoL. Both 
quantitative and qualitative findings support the notion that HRQoL is a multidimensional, 
continuingly changeable concept providing support for the World Health Organization’s 
definition. Also, they support the assumption that CR has a positive influence on individuals’ 
HRQoL. The effect of CR type needs further investigation as mixed findings were revealed in 
the present thesis. The pure effect of CR on individuals’ HRQoL seems difficult to investigate 
without taking into consideration individuals’ adjustment processes and positive growth 
triggered by the CR.  
The Self Regulation Model (SRM) might be considered a useful theoretical framework for 
developing theory-based interventions aiming to alter patients’ false beliefs since individuals’ 
making-meaning process seems to be aligned with it. Finally, the complementary insights 
concerning smoking (a factor associated with poorer mean change in HRQoL level over a one 
year period) may help health care providers to develop smoking cessation interventions tailored 
to cardiac patients.   
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Appendices  
1.1 Personality type and CHD  
In terms of personality, a lot of discussion has taken place for types A and D as potential 
risk factors for coronary heart disease. Type A personality (TAP) is characterized by an 
excessive drive, time urgency, and hostility. Empirical data have provided mixed evidence for 
the association between type A and CHD. For instance, Schwalbe (1990) reviewing five studies 
concluded that there is a relationship between TAP and the development of CHD, although two 
out of the five studies did not demonstrate any such evidence. Kawachi et al., (1998) found that 
TAP can predict CHD incidence if the Minnesota Multiphasic Personality Inventory-2 (MMPI-
2) is used. On the other hand, a systematic review (Myrtek, 2001) of 25 studies has suggested 
that type A personality cannot significantly predict CHD development. This shift in research 
evidence about the relation between TAP and CHD could be partly explained by early 
researchers’ desire to demonstrate evidence in favour of their theory and employing less 
stringent methods. In addition there are explanations suggesting that the cardiologists Friedman 
and Rosenman developed the Type A Behaviour Pattern (TABP) back in the 50’s in order to 
minimize research findings about the relation between tobacco use and the development of 
CHD (Petticrew, Lee, & McKee, 2012); in other words suggesting an attempt to direct attention 
to a cause of CHD other than smoking. This claim (Petticrew et al., 2012) is supported by 
evidence that all related research and supportive findings of the relationship between TAP and 
CHD were produced by studies (e.g. The Western Collaborative Group Study, 1974) conducted 
by the two fathers of the theory or fellows funded by the “Philip Morris” tobacco industry. 
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1.2 CHD treatment  
1.2.1 Medical therapy (MED) 
One approach of treatment for CHD is the pharmacological therapy (the term “medical” 
refers to medication and it is adopted in order to be consisted with literature on CHD).  Medical 
therapy for angina pectoris includes five categories of drugs: beta-blockers, calcium blockers, 
nitrates, aspirin and other antiplatelet drugs, and antilipid drugs. Most of these drugs act by 
dilating the coronary arteries and as a result improve the supply of blood and oxygen to the heart 
muscle, which in turn reduces the blood pressure and heart workload. Sublingual 
glyceryltrinitrate (GTN) is the standard treatment for immediate symptom control. GTN is used 
during an angina attack or prior to a task which might induce an attack. It is taken under the 
tongue as a tablet, where it is quickly absorbed to provide fast symptom relief. Medical therapy 
(MED) for angina can be used successfully to treat some patients for many years. In fact, many 
studies maintain that for stable angina in a low risk cardiac population modern medical therapy 
could be equally effective as coronary revascularisation (Deedwania, Carbajal, & Bobba, 2007; 
Prasad, Rihal, & Holmes, 2008).  
Furthermore, there is some evidence, even though not consistent throughout the literature, 
that even after coronary revascularization, medication may be necessary for reducing the 
atherosclerotic process and prevent death (Filion, Pilote, Rahme, & Eisenberg, 2007; Jaber, et al., 
2005) or myocardial infarction (Jaber, et al., 2005). 
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1.2.2 Coronary Revascularization 
1.2.2.1 PTCA/PCI 
Percutaneous transluminal coronary angioplasty (PTCA) was introduced in 1977 by Dr 
Gruntzig and his colleagues as an invasive (nonsurgical) method of coronary revascularization 
(Holmes & Williams, 2008). It is used in order to open the blocked artery. It involves cardiac 
catheterization (the insertion of a fine tube into a vein in the groin or sometimes in the arm, then 
through the coronary artery and across the blocked section). A balloon placed at the end of the 
catheter is inflated to widen the vessel disrupting the material blocking it (usually asa result of 
atherosclerosis). Then, the balloon is deflated and removed, resulting in an enlarged artery 
through which blood can flow to the heart muscle. PTCA is carried out under local anaesthesia 
and patients are mobile the following day. Usually this process requires a brief hospital stay not 
exceeding 36 hours. The main short-term adverse effects from catheterization are symptoms such 
as pain, tenderness and bruising at the wound area. Long-term negative outcomes consist mostly 
of restenosis (artery re-blockage due to atherosclerosis) causing approximately 30% of patients 
having to undergo the procedure again (Bittl, 1996). 
Within less than a decade (Holmes & Williams, 2008) a new method was developed in 
response to this problem: implanting intracoronary stents (bare metal stent, BMS) during PTCA. 
Stents are tiny metal tubes that are delivered by a catheter at the narrowed area in order to keep 
the artery open, thus preventing the collapse of the vessel and reducing the likelihood of 
restenosis or regrowth of atherosclerosis. In fact, results from clinical trials showed that coronary 
stenting significantly reduces restenosis (e.g. from 35% of incidences of restenosis after PTCA 
balloon treatment to 19% after angioplasty with stent (Mercado, et al., 2001)) and improves 
431 
 
clinical outcomes by minimizing the major adverse cardiac events and repeated revascularization 
(Agostoni et al., 2006).  
Although coronary restenosis after the insertion of a stent is reduced dramatically, the 
problem still exists (Butany, Carmichael, Leong, & Collins, 2005). The primary cause for the 
stenosis of a stented artery could be attributed to the neointima (Hoffmann et al., 2001). The 
neointima refers to a new thin tissue that can be formed on the stent. Stent design, surface 
material, and vessel damage related to the procedure have been implicated as predictors of 
neointima proliferation (Hoffmann, et al., 2001; Kastrati et al., 2000). To overcome this problem, 
intracoronary brachytherapy was developed (Sheppard, Eisenberg, Donath, & Meerkin, 2003).  
Manufacturers have tried to create Drug-Eluting Stents (DES) to cope with neointima. 
Nowadays, many drug-eluting stents are either in use ordeveloped. Current research findings 
indicate that drug eluting stents decrease the rate of restenosis from 31.7% to 10.5% with bare 
metal stents (Roiron, Sanchez, Bouzamondo, Lechat, & Montalescot, 2006). DES seem to be 
extremely beneficial at least in the short term. Research evidence highlights that without being 
more harmful than BMS (James et al., 2009; Morice et al., 2002), DES can be very useful in 
addressing neointima, especially for patients with a higher likelihood for restenosis (e.g. patients 
with diabetes (Kumbhani, Bavry, Kamdar, Helton, & Bhatt, 2008)) or with relatively small 
vessels (Douglas & King, 2007) and those of older age (Douglas et al., 2009). Dibra et al. (2007) 
suggest that DES is a more effective type of treatment for those patients with incidents of bare-
metal in-stent stenosis.  
All these changes and improvements have had an influence on the naming of treatment 
procedures as well. Rather than PTCA, the non-surgical procedures (no matter whether it is a 
balloon angioplasty or stent implantation, bare metal stent or drug eluting stent) are now referred 
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to by the broader term Percutaneous Coronary Intervention (PCI). Therefore, this latter term has 
been adopted in the current thesis and will be used from now on to refer to all types of non-
surgical revascularisation procedures. 
In summary, many novel methods have been introduced in the domain of non-surgical 
coronary artery treatment. Each one has its own advantages and disadvantages. However, all 
procedures have some possible consequences such as myocardial infarction. 
 
1.2.2.2 CABG 
The first Coronary Artery Bypass Grafting (CABG) was performed by Goetz, Rohman and 
their colleagues in 1960 (Mueller, Rosengart, & Isom, 1997). For many years, CABG was the 
established surgical method for the treatment of CHD (reducing angina and mortality rates). 
However, after the introduction of PCI, CABG was performed only for severe CHD. The 
mainstream CABG involves an opening in the chest bone (sternoctomy), which gives the cardiac 
surgeon adequate access to the heart. During this process, it was (and sometimes still is) 
necessary to stop the heart beating and the flow of blood through the heart and lungs. A 
heart/lung bypass machine artificially takes over the heart’s job of pumping and the lungs’ job of 
breathing; this procedure is known as on pump CABG or as cardiopulmonary bypass surgery 
(CPB). Arteries or veins (usually from the patient’s leg or arm) are used as a graft which is 
attached to the aorta, the main blood vessel of the heart, and to the coronary artery to bypass the 
blockage.   
Due to the nature of the CABG procedure, full recovery can take a long time. The majority of 
patients are discharged about five days after the operation (Peterson, et al., 2002). Patients are 
usually advised to stay at home for one month after surgery, a recovery period allowing their 
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wounds to heal. Around 3 months after CABG, most patients are expected to minimally have 
returned to their pre-surgery level of functioning. However, patients have reported recovery 
problems after the specific surgical procedure that may be present for a long time after discharge. 
For instance, many patients report pain, haematoma and infection in their leg from where the 
veins were removed to be used as grafts, although this has been reduced with the use of a new 
less invasive method for vein harvesting (Athanasiou, et al., 2003; Khan, et al., 2010; Markar, 
Kutty, Edmonds, Sadat, & Nair, 2010). Moreover, a great number of patients, especially those 
with diabetes or who are obese, show deep chest wound infections (Olsen, et al., 2002). Deep 
sternal infection can result in a longer hospital stay or increased mortality rates (Fowler et al., 
2005; Steingrimsson, Gottfredsson, Kristinsson, & Gudbjartsson, 2008; Toumpoulis, 
Anagnostopoulos, Derose, & Swistel, 2005) as well as psychological distress (Taillefer, et al., 
2006). This last outcome could be explained, firstly, by the fact that people with post-surgery 
chest pain experience greater levels of anxiety and depression (Taillefer, et al., 2006). Secondly, 
this relates to the fact that some infections, such as media stenitis, can cause chest pain, shortness 
of breath and dysphoria (Park, & Vallires, 2005), symptoms identical to angina that had patients 
undergo CABG in the first place. Patients may misinterpret the sternal discomfort due to 
inflammation as the pre-CABG angina pain and become distressed, fearing a failed operation.  
In short, research demonstrates several adverse postoperative outcomes following CABG. 
These include: mortality, myocardial infarction (Kendel, 2009), chest wall pain (Lahtinen, 
Kokki, & Hynynen, 2006) fluid retention and peripheral oedema, leg wound pain and 
inflammation, heart block, pulmonary oedemas and acute lung injury, deep vein thrombosis, 
pulmonary embolism (Kendel, 2009), sternal wound infections (Salehi-Omran et al., 2007), atrial 
fibrillation (Halonen, et al., 2007; Mathew, et al., 2004; Prasongsukarn, et al., 2005), and more 
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rarely neuro-ophthalmological complications (Shaw, et al., 1987; Thurtell, Besser, & Halmagyi, 
2008), and gastrointestinal complications (GIC) (Andersson, Nilsson, Brandt, Hoglund, & 
Andersson, 2005; Yoshida et al., 2005; Zhang, et al., 2009). 
Another negative outcome after CABG mentioned by many experts concerns neurocognitive 
impairment; yet, this remains controversial. Cognitive impairment after CABG has been 
mentioned as a common adverse event (Funder, Steinmetz, & Rasmussen, 2009; Liu et al., 2009; 
Newman et al., 2001), especially longitudinally (at 5 years (Stygall et al., 2003)). A systematic 
review conducted by van Dijk and his colleagues (2000) showed that 22.5% of patients who 
underwent cardiopulmonary bypass experienced cognitive declines. According to the particular 
review, cognitive impairment includes short-term subtle cognitive deficits, such as problems with 
short-term memory, concentration, attention, new learning, thinking clearly, processing 
information, and making decisions as well as major neurological complications, like stroke. 
However, there are a number of studies showing that there is some cognitive decline but it does 
not differ significantly between patients who underwent surgical revascularization and  non-
surgical patients, both at 3 year (Selnes, et al., 2007) and 6 year follow-up (Selnes, et al., 2008). 
An explanation for these conflicting results might be the difference in methodology adopted in 
each study (e.g. lack of control group or preoperative measurement such as dementia) and the 
age of the sample. For instance, in studies that have recruited an older age group and followed up 
for several years cognitive decline might be present due to the normal aging process and 
progression of cerebrovascular disease and not due to CABG (Selnes, 2008).  
In response to such negative clinical outcomes produced by on pump CABG, a new process 
has been developed where CABG is performed directly on the beating heart without the use of a 
cardiopulmonary bypass, via a median sternotomy. Nowadays, this procedure is known as off 
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pump CABG or OPCAB and it is globally used in approximately 1/3 of patients (Stavridis, 
2006). However, the literature is inconsistent concerning the superiority of the off-pump vs on-
pump cardiac surgery. A number of meta-analyses and reviews suggest that this new procedure 
in cardiac surgery has reduced the number of hospital days and incidence of atrial fibrillation 
(Bainbridge, Martin, & Cheng, 2005; Moller, Penninga, Wetterslev, Steinbruchel, & Gluud, 
2008; Sedrakyan, Wu, Parashar, Bass, & Treasure, 2006) but has not lessened the postoperative 
rates of stroke or myocardial infarction or mortality compared with on-pump CABG (Angelini et 
al., 2009; Bainbridge, et al., 2005; Chu et al., 2009; Feng, Shi, Zhao, & Xu, 2009).  Others 
maintain that the main benefit of off-pump CABG is a reduced incidence of stroke in high risk 
patients (Abu-Omar, & Taggart, 2009). Some meta-analyses and recent studies maintain that 
retrospective analyses support the notion that off pump CABG improves mortality and lessens 
the incidence of adverse events (Halkos & Puskas, 2009; Serrano et al., 2010; X. Sun et al., 
2009). Yet other researchers conclude that there is no difference between the two procedures 
concerning health outcomes or mortality in either low or high risk patients (Angelini, et al., 
2009) in annual follow-ups (Shroyer, et al., 2009). However, there is one issue on which the 
majority of recent studies seem to agree. Patients treated either with on or off pump CABG do 
not differ significantly in long-term neurocognitive impairment (e.g. one to 5 years after surgery 
(Marasco, Sharwood, & Abramson, 2008; Shroyer, et al., 2009; Stroobant, van Nooten, De 
Bacquer, Van Belleghem, & Vingerhoets, 2008)). 
Advances in cardiac surgery have resulted in the development of a novel surgical method for 
performing CABG using smaller incisions which do not require the use of cardiopulmonary 
bypass or median sternotomy, known as minimally invasive coronary artery bypass grafting 
(MIDCAB). In such procedures, the surgeon operates directly on the beating heart through a 
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small (6-8 cm) incision in the chest (Benetti, et al., 2010; McGinn, et al., 2009) although the 
incision might be slightly larger for certain patients (e.g. in obese patients). Research evidence 
suggests that this new surgical technique is effective in increasing survival rates and in 
minimising major adverse cardiac and cerebral events both in the short-term and long-term 
(Holzhey, et al., 2007). It involves significantly fewer wound infections but there is no major 
difference in postoperative hospital stay (Markar, et al., 2010).  
Advances are ongoing and yet another  new procedure has been introduced known as totally 
endoscopic robotic cardiac surgery (TECAB). Although research is quite limited on this, there is 
evidence that patients treated with this process with either off-pump or on-pump approaches 
show a significant reduction in major adverse cardiac events (MACE) 6 months after surgery. 
Findings suggest that the incidence of major adverse cardiac events is quite low, up to 5%  (de 
Canniere, et al., 2007), and restenosis is present in a few patients only at three-month follow-up 
(Folliguet, et al., 2010). 
In summary, a lot of advances have been made in the domain of surgical treatment of 
coronary artery disease. Each of these has advantages and disadvantages. New techniques, such 
as TECAB, seem promising for greater effectiveness with less adverse effects but further 
research needs to be carried out in order to be able to draw clear conclusions.   
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2.1 Instruments widely used to measure HRQoL in the Coronary Revascularization field 
There are a plethora of self-administered measurements that are widely used in the field of 
HRQoL research (Bowling, 2005). In the following paragraphs, generic and specific HRQoL 
measures related to CR will be introduced in order to present the most frequently used measures 
as well as their approach to the concept, by highlighting their constitutive domains.  
Generic measures   
SF-36 & RAND-36 
The SF-36v2TM  Health Survey is the most widely used questionnaire for measuring QoL. 
The SF-36 is a valid and reliable scale (Ware, 2000; Ware, Keller, Gandek, Brazier, & Sullivan, 
1995; Ware & Sherbourne, 1992) translated successfully into many languages (e.g. Chinese (Li, 
Wang, & Shen, 2003); French (Leplege, Ecosse, Verdier, & Perneger, 1998) ; Italian (Apolone, 
& Mosconi, 1998); Japanese (Fukuhara, Bito, Green, Hsiao, & Kurokawa, 1998); Dutch 
(Aaronson, et al., 1998); Greek (Anagnostopoulos, Niakas, & Pappa, 2005;  Pappa, 
Kontodimopoulos, & Niakas, 2005)). It consists of 36 items in eight subscales: physical 
functioning (PF-10 items), role limitations due to physical health problems (RP-4 items), bodily 
pain (BP-2 items), general health perceptions (GH-5 items), vitality (VT-4 items) tapping energy 
levels and fatigue, social functioning (SF-2 items), role limitations due to emotional problems 
(RE-3 items) and mental health (MH-5 items). It also includes one item measuring health 
transition (Ware, 2008). These subscales are measured on a 3-6 point Likert scale and then 
transformed to a 0-100 score. Higher scores indicate better status (e.g. in body pain items, the 
higher the score, the lower the pain). Moreover, it can be combined into two component 
summary scales; the physical component summary (PCS) that includes PF, GH, RP, BP 
subscales and the mental component summary (MCS) that includes VT, SF, RE, MH subscales. 
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In many research papers these two summaries are provided, in relation to norms established in a 
US population (Ware, 2008). Moreover, there are two shorter versions, the SF-20 and SF-12. 
The RAND-36 is an exact replication of the content of the SF-36 (Ware & Sherbourne, 
1992). Both were adapted from longer instruments completed by patients participating in the 
Medical Outcomes Study (MOS) (Hays, Sherbourne, & Mazel, 1993). However, the RAND uses 
a different scoring algorithm compared to the SF-36. The scores for PCS and MCS for the SF-36 
(or its shorter versions) are based on principal component analysis and orthorgonal rotation 
assuming that the two summary scores are uncorrelated. For the RAND-36 (and its shorter 
versions), however, these two summary scores are based on non-orthogonal rotation implying 
correlation between physical and mental health components (Hays, Prince-Embury, & Chen, 
1998). Research evidence suggests that this difference may affect the outcome. For instance, 
Lee, Browne and Villanueva (2008), in their study with 5,641 individuals, demonstrated that the 
results (PCS and MCS scores) measured by the SF-12 suggest that participants experienced 
lower dysfunction in both aspects compared to RAND-12 scores that revealed moderate to 
severe dysfunction.  
 
WHOQOL and WHOQOL-BREF 
The World Health Organization Quality of Life (WHOQOL) is a quality of life assessment 
developed by the WHOQOL Group based on the World Health Organization (WHOQOL group, 
1993) definition of QoL.  The WHOQOL has two versions: 1) one version consists of 100 items 
(WHOQOL-100; WHOQOL group, 1994) which produces scores relating to specific features of 
QoL (e.g. positive feelings, social support, financial resources), scores relating to broader 
domains (e.g. physical, psychological, social relationships) and a score relating to the overall 
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QoL and general health; 2) another shorter version consists of 26 items (WHOQOL group, 1998) 
that produces scores related only to broader domains. Both of them have been translated into 
more than 20 languages (e.g. Lithuanian, Chinese, Italian, Russian, Polish, Czech, Greek) and 
research evidence demonstrates that both are valid and reliable. Both WHOQOL versions are 
used in clinical practice, clinical trials, health research evaluation and policy making.  
The WHOQOL-BREF is more often used as an alternative to the WHOQOL-100 in 
evaluating improvement in quality of life following major therapeutic interventions for physical, 
psychological, and environmental domains. As stated earlier, it consists of 26 questions 
containing two global items on overall self-rated QOL and general health, and 24 items that are 
categorized into four domains, each aiming to assess respectively, physical capacity (7 items), 
psychological wellbeing (6-items), social relationships (3-items) and the environment (8 items). 
The four domains are scored on a 5-point Likert scale. Domains are scored in a positive 
direction. To calculate the final score per domain a two-step transformation of raw data is 
employed. The first one converts scores to a range between 4-20 and the second one converts 
domain scores to a 0-100 scale. 
 
EQ-5D  
The EQ-5D (EuroQol Group, 1990) is a valid and reliable five item scale evaluating 
mobility, self-care, usual activity, pain/discomfort, and anxiety/depression. The EQ-5D has been 
translated into many languages (e.g. Greek (Kontodimopoulos et al., 2008); Taiwanese (Chang et 
al., 2007); Portuguese (Ferreira, Ferreira, Pereira, & Oppe, 2014); Arabic (Aburuz, Bulatova, 
Twalbeh, & Gazawi, 2009)). Each item has three levels (no problems, some problems, extreme 
problems). A health score index is then calculated between 0 and 1, where 0 indicates death and 
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1 represents perfect health. In many cases, item scores are converted to a summary score in order 
to compare with the US norms. 
 
NHP  
The Nottingham Health Profile (Hunt, McEwen, & McKenna, 1985; S. M. Hunt, et al., 1981) 
is another valid and reliable instrument (Wiklund, 1990) translated into many languages other 
than English (e.g. Spanish, (Alonso, Anto, & Moreno, 1990); French, (Bucquet, Condon, & 
Ritchie, 1990); Greek, (Vidalis & Syngelakis, 2000); Japanese, (Nishimura et al., 2004); Danish, 
(Thorsen, McKenna, & Gottschalck, 1993)). 
It includes 45-items measuring subjective health status and consists of two parts. Part 1 
consists of 38 items over six domains: physical ability (PA-8 items), pain (P-8 items), sleep (S-5 
items), energy level (EL-3 items), social isolation (SI-5 items) and emotional reactions (ER-9 
items). Part 2 consists of 7 items capturing seven aspects of daily life (paid employment, jobs 
around the house, social life, personal relationships, sex life, hobbies and interests, and holidays). 
However, in the majority of QoL studies only the first part is administered. Scores range between 
0 (best possible health) to 100 (worst possible health). 
 
 
Disease-specific measures 
MacNew 
The MacNew Heart Disease Health-Related Quality of Life instrument assesses HRQoL in 
patients with coronary [ischaemic] heart disease (Hofer, et al., 2004; Lim, Valenti, & Knapp, 
1993). The MacNew is valid and reliable in many languages (e.g. Chinese (Yu, Thompson, Yu, 
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& Oldridge, 2008); Dutch (De Gucht, Van Elderen, van der Kamp, & Oldridge, 2004); UK 
English (Dempster, Donnelly, & O'Loughlin, 2004); Farsi/Iran (Asadi-Lari, Javadi, Melville, 
Oldridge, & Gray, 2003); German (Hofer, et al., 2004); Turkish (Daskapan et al., 2008) and 
Russian (Geulayov et al., 2013). The MacNew has been translated into Greek as well but its 
psychometric properties have not been fully tested (Merkouris, et al., 2009).  
The MacNew is a 27-item instrument focusing on three domains: emotional function (11 
items), social function (10 items) and physical limitation (6 items).  These domains are measured 
on a 7-point Likert scale where 1 indicates poor functioning and 7 high functioning.  
 
SAQ 
The Seattle Angina Questionnaire (SAQ (Spertus, et al., 1995)) is an instrument developed to 
measure the HRQoL of patients with CHD. The SAQ is a 19-item questionnaire consisting of 5 
domains: physical limitations (9 items), angina stability (1 item), angina frequency (2 items), 
treatment satisfaction (4 items) and quality of life (3 items). Domains are scored on a 5 or 6-point 
Likert scale, where 1 indicates poor functioning and 5 or 6 high functioning and then 
transformed to a 0 - 100 scale score. The SAQ has been translated into and validated in many 
languages (e.g. Japanese (Seki, et al., 2010); UK English (Garratt, Hutchinson, & Russell, 2001); 
Norwegian (Pettersen, Reikvam, & Stavem, 2005). However, while there is a plethora of SAQ 
translations, its psychometric properties have not been examined in line with scientific guidelines 
and criteria. As Zhang et al. (2013) have highlighted, researchers should not use simple 
translations without cultural adaptation because results may be misleading. For instance, the 
SAQ Chinese version has been used since 1996, but the validity and reliability of the translated 
version have never been appraised in published research. A recent mixed methods study (Zhang, 
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et al., 2013) on 1,787 patients demonstrated that the existing version is unsuitable to Chinese 
patients. For instance, the results of the quantitative part of the study demonstrated that internal 
consistency for the QoL domain was lower than the acceptable criterion (Cronbach’s α ≥0.70), 
the exploratory factor analysis indicated a four- instead of a five-factor model, while 
occasionally items in one subscale were strongly correlated to items in another subscale (e.g. 
“difficulty of taking pills” was highly related to the QoL subdomain). Furthermore, the findings 
of the qualitative part of the study showed that many participants did not fully understand many 
questions resulting in less accurate responses and/or a lot of missing data. Similarly, there is a 
Greek version that is widely used but there is no published paper demonstrating its validity and 
reliability in Greek patients.  
Coronary revascularization specific measure  
CROQ 
The coronary revascularisation outcome questionnaire (CROQ (Schroter & Lamping, 2004)) 
was developed to evaluate HRQoL and health outcomes before and after the two common 
revascularisation procedures, that is PCI and CABG, capturing also aspects of recovery. 
Research evidence demonstrates that the original English version (Schroter, 2001; Schroter & 
Lamping, 2004, 2006) as well as its adaptations (e.g. the Italian (Colangelo, Dilaghi, Bobbio, 
Gensini, & Pinna Pintor, 2006; Pintor, 2002); the Persian (Shahali, 2008); and the Japanese 
version (Seki, et al., 2010)) have rigorous psychometric properties.  
The CROQ consists of four versions; one pre-PTCA, one post-PTCA, one pre-CABG and one 
post-CABG. The two pre-operation versions (pre-PTCA and pre-CABG) are identical for the 
two procedures and capture four domains containing 32 core evaluative items and one 
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descriptive item, although the latter is not taken into account for the calculation of scale scores. 
More specifically, the four domains refer to: symptoms (7 items), physical functioning (8 items), 
psychosocial functioning (14 items), and cognitive functioning (3 items). The two post-operation 
versions contain the same 33 items as the pre-PTCA/CABG versions as well as two more 
domains calculated from 12 (post-PTCA version) or 17 (post-CABG version) core evaluative 
items. In addition, they include two items that are not taken into account when calculating scale 
scores; for example, “Since your heart operation, have you been readmitted to hospital for an 
overnight stay for any reason to do with your heart condition or heart operation?”. The two 
additional domains are adverse effects (6 items for the post-PTCA version and 11 for the post-
CABG version) and satisfaction with outcome (6 items for both versions). The CROQ subscales 
are measured on 3 to 6-point Likert scales and then transformed to 0-100 score. Furthermore, at 
the end of all versions there is an open-ended question: “Is there anything else you would like to 
tell us about your heart condition or heart operation that is not covered in this questionnaire? If 
so please write bellow”. 
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3.1 List of studies excluded from the systematic review with meta-analysis 
Table 3.1 List of studies excluded from the systematic review with meta-analysis  
N Citation   Reason for Exclusion  
1 Baldassarre,2002 Data Only  for MCS & PCS 
2 Barry, 2006 Insufficient data 
3 Brotons ,2001 Old data(1996-1997) &MSC+PCS 
4 Covinsky, 2008  Old data (1993-1998) 
5 El Baz, 2009 Data Only MCS & PCS   
6 Grady,2011 Data Only  for MCS & PCS 
7 Haddock,2003 Data Only  for MCS & PCS  
8 Halpin, 2008 Insufficient data 
9 Herlitz, 2005 ;2001;2003;2000 Old data(1988-1991) 
10 Ho, 2005 Old data(1992-1996) 
11 Karlsson, 2000 Old data(1990-1994) 
12 Kattainen,2005;2006 QoL instrument used-15D 
13 Kendel, 2011  Not all subdomains reported 
14 Khoueiry,2011 Not all subdomains reported 
15 Krzych,2009 Not all subdomains reported 
16 Loponen, 2007;2008 QoL instrument used-15D 
17 Loponen,2009 QoL instrument used-15D 
18 Martin, 2008 Not pure CR- Insufficient data for CABG 
19 Melo, 2000 Old data-Portuguese 
20 Panagopoulou, 2006 Not all subdomains reported 
21 Pedersen, 2011 Insufficient data-post 
22 Permanyer, 2001   Insufficient data  
23 Phillips Bute, 2003  Old data (1992-2002)+ins data 
24 Phillips Bute, 2006 Insufficient data 
25 Simchen, 2001  Old data(1994) 
26 Spertus,2004 Not all subdomains reported 
27 Thornton, 2005 Not all subdomains reported 
28 van Domburg, 2010 Insufficient data  
29 Spertus,2004 Not all subdomains reported 
30 Tully,2008 Insufficient data –only median 
31 Favaro,2007 Insufficient data-graphs with means 
32 Rumsfeld, 2003 Old data(1992-1996) 
33 Parry,2012 Not all subdomains reported 
34 Zwoliński,2013 Old data(1990-1999/1993) 
35 Nedeljković,2011 Not all subdomains reported 
36 Ghanta ,2011 Old data (1994-1999) 
37 Sen , 2012 Insufficient data 
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3.2 Quality scoring for the studies 
Table 1  Studies’ quality scoring 
Study 
Criteria      
Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 
Total/10 
Is
 th
e 
hy
po
th
es
is/
ai
m
/ 
ob
je
ct
iv
e 
of
 th
e 
stu
dy
 
? 
A
re
 p
at
ie
nt
s c
ha
ra
ct
er
ist
ic
s  
cl
ea
rly
 d
es
cr
ib
ed
 ?
 
W
er
e 
th
e 
m
ai
n 
ou
tc
om
e 
m
ea
su
re
s u
se
d 
ac
cu
ra
te
 
(v
al
id
 a
nd
 re
lia
bl
e)
? 
Fo
r v
al
id
 b
ut
 n
ot
 d
ise
as
e 
sp
ec
ifi
c 
=0
.5
 
A
re
 th
e 
di
str
ib
ut
io
ns
 o
f p
rin
ci
pa
l c
on
fo
un
de
rs
 in
 
ea
ch
 g
ro
up
 o
f s
ub
je
ct
s t
o 
be
 c
om
pa
re
d 
cl
ea
rly
 
de
sc
rib
ed
? 
H
av
e 
th
e 
ch
ar
ac
te
ris
tic
s o
f p
at
ie
nt
s l
os
t t
o 
fo
llo
w
-
up
 b
ee
n 
de
sc
rib
ed
? 
W
er
e 
lo
ss
es
 o
f p
at
ie
nt
s t
o 
fo
llo
w
-u
p 
ta
ke
n 
in
to
 
ac
co
un
t?
 
Is
 th
e 
pr
oc
ed
ur
e 
de
sc
rib
ed
 ?
 
W
er
e 
th
e 
sta
tis
tic
al
 te
sts
 u
se
d 
to
 a
ss
es
s t
he
 m
ai
n 
ou
tc
om
es
 a
pp
ro
pr
ia
te
? 
A
re
 th
e 
m
ai
n 
fin
di
ng
s o
f t
he
 st
ud
y 
cl
ea
rly
 
de
sc
rib
ed
? 
Lo
ss
 d
at
a 
gr
ea
te
r t
o 
lo
w
er
 to
 2
0%
 
? 
Azzopardi (2009)               1.00 1 0.5 0 0 0 1 0.5 1 1 6 
Barolia (2012) 1.00 0.5 0.5 0 0 0 0.5 1 1 1 5.5 
Benzer (2003)                 1.00 0 1 0 1 0 1 1 1 0 6 
Cohen (2011)                  0.50 1 0.5 1 0 0.5 1 1 1 0 6.5 
Colak (2008)                   1.00 1 0.5 0 1 0 0 1 1 0 5.5 
Damgaard (2011)                1.00 1 0.5 0 1 0 1 1 1 0 6.5 
de Quadros (2011)             0.50 1 0.5 0 0 0 0.5 0.5 0.5   3.5 
Denvir (2006)                 1.00 1 0.5 0 1 0 1 1 1   6.5 
Gjeilo (2008)                  1.00 0 0.5 0 1 0 0.5 0.5 1 1 5.5 
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Hofer (2006;2005)             1.00 0.5 1 0 1 0 0.5 1 1 0 6 
Houlind (2012) 1.00 1 0.5 0 1 0 0.5 0.5 1 0 5.5 
Hunt (2000)                    1.00 1 0.5 0 0 0 0.5 0.5 1 1 5.5 
Jensen (2006)                1.00 1 0.5 1 0.5 0 1 0.5 1 0 6.5 
Kiebzak (2002)                 1.00 0 0.5 0 0 0 1 1 1 0 4.5 
Krannich (2007) 1.00 1 0.5 0 0 0 0.5 0.5 0.5 0 4 
Krecki (2010)                  1.00 1 0.5 0 0.5 0 0.5 0.5 1 0 5 
Li (2010)                      1.00 1 0.5 0.5 1 0 0.5 1 1 1 7.5 
Lie (2009)                      1.00 1 0.5 0 1 0 1 0.5 1 1 7 
Lukkarinen (2006)             1.00 0 0.5 0 1 0 0.5 1 1 0 5 
Martin (2012) 1.00 1 0.5 0 1 0 0 0.5 1 0 5 
Mathisen (2005)                1.00 1 0.5 0.5 0 0 0.5 0.5 1 0 5 
Melberg (2010)                1.00 1 0.5 0 0 0 1 1 1   5.5 
Merkouris (2009)               1.00 1 1 0 0 0 0.5 0.5 1 0 5 
Peric (2010; 2006)             1.00 1 0.5 0 0 0 0.5 0.5 0.5 0 4 
Pfaffenberger (2010)           1.00 1 0.5 0 0.5 0 0.5 0.5 1 1 6 
Pirraglia (2003)                1.00 1 0.5 0.5 0 0 0.5 0.5 0.5 0 4.5 
Puskas (2004)               1.00 1 0.5 0 0 0 0.5 1 1 0 5 
Rothenhäusler (2010)           1.00 1 0.5 0.5 1 0 1 1 1 0 7 
Škodová (2011)                1.00 1 0.5 1 1 0 1 1 1 0 7.5 
Viswanathan (2011)            1.00 1 0.5 0 0 0 1 0.5 1   5 
Weilu (2011)                  1.00 1 0.5 0 0 0 1 0.5 1 1 6 
Weintraub (2008)              1.00 0 0.5 0 0 0 1 1 1 0 4.5 
Wong (2007)                   1.00 1 0.5 0 0 0 1 0.5 1 0 5 
Zang (2003)                     0.50 0.5 0.5 1 0.5 0 0.5 0.5 1 1 6 
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4.1 Differences in demographic and medical characteristics between individuals who 
participated in all measurement points and those who did not 
Table 4.1 Differences in demographic and medical characteristics between individuals who 
participated in all measurement points and those who did not 
 N(%)/Mean(SD) 
(n=472) 
N(%)/Mean(SD) 
3 points (n=291) 
N(%)/Mean(SD) 
1 or 2 points (n=181) p Value 
Age (yr) 60.43(10.89) 59.90(10.81) 61.72(11.01) 0.097 
Sex (female %) 113(23.9%) 80(26%) 26(18.8%) 0.059 
Place of residence 
(%) 
Athens 
Other big city 
Rural areas 
 
365(77.3%) 
31(6.6%) 
76(16.1%) 
 
256(76.6%) 
27(8.1%) 
51(15.3%) 
 
109(79.9%) 
4(2.9%) 
25(18.1%) 
0.202 
Marital status(%) 
Married  
Unmarried/living 
alone 
 
385(81.6) 
87(18.4) 
 
287(85.9) 
47(14.1) 
 
98(71%) 
40(29%) 
<0.001 
Educational 
status(%) 
6  years or less  
7-12 years (high 
school)  
12+ years  
 
122(26%) 
226(48.31%) 
122(26%) 
 
85(25.5%) 
166(49.8%) 
82(24.6%) 
 
37(27%) 
60(43.8%) 
40(29.2%) 
0.673 
Occupational status  
Unemployed 
Public/Private servant 
Freelance 
Pensioner  
 
69(14.6) 
123(26.1) 
97(20.6) 
183(38.8) 
 
56(16.8) 
86(25.7) 
76(22.8) 
116(34.7) 
 
13(9.4) 
37(26.8) 
21(15.2) 
67(48.6) 
0.014 
Risk factors (%) 
CHD family history  
Hypertension  
Cholesterol  
Diabetes 
Smoking 
BMI (kg/m2)** 
 
235(49.9%) 
175(37.5) 
153(32.8%) 
133(28.5%) 
238(50.7%) 
28.62(4.45) 
 
170(51.1%) 
123(36.9%) 
112(33.6%) 
99(29.7%) 
175(52.7%) 
28.81(4.45) 
 
65(47.1%) 
52(38.8%) 
41(30.6) 
34(25.4%) 
63(46.0%) 
28.08(4.43) 
 
0.479 
0.751 
0.586 
0.367 
0.189 
0.121 
Method of CR  
PCI 
CABG 
 
307(65%) 
165(35%) 
 
205(61.4%) 
129(38.6%) 
 
102(73.9%) 
36(26.1%) 
0.011 
*Participants: lost at some point (due to drop out or death) and those recruited for 1st time 3 months post treatment 
**BMI Categories:  Underweight = <18.5, Normal weight = 18.5–24.9, Overweight = 25–29.9, Obesity = BMI of 
30 or  greater 
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4.2CROQ versions 
4.2.1 CROQ before Coronary revasculariazation (PCI and CABG versions are identical, 
therefore only the CABG version is presented) 
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450 
 
451 
 
 
452 
 
4.2.2    CROQ -PCI  post treatment  
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454 
 
 
455 
 
 
456 
 
 
457 
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4.2.3 CROQ -CABG post treatment 
 
459 
 
 
460 
 
 
461 
 
 
462 
 
 
463 
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4.3 SF-36  
 
 
 
465 
 
 
466 
 
 
467 
 
 
468 
 
 
469 
 
 
470 
 
 
471 
 
 
472 
 
 
473 
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4.4 Demographic Information 
Demographics 
Date of birth:……………………………………         
Place of residence: ……………………………….. 
Please tick with √ each condition that represents you best: 
Sex :       Male     Female   
Family Status : 
 Single  
 Married                          
 Divorced  
 Other ……………………………         
Educational Status  : 
 Primary School (1- 6 Years) 
 Secondary School (7- 12 Years) 
 University(15+ Years)  
 Other …………………………… 
Occupational Status : 
 Unemployed             
 Public Servant/ Private Sector 
 Free Lancer 
 Pensioner  
 Other  
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4.5 Medical Information 
 
  
Medical Record * 
Do you have a family history of CHD?  
 Yes   
        No  
Please tick with   if you have or take medication for 
 Hypertension  
 Cholesterol   
  Diabetes 
Please state your weight  ……… and height ………… 
Are you a smoker?  Please tick with  the condition that represents you 
 Yes  
   No 
 Former  
Do you know the number of arteries that have been revascularized? If yes please 
indicate the number ………………. 
Do you know the kind of revascularization that your doctor have carried out?   
 Angioplasty     
  Metal stent    
  Drug eluting stent 
        On-Pump 
        Off-Pump 
 
*In case of follow up only 2 questions were asked 
1 Please state your weight  ………  
2 Are you a smoker?  Please tick with  the condition that represents you 
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4.6  Interview Schedule  
Interview schedule  
Opening questions  
1. A) How would you describe your life during the last year? 
B) What do you think caused coronary disease? 
C) How would you describe yourself now? 
Prompts : 
-appearance  
-character 
-sociality 
-activities  
 
 
HRQοL in general   
2. What does “quality of life” mean to you? 
Prompts  
-what makes a good life in general?  
-to you, in particular?  
-in relation to health?  
 
HRQοL, symptoms and physical functioning area   
3. How do you feel your body after CR  
Prompts: 
have you observed any changes (before and after intervention/surgery)?  
-experience of symptoms (presence/absence/recurrence in the last year) 
-performance of everyday life activities (ability/ease/difficulty)-can you describe any particular 
activity that makes you tired?  
 
 
HRQοL psychosocial functioning area  
4. How do you experience your social life after CR? 
Prompts: 
-have your family and friends changed their behaviour towards you (before CR/now)? 
-have you changed the way you relate to your family and friends (before CR/now)? 
-have you made any changes in your social activities (before CR/now)? 
 
 
5. How do you feel about your heart condition? 
Prompts: 
-what feelings do you have about your heart?  
-can you describe specific thoughts, images? 
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Changes in attitude towards self and life  
6. Have you observed any changes regarding the way you perceive life after CR? 
Prompts: 
-how do you perceive yourself in relation to your heart condition?  
-have you noted any changes in the way you enjoy life (define and experience life enjoyment)? 
-what might be the reasons that lead to this/these change(s)?  
7. Have there been any life events (apart from CR) that have affected the way you perceive 
yourself and your life? 
 
Changes in lifestyle/behavioural changes  
8. Can you describe any changes in aspects of your lifestyle and habits that you made/had to 
make/intended to make after CR? (for each change mentioned with particular emphasis on 
smoking)  
Prompts: 
-why? what was the trigger(s)/ the source of information? 
9. How did you feel about changing (then and now)/having to change these aspects? 
Prompts: 
-what factors contributed (facilitated/impeded) to obtaining or/and maintaining these changes 
 
Ending  
10. what would you say to an individual who now faces CR ? 
11. is there anything else that you would like to add in relation to your experience of CR? 
 
General Prompts during the interview  
 What comes to your mind? 
 Could you say more about this?  
 Could you give me an example of this?  
 You mean that .....(repeating the respondent’s phrase to ask for clarification or prompt 
further exploration) 
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4.7 University of Hertfordshire (UH) Ethics Committee Approval 
4.7.1  Study 1 & 2 UH Ethics Committee Approval  
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4.7.2   Study 3 UH Ethics Committee Approval  
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4.8 Scientific Committee Approval from Participating Hospitals 
4.8.1  Thriassio Hospital Scientific Committee Approval 
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4.8.2  Metropolitan Hospital Scientific Committee Approval 
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4.8.3  Attikon Hospital Scientific Committee Approval 
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4.9     Participant information Sheet 
4.9.1  Participant information Sheet (for study 1 & 2) 
PARTICIPANT INFORMATION SHEET 
 
I am a Greek PhD candidate in the field of health psychology from the University of 
Hertfordshire conducting a study on quality of life for people with your medical condition.  
  
If you agree to take part you will be asked to complete a questionnaire about your heart 
condition, your physical symptoms and functioning in everyday life in the last 4 weeks. 
Generally, this takes approximately 15 minutes. 
 
If you agree we will also contact you 2 to 3 months and twelve months (6 months in case of the 
2nd stage) after today in order to measure your improvement. This will be done by telephone (at a 
number provided by yourself, at a time that suits you) for approximately 15 minutes. The phone 
call after 12 months will be the final one.  
 
Any data you do provide today will remain both confidential and anonymous and will be used 
only for the purposes outlined here. 
 
We are also asking for your permission to record some information (e.g. weight, previous 
medical history etc) from your medical record which will remain confidential and anonymous 
as well and your permission to keep this information in our files for three years after the 
completion of study (February, 2012).  
 
You may use the contact number below should any queries or concerns arise in the future 
regarding the particular study. If you have any concerns about your medical condition please 
contact your doctor.  
 
 
You will have an opportunity to ask questions now and at the end of the session.   
 
Please note that any information you may supply today will only be used for the purposes 
outlined here, and you may withdraw your assistance at any time if you wish and without 
explanation. Moreover, keep in mind that the study is being carried out independently of 
the hospital and your decision with regard to your participation will not affect your health 
care. 
 
 
Thank you for your participation  
 
Name of Researcher:  Maria Takousi 
Contact Tel. no: 6937392080 
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The study is supervised by Dr Stefanie Schmeer, Dr Nick Troop and Dr Irene Manaras. For 
further details, requests or complaints you can contact Dr S. Schmeer (s.schmeer@herts.ac.uk) at 
the University of Hertfordshire, UK or Dr. I. Manaras at IST College, Greece. Call number: 
2104822222 (office hours: 12-6) 
 
The study has been approved by the University of Hertfordshire Ethics Committee; Protocol 
number PSY/03/10/MT  
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4.9.2  Participant information Sheet (for study 3) 
Pre-interviewing Briefing Sheet 
 
Title of project: Gaining in depth understanding of subjective meanings of HRQoL after CR 
 
Thank you for agreeing to participate in the present study. As you already know I am a Greek 
PhD candidate in the field of health psychology from the University of Hertfordshire conducting 
a study on quality of life for people with your medical condition. Currently, I am interested in 
find out your perception about life changes and HRQoL after Coronary Revascularization.  
 
Therefore, I will ask you some questions about your experiences and perception and I will record 
your responses as we discussed. The recording will allow me to capture any single word of your 
sayings. I will ask you specific questions already scheduled for the purpose of research, but I 
may ask you also some questions related to your sayings e.g. to find out more about your 
experience.  
 
Any data you do provide today will remain both confidential and anonymous and will be used 
only for the purposes outlined here.   
 
The interview is expected to be between 1-11/4 hours long. If you do not wish to reply to a 
question, please feel free to make it clear and we proceed to the next question. If you would like 
to stop the interview at any time, it is your right to do so without any explanations. 
 
Do you have any questions you would like to ask me before beginning? 
 
Please note that any information you may supply today will only be used for the purposes 
outlined here, and you may withdraw your assistance at any time if you wish and without 
explanation. Moreover, keep in mind that the study is being carried out independently of the 
hospital and your decision with regard to your participation will not affect your health care.  
 
 
Thank you for your participation. 
 
 
Name of Researcher: Maria Takousi  
Contact Tel. no: 6937392080 
 
Note: This study has been approved by School of Psychology Ethics Committee at the University of Hertfordshire (United Kingdom). 
Registration Protocol Number: PSY/06/12/MT. Furthermore, the study is supervised by Dr Nick Troop, Dr Stefanie Schmeer and Dr Irene 
Manaras. For further details, requests or complaints you can contact Dr N. Troop (n.a.troop@herts.ac.uk)  or Dr S. Schmeer 
(s.schmeer@herts.ac.uk) at the University of Hertfordshire, UK or Dr. I. Manaras (imanaras@ist.eud.gr) at IST College, Greece. Call 
number: 2104822222 (office hours: 12-6) 
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4.10 Consent Form  
4.10.1 Consent Form (for study 1 & 2) 
 
CONSENT FORM  
 
I ………………………………………………………………..(please write your name) 
give my full consent to take part in the research investigation carried out by Maria Takousi with 
the full understanding that I may withdraw at any time without giving any reason.  
 
If I withdraw from the study, the data that I have submitted will also be withdrawn at my request. 
I have received an information sheet explaining what the study entails and what will be expected 
from me.  
 
I understand that the information that I will submit will be confidential, and used only for this 
study. I have read and understood the above information.  
 
Please tick one box on each line 
I   agree    /do not agree   to participate in the study. 
 
I    grant   /do not grant   access to my medical records. 
 
 
Signed: _______________________________________ 
  
Date of birth: __________________________________ 
 
Date: _________________________________________ 
 
Telephone number:  _____________________________ 
 
Preferred contact hours: ____________________________ 
 
Researcher: Maria Takousi ________________________ 
 
Please keep in mind that any concerns about your medical condition should be discussed with 
your doctor. 
 
The study has been approved by the University of Hertfordshire Ethics Committee; Protocol 
number PSY/03/10/MT  
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4.10.2 Consent Form (for study 3) 
Consent form 
 
 
Title of project: Gaining in depth understanding of subjective meanings of HRQoL after CR 
 
Name of researcher: Maria Takousi, PhD candidate in Psychology. 
 
To be completed by participant (Please initial each box): 
. 
1. I confirm that I have read and understand the information sheet for the 
present study. I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily. 
 
 
2. I realize that I am able to leave the study at any time without reason. 
 
 
3. I consent record my interview  
 
 
4. I understand that relevant sections of the data collected by this study  
would be looked at by authorised persons from the University of 
Hertfordshire. Anonymised sections of the data collected may also be 
looked at by representatives from academic and professional assessment 
bodies in order to assess the quality of this doctoral research project and 
possibly a peer research group to check for data themes. All will have a 
duty of confidentiality to you as a research participant 
 
 
 
5. I agree to take part in the above study. 
 
6. I agree that anonymised quotes from my interview may be used in any 
publications 
 
 
7. I understand that any concerns about my medical condition should be 
discussed with my doctor. 
 
 
Participant Name:                                                              Signature:  
 
Date:  
 
The study has been approved by the University of Hertfordshire Ethics Committee; Protocol 
number PSY/06/12/MT
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4.11 Debriefing 
4.11.1 debriefing (for study 1 & 2) 
 
 
DEBRIEFING (baseline and 3months) 
 
The information you have provided will be used for creating a scientific questionnaire that will 
evaluate individuals’ health outcomes and health-related quality of life after coronary 
angioplasty/ bypass.  Also, the information you have provided will be used in detecting the 
impact of Coronary Revascularization in patients’ HRQoL. 
 
The particular instrument measures important aspects of a patient’s health condition such as 
symptoms, physical functioning etc. and you have helped us in measuring them more precisely.  
 
Please keep in mind that any concerns about your medical condition should be discussed with 
your doctor. 
 
Do you have any further questions regarding the study?  
 
 
 
Thank you for your help. 
 
You may contact me in the future on:  6937392080 Maria Takousi 
 
 
 
 
 
 
The study is supervised by Dr Stefanie Schmeer, Dr Nick Troop and Dr Irene Manaras. For 
further details, requests or complaints you can contact Dr S. Schmeer (s.schmeer@herts.ac.uk) 
at the University of Hertfordshire, UK or Dr. I. Manaras at IST College, Greece. Call number: 
2104822222 (office hours: 12-6) 
 
The study has been approved by the University of Hertfordshire Ethics Committee; Protocol 
number PSY/03/10/MT   
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DEBRIEFING (12 months) 
 
The information you have provided will be used for creating a scientific questionnaire that will 
evaluate individuals’ health outcomes and health related quality of life after coronary 
angioplasty/ bypass. Also, the information you have provided will be used in detecting the 
impact of Coronary Revascularization in patients’ HRQoL. 
 
The particular instrument measures important aspects of a patient’s health condition such as 
symptoms, physical functioning etc. and you have helped us in measuring them more precisely 
and finding out how well the questionnaire measures these things after one year.   
 
Please mind that any concerns about your medical condition should be discussed with your 
doctor. 
 
Do you have any further questions regarding the study?  
 
 
 
That’s it! Thank you for everything. 
 
You may contact me in the future on:  6937392080 Maria Takousi 
 
 
 
 
The study is supervised by Dr Stefanie Schmeer, Dr Nick Troop and Dr Irene Manaras. For 
further details, requests or complaints you can contact Dr S. Schmeer (s.schmeer@herts.ac.uk) 
at the University of Hertfordshire, UK or Dr. I. Manaras at IST College, Greece. Call number: 
2104822222 (office hours: 12-6) 
 
The study has been approved by the University of Hertfordshire Ethics Committee; Protocol 
number PSY/03/10/MT   
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4.11.2 Debrifing (for study 3) 
 
  Debriefing Sheet  
 
The information you have provided will be used for investigating health outcomes and health 
related quality of life after coronary angioplasty/ bypass among individuals. More precisely, the 
questionnaire phase (quantitative research) is developed to measure and assess the impact of CR 
in relation to the dimensions (symptoms, physical, psychosocial and cognitive functioning) of 
HRQoL in short and long term. The interview phase (qualitative research) is developed to 
explore how individuals make sense of HRQoL and which individuals concerns regarding life 
changes are related to HRQoL. 
 
 
Please mind that any concerns about your medical condition should be discussed with your 
doctor.  
 
 
Do you have any further questions regarding the study?  
 
 
 
Thank you for your participation. 
 
 
Name of Researcher: Maria Takousi  
Contact Tel. no: 6937392080 
 
 
Note: This study has been approved by School of Psychology Ethics Committee at the University of 
Hertfordshire (United Kingdom). Registration Protocol Number: < PSY/06/12/MT>. Furthermore, the 
study is supervised by Dr Nick Troop, Dr Stefanie Schmeer and Dr Irene Manaras. For further details, 
requests or complaints you can contact Dr N. Troop (n.a.troop@herts.ac.uk)  or Dr S. Schmeer 
(s.schmeer@herts.ac.uk) at the University of Hertfordshire, UK or Dr. I. Manaras 
(imanaras@ist.eud.gr) at IST College, Greece. Call number: 2104822222 (office hours: 12-6) 
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4.12 Participant comments on interview    
Interview Schedule De-Briefing. 
 
Participant name ................................................... 
Date.......................................................................... 
 
I. State the purpose of study 
 To explore individual’s understanding of HRQoL after CR 
 To investigate individual’s perception of change to life style due to CR 
 To ensure personal experience is heard. 
 
II. Detect participant’s experience about the interview 
How did you find the interview? It was any part hard for you? 
............................................................................................................................................................
............................................................................................................................................................
...................................................................................................................................................... 
 
In your opinion, could anything be done differently? Would you like anything differently? 
............................................................................................................................................................
............................................................................................................................................................
....................................................................................................................................................... 
 
Could you make some recommendations in order to help me improve the interview? 
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............................................................................................................................................................
............................................................................................................................................................
...................................................................................................................................................... 
 
III. Discover any unresolved themes raised from the interview 
Do you have any questions which you feel still need answering? 
............................................................................................................................................................
............................................................................................................................................................
...................................................................................................................................................... 
 
Are there any concerns raised due to the interview? 
............................................................................................................................................................
............................................................................................................................................................
........................................................................................................................ 
 
IV. Future concerns and contact with researcher. 
If you have any concerns or further queries about this research please do not hesitate to contact 
the researcher or the project supervisor. 
The researcher and supervisor will be available for contact up to 12 months after participation. 
Do you wish to be contacted to check themes? Yes         No  
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4.13 Leaflet for psychosocial support services  
 
INFORMATION LEAFLET 
ON SUPPORT AVAILABLE IF YOU FEEL DEPRESSED 
 
 
Everyone may feel depressed or anxious. These emotions are natural reactions to disappointment 
or apprehension. However, if you think your mood has been low for some time and is affecting 
your ability to cope with day-to-day life, you should contact your GP or counselling services 
and/or seek help and advice from professional organisations. Some of these organisations are 
listed below: 
 
 
Hellenic Counselling Association 
George 9, Plateia Kanigos, Athens 
Tel: 211 4055774, http://www.hac.com.gr/ 
 
Association of Greek Psychologists 
Leof. Basilisis Amalias 42, Athens 
Tel: 210 6913500, http://www.seps.gr/ 
 
Thriassio Hospital- Psychiatric Department 
Patriahou Grigoriou e 4, Aspropyrgos Attikis 
Tel:210 5571855 
 
Telephone center for psychosocial support (free of charge) 
Tel: 197 & 210 
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4.14 Table of themes for the 1st interview 
Mater theme 1: Experiencing the disease and its impact   
Themes Subthemes Key words  Page Text 
Becoming a 
patient  
 
 
Clinical 
interactions  
Mistrust of doctors  44 Youngsters who were in their practical training… they were looking at me in 
terror… and with a sorrowful look .and I told them don’t look at me like that… 
patients should not be looked at in this way,because it frustrates you, as if they 
wanted to burst into tears 
Mistrust of the Greek health care 
system 
4 I had no confidence tothe  Greek medical system 
Frustration with the hospitals’ cleaning 
services 
32 
 
32 
In the hospitals, that they provide almost nothing, that you can’t wash yourself 
That brings you to a point that you’re embarrassed of what you have… it’s the 
absolute humiliation 
Confronting 
medical 
uncertainty 
Feeling like a guinea pig  1 
 
I had become a guinea pig. I was drinking a handful of pills and swallowed 
them all together 
Doctors experiments with drugs  3 
 
They were doing experiments… all those things that happened to me were not 
because of the heart but pharmaceutical [side-effects] in reality 
Over-consuming drugs  8-9 Now drink magnesium and them potassium ... Whatever… a plethora of pills.  
Medical uncertainty  makes you feel 
insecure  
And despaired  
33 
 
35 
“We don’t know what else to do to you”, when they tell you that it makes you 
feel insecure  
And I was thinking… what they wanted me to do, did they want me to kill 
myself? 
Ineffective treatment    
Expecting divine(God’s) help  
7 And I was saying, since doctors cannot help me, something higher will help me  
Feeling 
helpless 
Feeling scared in the hospital 23 Why do they run like loons … don’t they know that this terrifies the patient? 
Feelling helpless/ loss of 
dignity/humiliation  
32 you callfor the nurse and have her say “coming now…  coming now” and you 
want to go to the bathroom since that morning and end up going in the 
afternoon… it’s the absolute humiliation 
Feeling angry when treated as nearly 
dead  
44 Looking at him as if saying “I wonder how can you be alive” 
Living a 
post -
surgery life 
Experiencing 
multiple health 
problems  
Disturbed bodily functionality   
Fearing diabetes 
Diabetes is a sneaky disease  
2 When I got the mi my whole body became desynchronized    .. 
What I am afraid most is  
It is a sneaky disease. 
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It can destroy your organs and cause 
more damage to the heart  
It can destroy your kidneys, eyesight. The heart even more. You can get 
gangrene and have your handsmutilated. 
Diabetes is a more frightening problem 3 This is because I fear it more than the heart. And I face trouble to control it. 
Living in grief  
 
(grief, loss of 
freedom 
desires and 
choices) 
Body functions limit desires  - 
(self pity- new dysfunctional body 
blocks life choices) 
 
Loss of freedom  
18 
 
20 
 
19 
I'm not like before when I could  do what I liked in life  
 
I cannot get on a plane and go anywhere I want.  
 
You do not have freedom  
Grief about limited choices and 
suppressed desires 
20 From now on I cannot have a new boyfriend, not that I want to but if I did…. 
Grief about loss of body independence 33 My body is falling apart … My poor body 
Grief for self- irreversible life path 30 It never came back on track 
Feeling 
overprotected  
Husband acting as lifeguard 24 He hadn’t slept for days…. He stood over me all night longlike the grim 
reaper  
Everydaylife 
adjustments 
Bland life/ losing pleasure 33 [you can] never eat sweets, no bread, almost no pasta, some rice only… 
whereas… whereas I was living on sweets … you can’t eat salt.… having to 
eat a burger without salt is tragic 
 Bland life/limitated-foods diet 33 There are a million of foods that automatically go out. The cheese and stuff 
etc…. 
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Mater theme 2: The self in the body    
Themes Subthemes Key words  Page Text 
Experiencing 
the altered 
body  
Body 
distortion 
Loss of parts /body is falling apart 8 Each time that I had a bath, I was observing my skin falling to pieces. 
Fear of 
unknown 
future  
Fear of the unknown when you have a 
sick  body  
12 I am afraid … the future  
 
Acceptance of 
the weak 
body 
Acceptance Acceptance of body weakness and 
behaviour modification in terms of 
mobility ( changes in bodily function) 
20 
25 
 
27 
I don’t have the same physical strength  
The body doesn’t “rock” as it used to 
 
I can do everything, but move more slowly 
Self-
reflection 
 
Perceptions 
of disease 
causality  
Causes of the health problem 
Heredity &  stress & perfectionist and 
introvert  
9 
10 
Heredity, my father suffers from CHD 
 it’s the stress… because I was a perfectionist, and my introversion 
I will get furious and I don’t express it… 
Disease as a 
trigger  
The old blind me (body and mind 
interaction) 
16 If I didn’t go through this I wouldn’t realize 
Self criticism  14 I believed that I was smarter than them but now I realize that I was the stupid 
one 
Experiencing 
a new me 
Psychologica
l self   
Less anxious  42 It's not that you do not stress yourself out but the intensity is different 
Detached/depressed 9 I am more detached from everything now 
Less controlling/ less perfectionist 
/more easy going  
9 
43 
Why should I pay attention to all these? 
You think that only you can do things perfectly and that’s the only way they work 
well. But I’ve seen that a lot of things can be done properly and work well 
without me interfering 
Sexual self  Loss of sexuality 31 
 
31 
I don’t have a physical problem, but then again the sensation, the pleasure is not 
the same  
I’m ruined in that respect 
Anger about the loss of sexuality 30 Sex is of vital importance! Just like food, so it was with sex too…now…  I lost it 
and that pissed me off  
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Mater theme 3: Self and others     
Themes Subthemes Key words  Page Text 
You are 
alone 
 
 
Being alone 
hurts 
Being alone hurts (realizations) 16 I was very much hurt by the fact that I was alone.  
Feel abandoned  15 I was left alone, completely alone  
Disappointed Disappointed with the extended 
family’s attitude 
Feeling hurt from others’ lack of 
compassion  
23 
 
12 
What hurts me most is the attitude of the members of my extended family  
 
It is hard to realise that your family believes you are dying  
 
Support Practical and 
emotional 
support  
Increased  practical support from 
friends  
Practical support from the nuclear 
family  
Limited practical support from family  
17 
35 
16 
24 
24 
16 
17 
Irrelevant people have helped me  
He offered me 50.000 euros 
Olga only …she was strong, a good friend… she took me on car trips, took 
me out for coffee… she really helped me a lot 
My children also helped me a lot.  
Do you know how it feels like when your own people don’t stand by you? 
I was expecting they would support my children. 
When I returned home after the surgery nobody offered to help me… I had 
to cook for my children…   
 
Aspects of 
gender 
identity 
Being a social 
person 
The polite  9 I was very social and friendly with everyone  
Being a 
women 
The feminine 34 In the past I was very good looking and attractive 
Being a 
daughter 
Over-offering  28 I had assumed all of my father’s responsibilities… a 
Joanna of all trades 
Being a 
mother 
The patient 18 I did a lot of patience to grow up my children 
Changes in 
relating 
with others    
Behaving in a 
different way    
Changes in feelings and behaviour  16 I changed towards those who hurt me  
Giving back 
what you get  
Mirroring their behaviour 10 
16 
17 
You become insensitive 
Their behaviour forced me to change  
She was strong, a good friend… why should I alter my behaviour towards 
her?  
Promoting 
independence  
Be more independent as a mother  10 You know… I would like to become more independent … I don’t want to be 
with them all the time 
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Allowing children to be more 
independent  
42 They can do things by themselves  
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Mater theme 4:  Strategies for living a good life  
Themes Subthemes Key words  Page Text 
Regaining 
control  
Setting 
boundaries  
Share responsibilities   10  Why should  everything be done by me? Kostas can tidy up his room 
Avoiding 
emotional 
expression   
Not sharing feelings  - disclosure 
makes problems difficult to control  
fear (facilitates suppression) 
44 
 
44 
I think that if I share my feelings, the problem will become worse  
 
It’s been so much time now, even with Olga I don’t discuss it any more 
Minimizing 
the impact of 
the disease 
Minimize the impact of the disease 
(minimize dysfunction to accept a new 
self) 
33 I have been destroyed a little bit   
Change is superficial - new attitude not 
new personality 
9 
11 
14 
Personality doesn’t change  
Personality doesn’t change the attitude towards others becomes different,  
My way of thinking and behaving changed  
Humor  Humor- use of humor to reduce 
anxiety and insecurity 
31 
44 
Greece has lost a sexy woman 
I was joking with the doctors 
Becoming 
doctor of the 
self 
Focus on the self to find solution and 
gain self-control   
8 
 
I’ve started to observe the impact on my body… when a drug caused side 
effects I stopped taking it   
Be cautious, mistrust helps to control 
medical insecurity  
44 Youngsters who were in their practical training 
Smoking to 
achieve 
emotional 
control    
Smoking for emotional control (to 
reduce anxiety and stress that harms 
you heart) 
39 
 
I couldn’t feel my feet and felt like fainting. So I thought since I could hold on 
through this, I told myself that I do have a strong heart after all. But there it 
was, as soon as this was over, I lit a cigarette 
Finding 
meaning of 
good life  
Achieving 
autonomy  
What makes sense in life –dignity & 
autonomy /independence  (first for me 
then for kids) 
Dependence makes you vulnerable 
(you don’t have control)   
38 
10 
 
38 
 
To be independent  
When you are not independent your dignity vanishes 
 
Quality of life is to be independent  
Prioritizing the 
self  
Rely on yourself to survive  10 You have to learn to survive on your own 
No need to be over-offering   42 You shouldn’t exhaust yourself because you don’t help yourself that way 
Protect yourself & your kids 34 You learn to protect yourself and your kids 
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5.1    Guidelines for translating and validating measures 
The following paragraphs discuss the three stage process (Ware, et al., 1995) for translating and 
validating measures 
 
5.1.1 Stage I: translation  
This step involves forward and backward translations and pilot testing. A minimum of two 
individuals should independently translate the source instrument into the target language. The 
translators should be fluent in the target language (preferably native speakers) as well as having a 
good knowledge of the source language and they should focus on the conceptual instead of the 
literal equivalence. In other words, they should translate the meaning rather than the literal 
words, avoiding any medical terms and trying to create a version that is easy to read and 
understand (e.g. avoiding long, complicated sentences). After that, the two translators and the 
main researcher agree upon a preliminary forward translation and give this to a bilingual 
scientific panel. The scientific panel should resolve any possible discrepancies between the 
forward and the original version of the questions and thus, create a revised forward version.  
Afterwards, the back translation should be made by two different individuals whose mother 
tongue is ideally the original language as well as having a good understanding of the target 
language. Any possible inconsistency should be resolved by the scientific panel. Additionally, a 
small pre-pilot (preliminary) study with the target group (e.g. patients) should be run to assess 
acceptability, feasibility and understanding of the translated version and obtaining a basic level 
of content and face validity.     
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5.1.2 Stage II: test of scaling assumptions  
The second stage focuses on testing the scaling assumptions. Five core assumptions should 
be explored: 1) equal item variance 2) missing data, 3) equality of item – scale correlations, 4) 
item discriminant validity and 5) reliability  
 
5.1.2.1 Equal item variance 
Equal item variance means that items measuring the same concept (e.g. physical functioning) 
should have approximately equal variance in order to contribute equally to the total scale score. 
To demonstrate equal item variance, descriptive statistics should be run illustrating the mean and 
the S.D. ranges for all items within each scale. In order to satisfy this assumption the items 
within each scale should demonstrate similar Standard Deviations of Likert Scores (S.D.S) 
compared to other items in the scale. 
 
5.1.2.2 Missing data  
In addition, descriptive statistics should demonstrate the amount of missing data. The 
proportion of missing data plays an important role in the degree of confidence that can be placed 
in a scale’s measurement. For instance, a large amount of missing data from a particular item 
could indicate problems in wording or understanding. A low level of missing data can indicate a 
good level of instrument comprehension and acceptability on the part of respondents (Streiner & 
Norman, 2008).   
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5.1.2.3 Equality of item-scale correlations  
Equality of item-scale correlation refers to the assumption that the items include 
approximately the same amount of information about the construct being measured. In other 
words, the correlations between items within the same scale should be generally similar. The 
strength of correlation should be >0.40. However, other experts in the field of psychometrics 
suggest that a value for item-scale correlation >0.20 is acceptable (Streiner & Norman, 2008). 
 
5.1.2.4 Item discriminant validity 
Item discriminant validity refers to the assumption that items of unrelated concepts should 
have a minimal correlation between them. In order to find support for item discriminant validity, 
the relationship between an item and its hypothesized scale should be significantly higher than 
the correlations between that item and all other scales. The standard criteria to assess item 
discriminant validity is based on standard errors. Two standard errors or more (≥2) indicates 
scaling success, meaning that the item-scale correlation is significantly higher for the 
hypothesized scale than for the competing scale. One (1) standard error indicates probable 
scaling success, meaning that the item-scale correlation is higher for the hypothesized scale than 
for the competing scale, but not significantly. Minus one (-1) standard error indicates probable 
scaling failure, meaning that the item-scale correlation is lower for the hypothesized scale than 
for the competing scale, but not significantly. Minus two standard errors (≥-2) indicates scaling 
failure, meaning that the item-scale correlation is significantly lower for the hypothesized scale 
than for the competing scale (Ware, 2004; Ware & Gandek, 1998). In recent years, computer 
programmes (e.g. Quality Metric Health Outcomes ScoringTM Software 3.0) have been used to 
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test scaling assumptions (Saris-Baglama et al., 2009). However, nowadays, many researchers use 
either inter-rater correlations (Danansuriya, Rajapaksa, & Varni, 2011) or zero-order correlations 
(Chorpita et al., 2010; Miller, Vachon, & Lynam, 2009; Schoofs, Hermans, & Raes, 2010) for 
establishing item discriminant validity. They accomplish this goal by demonstrating that items 
hypothesized to belong to one scale do not strongly correlate with items of another “irrelevant” 
scale (Streiner & Norman, 2008).   
 
5.1.2.5 Reliability of instrument 
Reliability refers to the degree to which an instrument is free from measurement error. The 
reliability of an instrument can be assessed by using two basic methods: internal consistency and 
test-retest reliability.  
 
Internal consistency  
Internal consistency, as the term implies, demonstrates the degree to which items of a scale 
measure the same construct (i.e. scale homogeneity) and can be assessed with the use of the 
Cronbach’s α (Cronbach, 1951) coefficient for items with three or more response choices 
(DeVellis, 2003; Field, 2005; Hays & Revicki, 2005; Marks, 2004; Streiner & Norman, 2008). 
The Cronbach’s α coefficient ranges from 0 to 1. The higher the value, the greater the 
consistency. For establishing internal consistency in a scale the α coefficient should ideally be 
greater than 0.70 for group comparisons (Anastasi & Urbina, 1997; Streiner & Norman, 2008).   
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Test-retest reliability  
Test-retest reliability, as the term suggests, reveals measurement stability. Test-retest 
reliability is measured by assessing the consistency between scores obtained by the same person 
on two different occasions (Anastasi & Urbina, 1997; Netemeyer, Bearden, & Sharma, 2003).  
Generally, test-retest reliability is evaluated by the Pearson Intra-class Correlation Coefficients 
(ICC) which represents the correlation between results for the two different time points. To 
establish test-retest reliability results should reach at least the criterion of 0.70 (Hays & Revicki, 
2005; Streiner, & Norman, 2008; Ware & Gandek, 1998).  
 
5.1.3 Stage III: Validation  
Validity refers to the degree to which a measure captures the concepts for which it was 
designed and the appropriateness of the items contributing to the scale. Typically, three types of 
validity are assessed: content, construct and criterion (DeVellis, 2003; McDowell, 2006; Ware & 
Gandek, 1998). All types measure the degree of confidence concerning the inferences drawn 
from scores (Streiner & Norman, 2008).    
 
5.1.3.1 Content validity  
Content validity is the extent to which the content of a scale is representative and relevant to 
the conceptual domain(s) it is aiming to measure (Haynes, Richard, & Kubany, 1995; Hays & 
Revicki, 2005; Stewart, Hays, & Ware, 1998; Streiner, & Norman, 2008; Sutton, & French, 
2004;). In the International Quality of Life Assessment (IQOLA) project, content validity was 
achieved through focus group studies, formal cognitive tests and empirical studies in many 
countries (Ware, 2004; Ware et al., 1995).  Usually, content validity is achieved by carrying out 
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a literature review and by interviewing representatives of target groups and specialists in the 
target field in order to obtain both patients’ and  experts’ point of view (Burns, 2010; Creswell & 
Clark, 2007). With such an approach both “content relevance” (the degree to which the content is 
relevant to participants) and “content coverage” (the degree to which all aspects of the subject 
area are covered) can be obtained (Streiner & Norman, 2008). Content relevance is often 
assessed with an additional approach known as Judgment stage (Lynn, 1986; Waltz & Bausell, 
1983; Wynd, Schmidt, & Schaefer, 2003), which involves firstly a quantitative analysis and then 
a qualitative one (Haynes, Richard, & Kubany, 1995). In this approach, at least 5 experts 
(judges) are recruited to rate each item, after a detailed description of each of the domains by the 
researcher, on a four point scale where 1 indicates totally irrelevant content and 4 reflects 
extremely relevant content (Streiner & Norman, 2008). In addition, they are asked to propose 
alternatives for each item that scores between 1 and 3. Then with the use of the Cohen’s Kappa 
coefficient the researcher calculates inter-rater agreement. Cohen’s Kappa should be above 0.70 
(Wynd, Schmidt, & Schaefer, 2003). The qualitative analysis focuses on the analysis of items 
with less than 0.70 of agreement which are then discussed with the five judges in order to make 
the appropriate changes. Often a very similar process is also adopted in the first stage (translation 
stage) for evaluating the conceptual equivalence between the source and the target instrument 
(Ware, 2004). Moreover, content validity can also be improved by comparing patient responses 
to items with open ended questions such as “ is there anything else you would like to tell us...” 
(Schroter, 2001). 
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5.1.3.2 Construct validity  
Construct validity refers to the degree to which an instrument correlates with variables in a 
way consistent with the theoretical framework (Stewart, Hays & Ware, 1998). In order to 
establish construct validity various analyses should be conducted; within-scale (internal) and in 
comparison to external criteria (external).  
 
Construct validity : internal  
In order to demonstrate within-scale construct validity, the structure of the scale should be 
identified (Gandek & Ware, 1998; Hays & Revicki, 2005).  
Factor analysis is usually performed to determine the structure of a scale.  It can be carried 
out to verify that items are correctly grouped together, that items in the same scale measure the 
same construct, that items in different scales measure different constructs, and finally, to identify 
items that contribute little to their intended scale. Items that measure a particular construct, such 
as physiological functioning, should load highly on the same factor and not on others measuring 
dissimilar constructs, such as cognitive functioning.   
When factors of a model are set a priori, Confirmatory Factor Analysis is usually applied 
(Stevens, 1996) using the AMOS, LISREL or R programme. However, when cultural adaptation 
is the aim of the study, exploratory analysis can be carried out using SPSS to run Principal Axis  
Factoring  extraction with a fixed number of factors (Newsom, 2005).  
The first step for this process is to produce a correlation matrix among the variables under 
investigation in order to confirm that there are positive correlations among items under the same 
factor. Frequently, the step of generating a Scree plot is excluded since the number of factors for 
extraction is set a priori. Afterwards, data quality is investigated both by the Kaiser-Meyer-Olkin 
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index which tests sampling adequacy (≥0.70), and by Bartlett’s Test of Sphericity which reveals 
whether the existing correlations among variables allow factor analysis (p<0.05). Then, the type 
of extraction is chosen (Principal Components Analysis (PCA) or Principal Axis Factoring 
(PAF). In research aiming at the cultural adaptation of a measure, PAF with a varimax rotation is 
commonly selected (Burges, Fernandez, Autonell, Melloni, & Bulbena, 2007; Dianat, Ghanbari, 
& AsghariJafarabadi, 2014; Ferrer et al., 2006; Karteroliotis, 2008; Khodadady & Ghahari, 
2011). An explanation might be that a PCA may provide poor estimates of loadings when sample 
is small (Snook  & Gorsuch, 1989). Minimum acceptable factor loading values are between 0.30 
and 0.40, depending on sample size (Field, 2005). Items may load on more than one factor 
(crossloading) and it is not always clear which factor they belong to. If the value of the 
difference between the crossloading items is greater than 0.20, the item is generally assumed to 
load on the factor for which it had the highest loading; if the difference is less than 0.20, the item 
should be ‘flagged’ as being related to more than one factor (Field, 2005).    
 
Construct validity : external   
To ascertain the construct validity of a scale with external criteria usually two fundamental 
aspects should be established: convergent and discriminant validity.  
Convergent validity refers to the extent to which different ways of measuring the same 
construct intercorrelate providing similar results. Conversely, discriminant validity refers to the 
degree to which a measure does not correlate greatly with measures that do not theoretically 
measure the same construct (Hays, & Revicki, 2005). For example, the physical functioning 
scale of two different instruments should be highly correlated (homotrait-heteromethod). In 
contrast, a cognitive functioning scale should not correlate with a physical functioning scale 
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(heterotrait-heteromethod or homomethod). Usually, these two subtypes of validity are evaluated 
simultaneously by using the multitrait-multimethod approach (Campbell & Fiske, 1959; Gandek 
& Ware, 1998; Hays & Revicki, 2005).  
 
5.1.3.3 Criterion validity  
Criterion validity consists of two basic subtypes; concurrent and predictive validity.  
Concurrent validity, the most common type in psychometrics, represents the extent to which 
the results of an instrument correlates with the another measure (usually the most widely used in 
a particular research field) or other proven scientific tool that measures the same concept 
(Ratanawongsa et al., 2008). For instance, a gold standard to measure a self reported blood 
pressure instrument against might be a blood pressure monitor. As experts suggest true ‘gold 
standard’ HRQoL instruments are not available, thus criterion validity is very rarely established 
(Hays & Revicki, 2005). Efforts to establish criterion validity are often made by using the SF-36 
(Seki et al., 2010).  
Predictive validity refers to the prognostic ability that a measure has regarding another 
concept that is theoretically related (Hays & Revicki, 2005). For instance, it could be theorized 
that a measure of HRQoL should be able to predict how fast patients will return to work after 
coronary revascularization.   
 
5.1.4 Sensitivity to change 
In the literature, the terms “responsiveness” and “sensitivity to change” are often used 
interchangeably. In general terms, they refer to an instrument’s ability to capture changes over 
time. However, there is a conceptual difference between these two notions (Corzillius, Fortin, & 
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Stucki, 1999; Liang, 2000). Responsiveness refers to a measure’s capacity to capture clinically 
meaningful changes that are important to patients or to physicians. Sensitivity to change refers to 
a measurement’s capacity to detect any change in state regardless whether the change is relevant 
or meaningful to the decision-maker. This distinction is of importance because a statistically 
significant change (difference) in state over time may not be synonymous with a clinically 
important change and vice versa (Kazis, Anderson, & Meenan, 1989; Pardasaney et al., 2012).  
Sensitivity to change is used to detect mean changes between two intervals by using paired t-
tests (Anastasi & Urbina, 1997).  Responsiveness as stated above, aims to capture clinically 
meaningful change. Various ways for determining clinically meaningful change have been 
suggested in the literature (Revicki, Hays, Cella, & Sloan, 2008). However, no clear consensus 
exists regarding the best way to determine it (Crosby, Kolotkin, & Williams, 2003; Revicki, 
Hays, Cella, & Sloan, 2008). A great number of researchers (Crosby, Kolotkin, & Williams, 
2003; Eisen, Ranganathan, Seal, & Spiro, 2007; Revicki, Hays, Cella, & Sloan, 2008) focus on 
determining responsiveness through distribution-based estimates (e.g. effect size (ES; Cohen, 
1988), standardized response mean (SRM; Guyatt, Bombardier, & Tugwell, 1986), and standard 
error of measurement (SEM; Wyrwich, Tierney, & Wolinsky, 1999)). Cohen (1988) suggested 
that effect size represents a standardized measure of individual (or group) change over time and 
“can be viewed as indicative of clinically meaningful change” (p. 274, Eisen, Ranganathan, Seal, 
& Spiro, 2007). ES can be measured by Cohen’s d, which is calculated by dividing the difference 
between pre-test and post-test scores by the standard deviation (SD) at pre-test (Cohen, 1988; 
Kinnear & Gray, 2008; Revicki, Hays, Cella, & Sloan, 2008). Using Cohen effect sizes of 0.20 
are defined as small, 0.50 as moderate and 0.80 or greater as large (Cohen, 1988; Crosby, 
Kolotkin, & Williams, 2003; Liang, Fossel, & Larson, 1990). The basic limitations for 
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determining responsiveness through ES are a) that SD and therefore effect size can be strongly 
influenced by sample size and b) ES does not account for the variation in change (Crosby, 
Kolotkin, & Williams, 2003; Revicki, Hays, Cella, & Sloan, 2008).  
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5.2 Descriptive statistics for CROQ versions to assess item equal variance  
5.2.1 Descriptive Statistics for PCI items per version  
 
Table 1. Descriptive statistics for CROQ-Gr PCI items of baseline version 
Subdomain  N Min Max Mean Std. Dev 
PCI pre version 
Symptoms  
chest pain 244 1 5 3.11 1.26 
discomfort 244 1 5 3.16 1.30 
shortness of breath 244 1 5 3.02 1.26 
angina radiates 244 1 5 3.77 1.35 
palpitations 244 1 5 4.04 1.22 
times per day 244 1 5 4.34 1.25 
troubles  244 1 5 3.41 .94 
Physical functioning       
moderate activites 244 1 3 2.43 .63 
lifting 244 1 3 2.50 .65 
climbing two or more flights of stairs 244 1 3 1.69 .78 
climbing one flight of stairs 244 1 3 1.82 .77 
bending 244 1 3 2.13 .77 
walking  a kl 244 1 3 1.84 .82 
walking 100 m 244 1 3 2.16 .75 
bathing 244 1 3 2.38 .60 
Psychosocial functioning  244     
overprotective environ 244 1 5 3.46 1.13 
burden on others 244 2 5 4.02 .88 
restriction of social activities 244 1 5 3.85 .98 
go far from home 244 2 5 3.96 .89 
worried  about heart cond 244 1 5 3.17 .99 
worried about overdoing 244 1 5 3.12 1.01 
worried about sudden attack 244 1 5 3.47 .89 
frightened by pain 244 1 5 3.66 .85 
uncertain about future 244 1 5 3.55 .98 
depressed 244 1 5 3.65 1.06 
frustrated / impatient 244 1 5 3.24 1.05 
enjoyment of life 244 1 5 3.51 1.07 
positive outlook of health 244 2 5 3.49 1.13 
plan ahead 244 2 5 4.01 1.06 
Cognitive functioning       
reasoning and solving problems 244 1 6 5.08 1.05 
forget 244 1 6 5.17 1.07 
concentration 244 1 6 5.14 1.08 
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Table 2. Descriptive statistics for CROQ-Gr PCI items of post 3 months version 
 N Min Max Mean Std. Dev 
Subdomain  
Symptoms       
post chest pain 254 4 5 4.87 .33 
post discomfort 254 3 5 4.79 .46 
post shortness of breath 254 3 5 4.76 .45 
post angina radiates 254 4 5 4.93 .25 
post palpitations 254 1 5 4.81 .46 
post intake frequency 254 3 5 4.94 .28 
post troubles 254 2 5 4.72 .55 
Physical functioning       
post moderate activities 254 1 3 2.88 .36 
post lifting 254 1 3 2.78 .44 
post climbing two or more flights  254 1 3 2.46 .63 
post climbing one flight of stairs 254 1 3 2.76 .47 
post bending 254 1 3 2.85 .44 
post walking  a km 254 1 3 2.74 .49 
post walking 100 m 254 1 3 2.86 .37 
post bathing 254 2 3 2.89 .30 
Psychosocial functioning       
post overprotective environ 254 1 5 3.95 1.06 
post burden on others 254 2 5 4.55 .70 
post restriction of social activities 254 2 5 4.44 .85 
post go far from home 254 2 5 4.67 .67 
post worried  about heart cond 254 1 5 4.13 .84 
post worried about overdoing 254 1 5 4.54 .80 
post worried about sudden attack 254 1 5 4.37 .80 
post frightened by pain 254 1 5 4.70 .69 
post uncertain about future 254 1 5 4.40 .82 
post depressed 254 1 5 4.36 .91 
post frustrated / impatient 254 1 5 4.20 .89 
post enjoyment of life 254 1 5 4.10 .94 
post positive outlook of health 254 1 5 4.28 .85 
post plan ahead 254 1 5 4.56 .74 
Cognitive functioning       
post reasoning and solving problems 254 2 6 5.60 .76 
post forget 254 1 6 5.56 .78 
post concentration 254 1 6 5.64 .77 
Adverse effects       
post pain in groin wound 254 3 5 4.92 .29 
post tenderness 254 3 5 4.89 .34 
post numbness or tingling 254 4 5 4.94 .23 
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Table 2. Descriptive statistics for CROQ-Gr PCI items of post 3 months version  (continued) 
 
 N Min Max Mean Std. Dev 
post bruising 254 3 5 4.85 .41 
post catheter point 254 4 5 4.94 .24 
post concern for bruises 254 3 5 4.84 .43 
Satisfaction       
post satisfaction about results 254 2 4 3.73 .50 
post satisfaction about operation info 254 1 4 3.45 .66 
post satisfaction about recovering info 254 1 4 3.53 .72 
post heart condition after operation 254 2 4 3.72 .38 
post recovery 254 1 4 3.60 .67 
post results from heart operation 254 1 4 3.41 .80 
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5.2.2 Descriptive Statistics for CABG items  per version  
 
Table 1. Descriptive statistics for CROQ-Gr CABG items of baseline version   
 N Min Max Mean S D 
Symptoms  
chest pain 146 2 5 3.05 .79 
discomfort 146 1 5 3.13 1.09 
shortness of breath 146 1 5 2.99 1.02 
angina radiates 146 1 5 3.63 .99 
palpitations 146 1 5 3.73 1.09 
sublingual  times per day 146 2 5 4.13 1.09 
troubles  146 1 5 2.92 .85 
Physical functioning  
moderate activities 146 1 3 1.98 .49 
lifting 146 1 3 1.96 .58 
climbing  two or more flight of stairs 146 1 3 1.64 .57 
climbing one flight of stairs  146 1 3 1.63 .68 
bending 146 1 3 1.83 .66 
walking  a km 146 1 3 1.64 .67 
walking 100 m 146 1 3 1.84 .58 
bathing 146 1 3 2.11 .58 
Psychosocial functioning  
overprotective environment 146 2 5 3.68 .79 
burden on others 146 2 5 4.11 .85 
restriction of social activities 146 2 5 4.08 .85 
go far from home 146 2 5 4.16 .84 
worried  about heart condition 146 2 5 3.42 .87 
worried about overdoing 146 2 5 3.71 1.03 
worried about sudden attack 146 2 5 3.84 .88 
frightened by pain 146 2 5 3.79 .93 
uncertain about future 146 1 5 3.66 1.01 
depressed 146 1 5 3.73 1.07 
frustrated / impatient 146 2 5 3.55 1.13 
enjoyment of life 146 2 5 3.92 1.01 
positive outlook of health 146 2 5 3.97 .95 
plan ahead 146 2 5 4.27 .91 
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Table 1. Descriptive statistics for CROQ-Gr CABG  items of baseline version   
 N Min Max Mean S D 
Cognitive functioning 
reasoning and solving problems 146 2 6 5.12 .76 
forget 146 2 6 4.95 .94 
concentration 146 3 6 5.01 .90 
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Table 2. Descriptive statistics for CROQ-Gr CABG items of post 3 months version   
Subdomain  N Min Max Mean S D 
Symptoms 
post chest pain 133 3 5 4.66 .53 
post discomfort 133 3 5 4.72 .51 
post shortness of breath 133 3 5 4.58 .51 
post angina radiates 133 3 5 4.85 .37 
post palpitations 133 3 5 4.93 .28 
post sublingual intake freq. 133 3 5 4.94 .28 
post troubles 133 3 5 4.55 .57 
Physical functioning 
post moderate activities 132 2 3 2.94 .24 
post lifting 132 2 3 2.86 .34 
post climbing two or more flights  132 1 3 2.60 .52 
post climbing one flight of stairs 132 1 3 2.62 .51 
post bending 132 2 3 2.84 .36 
post walking a km 132 1 3 2.67 .48 
post walking 100 m 132 2 3 2.77 .42 
post bathing 132 2 3 2.88 .32 
Psychosocial functioning 
post overprotective environment 132 2 5 3.73 .76 
post burden on others 132 3 5 4.52 .57 
post restriction of social activities 132 3 5 4.51 .67 
post go far from home 132 3 5 4.48 .68 
post worried  about heart cond 132 2 5 4.01 .79 
post worried about overdoing 132 3 5 4.64 .58 
post worried about sudden attack 132 3 5 4.48 .75 
post frightened by pain 132 2 5 4.36 .86 
post uncertain about future 132 2 5 4.54 .77 
post depressed 131 2 5 4.69 .66 
post frustrated / impatient 132 2 5 4.27 .89 
post enjoyment of life 132 2 5 4.26 .87 
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 Table 2. Descriptive statistics for CROQ-Gr CABG items of post 3 months version  
(continued) 
 N Min Max Mean S D 
post positive outlook of health 132 2 5 4.61 .67 
post plan ahead 129 2 5 4.73 .58 
Cognitive functioning 
post reasoning and solving problems 132 3 6 5.18 .91 
post forget 132 3 6 5.10 .98 
post concentration 132 3 6 5.31 .87 
Adverse effects 
croq.post.10a_cabg 132 2 5 4.01 .93 
croq.post.10b_cabg 131 2 5 4.42 .90 
croq.post.10c_cabg 132 1 5 3.55 1.06 
croq.post.10d_cabg 132 2 5 3.97 .87 
croq.post.10e_cabg 132 2 5 4.38 .81 
croq.post.10f_cabg 132 1 5 4.53 .83 
croq.post.10g_cabg 131 2 5 4.84 .50 
croq.post.10h_cabg 132 1 5 4.82 .62 
croq.post.10i_cabg 132 1 5 4.39 .93 
croq.post.10j_cabg 131 2 5 4.61 .63 
croq.post.10k_cabg 132 1 5 4.34 .85 
Satisfaction 
satisfaction about results 127 1 4 3.40 .78 
satisfaction about operation info 123 1 4 3.28 .88 
satisfaction about recovering info 117 1 4 3.19 .99 
post heart condition after operation 130 3 4 3.80 .33 
post recovery 129 1 4 2.62 1.15 
post results from heart operation 127 1 4 2.85 1.06 
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5.3  Zero-order item intercorrelations   
5.3.1  Zero-order item intercorrelations for PCI versions  
 
Table 1. Zero-order item intercorrelations for CROQ-Gr 
PCI pre revascularization (minimum-maximum) 
Scale Sym    Ph    Psy    Cogn   
Sym  0.12-0.75 0.04-0.41 0.04-0.21 0.02-0.11 
Ph   0.16-0.60 0.05-0.37 0.03-0.20 
Psy    0.56-0.77 0.01-0.25 
Cogn     0.85-0.91 
 
 
Table 2. Zero-order item intercorrelations for CROQ-Gr PCI post revascularization (minimum-
maximum) 
Scale Sym Ph Psy Cogn. Satisfaction Adverse effects 
Sym  0.15-0.46 0.13-0.36 0.03-0.36 0.01-0.32 0.02-0.29 0.01-0.26 
Ph   0.57-0.79 0.06-0.45 0.09-0.25 0.09-0.24 0.01-0.30 
Psy    0.38-0.72 0.06-0.29 0.07-0.36 0.07-0.32 
Cogn     0.72-0.79 0.04-0.13 0.01-0.23 
Satisfaction      0.56-0.82 0.11-0.38 
Adverse effects       0.62-0.85 
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5.3.2  Zero-order items’ intercorrelations for CABG versions  
 
 
 
Table 1. Zero-order item intercorrelations for CROQ-Gr CABG pre revascularization 
(minimum-maximum) 
Scale Sym    Ph    Psy    Cogn   
Sym (7 items) 0.20-0.59 0.03-0.40 0.02-0.40 0.02-0.40 
Ph 8 items - 0.33-0.69 0.07-0.35 0.07-0.25 
Psy 14 items - - 0.21-0.75 0.03-0.24 
Cogn. 3 items - - - 0.57-0.66 
Table 2.  Zero-order item intercorrelations for CROQ-Gr CABG post revascularization (minimum-maximum) 
Scale 1 2 3 4 5 6 7 
1. Sym (7 items) 0.12-0.60 0.03-0.46 0.02-0.33 0.05-0.23 0.11-0.62 0.02-0.60 0.01-0.38 
2. Ph (8 items)  0.26-0.84 0.01-0.37 0.01-0.26 0.03-0.36 0.01-0.23 0.01-0.34 
3. Psy (14 items)   0.21-0.73 0.01-0.21 0.04-0.35 0.04-0.49 0.04-0.47 
4. Cogn. (3 items)    0.74-0.90 0.02-0.42 0.06-0.47 0.16-0.52 
5. Satisfaction (6 items)     0.29-0.88 0.13-0.59 0.05-0.40 
6. Adverse effects (chest- 5items)      0.44-0.73 0.08-0.52 
7. Adverse effects (leg/arm- 6items)       0.45-0.81 
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7.1 Sample sizes for qualitative studies  
There are no specific set rules for determining the right sample size in qualitative studies 
(Baker, Edwards, & Doidge, 2012; Patton, 1990; Strauss, & Corbin, 2015; WHO, 2004). A 
number of scholars (e.g. Patton, 1990) suggest that qualitative sample size may be determined in 
relation to the time allotted, resources available and the study’s aims which guide the kind of 
qualitative analysis.  
However, it is generally accepted that the sample size for qualitative studies, although much 
smaller compared to quantitative studies, should be large enough to capture most possible 
perspectives. To accomplishing such a goal, saturation should be reached; saturation is present 
when adding more participants to the study does not result in gaining additional perspectives or 
information (Glaser, & Strauss, 1967). O’Reilly and Parker (2013), however argued that the 
concept of saturation in qualitative research and in particular in grounded theory “does not refer 
to the point at which no new ideas emerge, but rather means that categories are fully accounted 
for, the variability between them are explained and the relationships between them are tested and 
validated and thus a theory can emerge (p. 3). Nevertheless, various suggestions exist concerning 
sample size. For instance:  
Morse (1994) suggests for an ethnographic approach, approximately 30 - 50 participants, for 
grounded theory 30 - 50 interviews, and for phenomenological studies at least 6.   
Creswell (2014) suggests for a thematic or grounded theory a sample size of 20 – 30 while 
for phenomenological studies he recommends 5 to 25.  
Smith and Osborn (2003) suggest for an interpretative phenomenological analysis (IPA) 5-10 
participants. They argue that although the basic logic is to have a sample of approximately 15-20 
individuals, for IPA the danger of such large sample is that the researchers will be overwhelmed 
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by the vast amount of data generated and they will not be able to produce a sufficiently 
penetrating analysis. This actually is the reason that the majority of IPA studies published have 
very small number of participants (five or six). 
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7.2 Master table of themes  
1.  Modes of Patienthood: “Your psychology is everything” 
0.1. Experiencing the disease & its treatment: “it’s scary… many thoughts come to your mind” 
Confrontation  with the diagnosis & 
treatment     
“You get a fright… that’s exactly how you feel…“The doctor simply told 
me “don’t be scared, it’s nothing, it has become a routine operation 
now” [but] you don’t know, does this thing hurt?” 
Clinical interactions “Youngsters who were in their practical training” 
Receiving medical treatment          “The intensive care is a bit tiring… you can’t find peace and quiet 
Feeling helpless                               “looking at someone with terror… looking at him as if saying “I wonder 
how can you be alive” 
0.2. Living a post-CR life: “I have quality of life, but there are other things that you can’t amend” 
Defying patienthood                         “I don’t suppose it has affected my life… I don’t consider it a health 
problem ” 
Other concerns gaining primacy       “The sugar[diabetes] is troubling me more than the heart” 
Differences of stage of life                 “the operation hasn’t influenced my self-perception. The age maybe...” 
0.3. Search for understanding: “I had a lot of time to think about it… why…why all this 
happened  
Perception of disease causality             “It’s the stress… because I was a perfectionist, and my introversion” 
Self responsibility                                “The blame is all mine. It’s my fault, my wrong behavior brought us to 
this point…” 
2. The self in the body: “I am different person now” 
2.1.  Sensing the altered body:  “I feel different now… but sometimes it troubles me what tomorrow 
will bring” 
The body becomes visible “doesn’t say as used to do ” 
Fear of the unknown                             “but it’s the heart, I am afraid I may not …” 
2.2.  Experiencing a new me: “It's not that you do not stress yourself out but the intensity is 
different” 
Developing psychological self              “I am more relaxed… more distanced” 
My body-my self                                 “I don’t say we do the acrobatics but… we’re still young, our blood is 
warm ” 
3.  Self and others: “So what if they see it differently ... relax ... you cannot control everything” 
3.1.  You are alone: “and I was left alone, all alone” 
Being alone hurts                                  “I was very much hurt by the fact that I was alone”  
Feeling disappointed                                “Do you know what bothered me most? That they didn’t care to ask if 
my wife needed anything” 
3.2.  In need of support: “I felt as if they wanted to help” 
Receiving practical support                 “more on financial matters” 
What you really need                            “she took me on car trips, took me out for coffee… She really helped me 
a lot” 
3.3.  Changes in relating with others: “You should see things differently”  
Thinking in a different way                   “Why do I have to do everything?” 
Behaving in a different way                “The truth is, most of them (ex friends), I pushed them away” 
4. Towards living a good life: “Pull the sheet that blurs your mind” 
4.1. Positive Growth : If I didn’t go through this I wouldn’t realize… life is too short  
Increased appretiation of life  “Now I enjoy everything I do”  
Personal growth  “I am stronger now” 
Strengthening relationships  “I share quality time with my loved ones” 
4.2.  Strategies to regaining control: “I felt so good that I was alive …there are so many things that 
I would like to do” 
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Setting boundaries                                     “I just don’t get myself to do whatever he asks for ” 
Minimizing the impact of the disease  “It was nothing , it’s gone now ” 
Avoiding emotional expression                 “I can’t go on discussing the symptoms over and over again ” 
Using humor                                               “Greece has lost a sexy woman 
Making comparisons with others “I am better compared to him” 
4.3.  Challenges in living a new life style: “I want to change but…” 
Getting expert’s support                           “it would be useful if they gave you [medical] directives ”  
Persuading the self                                     “Just as the doctor had told me, I have to go walking, but I’m bored  
Quitting smoking                                       “we’ve given up far too many things now to quit smoking too ” 
